
<html lang="en"     class="pb-page"  data-request-id="04ddaa1b-7100-4aa4-9c8f-c49cbc19be5d"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;article:article:10.1021/acs.jmedchem.0c02063;issue:issue:10.1021/jmcmar.2021.64.issue-5;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator" /></meta><meta name="dc.Creator" content="Markus  Hartmann" /></meta><meta name="dc.Creator" content="Sofia-Iris  Bibli" /></meta><meta name="dc.Creator" content="Daniel  Tews" /></meta><meta name="dc.Creator" content="Xiaomin  Ni" /></meta><meta name="dc.Creator" content="Theresa  Kircher" /></meta><meta name="dc.Creator" content="Jan S.  Kramer" /></meta><meta name="dc.Creator" content="Whitney  Kilu" /></meta><meta name="dc.Creator" content="Jan  Heering" /></meta><meta name="dc.Creator" content="Victor  Hernandez-Olmos" /></meta><meta name="dc.Creator" content="Lilia  Weizel" /></meta><meta name="dc.Creator" content="Gerhard K. E.  Scriba" /></meta><meta name="dc.Creator" content="Sulaiman  Krait" /></meta><meta name="dc.Creator" content="Stefan  Knapp" /></meta><meta name="dc.Creator" content="Apirat  Chaikuad" /></meta><meta name="dc.Creator" content="Daniel  Merk" /></meta><meta name="dc.Creator" content="Ingrid  Fleming" /></meta><meta name="dc.Creator" content="Pamela  Fischer-Posovszky" /></meta><meta name="dc.Creator" content="Ewgenij  Proschak" /></meta><meta name="dc.Description" content="The metabolic syndrome (MetS) is a constellation of cardiovascular and metabolic symptoms involving insulin resistance, steatohepatitis, obesity, hypertension, and heart disease, and patients suffe..." /></meta><meta name="Description" content="The metabolic syndrome (MetS) is a constellation of cardiovascular and metabolic symptoms involving insulin resistance, steatohepatitis, obesity, hypertension, and heart disease, and patients suffe..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="February 23, 2021" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.0c02063" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2021 The Authors. Published by American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02063" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.0c02063" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.0c02063" /></link>
        
    
    

<title>Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.0c02063" /></meta><meta property="og:title" content="Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0011.jpeg" /></meta><meta property="og:description" content="The metabolic syndrome (MetS) is a constellation of cardiovascular and metabolic symptoms involving insulin resistance, steatohepatitis, obesity, hypertension, and heart disease, and patients suffering from MetS often require polypharmaceutical treatment. PPARγ agonists are highly effective oral antidiabetics with great potential in MetS, which promote adipocyte browning and insulin sensitization. However, the application of PPARγ agonists in clinics is restricted by potential cardiovascular adverse events. We have previously demonstrated that the racemic dual sEH/PPARγ modulator RB394 (3) simultaneously improves all risk factors of MetS in vivo. In this study, we identify and characterize the eutomer of 3. We provide structural rationale for molecular recognition of the eutomer. Furthermore, we could show that the dual sEH/PPARγ modulator is able to promote adipocyte browning and simultaneously exhibits cardioprotective activity which underlines its exciting potential in treatment of MetS." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.0c02063"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02063">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.0c02063&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.0c02063&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.0c02063&amp;href=/doi/10.1021/acs.jmedchem.0c02063" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2021</span><span class="cit-fg-volume">, 64</span><span class="cit-fg-issue">, 5</span><span class="cit-fg-pageRange">, 2815-2828</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/64/5" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.0c02000" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/acs.jmedchem.0c02234" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Markus Hartmann</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Markus Hartmann</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Markus++Hartmann">Markus Hartmann</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sofia-Iris Bibli</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sofia-Iris Bibli</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, D-60596 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sofia-Iris++Bibli">Sofia-Iris Bibli</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Tews</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Tews</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, D-89075 Ulm, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Tews">Daniel Tews</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaomin Ni</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaomin Ni</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaomin++Ni">Xiaomin Ni</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Theresa Kircher</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Theresa Kircher</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Theresa++Kircher">Theresa Kircher</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jan S. Kramer</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jan S. Kramer</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jan+S.++Kramer">Jan S. Kramer</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Whitney Kilu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Whitney Kilu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Whitney++Kilu">Whitney Kilu</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Jan Heering</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Jan Heering</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Jan++Heering">Jan Heering</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4922-1993" title="Orcid link">http://orcid.org/0000-0002-4922-1993</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Victor Hernandez-Olmos</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Victor Hernandez-Olmos</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Victor++Hernandez-Olmos">Victor Hernandez-Olmos</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Lilia Weizel</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Lilia Weizel</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Lilia++Weizel">Lilia Weizel</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Gerhard K. E. Scriba</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Gerhard K. E. Scriba</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Friedrich Schiller University Jena, Philosophenweg 14, D-07743 Jena, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Gerhard+K.+E.++Scriba">Gerhard K. E. Scriba</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2950-060X" title="Orcid link">http://orcid.org/0000-0003-2950-060X</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Sulaiman Krait</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sulaiman Krait</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Department of Pharmaceutical/Medicinal Chemistry, Friedrich Schiller University Jena, Philosophenweg 14, D-07743 Jena, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sulaiman++Krait">Sulaiman Krait</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Stefan Knapp</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Stefan Knapp</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div><div class="loa-info-affiliations-info">Buchmann Institute for Molecular Life Sciences, Goethe University, Max-von-Laue-Strasse 15, D-60438 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Knapp">Stefan Knapp</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5995-6494" title="Orcid link">http://orcid.org/0000-0001-5995-6494</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Apirat Chaikuad</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Apirat Chaikuad</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div><div class="loa-info-affiliations-info">Buchmann Institute for Molecular Life Sciences, Goethe University, Max-von-Laue-Strasse 15, D-60438 Frankfurt, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Apirat++Chaikuad">Apirat Chaikuad</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1120-2209" title="Orcid link">http://orcid.org/0000-0003-1120-2209</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Daniel Merk</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Daniel Merk</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Daniel++Merk">Daniel Merk</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5359-8128" title="Orcid link">http://orcid.org/0000-0002-5359-8128</a></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Ingrid Fleming</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ingrid Fleming</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute for Vascular Signalling, Centre for Molecular Medicine, Goethe University, D-60596 Frankfurt am Main, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ingrid++Fleming">Ingrid Fleming</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Pamela Fischer-Posovszky</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Pamela Fischer-Posovszky</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Division of Pediatric Endocrinology and Diabetes, Department of Pediatrics and Adolescent Medicine, Ulm University Medical Centre, D-89075 Ulm, Germany</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Pamela++Fischer-Posovszky">Pamela Fischer-Posovszky</a></span></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Ewgenij Proschak</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Ewgenij Proschak</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Institute of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</div><div class="loa-info-affiliations-info">Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany</div></div><span class="conrtib-corresp"><strong>*</strong>Email, <a href="/cdn-cgi/l/email-protection#0474766b77676c656f44746c657669676c61692a716a6d296276656a6f627176702a6061"><span class="__cf_email__" data-cfemail="5e2e2c312d3d363f351e2e363f2c333d363b33702b303773382c3f3035382b2c2a703a3b">[email protected]</span></a></span><span class="conrtib-corresp"></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Ewgenij++Proschak">Ewgenij Proschak</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1961-1859" title="Orcid link">http://orcid.org/0000-0003-1961-1859</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02063&amp;href=/doi/10.1021%2Facs.jmedchem.0c02063" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2021</span></span><span class="cit-volume">, 64</span><span class="cit-issue">, 5</span><span class="cit-pageRange">, 2815–2828</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">February 23, 2021</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 December 2020</li><li><span class="item_label"><b>Published</b> online</span>23 February 2021</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 11 March 2021</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.0c02063" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.0c02063</a></div><div class="article_header-article-copyright"><strong>Copyright © 2021 The Authors. Published by American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D2815%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMarkus%2BHartmann%252C%2BSofia-Iris%2BBibli%252C%2BDaniel%2BTews%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D64%26issueNum%3D5%26contentID%3Dacs.jmedchem.0c02063%26title%3DCombined%2BCardioprotective%2Band%2BAdipocyte%2BBrowning%2BEffects%2BPromoted%2Bby%2Bthe%2BEutomer%2Bof%2BDual%2BsEH%252FPPAR%25CE%25B3%2BModulator%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D2828%26publicationDate%3DMarch%2B2021">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.0c02063"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">613</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val">-</div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.0c02063" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Combined Cardioprotective and Adipocyte Browning Effects Promoted by the Eutomer of Dual sEH/PPARγ Modulator&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Markus&quot;,&quot;last_name&quot;:&quot;Hartmann&quot;},{&quot;first_name&quot;:&quot;Sofia-Iris&quot;,&quot;last_name&quot;:&quot;Bibli&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Tews&quot;},{&quot;first_name&quot;:&quot;Xiaomin&quot;,&quot;last_name&quot;:&quot;Ni&quot;},{&quot;first_name&quot;:&quot;Theresa&quot;,&quot;last_name&quot;:&quot;Kircher&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;S. Kramer&quot;},{&quot;first_name&quot;:&quot;Whitney&quot;,&quot;last_name&quot;:&quot;Kilu&quot;},{&quot;first_name&quot;:&quot;Jan&quot;,&quot;last_name&quot;:&quot;Heering&quot;},{&quot;first_name&quot;:&quot;Victor&quot;,&quot;last_name&quot;:&quot;Hernandez-Olmos&quot;},{&quot;first_name&quot;:&quot;Lilia&quot;,&quot;last_name&quot;:&quot;Weizel&quot;},{&quot;first_name&quot;:&quot;Gerhard&quot;,&quot;last_name&quot;:&quot;K. E. Scriba&quot;},{&quot;first_name&quot;:&quot;Sulaiman&quot;,&quot;last_name&quot;:&quot;Krait&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Knapp&quot;},{&quot;first_name&quot;:&quot;Apirat&quot;,&quot;last_name&quot;:&quot;Chaikuad&quot;},{&quot;first_name&quot;:&quot;Daniel&quot;,&quot;last_name&quot;:&quot;Merk&quot;},{&quot;first_name&quot;:&quot;Ingrid&quot;,&quot;last_name&quot;:&quot;Fleming&quot;},{&quot;first_name&quot;:&quot;Pamela&quot;,&quot;last_name&quot;:&quot;Fischer-Posovszky&quot;},{&quot;first_name&quot;:&quot;Ewgenij&quot;,&quot;last_name&quot;:&quot;Proschak&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2021&quot;,&quot;month&quot;:&quot;02&quot;,&quot;day&quot;:&quot;23&quot;,&quot;issue&quot;:&quot;5&quot;,&quot;volume&quot;:&quot;64&quot;,&quot;pages&quot;:&quot;2815-2828&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.0c02063&quot;},&quot;abstract&quot;:&quot;The metabolic syndrome (MetS) is a constellation of cardiovascular and metabolic symptoms involving insulin resistance, steatohepatitis, obesity, hypertension, and heart disease, and patients suffering from MetS often require polypharmaceutical treatment. PPARγ agonists are highly effective oral antidiabetics with great potential in MetS, which promote adipocyte browning and insulin sensitization. However, the application of PPARγ agonists in clinics is restricted by potential cardiovascular adverse events. We have previously demonstrated that the racemic dual sEH/PPARγ modulator RB394 (3) simultaneously improves all risk factors of MetS in vivo. In this study, we identify and characterize the eutomer of 3. We provide structural rationale for molecular recognition of the eutomer. Furthermore, we could show that the dual sEH/PPARγ modulator is able to promote adipocyte browning and simultaneously exhibits cardioprotective activity which underlines its exciting potential in treatment of MetS.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02063&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02063" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02063&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02063" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.0c02063&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02063" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.0c02063&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.0c02063&amp;href=/doi/10.1021/acs.jmedchem.0c02063" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.0c02063" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.0c02063" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.0c02063&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.0c02063%26sid%3Dliteratum%253Aachs%26pmid%3D33620196%26genre%3Darticle%26aulast%3DHartmann%26date%3D2021%26atitle%3DCombined%2BCardioprotective%2Band%2BAdipocyte%2BBrowning%2BEffects%2BPromoted%2Bby%2Bthe%2BEutomer%2Bof%2BDual%2BsEH%252FPPAR%25CE%25B3%2BModulator%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D64%26issue%3D5%26spage%3D2815%26epage%3D2828%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (2)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291137" title="Lipids">Lipids</a>,</li><li><a href="/action/doSearch?ConceptID=292589" title="Agonists">Agonists</a>,</li><li><a href="/action/doSearch?ConceptID=291793" title="Inhibition">Inhibition</a>,</li><li><a href="/action/doSearch?ConceptID=292178" title="Organic compounds">Organic compounds</a>,</li><li><a href="/action/doSearch?ConceptID=292444" title="Molecular structure">Molecular structure</a>,</li><li><a href="/action/doSearch?ConceptID=291070" title="Pharmaceuticals">Pharmaceuticals</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/64/5" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/jmcmar.2021.64.issue-5/20210311/jmcmar.2021.64.issue-5.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">The metabolic syndrome (MetS) is a constellation of cardiovascular and metabolic symptoms involving insulin resistance, steatohepatitis, obesity, hypertension, and heart disease, and patients suffering from MetS often require polypharmaceutical treatment. PPARγ agonists are highly effective oral antidiabetics with great potential in MetS, which promote adipocyte browning and insulin sensitization. However, the application of PPARγ agonists in clinics is restricted by potential cardiovascular adverse events. We have previously demonstrated that the racemic dual sEH/PPARγ modulator RB394 (<b>3</b>) simultaneously improves all risk factors of MetS in vivo. In this study, we identify and characterize the eutomer of <b>3</b>. We provide structural rationale for molecular recognition of the eutomer. Furthermore, we could show that the dual sEH/PPARγ modulator is able to promote adipocyte browning and simultaneously exhibits cardioprotective activity which underlines its exciting potential in treatment of MetS.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41424" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41424" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The metabolic syndrome (MetS) is a multifactorial pathological condition and defined as a constellation of cardiovascular and metabolic symptoms involving insulin resistance, steatohepatitis, obesity, hypertension, and heart disease. MetS or syndrome X has become a global epidemic, with an estimated prevalence of 20–27% in developing countries. MetS has its origin in central obesity and consists of four major risk factors: type II diabetes (T2D), dyslipidemia, heart disease, and hypertension.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Although safe therapeutics are available to treat each single risk factor, management of MetS often results in polypharmaceutical treatment regimes, with poor compliance, drug–drug interactions, and insufficient therapeutic success.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Therefore, multitarget therapeutic options which either treat multiple risk factors of the metabolic syndrome or increase the efficacy of the current therapeutic options are in the focus of current research.<a onclick="showRef(event, 'ref3 ref4 ref5 ref6'); return false;" href="javascript:void(0);" class="ref ref3 ref4 ref5 ref6">(3−6)</a></div><div class="NLM_p">The incidence of MetS often parallels the incidence of obesity and incidence of type 2 diabetes (one of the outcomes of MetS). In this metabolic derangement, peroxisome proliferator-activated receptors (PPARs), i.e., nuclear receptors involved in the regulation of metabolic homeostasis, represent a valuable therapeutic target. PPAR activators have provided significant benefit in patients with primary hypertriglyceridemia (i.e., fibrates and omega-3 fatty acids, both PPARα agonists), as well as in cases of mixed hyperlipidemias with raised  triglycerides (TGs) and low high density lipoprotein (HDL-C). Conversely, PPAR-γ activators have become drugs of choice in T2D. PPAR agonists are generally recognized as effective pharmacological tools for the management of MetS.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> Activation of PPARγ leads to multimodal insulin sensitization, including increased glucose uptake by muscle cells, decreased lipolysis and hepatic glucose production, and improved insulin secretion.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a> Designed multitarget ligands that address PPARγ as one of the targets offer a valuable option to fully utilize the beneficial effects of PPARγ activation.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> The combination of PPARγ modulation with inhibition of the soluble epoxide hydrolase (sEH) is a promising designed multitarget ligand (DML) approach to treat MetS. sEH, encoded by the EPHX2 gene, converts polyunsaturated fatty acid epoxides—such as the epoxy eicosatrienoic acids (EETs) to the corresponding dihydroxy eicosatrienoic acids (DHETs). Elevated EET levels resulting from sEH inhibition alleviate symptoms of MetS in vivo.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Furthermore, treatment with glitazones is restricted due to black box heart failure warning,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> which is, however, controversially discussed in the literature.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> Nevertheless, the underlying molecular mechanism for water retention and edema caused by glitazones is well-investigated and is caused by the stimulation of epithelial sodium channel (ENaC)-mediated renal salt reabsorption.<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> ENaC stimulation can be suppressed by sEH inhibition and subsequent accumulation of EETs.<a onclick="showRef(event, 'ref13 ref14'); return false;" href="javascript:void(0);" class="ref ref13 ref14">(13,14)</a> Treatment of hypertensive and diabetic rats with <b>1</b> (TPPU, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), an sEH inhibitor, exhibited pronounced cardioprotective effects in hearts ex vivo<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and reversed cardiac dysfunction in the high-fructose diet rat model of metabolic syndrome.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Taken together, a pronounced crosstalk between PPARγ and sEH signaling has been demonstrated in multiple disease models,<a onclick="showRef(event, 'ref17 ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref17 ref18 ref19">(17−19)</a> suggesting synergistic efficacy and safety of a DML targeting both proteins simultaneously. This assumption could be confirmed by the combination of the PPARγ agonist <b>2</b> (rosiglitazone, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>) and sEH inhibitor in the spontaneously hypertensive obese rat (SHROB) model of MetS.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selective sEH inhibitor <b>1</b>, selective PPARγ agonist <b>2</b>, and dual sEH/PPARγ modulator <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Inspired by the promising results of the combination therapy, we developed an <i>N</i>-benzyl benzamide based DML <b>3</b> (RB394, <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>), which is able to activate PPARγ and simultaneously inhibit sEH at submicromolar concentrations.<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> Application of <b>3</b> in SHROB and ZSF-1 rat models of MetS led to improvement of diabetes, hypertension, and dyslipidemia as well as kidney and liver fibrosis.<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> In this study, we provide evidence that incorporation of sEH inhibitory activity into a PPARγ agonist retains the beneficial metabolic effects while making the compound cardioprotective. Thus, DMLs targeting sEH and PPARγ simultaneously might be an interesting option for treatment of metabolic disorders in context of MetS.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_68600" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_68600" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i4" class="anchor-spacer"></div><h3 class="article-section__title" id="_i4"> Chemistry</h3><div class="NLM_p">The synthetic procedure to the enatiomers of <b>3</b> was inspired by Namura et al., who reported on efficient enantioselective synthesis of PPARα agonists using chiral Evans oxazolidinone auxiliar.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Synthesis commenced with 4-formylbenzoic acid <b>4</b>, which was esterified to benzyl ester <b>5</b>, followed by sodium borohydride mediated reduction of the formyl group to the corresponding alcohol <b>6</b>. After conversion of <b>6</b> to benzyl bromide <b>7</b> with phosphorus tribromide, <b>7</b> was coupled to the butanoic acid Evans auxiliar adduct <b>9</b> in an asymmetric alkylation reaction, leading to <b>10</b>. The benzyl protecting group of the intermediate <b>10</b> was subsequently cleaved by hydrogenolysis and the resulting free acid <b>11</b> was coupled to 4-methoxy-2-(trifluoromethyl) benzyl amine (<a class="ref internalNav" href="#sch1" aria-label="Scheme 1">Scheme 1</a>). Alkaline/oxidative cleavage of the Evans auxiliar produced the (<i>R</i>)-<b>3</b> and (<i>S</i>)-<b>3</b> enantiomers, respectively.</div><figure id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0010.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1.0 equiv BnBr, 1.0 equiv Cs<sub>2</sub>CO<sub>3</sub>, DMF abs, rt, 3 h, 91%; (b) 1.0 equiv NaBH<sub>4</sub>, MeOH, 0 °C, 16 h, 71%; (c) 1.0 equiv PBr<sub>3</sub>, THF abs, 0 °C → rt, 3 h, 83%; (d) 1.0 equiv <i>n</i>-BuLi, 1.1 equiv butyryl chloride, −78 °C, 30 min, 94%; (e) 1.1 equiv NaHMDS, 1.5 equiv <b>7</b>, THF abs, −78 °C, 67%; (f) Pd/C, 5 bar H<sub>2</sub>, MeOH, 5 h, rt, 76–86%; (g) 1.0 equiv <b>11</b>, 1.5 equiv HBTU, 1.5 equiv EDC × HCl, 6.0 equiv <i>N</i>-methylmorpholine, 1.1 equiv 4-methoxy-2-(trifluoromethyl)benzylamine, rt, 16 h, 75–84%; (h) 8.0 equiv H<sub>2</sub>O<sub>2</sub>, 2.0 equiv LiOH, THF:H<sub>2</sub>O (3:1 v/v), rt, 16 h, 87–92%.</p></p></figure><div class="NLM_p">To determine the enantiomeric excess of the enantioselective synthesis, an enantioselective capillary electrophoresis method has been developed. Enantioseparation was achieved in a fused silica capillary using a 100 mM sodium acetate buffer, pH 5.0, containing 35 mg/mL hydroxypropyl-α-cyclodextrin as background electrolyte at an applied voltage of 20 kV. Enantiomeric excess of (<i>R</i>)-<b>3</b> was determined as 98% ee, while (<i>S</i>)-<b>3</b> could be obtained in 97% ee (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_001.pdf" class="ext-link">Supporting Information</a>). The CD spectra of both compounds are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>.</div><figure id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0002.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CD spectra of the enantiomers (<i>R</i>)-<b>3</b> and (<i>S</i>)-<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i5" class="anchor-spacer"></div><h3 class="article-section__title" id="_i5"> In Vitro Identification of the Eutomer</h3><div class="NLM_p">To identify the eutomer, we subjected both enantiomers of <b>3</b> to in vitro assays with both targets. In the case of PPARγ, we performed a homogeneous time resolved FRET (HTRF) cofactor recruitment assay, using a CBP (CREB-binding protein) derived peptide coupled to Tb cryptate as FRET donor and PPARγ LBD, expressed as a fusion protein with N-terminal superfolder GFP (sGFP).<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> Rosiglitazone <b>2</b> potently induced the recruitment of CBP peptide with an EC<sub>50</sub> of 0.083 μM. (<i>R</i>)-<b>3</b> also promoted cofactor recruitment with a slightly diminished upper plateau of the HTRF signal and an EC<sub>50</sub> of 0.27 μM. (<i>S</i>)-<b>3</b> exhibited markedly lower recruitment efficiency as well as a reduced EC<sub>50</sub> of 5.2 μM (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>A). The inhibitory activity toward sEH was investigated using a fluorescence-based activity assay. TPPU <b>1</b> potently inhibited sEH hydrolase activity with an IC<sub>50</sub> of 0.013 μM, while both enantiomers of <b>3</b> exhibited almost equal potency ((<i>S</i>)-<b>3</b>, IC<sub>50</sub> = 0.24 μM; (<i>R</i>)-<b>3</b>, IC<sub>50</sub> = 0.2 μM; <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>B).</div><figure id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0003.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>3</b> promotes PPARγ cofactor recruitment (A) and inhibits sEH in vitro (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6"> Structural Analysis</h3><div class="NLM_p">To rationalize the experimental observations on the enantiomers of <b>3</b>, crystallographic analysis of (<i>R</i>)-<b>3</b> in complex with both sEH and PPARγ was performed (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>). The X-ray structure of (<i>R</i>)-<b>3</b> in complex with the C-terminal hydrolase domain of sEH revealed binding to the catalytic center. Thereby, the amide moiety acts as an epoxide mimetic and exhibits directed hydrogen bond interactions toward Y383, Y466, and D335. The carboxylate moiety is engaged in one hydrogen bond interaction toward backbone NH. The stereogenic α-carbon of (<i>R</i>)-<b>3</b> as well as the ethyl residue are pointing out into a wide hydrophobic tunnel. This observation fits to the equipotent inhibitory potency of both enantiomers toward sEH.</div><figure id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0004.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structures of (<i>R</i>)-<b>3</b> in complex with sEH (A) and PPARγ (C). Electron density maps contoured at 1σ for the bound ligand are shown in the right panel (B + D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In contrast, the X-ray structure of (<i>R</i>)-<b>3</b> in complex with PPARγ LBD reveals tight engagement of the carboxylate moiety into directed hydrogen bond interactions toward S289, H323, Y473, and H449. These interactions can be considered as canonical for full agonists of PPARγ. The α-ethyl substituent is tightly enclosed in a small hydrophobic pocket (<a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a>C, orange). Thereby, (<i>S</i>)-<b>3</b> would not be able to fit the hydrophobic pocket in a similar fashion, which explains its weaker activity and efficacy.</div><div class="NLM_p">Most interestingly, our observations on the enantiomeric preference of the <i>R</i>-enantiomer are in complete contrast to the studies on pan-PPAR agonists TIPP-703 by Oyama et al.<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a> and Kuwabara et al.<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> Compound <b>13</b> (TIPP-703) and related compounds were more active in their <i>S</i>-configuration. The reason for this can be found in the superposition of the X-ray structures (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). The carboxylate moiety of <b>13</b> is further away from the interacting key residues S289, H323, Y473, and H449. The cocrystal structure of <b>13</b> reveals a movement of F363, which liberates more space in the lipophilic pocket adjacent to the α-position. The structural reason for the induced movement of F363 is speculative, one reason could be the interactions of the butoxy moiety which pull the acidic group of <b>13</b> away from the helix 12.</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0005.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural comparison of PPARγ between (<i>R</i>)-<b>3</b> (cyan) bound and TIPP-703 bound (salmon stick) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VJI">3VJI</a>)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7"> Cellular Effects</h3><div class="NLM_p">In vitro experiments indicated that (<i>R</i>)-<b>3</b> is the eutomer of the racemate <b>3</b> considering PPARγ activation, while sEH inhibition can be achieved using almost equal concentrations of both enantiomers. We subjected both enantiomers as well as the racemate to the cell-based reporter gene assay using a Gal4-DBD-PPARγ-LBD chimera (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>A). Indeed, the racemate <b>3</b> and (<i>R</i>)-<b>3</b> potently promoted the induction of luciferase reporter gene with EC<sub>50</sub> values of 0.39 and 0.40 μM, respectively. The distomer (<i>S</i>)-<b>3</b> displayed a much weaker fold-activation with EC<sub>50</sub> of 2.5 μM. The fact that maximum fold activation of the racemate is lower than (<i>R</i>)-<b>3</b> supports the assumption that (<i>S</i>)-<b>3</b> acts as a partial PPARγ agonist, which competes with the eutomer (<i>R</i>)-<b>3</b>.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0006.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>3</b> promotes reporter gene expression in Gal4-chimera assays. (A) (<i>R</i>)-<b>3</b> is acting as full agonist of PPARγ, while (<i>S</i>)-<b>3</b> exhibits partial agonistic activity. (B) (<i>R</i>)-<b>3</b> selectively activates PPARγ but not other nuclear receptors at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">We also investigated the selectivity of (<i>R</i>)-<b>3</b> toward selected nuclear receptors at a fixed concentration of 10 μM in a reporter gene assay panel (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>B). (<i>R</i>)-<b>3</b> weakly activated PPARα, and other tested receptors were not activated. Similar compounds developed by Nomura et al. were potent PPARα agonists, however, only in the (<i>S</i>)-configuration.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> In agreement with our results, (<i>R</i>)-configured propionic acid derivatives displayed only weak PPARα activation.</div><div class="NLM_p">The next task was the analysis of both enantiomers in a cellular system with endogeneous expression of PPARγ. To this end, we used the human Simpson–Golabi–Behmel syndrome (SGBS) preadipocyte cell strain.<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> SGBS cells are a model system for human adipocyte biology and characterized by a high capacity to PPARγ-induced adipogenesis<a onclick="showRef(event, 'ref29 ref30'); return false;" href="javascript:void(0);" class="ref ref29 ref30">(29,30)</a> and also express EPHX2 (data not shown).</div><div class="NLM_p">SGBS cells were subjected to adipogenic differentiation in the presence of increasing doses of the PPARγ agonist <b>2</b>, (<i>R</i>)-<b>3</b>, and (<i>S</i>)-<b>3</b>. Upon morphological inspection, we observed the formation of intracellular lipid droplets after treatment with all three substances (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>). A Nile red staining to quantify lipid accumulation revealed that (<i>R</i>)-<b>3</b> potently activates PPARγ, while (<i>S</i>)-<b>3</b> is less active. Comparable results underlining the divergent potency of (<i>R</i>)-<b>3</b> and (<i>S</i>)-<b>3</b> were obtained when measuring the mRNA expression of adipogenic marker genes, i.e., PPARγ itself but also perilipin, a lipid droplet-associated protein only expressed in mature adipocytes (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).</div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0007.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>3</b> promotes adipogenic differentiation of SGBS cells. SGBS cells were subjected to adipogenic differentiation in the in the presence of <b>2</b>, (<i>R</i>)-<b>3</b>, and (<i>S</i>)-<b>3.</b> (A) Representative microphotographs of cell cultures. Adipogenic differentiation was further assessed by intracellular lipid staining using Nile red (B) and mRNA expression of perilipin A (PLIN) (C). Mean values + SEM of <i>n</i> = 3 independent experiments are shown. Two-way ANOVA (vs vehicle control), *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Upon chronic cold exposure, white adipose tissue (WAT) can partially convert into thermogenic, beige adipose tissue, which shares main similarities with classical brown adipose tissue (BAT). This process is commonly referred to as browning and is associated with improved glucose and lipid metabolism in mice.<a onclick="showRef(event, 'ref200'); return false;" href="javascript:void(0);" class="ref ref200">(31)</a> Thus, the induction of browning in white adipocytes might lead to metabolic benefits. PPARγ activation leads to browning of white adipocytes in vitro.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> We thus investigated whether <b>3</b> could also induce a white-to-brown transition in SGBS cells (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>). As expected, incubation of SGBS cells with rosiglitazone during the first 4 days of adipogenic differentiation resulted in an induction of uncoupling protein-1 (UCP1) expression in mature adipocytes. (<i>R</i>)-<b>3</b> also induced UCP1 but at higher concentrations, while (<i>S</i>)-<b>3</b> had a lower effect. Also expected, the mRNA expression of the mitochondrial marker UQCRC2 (Ubiquinol-cytochrome C reductase core protein 2), a subunit of the respiratory chain complex III showed a comparable expression pattern with a dose-dependent upregulation induced by rosiglitazone and to a weaker extent (<i>R</i>)-<b>3</b> and again weaker, (<i>S</i>)-<b>3</b>.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0008.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>3</b> induces browning in human white adipocytes. SGBS cells were differentiated into adipocytes in the presence of increasing concentrations of <b>2</b>, (<i>R</i>)-<b>3</b>, and (<i>S</i>)-<b>3</b>. Expression of the brown adipocyte marker uncoupling protein 1 (UCP1, A), and the mitochondrial marker UQCRC2 (B) was determined by qRT-PCR. Cellular respiration in the presence of dibutyryl-cAMP was determined using a plate-based respirometer (C–E). Basal (C), ATP-linked/oligomycin-sensitve (D), and proton leak/oligomycin-insensitive (E) respiration was calculated from the data before and after oligomycin injection. Mean values + SEM of <i>n</i> = 3 independent experiments are shown. Two-way ANOVA (vs vehicle control), *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Next, we determined the respiratory activity in these cells to find out if the increased expression of UCP1 had a functional impact and uncoupled the electron transport chain. To induce the release of fatty acids, the physiological inducer of UCP1, cAMP was added to the cultures. (<i>R</i>)-<b>3</b> increased the level of basal respiration as well as ATP-linked and proton leak respiration, although to a lesser extent than rosiglitazone but stronger than (<i>S</i>)-<b>3</b>. These data indicate that (<i>R</i>)-<b>3</b> is able to induce browning in human adipocytes.</div></div><div id="sec2_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Cardioprotective Effects in ex Vivo Model</h3><div class="NLM_p">PPARγ agonism combined with soluble epoxide hydrolase (sEH) antagonism shows the potential for a beneficial outcome in terms of macrovascular events. Manipulation of sEH activity per se has been shown to exert cardioprotective functions. In particular, deletion of the sEH improved coronary reactive hyperemia (CRH),<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a> while the elevated levels of EETs observed in the sEH depleted mice<a onclick="showRef(event, 'ref31 ref32'); return false;" href="javascript:void(0);" class="ref ref31 ref32">(32,33)</a> have been linked to cardioprotective effects after myocardial ischemia/reperfusion injury.<a onclick="showRef(event, 'ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref33 ref34">(34,35)</a> Herein, we sought to investigate whether the combination of sEH inhibition and PPARγ activation affects cardiac function in response to reactive hyperemia and global no-flow ischemia induced in isolated murine hearts. To choose the appropriate dose of the novel dual sEH/PPARγ modulator (<i>R</i>)-<b>3</b>, we compared it with the widely used sEH inhibitor (<i>trans</i>-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid (t-AUCB).<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(36,37)</a> Initially, we performed a concentration response for the administration of (<i>R</i>)-<b>3</b>. Interestingly, bolus administration of either t-AUCB or (<i>R</i>)-<b>3</b> at a concentration of 300 nM or 30 nM increased the beating rate of the isolated hearts. As such an effect was not observed at a dose of 3 nM further experiments used this concentration but as a continuous infusion (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>A). The proposed concentration was able to alter the ratio of the 14,15 EET/14,15 DHET 15 min postapplication and achieved approximately 70% of the levels detected in the effluents of sEH–/– hearts (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>B). Subsequently, we evaluated the effects of sEH inhibition in the coronary vascular function. As ex vivo hearts possess limited coronary vascular reserve and responses to vasodilators are poorly suited to study coronary function, we evaluated the effects of sEH inhibition on reactive hyperemia. During CRH, blood flow increases transiently in response to ischemia or interruption of blood supply,<a onclick="showRef(event, 'ref37'); return false;" href="javascript:void(0);" class="ref ref37">(38)</a> and is associated with coronary vasodilation in response to cessation in coronary perfusion. The increase in blood flow associated with CRH increases repayment volume (RV) to prevent injury due to ischemia, therefore it is considered as a protective mechanism. sEH deletion or PPARγ agonism (with rosiglitazone) have been linked to increased repayment volume.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a> In addition, rosiglitazone enhances the CRH in the sEH depleted mice.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a> sEH deletion increased repayment volume by 28.57%. Inhibition of sEH with t-AUCB exerted similar effects. Simultaneous manipulation of sEH and PPARγ with (<i>R</i>)-<b>3</b> was more effective at increasing repayment volume by 85.7% after 15 s of coronary occlusion. Addition of (<i>R</i>)-<b>3</b> in sEH–/– hearts potentiated the effect by 64.4% (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>C,D). Finally, we tested the capacity of (<i>R</i>)-<b>3</b> to affect the outcome of acute myocardial infarction. Infarcted area was visualized following 20 min of global no-flow ischemia and 2 h of reperfusion. sEH inhibition exhibited cardioprotective effects which were further potentiated (by 4.2%) after dual inhibition of sEH and activation of PPARγ with (<i>R</i>)-<b>3</b> (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>E). Interestingly, although sEH inhibition improved left heart function, (<i>R</i>)-<b>3</b> with its additional PPARγ activation elicited better results as indicated by the increase in left ventricular developed pressure (LVDP, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>F) and decrease in left ventricular end diastolic pressure (LVEDP, <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>G), 20 min after global ischemia compared to the solvent treated isolated hearts. Taken together, these data indicate that single sEH inhibition or deletion suffice to increase the repayment volume and reduce the myocardial infarct size. However, (<i>R</i>)-<b>3</b> potentiates the cardioprotective effects and in particular the left heart function achieved by the manipulation of PPARγ.</div><figure id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0009.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of (<i>R</i>)-<b>3</b> in heart function. (A) Heart rate of perfused hearts treated with solvent alone (DMSO), or the indicated concentrations of t-AUCB and (<i>R</i>)-<b>3</b>. (B) 14,15 EET/DHET ratio in the perfusates of hearts under basal conditions (before drug application) and 15 min following 3 nM circulating application of the compounds. WT and sEH–/– were used. (C) Coronary flow tracing following 15 s of occlusion in isolated hearts treated with solvent, t-AUCB, and (<i>R</i>)-<b>3</b> with 3 nmol/L 15 min prior to occlusion in WT or sEH–/– hearts. (D) Repayment volume in 1 min in hearts as in (C). (E) Infarct sizes of isolated wild-type and sEH<sup>–/–</sup> hearts after ischemia/reperfusion injury. Infarct sizes were visualized by TTC staining (lower panel; infarct areas are presented discolored) and the ratio of the infarcted areas relative to the whole myocardial areas is presented as %. <i>n</i> = 5 per group; ***<i>p</i> < 0.001. (F) Left ventricular developed pressure (LVDP) and (G) left ventricular end diastolic pressure (LVEDP) in perfused hearts from WT mice treated as in (C) <i>n</i> = 4–6/group. One- or Two-Way ANOVA (Bonferroni), *<i>p</i> < 0.5, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27428" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27428" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">In the present study, we demonstrated that (<i>R</i>)-<b>3</b> is the eutomer of compound <b>3</b> (RB394) considering PPARγ activation, while sEH is potently inhibited by both enantiomers of <b>3</b>. Structural analysis provides the rationale for enantiomer preference. Our observations made in SGBS cells strongly support the well-established observation on the beneficial effects of PPARγ agonists promoting adipocyte browning. Direct comparison of the full agonist (<i>R</i>)-<b>3</b> and partial agonist (<i>S</i>)-<b>3</b> in SGBS cells suggest that the effects correlate with PPARγ activation, while sEH inhibition did not affect adipocyte browning. This seems to be in contrast to recent findings by Overby et al.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(39)</a> They showed that the sEH inhibitor t-TUBC increased in vitro adipogenesis in murine and human brown preadipocytes along with an upregulation of typical brown adipocyte marker genes and increased mitochondrial uncoupling. Treatment with t-TUBC in vivo resulted in reduced serum triglyceride levels in mice subjected to a high fat diet. Unfortunately, the authors did not provide data on white preadipocytes or WAT, therefore the data sets are not comparable. Given the high efficacy in improvement of diabetic markers and lipid profiles of compound <b>3</b> in rat models of MetS,<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> further comparative investigations of selective PPARγ agonists, sEH inhibitors, and dual sEH/PPARγ modulators in the context of adipocyte browning in vivo are required.</div><div class="NLM_p last">Most interestingly, sEH inhibitors have already been attributed cardioprotective properties but (<i>R</i>)-<b>3</b> was able to improve on the effects of targeted sEH inhibition, at least in the isolated buffer perfused heart. In the light of limited use of PPARγ agonists in clinics due to proposed adverse cardiovascular effects, sEH inhibitors as add-on therapy or dual sEH/PPARγ modulators could potentially protect the patients from the latter, especially, MetS patients relying on polypharmaceutical treatment could benefit from safe agents that promote PPARγ activation and reduce the number of drugs in treatment of different risk factors.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a></div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_12860" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_12860" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i11" class="anchor-spacer"></div><h3 class="article-section__title" id="_i11"> General</h3><div class="NLM_p last">All starting materials, solvents, and reagents were purchased from commercial suppliers, (e.g., Sigma-Aldrich, Apollo Scientific, Acros Organics, TCI Chemicals) and used without further purification. NMR spectra were recorded on a Bruker AMX 250, Bruker AV 300, Bruker AV 400,or a Bruker AV500 spectrometer (Bruker Corporation, Billerica, MA, USA). Chemical shifts (δ) are reported in ppm relative to tetramethylsilane (TMS) as reference. Multiplicity is reported: s, singlet; d, doublet; dd, doublet of doublets; t, triplet; dt, doublet of triplet; tt, triplet of triplet; m, multiplet. Approximate coupling constants (<i>J</i>) are given in hertz (Hz). Reactions under hydrogen atmosphere were performed in a autoclave model 4766 (Parr Instrument Company, Moline, IL, USA). Mass spectra were obtained on a VG Platform II (Thermo Fischer Scientific, Inc., Waltham, MA, USA) using electrospray ionization (ESI). High-resolution mass spectra were recorded on a Maldi LTQ Orbitrap XL instrument (Thermo Fisher Scientific). Thin layer chromatography for reaction control was performed on silica gel 60 F<sub>254</sub> aluminum sheets (Merck, Germany). Preparative column chromatography was performed on silica gel 63–200 μM (Merck, Germany). Compounds were purified by flash chromatography with an IntelliFlash 310 (AnaLogix) or preparative HPLC using a Shimadzu preparative Prominence Modular HPLC (Shimadzu, Kyoto, Japan) with the following conditions: column, Luna (10 μ C18(2) 100 Å; 250 mm × 21.2 mm; Phenomenex, Torrance, CA, USA.); mobile phase was a gradient of H<sub>2</sub>O + 0.1% formic acid/ACN 50:50 to 10:90 in 10 min, holding for additional 5 min, back to 50:50 in 3 min and holding for 2 min at a flow rate of 21 mL/min and UV detection at 254 and 280 nm. Compound purity was analyzed on a LC2020 system (Shimadzu, Kyoto, Japan) using UV detection at 254 and 280 nm equipped with a Luna column (10 μ C18(2) 100 Å; 250 mm × 21.2 mm; Phenomenex, Torrance, CA, USA) using a gradient (H<sub>2</sub>O + 0.1% formic acid/ACN 90:10 to 10:90 after 10 min and holding at 10:90 for additional 6 min, back to 90:10 in 1 min and holding for additional 3 min) at a flow rate of 1 mL/min. The enantiomeric excess was determined on a Beckman P/ACE MDQ (Beckman Coulter, Krefeld, Germany) equipped with a UV–vis diode with a detection wavelength of 200 nm decrease in software (version 8.0). Separations were performed in 40/50.2 cm, 50 μm i.d. Polymicro fused-silica capillaries (CM Scientific, Silsden, UK) at 20 °C and an applied voltage of 20 kV using a 100 mM sodium acetate buffer, pH 5.0, containing 35 mg/mL hydroxypropyl-α-cyclodextrin as background electrolyte.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i12" class="anchor-spacer"></div><h3 class="article-section__title" id="_i12"> Synthesis</h3><div id="sec4_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Benzyl 4-Formylbenzoate (<b>5</b>)</h4><div class="NLM_p last">4-Formylbenzoic acid <b>4</b> (2.0 g, 12.9 mmol, 1.0 equiv) was solved in dry DMF (25 mL) and treated with Cs<sub>2</sub>CO<sub>3</sub> (4.2 g, 12.9 mmol, 1.0 equiv). After 30 min, benzyl bromide (1.53 mL, 12.9 mmol, 1.0 equiv) was added and the suspension was stirred at room temperature for 3 h. The reaction mixture was filtered, and the filtrate was mixed with a solution of ethyl acetate and <i>n</i>-hexane (1:5). The organic phase was washed with water, followed by saturated NaHCO<sub>3</sub> solution and brine. Afterward, organic phase was dried over MgSO<sub>4</sub> and solvent was removed under reduced pressure to obtain desired product as colorless solid (2.83 g, 11.8 mmol, 91%), which could be used further without additional purification. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 10.10 (s, 1H, CHO), 8.17 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.2 Hz, 2H, H<sub>ar</sub>), 8.03 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.2 Hz, 2H, C<sub>ar</sub>), 7.49 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2 Hz, 2H, H<sub>ar</sub>), 7.44–7.33 (m, 3H, H<sub>ar</sub>), 5.38 (s, 2H, O-CH<sub>2</sub>) ppm. <sup>13</sup>C NMR (101 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 192.9, 164.7, 139.2, 135.8, 134.3, 129.9 (2 × C), 129.7 (2 × C), 128.6 (2 × C), 128.2 (2 × C), 128.1, 66.7 ppm. ESI-MS: 262.80 [M + Na]<sup>+</sup>.</div></div><div id="sec4_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> Benzyl 4-(Hydroxymethyl)benzoate (<b>6</b>)</h4><div class="NLM_p last">To an ice-cooled solution of <b>5</b> (3.58 g, 14.9 mmol, 1.0 equiv) in MeOH (40 mL), sodium borohydride (0.56 g, 14.9 mmol, 1.0 equiv) was added under argon atmosphere and stirred overnight, while solution was warming up to room temperature. The reaction was quenched by addition of 2 M aqueous HCl and extracted with dichloromethane (20 mL). The organic phase was washed with water, saturated NaHCO<sub>3</sub> solution, and brine (each 30 mL) before drying over MgSO<sub>4</sub>. After removal of solvent, the colorless product (2.57 g, 10.6 mmol, 71%) obtained could be used without further synthesis. <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.97–7.87 (m, 2H, H<sub>ar</sub>), 7.48–7.27 (m, 7H, H<sub>ar</sub>), 5.58 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 5.7 Hz, 1H, OH), 5.31 (s, 2H, ArO-CH<sub>2</sub>), 4.56 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 5.5 Hz, 2H, HO-CH<sub>2</sub>) ppm. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 166.2, 148.8, 136.6, 129.6 (2 × C), 129.0 (2 × C), 128.6, 128.4 (2 × C), 128.3, 126.9, 126.8, 66.5, 62.8 ppm. ESI-MS (<i>m</i>/<i>z</i>): 241.19 [M – H]<sup>−</sup>.</div></div><div id="sec4_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> Benzyl 4-(Bromomethyl)benzoate (<b>7</b>)</h4><div class="NLM_p last">To an ice-cooled solution of (<b>6</b>) (7.60 g, 31.4 mmol, 1 equiv) in 40 mLof dry THF, phosphorus tribromide (8.49 g, 5.7 mL, 31.4 mmol, 1 equiv) was added slowly. After completion, the ice bath was removed and the reaction mixture was stirred at room temperature for 3 h. The reaction was quenched by addition of 30 mL of H<sub>2</sub>O. The organic phase was washed with 30 mL of brine twice, dried over MgSO<sub>4</sub>, and evaporated under reduced pressure. The crude product was purified by flash chromatography (hexane/ethyl acetate 100:0–90:10), and pure product could be isolated as colorless solid (7.92 g, 26 mmol, 83%). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.03–7.93 (m, 2H, H<sub>ar</sub>), 7.61 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.4 Hz, 2H, H<sub>ar</sub>), 7.53–7.31 (m, 5H, H<sub>ar</sub>), 5.35 (s, 2H, Br-CH<sub>2</sub>), 4.76 (s, 2H, O-CH<sub>2</sub>) ppm. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 165.2, 143.5, 135.0, 129.6 (2 × C), 129.7 (2 × C), 128.5 (2 × C), 128.1, 128.0 (2 × C), 66.3, 33.1 ppm.</div></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i16" class="anchor-spacer"></div><h3 class="article-section__title" id="_i16"> General Method for <i>N</i>-Acylation of Oxazolidine-2-ones</h3><div class="NLM_p">A solution of (<i>R</i>)- or (<i>S</i>)-4-benzyl-2-oxazilidinone <b>8</b> (1.0 equiv) in dry THF (3 mL/mmol) was cooled to −78 °C and treated with <i>n</i>-butyl lithium (1.0 equiv). After 15 min, butyryl chloride (1.1 equiv) was added and the reaction mixture was stirred at −78 °C for an additional 30 min. After warming the reaction mixture up to 0 °C and stirring for another 15 min, the reaction was quenched by addition of saturated, aqueous NH<sub>4</sub>Cl solution. The mixture was concentrated in vacuum and taken up in diethyl ether. The organic phase was washed with saturated, aqueous Na<sub>2</sub>SO<sub>4</sub> solution, followed by brine and dried in vacuum. After purification through flash chromatography (hexane/ethyl acetate 5:3), the product was isolated as a colorless oil (<i>S</i>)-<b>9</b>: 2.60 g, 10.5 mmol, 94%; (<i>R</i>)-<b>9</b>: 2.65 g, 10.7 mmol, 96%).</div><div id="sec4_3_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> (<i>R</i>)-4-Benzyl-3-butyryloxazolidin-2-one ((<i>R</i>)-<b>9</b>), (<i>S</i>)-4-Benzyl-3-butyryloxazolidin-2-one ((<i>S</i>)-<b>9</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 7.36–7.17 (m, 5H, H<sub>ar</sub>), 4.71–4.60 (m, 1H, CH), 4.32 (t, <sup>3</sup><i>J</i><sub>HH</sub>= 8.5 Hz, 1H, CH), 4.17 (dd, <sup>3</sup><i>J</i><sub>HH</sub>= 8.8 Hz, <sup>4</sup><i>J</i><sub>HH</sub> = 2.9 Hz, 1H, CH), 3.01 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.5 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 3.5 Hz, 1H, CH), 2.92 (dd, <sup>2</sup><i>J</i><sub>HH</sub>= 13.7 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 7.5 Hz, 1H, CH), 2.76 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 12.3 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 4.8 Hz, 2H, CH<sub>2</sub>), 1.70–1.53 (m, 2H, CH<sub>2</sub>), 0.93 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 10.2 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 4.6 Hz, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>) δ = 172.4, 153.4, 135.7, 129.5 (2 × C) 128.6 (2 × C) 126.9, 66.1, 54.2, 36.7, 17.3, 13.6 ppm.</div></div></div><div id="sec4_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> General Method for Asymmetric Alkylation</h3><div class="NLM_p">A solution of the (<i>R</i>)-<b>9</b> or (<i>S</i>)-<b>9</b> (1.0 equiv) in dry THF (15 mL/mmol) was cooled to −78 °C, and 1 M NaHMDS in THF (1.1 equiv) was added slowly. After additional 30 min of stirring at −78 °C a solution of <b>7</b> (1.5 equiv) in THF was added. The solution was allowed to warm up to room temperature overnight. The reaction mixture was quenched by addition of saturated, aqueous NH<sub>4</sub>Cl solution. The product was extracted with ethyl acetate. The organic phase was washed with brine and dried over MgSO<sub>4</sub>. After removal of the solvent, the crude product was purified by flash chromatography (hexane/ethyl acetate 100:0–80:20) and the product could be isolated as colorless oil ((4<i>R</i>,2<i>S</i>)-<b>10</b>: 566 mg, 1.2 mmol, 67%; (4<i>S</i>,2<i>R</i>)-<b>10</b>: 1.78 g, 3,8 mmol, 66%).</div><div id="sec4_4_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> Benzyl 4-((<i>S</i>)-2-((<i>R</i>)-4-Benzyl-2-oxooxazolidine-3-carbonyl)butyl)benzoate ((4<i>S</i>,2<i>R</i>)-<b>10</b>), Benzyl 4-((<i>R</i>)-2-((<i>S</i>)-4-Benzyl-2-oxooxazolidine-3-carbonyl)butyl)benzoate ((4<i>R</i>,2<i>S</i>)-<b>10</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 7.95 (d, 2H, H<sub>ar</sub>), 7.47–7.32 (m, 5H, H<sub>ar</sub>), 7.17–7.10 (m, 3H, H<sub>ar</sub>), 6.80 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 6.4 Hz, <sup>4</sup><i>J</i><sub>HH</sub>= 3.1 Hz, 2H, H<sub>ar</sub>), 5.33 (s, 2H, O-CH<sub>2</sub>), 4.72–4.60 (m, 1H, CH), 4.30 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 8.5 Hz, 1H, CH), 4.11 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9 Hz, <sup>4</sup><i>J</i><sub>HH</sub> = 2.7 Hz, 1H, CH), 4.06–3.95 (m, 1H, CH), 3.05 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.2 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 8.7 Hz, 1H, CH), 2.90–2.82 (m, 1H, CH), 2.79 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 10.2 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 3.3 Hz, 1H, CH), 2.69 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.6 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 6.7 Hz, 1H, CH), 1.79–1.58 (m, 1 H, CH), 1.57–1.38 (m, 1H, CH), 0.88 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4 Hz, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (75 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 174.4, 165.5, 153.0, 145.6, 136.2, 135.2, 127.7, 129.7 (2 × C), 129.4 (2 × C), 129.3 (2 × C), 128.5 (2 × C), 128.3 (2 × C), 128.1, 127.9 (2 × C), 126.8, 65.7, 65.0, 54.2, 45.4, 36.8, 36.2, 24.7, 11.3 ppm.</div></div></div><div id="sec4_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> General Method for Hydrogenolysis of Benzyl Esters</h3><div class="NLM_p">(4<i>S</i>,2<i>R</i>)-<b>10</b> or (4<i>R</i>,2<i>S</i>)-<b>10</b> (1.0 equiv) was dissolved in MeOH (5 mL/mmol) and treated with palladium (w = 10%) on charcoal (1 mol % Pd). The reaction mixture was stirred at room temperature for 5 h in an autoclave under a hydrogen atmosphere of 5 bar. The purification was realized by column chromatography (hexane/ethyl acetate 3:1 + 1% acetic acid), and both enantiomers could be isolated as colorless oils ((4<i>S</i>,2<i>R</i>)-<b>11</b>: 1.23 g, 3.24 mmol, 86%; (<b>4</b><i>R</i><b>,2</b><i>S</i>)-<b>11</b>: 1.32 g, 3.47 mmol, 76%).</div><div id="sec4_5_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> 4-((<i>S</i>)-2-((<i>R</i>)-4-Benzyl-2-oxooxazolidine-3-carbonyl)butyl)benzoic Acid ((4<i>S</i>,2<i>R</i>)-<b>11</b>), 4-((<i>R</i>)-2-((<i>S</i>)-4-Benzyl-2-oxooxazolidine-3-carbonyl)butyl)benzoic Acid ((4<i>R</i>,2<i>S</i>)-<b>11</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (250 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 12.34 (bs, 1H, COOH), 7.93–7.81 (m, 2H, H<sub>ar</sub>), 7.43–7.31 (m, 2H, H<sub>ar</sub>), 7.22–7.11 (m, 3H, H<sub>ar</sub>), 6.86–6.78 (m, 2H, H<sub>ar</sub>), 4.71–4.62 (m, 1H, CH), 4.30 (t,<sup>3</sup><i>J</i><sub>HH</sub> = 8.5 Hz, 1H, CH), 4.11 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.8 Hz, <sup>4</sup><i>J</i><sub>HH</sub> = 2.6 Hz, 1H, CH), 4.06–3.95 (m, 1H, CH), 3.09–2.77 (m, 4H, CH<sub>2</sub>), 2.69 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.6 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 6.7 Hz, 1H, CH), 1.77–1.59 (m, 1H, CH), 1.55–1.38 (m, 1H, CH), 0.88 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4 Hz, 3H, CH<sub>3</sub>) ppm.</div></div></div><div id="sec4_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> General Method for Amide Coupling</h3><div class="NLM_p">(4<i>S</i>,2<i>R</i>)-<b>11</b> or (4<i>R</i>,2<i>S</i>)-<b>11</b> (1.0 equiv) and HBTU (1.5 equiv) were dissolved in dry DMF (10 mL/mmol) under argon atmosphere and cooled to 0 °C. EDC·HCl (1.5 equiv), 4-methoxy-2-(trifluoromethyl)benzylamine (1.1 equiv), and <i>N</i>-methylmorpholine (6.0 equiv) were added, and the mixture was allowed to warm up to room temperature overnight. After the reaction was completed, the solvent was removed under reduced pressure and ethyl acetate was added. The organic phase was washed twice with H<sub>2</sub>O and brine. The organic phase was dried over MgSO<sub>4</sub>, and solvent was removed under reduced pressure. The product could be isolated after purification through flash chromatography (hexane/ethyl acetate 100:0–50:50) as pale-yellow oil ((4<i>S</i>,2<i>R</i>)-<b>12</b>: 1.38 g, 2.43 mmol, 75%; (4<i>R</i>,2<i>S</i>)-<b>12</b>: 1.66 g, 2.9 mmol, 84%).</div><div id="sec4_6_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> 4-((<i>S</i>)-2-((<i>R</i>)-4-Benzyl-2-oxooxazolidine-3-carbonyl)butyl)-<i>N</i>-(4-methoxy-2-(trifluoromethyl)benzyl)-benzamide ((4<i>S</i>,2<i>R</i>)-<b>12</b>), 4-((<i>R</i>)-2-((<i>S</i>)-4-Benzyl-2-oxooxazolidine-3-carbonyl)butyl)-<i>N</i>-(4-methoxy-2-(trifluoromethyl)benzyl)benzamide ((4<i>R</i>,2<i>S</i>)-<b>12</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 8.98 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 5.8 Hz, 1H, NH), 7.89 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.2 Hz, 2H, H<sub>ar</sub>), 7.39–7.34 (m, 3H, H<sub>ar</sub>), 7.20 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 2.6 Hz, 1H, H<sub>ar</sub>), 7.18–7.14 (m, 3H, H<sub>ar</sub>), 7.12 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.6 Hz, <sup>4</sup><i>J</i><sub>HH</sub> = 2.5 Hz, 1H, H<sub>ar</sub>), 6.81 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 7.2 Hz, <sup>4</sup><i>J</i><sub>HH</sub> = 2.0 Hz, 2H, H<sub>ar</sub>), 4.70–4.65 (m, 1H, N-CH), 4.56 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 5.5 Hz, 2H, NH-CH<sub>2</sub>), 4.31 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 8.6 Hz, 1H, CH), 4.12 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 8.9 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 2.6 Hz, 1H, CH), 4.02 (dt, <sup>2</sup><i>J</i><sub>HH</sub> = 13.0 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 6.6 Hz, 1H, CH), 3.80 (s, 3H, O-CH<sub>3</sub>), 3.04 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.2 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 8.7 Hz, 1H, CH), 2.85–2.77 (m, 2H, 2 × CH), 2.71 (dd, <sup>2</sup>J<sub>HH</sub> = 13.6 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 6.9 Hz, 1H, CH), 1.73–1.63 (m, 1H, CH), 1.53–1.43 (m, 1H, CH), 0.89 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4 Hz, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (126 MHz, DMSO-<i>d</i><sub>6</sub>): δ = 174.6, 166.2, 158.0, 153.1, 143.3, 135.3, 132.0, 130.1, 129.5 (2 × C), 129.2 (2 × C), 129.1, 128.4 (2 × C), 127.4 (2 × C), 126.8, 125.3, 123.1, 117.6, 111.5, 65.7, 55.6, 54.3, 45.5, 38.8, 36.7, 36.3, 24.7, 11.3 ppm. <sup>19</sup>F-NMR (471 MHz, DMSO-<i>d</i><sub>6</sub>): δ = −59.11 (Ar-CF<sub>3</sub>) ppm. ESI-MS (<i>m</i>/<i>z</i>): 567.20 [M – H]<sup>−</sup>.</div></div></div><div id="sec4_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> General Method for Oxidative Cleavage of Evans Auxiliar</h3><div class="NLM_p">(4<i>S</i>,2<i>R</i>)-<b>12</b> or (4<i>R</i>,2<i>S</i>)-<b>12</b> (1.0 equiv) was dissolved in a THF:H<sub>2</sub>O mixture (10 mL/mmol, 3:1 v/v) and cooled to 0 °C. Thereafter H<sub>2</sub>O<sub>2</sub> (w = 30% in H<sub>2</sub>O, 8.0 equiv) and LiOH (2.0 equiv) were added. The reaction mixture was allowed to warm up overnight. Solvent was removed under reduced pressure, and pH was adjusted to 2. The residue was extracted three times with ethyl acetate, and the combined organic phase was dried over MgSO<sub>4</sub>. The crude product was purified by preparative HPLC, and the two enantiomers could be isolated as colorless solids ((<b><i>S</i></b>)<b>-3</b>: 1.04, 2.54 mmol, 87%; (<i>R</i>)<b>-3</b>: 0.91g, 2.22 mmol, 92%).</div><div id="sec4_7_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i25" class="anchor-spacer"></div><h4 class="article-section__title" id="_i25"> (<i>S</i>)-2-(4-((4-Methoxy-2-(trifluoromethyl)benzyl)carbamoyl)benzyl)butanoic Acid ((<i>R</i>)-<b>3</b>), (<i>R</i>)-2-(4-((4-Methoxy-2-(trifluoromethyl)benzyl)carbamoyl)benzyl)butanoic Acid ((<i>S</i>)-<b>3</b>)</h4><div class="NLM_p last"><sup>1</sup>H NMR (500 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 7.79 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.3 Hz, 2H, H<sub>ar</sub>), 7.46 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.6 Hz, 1H, H<sub>ar</sub>), 7.32 (d, <sup>3</sup><i>J</i><sub>HH</sub> = 8.2 Hz, 2H, H<sub>ar</sub>), 7.21 (d, <sup>4</sup><i>J</i><sub>HH</sub> = 2.6 Hz, 1H, H<sub>ar</sub>), 7.13 (dd, <sup>3</sup><i>J</i><sub>HH</sub> = 8.6 Hz, <sup>4</sup><i>J</i><sub>HH</sub> = 2.6 Hz, 1H, H<sub>ar</sub>), 4.69 (s, 2H, N-CH<sub>2</sub>), 3.83 (s, 3H, O-CH<sub>3</sub>), 2.96 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.6 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 8.9 Hz, 1H, CH), 2.83 (dd, <sup>2</sup><i>J</i><sub>HH</sub> = 13.7 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 6.1 Hz, 1H, CH), 2.60 (tt, <sup>3</sup><i>J</i><sub>HH</sub> = 8.7 Hz, <sup>3</sup><i>J</i><sub>HH</sub> = 5.8 Hz, 1H, CH), 1.70–1.55 (m, 2H, CH<sub>2</sub>), 0.96 (t, <sup>3</sup><i>J</i><sub>HH</sub> = 7.4 Hz, 3H, CH<sub>3</sub>) ppm. <sup>13</sup>C NMR (126 MHz, MeOD-<i>d</i><sub>4</sub>) δ = 177.6, 168.8, 158.8, 144.0, 132.0, 130.3, 128.8 (2 × C), 128.4 (<sup>2</sup><i>J</i><sub>CF</sub> = 30.7 Hz), 128.2, 127.1 (2 × C), 124.3 (<sup>1</sup><i>J</i><sub>CF</sub> = 273.3 Hz), 116.6, 111.8 (<sup>3</sup><i>J</i><sub>CF</sub> = 5.9 Hz), 54.7, 49.0, 38.5, 38.4, 25.0, 10.6 ppm. <sup>19</sup>F-NMR (471 MHz, MeOD-<i>d</i><sub>4</sub>): δ = −61.6 (Ar-CF<sub>3</sub>) ppm. ESI-MS (<i>m</i>/<i>z</i>): 408.13 [M – H]<sup>−</sup>.</div></div><div id="sec4_7_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i26" class="anchor-spacer"></div><h4 class="article-section__title" id="_i26"> <i>R</i>-(<b>3</b>)</h4><div class="NLM_p last">MALDI-HRMS: <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>23</sub>F<sub>3</sub>NO<sub>4</sub> [M + H<sup>+</sup>] 410.15857 measured 410.15691 (Δ<i>m</i> = 0.00166 g; 4.05 ppm).</div></div><div id="sec4_7_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> <i>S</i>-(<b>3</b>)</h4><div class="NLM_p last">MALDI-HRMS: <i>m</i>/<i>z</i> calculated for C<sub>21</sub>H<sub>23</sub>F<sub>3</sub>NO<sub>4</sub> [M + H<sup>+</sup>] 410.15857 measured 410.15698 (Δ<i>m</i> = 0.00159 g; 3.88 ppm)</div></div><div id="sec4_7_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> CD Spectrometry</h4><div class="NLM_p">CD spectra of (<i>R</i>)-<b>3</b> and (S)-<b>3</b> were recorded on a spectropolarimeter Jasco J-810 (Jasco Labortechnik, Pfungstadt) at a concentration of 0.5 mM in MeOH, using a 1 mm cuvette and a total volume of 300 μL from 180 to 300 nm. Spectra were recorded by accumulating three scans with a scan rate of 100 nm/min, and background correction was accomplished by subtraction of methanol spectrum.</div><div class="NLM_p last">Smoothing of the spectra was accomplished under usage of Jasco spectra analysis software with means movement method for convulsion width of 25 data points.</div></div><div id="sec4_7_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> sEH Activity Assay</h4><div class="NLM_p last">Fluorescence-based sEH activity assay was performed as described previously.<a onclick="showRef(event, 'ref39'); return false;" href="javascript:void(0);" class="ref ref39">(40)</a> The IC<sub>50</sub> values of the compounds were determined by a fluorescence-based assay system in 96 well microtiter plates. Fluorogenic substrate 3-phenyl-cyano-(6-methoxy-2-naphthalenyl)methyl ester-2-oxirane-acetic acid (PHOME)<a onclick="showRef(event, 'ref40'); return false;" href="javascript:void(0);" class="ref ref40">(41)</a> was used, and the formation of the fluorescent 6-methoxy-2-naphthaldehyde was measured (λ<sub>em</sub> = 330 nm, λ<sub>ex</sub> = 465 nm) on a Tecan Infinite F200 Pro plate reader. Recombinant human sEH was dissolved in pH 7 bis-Tris buffer with 0.1 mg/mL BSA containing a 0.01% Triton-X 100 (final protein concentration 3 nM). The 89 μL aliquots of protein were incubated with 1 μL different concentrations of compounds (final DMSO concentration 1%) for 30 min at room temperature. Ten μL aliquots of substrate were added (to the final concentration 50 μM). The hydrolysis reaction was monitored for 30 min (one point per minute). A blank control (no protein and no compound) as well as a positive control (no compound) were carried out as well. All measurements were performed in triplicate.</div></div><div id="sec4_7_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> PPARγ Cofactor Recruitment Assay</h4><div class="NLM_p last">Recruitment of coregulator peptides to the PPARγ-LBD was studied using a homogeneous time-resolved fluorescence resonance energy transfer (HTRF) assay system. Therefore, terbium cryptate as streptavidin conjugate (Tb-SA; Cisbio Bioassays, Codolet, France) coupled to biotinylated CBP coactivator peptide [biotin-NLVPDAASKHKQLSELLRGGSGS] (custom synthesis, AnaSpec, Fremont, USA) was used as the FRET donor and recombinant sGFP-PPARγ LBD as the FRET acceptor. To measure dose dependent CBP recruitment, test compounds were titrated against 100 nM sGFP-PPARγ LBD and 12 nM terbium coupled copeptide, with a dilution factor of 0.4. Assay solutions were prepared in 25 mM HEPES, pH 7.5, 150 mM KF, 10% (w/v) glycerol, 5 mM DTT, and 0.1% (w/v) CHAPS. After 2 h incubation at RT, the fluorescence intensities (FI) after excitation at 340 nm were detected at 520 nm for sGFP acceptor fluorescence and 620 nm for Tb-SA donor fluorescence on a SPARK plate reader (Tecan Group Ltd.). HTRF was calculated by dividing FI520 nm by FI620 nm and the multiplication with 10 000. Experiments were performed in a 384 well format using white flat bottom polystyrol microtiter plates (Greiner Bio-One, Frickenhausen, Germany).</div></div><div id="sec4_7_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i31" class="anchor-spacer"></div><h4 class="article-section__title" id="_i31"> Reporter Gene Assays</h4><div id="sec4_7_7_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Plasmids</h5><div class="NLM_p last">The Gal4-fusion receptor plasmids pFA-CMV-hPPARα-LBD (uniprot <a href="https://Q07869" class="ext-link">Q07869</a>, residues 164–466), pFA-CMV-hPPARδ-LBD (uniprot <a href="https://Q03181" class="ext-link">Q03181</a>, residues 138–441), pFA-CMV-hPPARγ-LBD (uniprot <a href="https://P37231" class="ext-link">P37231</a>, residues 203–505), pFA-CMV-hLXRα-LBD (uniprot <a href="https://Q13133" class="ext-link">Q13133</a>, residues 182–447), pFA-CMV-hRARα-LBD (uniprot <a href="https://P10276-1" class="ext-link">P10276-1</a>, residues 177–462), pFA-CMV-hVDR-LBD (uniprot <a href="https://P11473-1" class="ext-link">P11473-1</a>, residues 119–427), pFA-CMV-hCAR-LBD (uniprot entry <a href="https://Q4994-6" class="ext-link">Q4994-6</a>, residues 48–324), and pFA-CMV-hPXR-LBD (uniprot <a href="https://O75469-1" class="ext-link">O75469-1</a>, residues 138–434) coding for the hinge region and ligand binding domain (LBD) of the canonical isoform of the respective nuclear receptor have been cloned by integrating cDNA fragments obtained from PCR amplification of commercial cDNA (Source BioScience, Nottingham, UK) or obtained from PCR amplification of human monocytes into the BamH1 cleavage site of the pFA-CMV vector (Stratagene, La Jolla, CA, USA) and, in some cases, an afore inserted <i>Kpn</i>I cleavage site as reported previously.<a onclick="showRef(event, 'ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref41 ref42 ref43 ref44">(42−45)</a> pFR-Luc (Stratagene) was used as reporter plasmid and pRL-SV40 (Promega) for normalization of transfection efficiency and cell growth.</div></div><div id="sec4_7_7_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i33" class="anchor-spacer"></div><h5 class="article-section__title" id="_i33"> Assay Procedure</h5><div class="NLM_p last">HEK293T cells were grown in DMEM high glucose, supplemented with 10% FCS, sodium pyruvate (1 mM), penicillin (100 U/mL), and streptomycin (100 μg/mL) at 37 °C and 5% CO<sub>2</sub>. The day before transfection, HEK293T cells were seeded in 96-well plates (3 × 10<sup>4</sup> cells/well). Before transfection, medium was changed to Opti-MEM without supplements. Transient transfection was carried out using Lipofectamine LTX reagent (Invitrogen) according to the manufacturer’s protocol with pFR-Luc (Stratagene), pRL-SV40 (Promega), and the corresponding Gal4-fusion nuclear receptor plasmid. Five hours after transfection, medium was changed to Opti-MEM supplemented with penicillin (100 U/mL), streptomycin (100 μg/mL), now additionally containing 0.1% DMSO and the respective test compound or 0.1% DMSO alone as untreated control. Each concentration was tested in duplicate, and each experiment was repeated independently five times. Following overnight (12–14 h) incubation with the test compounds, cells were assayed for luciferase activity using Dual-Glo luciferase assay system (Promega) according to the manufacturer’s protocol. Luminescence was measured with a Spark 10 M luminometer (Tecan Deutschland GmbH). Normalization of transfection efficiency and cell growth was done by division of firefly luciferase data by renilla luciferase data and multiplying the value by 1000, resulting in relative light units (RLU). Fold activation was obtained by dividing the mean RLU of a test compound at a respective concentration by the mean RLU of untreated control. Relative activation was obtained by dividing the fold activation of a test compound at a respective concentration by the fold activation of a respective reference agonist at 1 μM (PPARα, GW7647; PPARγ, pioglitazone; PPARδ, L165,041; LXRα, T0901317; RARα, tretinoin; VDR, calcitriol; CAR, CITCO; PXR, SR12813).</div></div></div><div id="sec4_7_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i34" class="anchor-spacer"></div><h4 class="article-section__title" id="_i34"> SGBS Cell Assays</h4><div id="sec4_7_8_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Cell Culture and Adipogenic Differentiation</h5><div class="NLM_p last">SGBS cells<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> were cultured and differentiated into adipocytes using a protocol described before.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> Briefly, cells were seeded into cell culture vessels in DMEM:F12 containing 3.3 mM biotin, 1.7 mM panthotenate, and 10% FCS. Adipogenic differentiation was induced for 14 days in serum-free DMEM:F12 medium supplemented with 10 μg/mL apo-transferrin, 10 nM insulin, 200 pM T3, and 1 μM cortisol. For the first 4 days, 250 μM isobutylmethylxanthine, and 25 nM dexamethasone and indicated concentrations of <b>2</b>, (<i>R</i>)-<b>3</b>, or (<i>S</i>)-<b>3</b> were added. Equal volume of DMSO was used as vehicle control. Adipogenic differentiation was monitored by Nile red staining.<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(46)</a></div></div><div id="sec4_7_8_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Determination of Cellular Respiration</h5><div class="NLM_p last">Cells were plated in 96 well cell culture microplates (XFe96, Agilent Technologies, Santa Clara, USA) and differentiated into adipocytes for 14 days as indicated above in the presence of vehicle (DMSO), rosiglitazone, (<i>R</i>)-<b>3</b>, or (<i>S</i>)-<b>3</b>. One day before measurement, the culture medium was changed to insulin-free medium. On the day of measurement, the cells were incubated for 1 h in bicarbonate-free DMEM medium containing 5 mM HEPES, 10 mM glucose, 1 mM pyruvate, 2 mM glutamine, and 1% bovine serum albumin. Oxygen consumption rates (OCR) were measured simultaneously using a Seahorse XFe96 flux analyzer (Agilent Technologies). To mimic thermogenic activation, the cells were treated with 0.5 mM dibutyryl cyclic adenosinmonophosphate (cAMP). Uncoupled (proton leak) respiration was profiled by injecting 2 μM oligomycin (inhibiting the ATP synthase), and full substrate oxidation capacity was determined by injecting 4 μM carbonylcyanide-<i>p</i>-trifluoromethoxyphenylhydrazone (FCCP, a chemical uncoupler). Nonmitochondrial respiration was determined by injecting 1.5 μM antimycin A and 1.5 μM rotenone (inhibiting electron flux through complex I and III). OCRs were determined by machine algorithms and plotted against time. Data were either normalized cell content by staining with JanusGreen.<a onclick="showRef(event, 'ref46'); return false;" href="javascript:void(0);" class="ref ref46">(47)</a></div></div><div id="sec4_7_8_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> Gene Expression Analysis</h5><div class="NLM_p last">RNA was isolated using the Direct-Zol RNA kit (Zymo Research, Irvine, USA). Then 0.5 μg of total RNA was reverse transcribed using SuperScript II reverse transcriptase (ThermoFisher Scientific). Relative expression of target genes was analyzed by quantitative real-time PCR using the ssoAdvanced Universal SYBR Green Supermix on a CFX Connect Real Time PCR Detection System (BioRad, Munich, Germany). Expression values were calculated using the dCt method with hypoxanthine-guanine phosphoribosyltransferase (HPRT) as a reference gene. Sequences of the primers are available on request.</div></div></div><div id="sec4_7_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i38" class="anchor-spacer"></div><h4 class="article-section__title" id="_i38"> Protein Purification and Crystallization</h4><div class="NLM_p">The LBD PPARγ (aa.203–477) was subcloned into pNIC28-Bsa4 and overexpressed in <i>Escherichia coli</i> Rosetta2. The N-terminally-His<sub>6</sub>-tagged recombinant protein was purified initially by Ni<sup>2+</sup>-affinity chromatography. The tag was removed by TEV protease treatment, and the cleaved protein was further purified by reverse Ni<sup>2+</sup>-affinity chromatography and subsequently size exclusion chromatography. The pure protein in 20 mM Tris, pH 8, 200 mM NaCl, and 0.5 mM TCEP at 12 mg/mL was mixed with (<i>R</i>)-<b>3</b> and incubated on ice for 1 h before crystallization. The crystals of the complexes were obtained by sitting drop vapor diffusion method at 20 °C and the condition containing 27% PEG 3350, 0.2 M sodium citrate tribasic dehydrate.</div><div class="NLM_p last">The C-terminal sEH hydrolase domain (aa 222–555) was subcloned into pET24a(+) and expressed in <i>E. coli</i> BL21-(DE3) cells. Recombinant protein was purified by nickel affinity chromatography followed by size exclusion chromatography in the buffer containing 50 mM NaCl, 50 mM sodium phosphate, 10% (v/v) glycerol, 2 mM DTT, pH 7.4. The recombinant protein was concentrated to ∼16.5 mg/mL and cocrystallized with (<i>R</i>)-<b>3</b> at 20 °C. Crystals of complex were obtained from condition of 28% PEG6000, 70 mM ammonium acetate, 200 mM magnesium acetate tetrahydrate, and 100 mM sodium cacodylate, pH 6.13</div></div></div><div id="sec4_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> Structure Determination</h3><div class="NLM_p last">Diffraction data were collected at Swiss Light Source, X06DA. Data were processed with XDS<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(48)</a> and scaled with aimless.<a onclick="showRef(event, 'ref48'); return false;" href="javascript:void(0);" class="ref ref48">(49)</a> Initial structure solution was obtained by molecular replacement using Phaser<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(50)</a> and the published coordinates (PDB of PPARγ, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TSG">6TSG</a>; PDB of sEH, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FR2">6FR2</a>). Manual model rebuilding was performed using COOT,<a onclick="showRef(event, 'ref50'); return false;" href="javascript:void(0);" class="ref ref50">(51)</a> and the structures were refined using REFMAC.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(52)</a> Data collection and refinement statistics are summarized in Supporting Information, <a href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_001.pdf" class="ext-link">Table S1</a>.</div></div><div id="sec4_8_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> Ex Vivo Assays</h3><div class="NLM_p">The sEH inhibitor <i>trans</i>-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]-benzoic acid (<i>t</i>-AUCB) is a generous gift from Bruce D. Hammock and was synthesized as described.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(53)</a> All other chemicals were obtained from Sigma-Aldrich.</div><div id="sec4_8_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> Animals</h4><div class="NLM_p last">Six- to eight-week-old C57BL/6 mice were purchased from Charles River. Floxed sEH mice (Ephx2tm1.1Arte) were generated by TaconicArtemis GmbH. They were either crossed with Gt(ROSA)26Sortm16(Cre)Arte mice (TaconicArtemis) expressing Cre under the control of the endogenous Gt(ROSA)26Sor promoter to generate mice globally lacking sEH. All animals were housed in conditions that conform to the Guide for the Care and Use of Laboratory Animals published by the NIH (publication no. 85–23). Age- and strain-matched animals (littermates) of both genders were used throughout. Mice were maintained in cages with a 12:12 h light–dark cycle and free access to standard chow and water.</div></div><div id="sec4_8_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Langendorff Perfused Heart Preparation</h4><div class="NLM_p last">The Langendorff perfused heart was performed as previously described.<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(32)</a> Mice were euthanatized with 5% isoflurane. Hearts were excised and immediately placed into heparinized (5 U/ml) ice-cold Krebs–Henseleit buffer containing (in mmol/L) 119.0 NaCl, 11.0 glucose, 22.0 NaHCO<sub>3</sub>, 4.7 KCl, 1.2 KH<sub>2</sub>PO<sub>4</sub>, 1.2 MgSO<sub>4</sub>, 2.5 CaCl<sub>2</sub>, 2.0 pyruvate, and 0.5 EDTA. After removal of the lung and surrounding tissue around the heart, the aorta was rapidly cannulated with a 20 gauge, blunt-ended needle and continuously perfused with 37 °C buffer continuously bubbled with ([95% O<sub>2</sub>]–[5% CO<sub>2</sub>]) at a constant perfusion pressure of 80 mmHg. The left atrium was excised, and a water-filled balloon was inserted into the left ventricle. The balloon was connected to a pressure transducer for continuous measurement of left ventricular developed pressure (LVDP) and heart rate (HR). The heart was then immersed in a water-jacketed perfusate bath (37 °C) and left to beat spontaneously. Left ventricular diastolic pressure was adjusted to 2–5 mmHg. A Power-Lab Chart data acquisition system (AD Instruments, Colorado Springs, CO) was used for data acquisition. Heart was allowed to stabilize for 30 min before initiation of CRH. Subsequently, hearts were treated with solvent or the mentioned compounds for 15 min in a circulating mode. Only hearts whose peak CF increased by more than 2-fold after a 15 s total occlusion were included in the analysis. For coronary reactive hyperemic response, hearts were subjected to 15 s of total occlusion by closing the valve directly above the cannulated heart. For global ischemia/reperfusion experiments, hearts were subjected to 20 min of no flow ischemia followed by 2 h of reperfusion. In the end of the experiment, hearts were washed with 5 mL of triphenyltetrazolium-chloride in PBS cut until 1 mm slices and placed for 15 min at 37 °C. Subsequently, the heart slices were compressed between two histological glass surfaces and scanned. The necrotic areas were visualized by decoloration. ImageJ was used to calculate the infarcted areas.</div></div><div id="sec4_8_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> Epoxide/diol Profiling</h4><div class="NLM_p last">Heart effluents were used, and 14,15-EET and 14,15-DHET were measured as previously described with a Sciex QTrap5500 mass spectrometer operating in multiple-reaction monitoring mode in the negative ionization mode.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(54)</a></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i44"><a href="/doi/suppl/10.1021/acs.jmedchem.0c02063" class="ext-link">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_52144" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_52144" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a href="/doi/10.1021/acs.jmedchem.0c02063?goto=supporting-info" class="ext-link">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02063</a>.<ul class="NLM_list-list_type-label" id="silist"><li><p class="inline">Electropherograms for determination of enantiomeric excess, data collection, and refinement statistics (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_001.pdf" class="ext-link">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_002.csv" class="ext-link">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_001.pdf">jm0c02063_si_001.pdf (463.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_002.csv">jm0c02063_si_002.csv (0.22 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and experimental details for all new crystal structures will be released from the Protein Data Bank upon article publication: sEH in complex with (<i>R</i>)-<b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7G">7A7G</a>), PPARγ in complex with (<i>R</i>)-<b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7H">7A7H</a>).</p><div class="testing" data-doi="10.1021/acs.jmedchem.0c02063" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43374" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43374" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ewgenij Proschak</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Fraunhofer
Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1961-1859" title="Orcid link">http://orcid.org/0000-0003-1961-1859</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#ddadafb2aebeb5bcb69dadb5bcafb0beb5b8b0f3a8b3b4f0bbafbcb3b6bba8afa9f3b9b8"><span class="__cf_email__" data-cfemail="c1b1b3aeb2a2a9a0aa81b1a9a0b3aca2a9a4acefb4afa8eca7b3a0afaaa7b4b3b5efa5a4">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Markus Hartmann</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sofia-Iris Bibli</span> - <span class="hlFld-Affiliation affiliation">Institute
for Vascular Signalling, Centre for Molecular Medicine, Goethe University, D-60596 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Tews</span> - <span class="hlFld-Affiliation affiliation">Division
of Pediatric Endocrinology and Diabetes, Department of Pediatrics
and Adolescent Medicine, Ulm University
Medical Centre, D-89075 Ulm, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaomin Ni</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Theresa Kircher</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan S. Kramer</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Whitney Kilu</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jan Heering</span> - <span class="hlFld-Affiliation affiliation">Fraunhofer
Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4922-1993" title="Orcid link">http://orcid.org/0000-0002-4922-1993</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Victor Hernandez-Olmos</span> - <span class="hlFld-Affiliation affiliation">Fraunhofer
Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, D-60596 Frankfurt, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Lilia Weizel</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gerhard K. E. Scriba</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Friedrich
Schiller University Jena, Philosophenweg 14, D-07743 Jena, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-2950-060X" title="Orcid link">http://orcid.org/0000-0003-2950-060X</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sulaiman Krait</span> - <span class="hlFld-Affiliation affiliation">Department
of Pharmaceutical/Medicinal Chemistry, Friedrich
Schiller University Jena, Philosophenweg 14, D-07743 Jena, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Knapp</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Buchmann
Institute for Molecular Life Sciences, Goethe
University, Max-von-Laue-Strasse 15, D-60438 Frankfurt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0001-5995-6494" title="Orcid link">http://orcid.org/0000-0001-5995-6494</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Apirat Chaikuad</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span>; 
    <span class="hlFld-Affiliation affiliation">Buchmann
Institute for Molecular Life Sciences, Goethe
University, Max-von-Laue-Strasse 15, D-60438 Frankfurt, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0003-1120-2209" title="Orcid link">http://orcid.org/0000-0003-1120-2209</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Daniel Merk</span> - <span class="hlFld-Affiliation affiliation">Institute
of Pharmaceutical Chemistry, Goethe University, Max-von-Laue-Strasse 9, D-60438 Frankfurt am Main, Germany</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5359-8128" title="Orcid link">http://orcid.org/0000-0002-5359-8128</a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ingrid Fleming</span> - <span class="hlFld-Affiliation affiliation">Institute
for Vascular Signalling, Centre for Molecular Medicine, Goethe University, D-60596 Frankfurt am Main, Germany</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pamela Fischer-Posovszky</span> - <span class="hlFld-Affiliation affiliation">Division
of Pediatric Endocrinology and Diabetes, Department of Pediatrics
and Adolescent Medicine, Ulm University
Medical Centre, D-89075 Ulm, Germany</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare the following competing financial interest(s): E.P. has a patent application that covers the composition of matter for dual PPAR/sEH ligands.<br /></br></div></li></ul></div><div class="ack" id="ack1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i47">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_66073" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_66073" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Bruce D. Hammock for kindly providing us the reference sEH inhibitor t-AUCB for ex vivo experiments. A.C. and S.K. are grateful for support by the SGC, a registered charity (no. 1097737) that receives funds from AbbVie, Bayer Pharma AG, Boehringer Ingelheim, Canada Foundation for Innovation, Eshelman Institute for Innovation, Genome Canada, Innovative Medicines Initiative (EU/EFPIA), Janssen, Merck KGaA, Germany, MSD, Novartis Pharma AG, Ontario Ministry of Economic Development and Innovation, Pfizer, São Paulo Research Foundation-FAPESP, Takeda, Wellcome. We acknowledge the Paul Scherrer Institut, Villigen, Switzerland, for provision of synchrotron radiation beamtime at beamline Beamline X06SA of the SLS. This work was supported by the German Research Foundation (DFG, Heisenberg-Professur PR1405/4-2; SFB 1039, TP A06 and A07; SFB 1177) and by research funding program Landes-Offensive zur Entwicklung Wissenschaftlich-ökonomischer Exzellenz (LOEWE) of the State of Hessen, Research Center for Translational Medicine and Pharmacology TMP, and Frankfurt Cancer Centre (FCI), as well as German Cancer Consortium (DKTK). D.T. is supported by the German Research Foundation (DFG, TE912/2–2). P.F.-P. is supported by the German Research Foundation (DFG, Fi1700/5-1; Heisenberg Professorship, Fi1700/7-1). The table of content figure has been designed using resources from <a href="http://Freepik.com" class="extLink">Freepik.com</a>.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">CBP</td><td class="NLM_def"><p class="first last">CREB-binding protein;</p></td></tr><tr><td class="NLM_term">CRH</td><td class="NLM_def"><p class="first last">coronary reactive hyperemia</p></td></tr><tr><td class="NLM_term">EET</td><td class="NLM_def"><p class="first last">epoxy eicosatrienoic acid</p></td></tr><tr><td class="NLM_term">ENaC</td><td class="NLM_def"><p class="first last">epithelial sodium channel</p></td></tr><tr><td class="NLM_term">DHET</td><td class="NLM_def"><p class="first last">dihydroxy eicosatrienoic acid</p></td></tr><tr><td class="NLM_term">DMEM</td><td class="NLM_def"><p class="first last">Dulbecco’s Modified Eagle’s Medium</p></td></tr><tr><td class="NLM_term">DML</td><td class="NLM_def"><p class="first last">designed multitarget ligand</p></td></tr><tr><td class="NLM_term">HBTU</td><td class="NLM_def"><p class="first last">2-(1<i>H</i>-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium hexafluorophosphate</p></td></tr><tr><td class="NLM_term">HTRF</td><td class="NLM_def"><p class="first last">homogeneous time-resolved fluorescence resonance energy transfer</p></td></tr><tr><td class="NLM_term">LBD</td><td class="NLM_def"><p class="first last">ligand binding domain</p></td></tr><tr><td class="NLM_term">LVEDP</td><td class="NLM_def"><p class="first last">left ventricular end diastolic pressure</p></td></tr><tr><td class="NLM_term">LVDP</td><td class="NLM_def"><p class="first last">left ventricular developed pressure</p></td></tr><tr><td class="NLM_term">MetS</td><td class="NLM_def"><p class="first last">metabolic syndrome</p></td></tr><tr><td class="NLM_term">NaHMDS</td><td class="NLM_def"><p class="first last">sodium bis(trimethylsilyl)amide</p></td></tr><tr><td class="NLM_term">PPAR</td><td class="NLM_def"><p class="first last">peroxisome proliferator-activated receptor</p></td></tr><tr><td class="NLM_term">RV</td><td class="NLM_def"><p class="first last">repayment volume</p></td></tr><tr><td class="NLM_term">sEH</td><td class="NLM_def"><p class="first last">soluble epoxide hydrolase</p></td></tr><tr><td class="NLM_term">SGBS</td><td class="NLM_def"><p class="first last">Simpson–Golabi–Behmel syndrome</p></td></tr><tr><td class="NLM_term">sGFP</td><td class="NLM_def"><p class="first last">superfolder gree fluorescent protein</p></td></tr><tr><td class="NLM_term">SHROB</td><td class="NLM_def"><p class="first last">spontaneously hypertensive obese rat</p></td></tr><tr><td class="NLM_term">T2D</td><td class="NLM_def"><p class="first last">type II diabetes</p></td></tr><tr><td class="NLM_term">UQCRC2</td><td class="NLM_def"><p class="first last">ubiquinol-cytochrome C reductase core protein 2</p></td></tr><tr><td class="NLM_term">UCP1</td><td class="NLM_def"><p class="first last">uncoupling protein-1.</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43000" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43000" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 54 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saklayen, M. G.</span></span> <span> </span><span class="NLM_article-title">The global epidemic of the metabolic syndrome</span>. <i>Curr. Hypertens. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.1007/s11906-018-0812-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1007%2Fs11906-018-0812-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=29480368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC1MrltlShug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=12&author=M.+G.+Saklayen&title=The+global+epidemic+of+the+metabolic+syndrome&doi=10.1007%2Fs11906-018-0812-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Global Epidemic of the Metabolic Syndrome</span></div><div class="casAuthors">Saklayen Mohammad G</div><div class="citationInfo"><span class="NLM_cas:title">Current hypertension reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome, variously known also as syndrome X, insulin resistance, etc., is defined by WHO as a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia.  Though there is some variation in the definition by other health care organization, the differences are minor.  With the successful conquest of communicable infectious diseases in most of the world, this new non-communicable disease (NCD) has become the major health hazard of modern world.  Though it started in the Western world, with the spread of the Western lifestyle across the globe, it has become now a truly global problem.  The prevalence of the metabolic syndrome is often more in the urban population of some developing countries than in its Western counterparts.  The two basic forces spreading this malady are the increase in consumption of high calorie-low fiber fast food and the decrease in physical activity due to mechanized transportations and sedentary form of leisure time activities.  The syndrome feeds into the spread of the diseases like type 2 diabetes, coronary diseases, stroke, and other disabilities.  The total cost of the malady including the cost of health care and loss of potential economic activity is in trillions.  The present trend is not sustainable unless a magic cure is found (unlikely) or concerted global/governmental/societal efforts are made to change the lifestyle that is promoting it.  There are certainly some elements in the causation of the metabolic syndrome that cannot be changed but many are amenable for corrections and curtailments.  For example, better urban planning to encourage active lifestyle, subsidizing consumption of whole grains and possible taxing high calorie snacks, restricting media advertisement of unhealthy food, etc.  Revitalizing old fashion healthier lifestyle, promoting old-fashioned foods using healthy herbs rather than oil and sugar, and educating people about choosing healthy/wholesome food over junks are among the steps that can be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnFm2oNMafwjUE-swuRqsHfW6udTcc2eYf0rbQmbU9Gbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrltlShug%253D%253D&md5=c02a7c88c75bedba56a72fcdb6666e7f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11906-018-0812-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-018-0812-z%26sid%3Dliteratum%253Aachs%26aulast%3DSaklayen%26aufirst%3DM.%2BG.%26atitle%3DThe%2520global%2520epidemic%2520of%2520the%2520metabolic%2520syndrome%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2018%26volume%3D20%26spage%3D12%26doi%3D10.1007%2Fs11906-018-0812-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grundy, S. M.</span></span> <span> </span><span class="NLM_article-title">Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1038/nrd2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fnrd2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16582875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVaksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=295-309&author=S.+M.+Grundy&title=Drug+therapy+of+the+metabolic+syndrome%3A+minimizing+the+emerging+crisis+in+polypharmacy&doi=10.1038%2Fnrd2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy</span></div><div class="casAuthors">Grundy, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The metabolic syndrome - a collection of factors assocd. with increased risk for cardiovascular disease and diabetes - is becoming increasingly common, largely as a result of the increase in the prevalence of obesity.  Although it is generally agreed that first-line clin. intervention for the metabolic syndrome is lifestyle change, this is insufficient to normalize the risk factors in many patients, and so residual risk could be high enough to justify drug therapy.  However, at present there are no approved drugs that can reliably reduce all of the metabolic risk factors over the long term, and so there is growing interest in therapeutic strategies that might target multiple risk factors more effectively, thereby minimizing problems with polypharmacy.  This review summarizes current understanding of the nature of the metabolic syndrome, and discusses each of the risk factors of the metabolic syndrome as possible primary drug targets; potential secondary or tertiary targets are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr5GF2KUFU7Vg90H21EOLACvtfcHk0lj7UHmh5dwsKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVaksr4%253D&md5=bc5c9f4b7bf4d81c65cd2e564e350a4a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2005%26sid%3Dliteratum%253Aachs%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26atitle%3DDrug%2520therapy%2520of%2520the%2520metabolic%2520syndrome%253A%2520minimizing%2520the%2520emerging%2520crisis%2520in%2520polypharmacy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D295%26epage%3D309%26doi%3D10.1038%2Fnrd2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masquio, D. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Piano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, R. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanches, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corgosinho, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netto, B. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho-Ferreira, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nascimento, C. M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mello, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tufik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dâmaso, A. R.</span></span> <span> </span><span class="NLM_article-title">The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1920</span>– <span class="NLM_lpage">1930</span>, <span class="refDoi"> DOI: 10.1017/S0007114515001129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1017%2FS0007114515001129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=25907896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2015&pages=1920-1930&author=D.+C.+L.+Masquioauthor=A.+de+Pianoauthor=R.+M.+S.+Camposauthor=P.+L.+Sanchesauthor=J.+Carnierauthor=F.+C.+Corgosinhoauthor=B.+D.+M.+Nettoauthor=J.+P.+Carvalho-Ferreiraauthor=L.+M.+Oyamaauthor=C.+M.+O.+Nascimentoauthor=M.+T.+de+Melloauthor=S.+Tufikauthor=A.+R.+D%C3%A2maso&title=The+role+of+multicomponent+therapy+in+the+metabolic+syndrome%2C+inflammation+and+cardiovascular+risk+in+obese+adolescents&doi=10.1017%2FS0007114515001129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents</span></div><div class="casAuthors">Masquio, Deborah C. L.; de Piano, Aline; Campos, Raquel M. S.; Sanches, Priscila L.; Carnier, June; Corgosinho, Flavia C.; Netto, Barbara D. M.; Carvalho-Ferreira, Joana P.; Oyama, Lila M.; Nascimento, Claudia M. O.; de Mello, Marco T.; Tufik, Sergio; Damaso, Ana R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Nutrition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1920-1930</span>CODEN:
                <span class="NLM_cas:coden">BJNUAV</span>;
        ISSN:<span class="NLM_cas:issn">0007-1145</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Obesity is characterized by low-grade inflammation, which increases the metabolic syndrome (MetS) and cardiovascular risks.  The aim of the present study was to verify the role of multicomponent therapy in controlling the MetS, inflammation and carotid intima-media thickness (cIMT) in obese adolescents.  The second aim was to investigate the relationships between adipokines, the MetS parameters and cIMT.  A total of sixty-nine obese adolescents participated in the present study and completed 1 yr of multicomponent therapy (a combination of strategies involving nutrition, psychol., phys. exercise and clin. therapy), and were divided according to their MetS diagnosis as follows: MetS (n 19); non-MetS (n 50).  Blood analyses of glucose, lipid and adipokine concns. (adiponectin, leptin, plasminogen activator inhibitor 1 (PAI-1) and C-reactive protein) were collected.  Insulin resistance was assessed using the homeostasis model assessment for insulin resistance, quant. insulin sensitivity check index and homeostasis model assessment-adiponectin. cIMT and visceral and s.c. fat were estd. using ultrasonog.  At baseline, the MetS group presented higher waist circumference, glucose and insulin levels, and systolic and median blood pressures compared with the non-MetS group.  After therapy, both groups showed improvements in the anthropometric profile, body compn., insulin level, insulin resistance, insulin sensibility, TAG and VLDL-cholesterol, adiponectin, leptin and PAI-1 levels, blood pressure and cIMT.  The prevalence of the MetS was reduced from 27·5 to 13·0 %.  Metabolic syndrome patients showed resistance in the attenuation of total cholesterol and LDL-cholesterol (LDL-C) levels and leptin:adiponectin and adiponectin:leptin ratios.  In the MetS group, the variation in the adiponectin:leptin ratio was correlated with variations in glucose, insulin sensibility, total cholesterol, LDL-c and systolic blood pressure.  Addnl., the no. of MetS parameters was correlated with the carotid measurement.  Moreover, the variation in cIMT was correlated with the variations in insulin sensibility, total cholesterol and LDL-c.  For the entire group, the no. of MetS alterations was correlated with the leptin level and leptin:adiponectin ratio and adiponectin:leptin ratio after therapy.  In conclusion, multicomponent therapy was effective in controlling the MetS, inflammation and cIMT in the obese adolescents.  However, the MetS patients showed resistance in the attenuation of the atherogenic lipid profile and leptin:adiponectin ratio and adiponectin:leptin ratio.  These results suggest that the MetS patients have increased cardiovascular risks, and that it is important to attempt to control the inflammatory process that occurs due to obesity in clin. practice in order to improve the health of adolescents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwQ2CPRJqyybVg90H21EOLACvtfcHk0lj7UHmh5dwsKw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FL&md5=c50ee408c995b7a6069d52b146113dbb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1017%2FS0007114515001129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114515001129%26sid%3Dliteratum%253Aachs%26aulast%3DMasquio%26aufirst%3DD.%2BC.%2BL.%26aulast%3Dde%2BPiano%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DR.%2BM.%2BS.%26aulast%3DSanches%26aufirst%3DP.%2BL.%26aulast%3DCarnier%26aufirst%3DJ.%26aulast%3DCorgosinho%26aufirst%3DF.%2BC.%26aulast%3DNetto%26aufirst%3DB.%2BD.%2BM.%26aulast%3DCarvalho-Ferreira%26aufirst%3DJ.%2BP.%26aulast%3DOyama%26aufirst%3DL.%2BM.%26aulast%3DNascimento%26aufirst%3DC.%2BM.%2BO.%26aulast%3Dde%2BMello%26aufirst%3DM.%2BT.%26aulast%3DTufik%26aufirst%3DS.%26aulast%3DD%25C3%25A2maso%26aufirst%3DA.%2BR.%26atitle%3DThe%2520role%2520of%2520multicomponent%2520therapy%2520in%2520the%2520metabolic%2520syndrome%252C%2520inflammation%2520and%2520cardiovascular%2520risk%2520in%2520obese%2520adolescents%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2015%26volume%3D113%26spage%3D1920%26epage%3D1930%26doi%3D10.1017%2FS0007114515001129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheen, A. J.</span></span> <span> </span><span class="NLM_article-title">Management of the metabolic syndrome</span>. <i>Minerva Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=15257254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BD2czltlOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=31-45&author=A.+J.+Scheen&title=Management+of+the+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Management of the metabolic syndrome</span></div><div class="casAuthors">Scheen A J</div><div class="citationInfo"><span class="NLM_cas:title">Minerva endocrinologica</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">31-45</span>
        ISSN:<span class="NLM_cas:issn">0391-1977</span>.
    </div><div class="casAbstract">The metabolic syndrome (MetS) is strongly associated with insulin resistance and consists of a constellation of factors that raise the risk for cardiovascular diseases and diabetes mellitus.  Therefore, the primary goals of treating MetS are prevention of type 2 diabetes and cardiovascular events.  Three levels of intervention may be considered for individuals with MetS : 1) management of underlying risk conditions by controlling weight excess, enhancing regular physical exercise and promoting healthy diet; 2) management of individual risk factors such as dyslipidaemia, hypertension, hyperglycaemia and prothrombotic state; and 3) targeting insulin resistance by using specific insulin sensitizers such as thiazolidinediones.  The most important therapeutic intervention effective in subjects with MetS should focus on modest weight reduction and regular leisure-time physical activities.  Although lifestyle modification is the first-line therapy, drug therapy may be necessary in many patients to achieve recommended goals regarding lipid profile, blood pressure and blood glucose control.  Rather than to use a magic bullet that might fully reverse the underlying cause of the syndrome, one appealing alternative would be to use a so-called "polypill" targeting each of the components of MetS.  However, such a polypill should ideally contain numerous molecules that all have shown a potential interest for the management of MetS such as metformin, acarbose, a thiazolidinedione, a statin, a fibrate, an inhibitor of the renin-angiotensin system, aspirin.  The growing prevalence and high-risk nature of MetS highlights the need to identify individuals with this condition and to treat them with an aggressive multitargeted approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvHJ3qSMrH5D0O18WR3iAofW6udTcc2eaJfQEvF_Cbk7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltlOqsA%253D%253D&md5=10a02189186d78c97e73c7a038585ce8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScheen%26aufirst%3DA.%2BJ.%26atitle%3DManagement%2520of%2520the%2520metabolic%2520syndrome%26jtitle%3DMinerva%2520Endocrinol.%26date%3D2004%26volume%3D29%26spage%3D31%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artasensi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumagalli, L.</span></span> <span> </span><span class="NLM_article-title">Type 2 Diabetes Mellitus: A review of multi-target drugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1987</span>, <span class="refDoi"> DOI: 10.3390/molecules25081987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.3390%2Fmolecules25081987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVekurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=1987&author=A.+Artasensiauthor=A.+Pedrettiauthor=G.+Vistoliauthor=L.+Fumagalli&title=Type+2+Diabetes+Mellitus%3A+A+review+of+multi-target+drugs&doi=10.3390%2Fmolecules25081987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Type 2 diabetes mellitus: a review of multi-target drugs</span></div><div class="casAuthors">Artasensi, Angelica; Pedretti, Alessandro; Vistoli, Giulio; Fumagalli, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1987</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Diabetes Mellitus (DM) is a multi-factorial chronic health condition that affects a large part of population and according to the World Health Organization (WHO) the no. of adults living with diabetes is expected to increase.  Since type 2 diabetes mellitus (T2DM) is suffered by the majority of diabetic patients (around 90-95%) and often the mono-target therapy fails in managing blood glucose levels and the other comorbidities, this review focuses on the potential drugs acting on multi-targets involved in the treatment of this type of diabetes.  In particular, the review considers the main systems directly involved in T2DM or involved in diabetes comorbidities.  Agonists acting on incretin, glucagon systems, as well as on peroxisome proliferation activated receptors are considered.  Inhibitors which target either aldose reductase and tyrosine phosphatase 1B or sodium glucose transporters 1 and 2 are taken into account.  Moreover, with a view at the multi-target approaches for T2DM some phytocomplexes are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXBBSvnXojZrVg90H21EOLACvtfcHk0lhfmksH1K3NaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVekurvM&md5=322b179431f83be70a49934d0408fdca</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25081987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25081987%26sid%3Dliteratum%253Aachs%26aulast%3DArtasensi%26aufirst%3DA.%26aulast%3DPedretti%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DFumagalli%26aufirst%3DL.%26atitle%3DType%25202%2520Diabetes%2520Mellitus%253A%2520A%2520review%2520of%2520multi-target%2520drugs%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D1987%26doi%3D10.3390%2Fmolecules25081987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammazzalorso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccallini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, R.</span></span> <span> </span><span class="NLM_article-title">Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.ejmech.2019.04.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=31009912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXot1Sqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2019&pages=261-273&author=A.+Ammazzalorsoauthor=C.+Maccalliniauthor=P.+Amoiaauthor=R.+Amoroso&title=Multitarget+PPAR%CE%B3+agonists+as+innovative+modulators+of+the+metabolic+syndrome&doi=10.1016%2Fj.ejmech.2019.04.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome</span></div><div class="casAuthors">Ammazzalorso, Alessandra; Maccallini, Cristina; Amoia, Pasquale; Amoroso, Rosa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A multitarget pharmacol. approach could be advantageous for the therapy of metabolic multiple diseases, such as the metabolic syndrome, which is characterized by metabolic abnormalities assocd. with diabetes, obesity, hypertension, and increased cardiovascular risk.  PPAR receptors play a crit. role in metabolic disorders, affecting glucose and lipid metab.  Drugs simultaneously targeting PPAR and other validated metabolic targets, represent a promising multitarget approach to combine antihyperglycemic, antihyperlipidemic, and antihypertensive effects.  This review offers a survey of recently developed multitarget PPARγ agonists as antidiabetic and antihypertensive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-jgSct1kWrVg90H21EOLACvtfcHk0lhfmksH1K3NaA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXot1Sqtbw%253D&md5=505cfff367fe74704ef5f2c7a27719ec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.030%26sid%3Dliteratum%253Aachs%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DMaccallini%26aufirst%3DC.%26aulast%3DAmoia%26aufirst%3DP.%26aulast%3DAmoroso%26aufirst%3DR.%26atitle%3DMultitarget%2520PPAR%25CE%25B3%2520agonists%2520as%2520innovative%2520modulators%2520of%2520the%2520metabolic%2520syndrome%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D173%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ejmech.2019.04.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, M.</span></span> <span> </span><span class="NLM_article-title">The roles of peroxisome proliferator-activated receptors in the metabolic syndrome</span>. <i>Prog. Mol. Biol. Transl Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-800101-1.00007-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2FB978-0-12-800101-1.00007-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24373239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVyru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2014&pages=217-266&author=M.+Mansour&title=The+roles+of+peroxisome+proliferator-activated+receptors+in+the+metabolic+syndrome&doi=10.1016%2FB978-0-12-800101-1.00007-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of peroxisome proliferator-activated receptors in the metabolic syndrome</span></div><div class="casAuthors">Mansour, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Molecular Biology and Translational Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus</span>),
    <span class="NLM_cas:pages">217-266</span>CODEN:
                <span class="NLM_cas:coden">PNARC5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The epidemic of obesity and its assocn. with insulin resistance, glucose intolerance, hypertension, and dyslipidemia, collectively known as the metabolic syndrome or syndrome X, is one of the most challenging health problems facing industrialized countries.  The nuclear receptors, peroxisome proliferator-activated receptors (PPARs alpha (α), beta (β) also known as delta (δ), and gamma (γ)), have well-documented roles in lipid and glucose metab.  Pharmacol., PPARα is activated by fibrate hypolipidemic drugs, whereas PPARγ is activated by insulin sensitizers thiazolidinediones (TZDs).  No marketed drug is yet available for PPARβ(δ).  The identification of fibrates and TZDs as resp. ligands for PPARα and PPARγ was a groundbreaking finding that sparked notable pharmaceutical interest in PPARs as potential drug targets for treatment of the metabolic syndrome.  Limiting side effects assocd. with clin. use of TZDs have emerged in recent years.  New and novel PPAR drugs with broad safety margins and therapeutic potentials for the metabolic syndrome are in development.  These include partial, dual, or pan PPAR agonists; PPAR antagonists; and selective PPAR modulators.  The objective of this chapter is to highlight the therapeutic benefits of targeting more than one PPAR subtype in the treatment of the metabolic syndrome.  The pros and cons obsd. during clin. use of TZDs and the strategies and progress made in the prodn. of new generations of safe and effective PPAR ligands are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWkbaPrTcBRLVg90H21EOLACvtfcHk0lifePXiXpU3uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVyru7k%253D&md5=a7429187568000b6fef10914d0ae67b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-800101-1.00007-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-800101-1.00007-7%26sid%3Dliteratum%253Aachs%26aulast%3DMansour%26aufirst%3DM.%26atitle%3DThe%2520roles%2520of%2520peroxisome%2520proliferator-activated%2520receptors%2520in%2520the%2520metabolic%2520syndrome%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl%2520Sci.%26date%3D2014%26volume%3D121%26spage%3D217%26epage%3D266%26doi%3D10.1016%2FB978-0-12-800101-1.00007-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFronzo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Ghani, M.</span></span> <span> </span><span class="NLM_article-title">In Vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion</span>. <i>Diabetes Care</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">S162</span>– <span class="NLM_lpage">S174</span>, <span class="refDoi"> DOI: 10.2337/dcS13-2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.2337%2FdcS13-2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=23882042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2ksrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=S162-S174&author=R.+Eldorauthor=R.+A.+DeFronzoauthor=M.+Abdul-Ghani&title=In+Vivo+actions+of+peroxisome+proliferator-activated+receptors%3A+glycemic+control%2C+insulin+sensitivity%2C+and+insulin+secretion&doi=10.2337%2FdcS13-2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion</span></div><div class="casAuthors">Eldor, Roy; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Care</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S162-S174</span>CODEN:
                <span class="NLM_cas:coden">DICAD2</span>;
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">A review.  Troglitazone also was shown to improve endothelial dysfunction in obesity and T2DM, induce ovulation in PCOS, and effectively treat lipodystrophy.  This article describes the in vivo actions of peroxisome proliferator-activated receptors (PPARs).  PPARγ agonists, thiazolidinediones, are potent insulin sensitizers, enhance insulin secretion and improve glucose tolerance are focused.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoasSu_DODI-LVg90H21EOLACvtfcHk0lifePXiXpU3uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2ksrrI&md5=6487c51b2ef0de5711e8f966bdc2fc1b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2337%2FdcS13-2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252FdcS13-2003%26sid%3Dliteratum%253Aachs%26aulast%3DEldor%26aufirst%3DR.%26aulast%3DDeFronzo%26aufirst%3DR.%2BA.%26aulast%3DAbdul-Ghani%26aufirst%3DM.%26atitle%3DIn%2520Vivo%2520actions%2520of%2520peroxisome%2520proliferator-activated%2520receptors%253A%2520glycemic%2520control%252C%2520insulin%2520sensitivity%252C%2520and%2520insulin%2520secretion%26jtitle%3DDiabetes%2520Care%26date%3D2013%26volume%3D36%26spage%3DS162%26epage%3DS174%26doi%3D10.2337%2FdcS13-2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span>. <i>Exp. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">758614</span>, <span class="refDoi"> DOI: 10.1155/2012/758614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1155%2F2012%2F758614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=22007192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=758614&author=A.+Iyerauthor=K.+Kauterauthor=M.+A.+Alamauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=L.+Brown&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+ameliorates+diet-induced+metabolic+syndrome+in+rats&doi=10.1155%2F2012%2F758614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span></div><div class="casAuthors">Iyer Abishek; Kauter Kathleen; Alam Md Ashraful; Hwang Sung Hee; Morisseau Christophe; Hammock Bruce D; Brown Lindsay</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">758614</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signs of metabolic syndrome following chronic excessive macronutrient intake include body weight gain, excess visceral adipose deposition, hyperglycaemia, glucose and insulin intolerances, hypertension, dyslipidaemia, endothelial damage, cardiovascular hypertrophy, inflammation, ventricular contractile dysfunction, fibrosis, and fatty liver disease.  Recent studies show increased activity of soluble epoxide hydrolase (sEH) during obesity and metabolic dysfunction.  We have tested whether sEH inhibition has therapeutic potential in a rat model of diet-induced metabolic syndrome.  In these high-carbohydrate, high-fat-fed rats, chronic oral treatment with trans-4-[4-(3-adamantan-1-ylureido)-cyclohexyloxy]-benzoic acid (t-AUCB), a potent sEH inhibitor, alleviated the signs of metabolic syndrome in vivo including glucose, insulin, and lipid abnormalities, changes in pancreatic structure, increased systolic blood pressure, cardiovascular structural and functional abnormalities, and structural and functional changes in the liver.  The present study describes the pharmacological responses to this selective sEH inhibitor in rats with the signs of diet-induced metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1vi0lpx2a9IJKJbLTgsvCfW6udTcc2eYfcojIaoEV_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D&md5=225f1e58564b2942facc133619680a62</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2012%2F758614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F758614%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DKauter%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DM.%2BA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBrown%26aufirst%3DL.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520ameliorates%2520diet-induced%2520metabolic%2520syndrome%2520in%2520rats%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2012%26volume%3D2012%26spage%3D758614%26doi%3D10.1155%2F2012%2F758614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanne, J. H.</span></span> <span> </span><span class="NLM_article-title">FDA Places “Black Box” warning on antidiabetes drugs</span>. <i>BMJ</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">1237</span>, <span class="refDoi"> DOI: 10.1136/bmj.39244.394456.DB</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1136%2Fbmj.39244.394456.DB" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=17569906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BD2szlsVygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2007&pages=1237&author=J.+H.+Tanne&title=FDA+Places+%E2%80%9CBlack+Box%E2%80%9D+warning+on+antidiabetes+drugs&doi=10.1136%2Fbmj.39244.394456.DB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">FDA places "black box" warning on antidiabetes drugs</span></div><div class="casAuthors">Tanne Janice Hopkins</div><div class="citationInfo"><span class="NLM_cas:title">BMJ (Clinical research ed.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">7606</span>),
    <span class="NLM_cas:pages">1237</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTaMDxcpb8CTEC-75aqa5AfW6udTcc2eYfcojIaoEV_Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szlsVygsg%253D%253D&md5=9c80d2778494351320db01b3f324345a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1136%2Fbmj.39244.394456.DB&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.39244.394456.DB%26sid%3Dliteratum%253Aachs%26aulast%3DTanne%26aufirst%3DJ.%2BH.%26atitle%3DFDA%2520Places%2520%25E2%2580%259CBlack%2520Box%25E2%2580%259D%2520warning%2520on%2520antidiabetes%2520drugs%26jtitle%3DBMJ%26date%3D2007%26volume%3D334%26spage%3D1237%26doi%3D10.1136%2Fbmj.39244.394456.DB" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goltsman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winaver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abassi, Z.</span></span> <span> </span><span class="NLM_article-title">Does thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.pharmthera.2016.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=27598860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOqur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2016&pages=75-97&author=I.+Goltsmanauthor=E.+E.+Khouryauthor=J.+Winaverauthor=Z.+Abassi&title=Does+thiazolidinedione+therapy+exacerbate+fluid+retention+in+congestive+heart+failure%3F&doi=10.1016%2Fj.pharmthera.2016.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?</span></div><div class="casAuthors">Goltsman, Ilia; Khoury, Emad E.; Winaver, Joseph; Abassi, Zaid</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-97</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The ever-growing global burden of congestive heart failure (CHF) and type 2 diabetes mellitus (T2DM) as well as their co-existence necessitate that anti-diabetic pharmacotherapy will modulate the cardiovascular risk inherent to T2DM while complying with the accompanying restrictions imposed by CHF.  The thiazolidinedione (TZD) family of peroxisome proliferator-activated receptor γ (PPARγ) agonists initially provided a promising therapeutic option in T2DM owing to anti-diabetic efficacy combined with pleiotropic beneficial cardiovascular effects.  However, the utility of TZDs in T2DM has declined in the past decade, largely due to concomitant adverse effects of fluid retention and edema formation attributed to salt-retaining effects of PPARγ activation on the nephron.  Presumably, the latter effects are potentially deleterious in the context of pre-existing fluid retention in CHF.  However, despite a considerable body of evidence on mechanisms responsible for TZD-induced fluid retention suggesting that this class of drugs is rightfully prohibited from use in CHF patients, there is a paucity of exptl. and clin. studies that investigate the effects of TZDs on salt and water homeostasis in the CHF setting.  In an attempt to elucidate whether TZDs actually exacerbate the pre-existing fluid retention in CHF, our review summarizes the pathophysiol. of fluid retention in CHF.  Moreover, we thoroughly review the available data on TZD-induced fluid retention and proposed mechanisms in animals and patients.  Finally, we will present recent studies challenging the common notion that TZDs worsen renal salt and water retention in CHF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn2ZHQfnXqSLVg90H21EOLACvtfcHk0li2cbSkAF379Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOqur7I&md5=1241f6509961d4acd375f0f2fac0cb9c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DGoltsman%26aufirst%3DI.%26aulast%3DKhoury%26aufirst%3DE.%2BE.%26aulast%3DWinaver%26aufirst%3DJ.%26aulast%3DAbassi%26aufirst%3DZ.%26atitle%3DDoes%2520thiazolidinedione%2520therapy%2520exacerbate%2520fluid%2520retention%2520in%2520congestive%2520heart%2520failure%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D168%26spage%3D75%26epage%3D97%26doi%3D10.1016%2Fj.pharmthera.2016.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohan, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breyer, M. D.</span></span> <span> </span><span class="NLM_article-title">Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1038/nm1278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fnm1278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16007095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=861-866&author=Y.+Guanauthor=C.+Haoauthor=D.+R.+Chaauthor=R.+Raoauthor=W.+Luauthor=D.+E.+Kohanauthor=M.+A.+Magnusonauthor=R.+Redhaauthor=Y.+Zhangauthor=M.+D.+Breyer&title=Thiazolidinediones+expand+body+fluid+volume+through+PPARgamma+stimulation+of+ENaC-mediated+renal+salt+absorption&doi=10.1038%2Fnm1278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption</span></div><div class="casAuthors">Guan, YouFei; Hao, Chuanming; Cha, Dae Ryong; Rao, Reena; Lu, Wendell; Kohan, Donald E.; Magnuson, Mark A.; Redha, Reyadh; Zhang, Yahua; Breyer, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">861-866</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thiazolidinediones (TZDs) are widely used to treat type 2 diabetes mellitus; however, their use is complicated by systemic fluid retention.  Along the nephron, the pharmacol. target of TZDs, peroxisome proliferator-activated receptor-γ (PPARγ, encoded by Pparg), is most abundant in the collecting duct.  Here we show that mice treated with TZDs experience early wt. gain from increased total body water.  Wt. gain was blocked by the collecting duct-specific diuretic amiloride and was also prevented by deletion of Pparg from the collecting duct, using Pparg flox/flox mice.  Deletion of collecting duct Pparg decreased renal Na+ avidity and increased plasma aldosterone.  Treating cultured collecting ducts with TZDs increased amiloride-sensitive Na+ absorption and Scnn1g mRNA (encoding the epithelial Na+ channel ENaCγ) expression through a PPARγ-dependent pathway.  These studies identify Scnn1g as a PPARγ target gene in the collecting duct.  Activation of this pathway mediates fluid retention assocd. with TZDs, and suggests amiloride might provide a specific therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT0K7RMD2IPLVg90H21EOLACvtfcHk0li2cbSkAF379Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFemsLY%253D&md5=783b458ea599055391ed0c1f050ad9e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnm1278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1278%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DCha%26aufirst%3DD.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DKohan%26aufirst%3DD.%2BE.%26aulast%3DMagnuson%26aufirst%3DM.%2BA.%26aulast%3DRedha%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBreyer%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520expand%2520body%2520fluid%2520volume%2520through%2520PPARgamma%2520stimulation%2520of%2520ENaC-mediated%2520renal%2520salt%2520absorption%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D861%26epage%3D866%26doi%3D10.1038%2Fnm1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidkovka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">4377</span>– <span class="NLM_lpage">4386</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.508416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1074%2Fjbc.M113.508416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24368771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFWhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4377-4386&author=J.+H.+Capdevilaauthor=N.+Pidkovkaauthor=S.+Meiauthor=Y.+Gongauthor=J.+R.+Falckauthor=J.+D.+Imigauthor=R.+C.+Harrisauthor=W.+Wang&title=The+Cyp2c44+epoxygenase+regulates+epithelial+sodium+channel+activity+and+the+blood+pressure+responses+to+increased+dietary+salt&doi=10.1074%2Fjbc.M113.508416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Cyp2c44 Epoxygenase Regulates Epithelial Sodium Channel Activity and the Blood Pressure Responses to Increased Dietary Salt</span></div><div class="casAuthors">Capdevila, Jorge H.; Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Falck, John R.; Imig, John D.; Harris, Raymond C.; Wang, Wenhui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4377-4386</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypertension is a major risk factor for cerebral, cardiovascular, and renal disease, and its prevalence and devastating consequences raises a need for new strategies for its early diagnosis and treatment.  We show here that lack of a Cyp2c44 epoxygenase causes dietary salt-sensitive hypertension, a common form of the human disease.  Cyp2c44(-/-) mice on normal salt diets are normotensive but become hypertensive when fed high salt.  Hypertensive Cyp2c44(-/-) mice show a hyperactive kidney epithelial sodium channel (ENaC) and redns. in ERK1/2 and ENaC subunit phosphorylation.  The demonstration that amiloride, an ENaC inhibitor, lowers the blood pressure of hypertensive Cyp2c44(-/-) mice identifies a role for the channel in the hypertensive phenotype of the animals.  These studies: (a) identify an antihypertensive role for the kidney Cyp2c44 epoxygenase and for its epoxyeicosatrienoic acid (EET) metabolites in the in vivo control of ENaC activity and the activation of mitogenic kinase pathways; (b) provide evidence for a Cyp2c44 epoxygenase, EET-mediated mechanism of ENaC regulation involving an ERK1/2-catalyzed threonine phosphorylation of the channel γ subunit: and (c) characterize a common scientific platform that could explain the seemingly unrelated biol. activities attributed to the epoxygenase metabolites in cell proliferation, angiogenesis, channel activity, and blood pressure control.  It is expected that these results will serve as a basis for the development of novel strategies for the early diagnosis and treatment of hypertension and of pathophysiologies assocd. with dysfunctional mitogenic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23ueUEHF7RbVg90H21EOLACvtfcHk0li2cbSkAF379Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFWhtbY%253D&md5=b8577bad7b9ee3f3002c40259f0a931b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.508416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.508416%26sid%3Dliteratum%253Aachs%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DPidkovka%26aufirst%3DN.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DThe%2520Cyp2c44%2520epoxygenase%2520regulates%2520epithelial%2520sodium%2520channel%2520activity%2520and%2520the%2520blood%2520pressure%2520responses%2520to%2520increased%2520dietary%2520salt%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4377%26epage%3D4386%26doi%3D10.1074%2Fjbc.M113.508416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlov, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christain, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckář, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staruschenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1042/CS20130479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1042%2FCS20130479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24707975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGhurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=463-474&author=M.+A.+H.+Khanauthor=T.+S.+Pavlovauthor=S.+V.+Christainauthor=J.+Neck%C3%A1%C5%99author=A.+Staruschenkoauthor=K.+M.+Gauthierauthor=J.+H.+Capdevilaauthor=J.+R.+Falckauthor=W.+B.+Campbellauthor=J.+D.+Imig&title=Epoxyeicosatrienoic+acid+analogue+lowers+blood+pressure+through+vasodilation+and+sodium+channel+inhibition&doi=10.1042%2FCS20130479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition</span></div><div class="casAuthors">Khan, Md. Abdul Hye; Pavlov, Tengis S.; Christain, Sarah V.; Neckar, Jan; Staruschenko, Alexander; Gauthier, Kathryn M.; Capdevila, Jorge H.; Falck, John R.; Campbell, William B.; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">463-474</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) contribute to hemodynamics, electrolyte homeostasis, and blood pressure regulation, leading to the concept that EETs can be therapeutically targeted for hypertension.  In the present study, multiple structural EET analogs were synthesized based on the EET pharmacophore and vasodilator structure-activity studies.  Four EET analogs with 91-119% vasodilatory activity in the isolated bovine coronary artery (EC50: 0.18-1.6 μM) were identified and studied for blood-pressure-lowering in hypertension.  Two EET analogs in which the COOH group at carbon 1 of the EET pharmacophore was replaced with either an aspartic acid (EET-A) or a heterocyclic surrogate (EET-X) were administered for 14 days [10 mg/kg per day i.p.].  Both EET-A and EET-X lowered blood pressure in spontaneously hypertensive rats (SHRs) and in angiotensin II (AngII) hypertension.  On day 14, the mean arterial pressures in EET analog-treated AngII-hypertensive and SHRs were 30-50 mm Hg (EET-A) and 15-20 mm Hg (EET-X) lower than those in vehicle-treated controls.  These EET analogs (10 mg/kg per day) were further tested in AngII hypertension by administering orally in drinking water for 14 days and EET-A lowered blood pressure.  Addnl. expts. demonstrated that EET-A inhibits epithelial sodium channel (ENaC) activity in cultured cortical collecting duct cells and reduced renal expression of ENaC subunits in AngII hypertension.  In conclusion, we have characterized EET-A as an orally active antihypertensive EET analog that protects vascular endothelial function and has ENaC inhibitory activity in AngII hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVcQSUHDf_07Vg90H21EOLACvtfcHk0lhx5BoxaDsXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGhurzI&md5=2b4f6e9877a4a077fefd9f08ee3141be</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1042%2FCS20130479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20130479%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BA.%2BH.%26aulast%3DPavlov%26aufirst%3DT.%2BS.%26aulast%3DChristain%26aufirst%3DS.%2BV.%26aulast%3DNeck%25C3%25A1%25C5%2599%26aufirst%3DJ.%26aulast%3DStaruschenko%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DK.%2BM.%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DEpoxyeicosatrienoic%2520acid%2520analogue%2520lowers%2520blood%2520pressure%2520through%2520vasodilation%2520and%2520sodium%2520channel%2520inhibition%26jtitle%3DClin.%2520Sci.%26date%3D2014%26volume%3D127%26spage%3D463%26epage%3D474%26doi%3D10.1042%2FCS20130479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Islam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razdan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamdar, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen
Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">e12259</span>, <span class="refDoi"> DOI: 10.1111/1755-5922.12259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1111%2F1755-5922.12259" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=e12259&author=O.+Islamauthor=P.+Patilauthor=S.+K.+Goswamiauthor=R.+Razdanauthor=M.+N.+Inamdarauthor=M.+Rizwanauthor=J.+Mathewauthor=B.+Inceogluauthor=K.+S.+Stephen%0ALeeauthor=S.+H.+Hwangauthor=B.+D.+Hammock&title=Inhibitors+of+soluble+epoxide+hydrolase+minimize+ischemia-reperfusion-induced+cardiac+damage+in+normal%2C+hypertensive%2C+and+diabetic+rats&doi=10.1111%2F1755-5922.12259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2F1755-5922.12259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1755-5922.12259%26sid%3Dliteratum%253Aachs%26aulast%3DIslam%26aufirst%3DO.%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DGoswami%26aufirst%3DS.%2BK.%26aulast%3DRazdan%26aufirst%3DR.%26aulast%3DInamdar%26aufirst%3DM.%2BN.%26aulast%3DRizwan%26aufirst%3DM.%26aulast%3DMathew%26aufirst%3DJ.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DStephen%2BLee%26aufirst%3DK.%2BS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DInhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520minimize%2520ischemia-reperfusion-induced%2520cardiac%2520damage%2520in%2520normal%252C%2520hypertensive%252C%2520and%2520diabetic%2520rats%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2017%26volume%3D35%26spage%3De12259%26doi%3D10.1111%2F1755-5922.12259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Froogh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alruwaili, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, A.</span></span> <span> </span><span class="NLM_article-title">The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>318</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">H985</span>– <span class="NLM_lpage">H993</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00633.2019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajpheart.00633.2019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=32167781" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2020&pages=H985-H993&issue=4&author=G.+Frooghauthor=S.+Kandhiauthor=R.+Duvviauthor=Y.+Leauthor=Z.+Wengauthor=N.+Alruwailiauthor=J.+O.+Asheauthor=D.+Sunauthor=A.+Huang&title=The+contribution+of+chymase-dependent+formation+of+ANG+II+to+cardiac+dysfunction+in+metabolic+syndrome+of+young+rats%3A+roles+of+fructose+and+EETs&doi=10.1152%2Fajpheart.00633.2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00633.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00633.2019%26sid%3Dliteratum%253Aachs%26aulast%3DFroogh%26aufirst%3DG.%26aulast%3DKandhi%26aufirst%3DS.%26aulast%3DDuvvi%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DY.%26aulast%3DWeng%26aufirst%3DZ.%26aulast%3DAlruwaili%26aufirst%3DN.%26aulast%3DAshe%26aufirst%3DJ.%2BO.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DA.%26atitle%3DThe%2520contribution%2520of%2520chymase-dependent%2520formation%2520of%2520ANG%2520II%2520to%2520cardiac%2520dysfunction%2520in%2520metabolic%2520syndrome%2520of%2520young%2520rats%253A%2520roles%2520of%2520fructose%2520and%2520EETs%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2020%26volume%3D318%26issue%3D4%26spage%3DH985%26epage%3DH993%26doi%3D10.1152%2Fajpheart.00633.2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, M. A.</span></span> <span> </span><span class="NLM_article-title">Effect of soluble epoxide hydrolase on the modulation of coronary reactive hyperemia: role of oxylipins and PPARγ</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>), <span class="NLM_elocation-id">e0162147</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0162147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1371%2Fjournal.pone.0162147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=27583776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFKjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&issue=9&author=A.+Hanifauthor=M.+L.+Edinauthor=D.+C.+Zeldinauthor=C.+Morisseauauthor=M.+A.+Nayeem&title=Effect+of+soluble+epoxide+hydrolase+on+the+modulation+of+coronary+reactive+hyperemia%3A+role+of+oxylipins+and+PPAR%CE%B3&doi=10.1371%2Fjournal.pone.0162147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of soluble epoxide hydrolase on the modulation of coronary reactive hyperemia: role of oxylipins and PPARγ</span></div><div class="casAuthors">Hanif, Ahmad; Edin, Matthew L.; Zeldin, Darryl C.; Morisseau, Christophe; Nayeem, Mohammed A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0162147/1-e0162147/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Coronary reactive hyperemia (CRH) is a physiol. response to ischemic insult that prevents the potential harm assocd. with an interruption of blood supply.  The relationship between the pharmacol. inhibition of sol. epoxide hydrolase (sEH) and CRH response to a brief ischemia is not known.  SEH is involved in the main catabolic pathway of epoxyeicosatrienoic acids (EETs), which are converted into dihydroxyeicosatrienoic acids (DHETs).  EETs protect against ischemia/reperfusion injury and have numerous beneficial physiol. effects.  We hypothesized that inhibition of sEH by t-AUCB enhances CRH in isolated mouse hearts through changing the oxylipin profiles, including an increase in EETs/DHETs ratio.  Compared to controls, t-AUCB-treated mice had increased CRH, including repayment vol. (RV), repayment duration, and repayment/debt ratio (p < 0.05).  Treatment with t-AUCB significantly changed oxylipin profiles, including an increase in EET/DHET ratio, increase in EpOME/DiHOME ratio, increase in the levels of HODEs, decrease in the levels of mid-chain HETEs, and decrease in prostanoids (p < 0.05).  Treatment with MS-PPOH (CYP epoxygenase inhibitor) reduced CRH, including RV (p < 0.05).  Involvement of PPARγ in the modulation of CRH was demonstrated using a PPARγ-antagonist (T0070907) and a PPARγ-agonist (rosiglitazone).  T0070907 reduced CRH (p < 0.05), whereas rosiglitazone enhanced CRH (p < 0.05) in isolated mouse hearts compared to the non-treated.  These data demonstrate that sEH inhibition enhances, whereas CYP epoxygenases- inhibition attenuates CRH, PPARγ mediate CRH downstream of the CYP epoxygenases- EET pathway, and the changes in oxylipin profiles assocd. with sEH-inhibition collectively contributed to the enhanced CRH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvJtAwIDhKO7Vg90H21EOLACvtfcHk0lhx5BoxaDsXGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFKjsbk%253D&md5=ca0c403dec657b9e0106b2f973dbf878</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0162147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0162147%26sid%3Dliteratum%253Aachs%26aulast%3DHanif%26aufirst%3DA.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DNayeem%26aufirst%3DM.%2BA.%26atitle%3DEffect%2520of%2520soluble%2520epoxide%2520hydrolase%2520on%2520the%2520modulation%2520of%2520coronary%2520reactive%2520hyperemia%253A%2520role%2520of%2520oxylipins%2520and%2520PPAR%25CE%25B3%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D9%26doi%3D10.1371%2Fjournal.pone.0162147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>167</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1298</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2012.03.167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.ijcard.2012.03.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=22525341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2013&pages=1298-1304&issue=4&author=D.+Xuauthor=B.+B.+Davisauthor=Z.+Wangauthor=S.+Zhaoauthor=B.+Wastiauthor=Z.+Liuauthor=N.+Liauthor=C.+Morisseauauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=A+potent+soluble+epoxide+hydrolase+inhibitor%2C+t-AUCB%2C+acts+through+PPAR%CE%B3+to+modulate+the+function+of+endothelial+progenitor+cells+from+patients+with+acute+myocardial+infarction&doi=10.1016%2Fj.ijcard.2012.03.167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span></div><div class="casAuthors">Xu Dan-yan; Davis Benjamin B; Wang Zhen-he; Zhao Shui-ping; Wasti Binaya; Liu Zhe-liang; Li Ning; Morisseau Christophe; Chiamvimonvat Nipavan; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1298-304</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Epoxyeicosatrienoic acids (EETs) are natural angiogenic mediators regulated by soluble epoxide hydrolase (sEH).  Inhibitors of sEH can stabilize EETs levels and were reported to reduce atherosclerosis and inhibit myocardial infarction in animal models.  In this work, we investigated whether increasing EETs with the sEH inhibitor t-AUCB would increase angiogenesis related function in endothelial progenitor cells (EPCs) from patients with acute myocardial infarction (AMI).  METHODS AND RESULTS:  EPCs were isolated from 50 AMI patients and 50 healthy subjects (control).  EPCs were treated with different concentrations of t-AUCB for 24h with or without peroxisome proliferator activated receptor γ (PPARγ) inhibitor GW9662.  Migration of EPCs was assayed in trans-well chambers.  Angiogenesis assays were performed using a Matrigel-Matrix in vitro model.  The expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1α (HIF-1α) mRNA and protein in EPCs was measured by real-time PCR or Western blot, respectively.  Also, the concentration of EETs in the culture supernatant was detected by ELISA.  The activity of EPCs in the AMI patient group was reduced compared to healthy controls.  Whereas increasing EET levels with t-AUCB promoted a dose dependent angiogenesis and migration in EPCs from AMI patients.  Additionally, the t-AUCB dose dependently increased the expression of the angiogenic factors VEGF and HIF-α.  Lastly, we provide evidence that these effects were PPARγ dependent.  CONCLUSION:  The results demonstrate that the sEH inhibitor positively modulated the functions of EPCs in patients with AMI through the EETs-PPARγ pathway.  The present study suggests the potential utility of sEHi in the therapy of ischemic heart disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvyM8pXNI2_xKDYG3bNImrfW6udTcc2eZvapuUBai0Drntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D&md5=664e589b7aba463a46d40a45ef424ef8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2012.03.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2012.03.167%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DB.%2BB.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DWasti%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DA%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520t-AUCB%252C%2520acts%2520through%2520PPAR%25CE%25B3%2520to%2520modulate%2520the%2520function%2520of%2520endothelial%2520progenitor%2520cells%2520from%2520patients%2520with%2520acute%2520myocardial%2520infarction%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D167%26issue%3D4%26spage%3D1298%26epage%3D1304%26doi%3D10.1016%2Fj.ijcard.2012.03.167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toews, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padanilam, B. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy</span>. <i>Am. J. Physiol. Renal Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>308</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">F131</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00531.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajprenal.00531.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=25377915" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2015&pages=F131-139&issue=2&author=J.+Kimauthor=S.+P.+Yoonauthor=M.+L.+Toewsauthor=J.+D.+Imigauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=B.+J.+Padanilam&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+prevents+renal+interstitial+fibrogenesis+in+obstructive+nephropathy&doi=10.1152%2Fajprenal.00531.2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00531.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00531.2014%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DS.%2BP.%26aulast%3DToews%26aufirst%3DM.%2BL.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPadanilam%26aufirst%3DB.%2BJ.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520renal%2520interstitial%2520fibrogenesis%2520in%2520obstructive%2520nephropathy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2015%26volume%3D308%26issue%3D2%26spage%3DF131%26epage%3D139%26doi%3D10.1152%2Fajprenal.00531.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherian
Shaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span>. <i>Exp. Biol. Med. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>237</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1402</span>– <span class="NLM_lpage">1412</span>, <span class="refDoi"> DOI: 10.1258/ebm.2012.012225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1258%2Febm.2012.012225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2012&pages=1402-1412&issue=12&author=J.+D.+Imigauthor=K.+A.+Walshauthor=M.+A.+H.+Khanauthor=T.+Nagasawaauthor=M.+Cherian%0AShawauthor=S.+M.+Shawauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+inhibition+and+peroxisome+proliferator+activated+receptor+%CE%B3+agonist+improve+vascular+function+and+decrease+renal+injury+in+hypertensive+obese+rats&doi=10.1258%2Febm.2012.012225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span></div><div class="casAuthors">Imig, John D.; Walsh, Katie A.; Abdul Hye Khan, Md; Nagasawa, Tasuku; Cherian-Shaw, Mary; Shaw, Sean M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1402-1412</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Cardiometabolic syndrome occurs with obesity and consists of pathophysiol. factors that increase the risk for cardiovascular events.  Sol. epoxide hydrolase inhibition (sEHi) is a novel therapeutic approach that exerts renal and cardiovascular protection.  Although sEHi as a therapeutic approach is promising, it could be more effective for the treatment of cardiometabolic syndrome when combined with peroxisome proliferator activated receptor γ (PPARγ) agonists.  We hypothesized that the PPARγ agonist, rosiglitazone in combination with a sEHi (tAUCB) will provide synergistic actions to decrease blood pressure, improve vascular function, decrease inflammation, and prevent renal damage in spontaneously hypertensive obese rats (SHROB).  SHROB were treated with rosiglitazone, tAUCB or the combination of tAUCB and rosiglitazone for four-weeks and compared with spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats.  Blood pressure increased in SHROB (164 ± 7 mmHg) and decreased 10 mmHg when treated with rosiglitazone, tAUCB, or tAUCB and rosiglitazone.  Mesenteric artery dilation to the KATP channel opener pinacidil was attenuated in SHROB (EMax = 77 ± 7%), compared with WKY (EMax = 115 ± 19) and SHR (EMax = 93 ± 12%).  Vasodilation to pinacidil was improved by rosiglitazone (EMax = 92 ± 14%) but not tAUCB.  Renal macrophage infiltration increased in SHROB and significantly decreased with rosiglitazone or tAUCB and rosiglitazone treatment.  Albuminuria was increased in SHROB (90 ± 20 mg/d) and was significantly decreased by the combination of tAUCB and rosiglitazone (37 ± 9 mg/d).  Glomerular injury in SHROB was also significantly decreased by tAUCB and rosiglitazone.  These results indicate that even though sEHi or PPARγ agonist have benefits when used individually, the combination is more beneficial for the multidisease features in cardiometabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq2SjZgeqAHrVg90H21EOLACvtfcHk0ljoldVBRUpMEA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D&md5=d22fb0c9e2e8acf30dd6ce7614ad403c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1258%2Febm.2012.012225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2012.012225%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DWalsh%26aufirst%3DK.%2BA.%26aulast%3DKhan%26aufirst%3DM.%2BA.%2BH.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DCherian%2BShaw%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DS.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520and%2520peroxisome%2520proliferator%2520activated%2520receptor%2520%25CE%25B3%2520agonist%2520improve%2520vascular%2520function%2520and%2520decrease%2520renal%2520injury%2520in%2520hypertensive%2520obese%2520rats%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2012%26volume%3D237%26issue%3D12%26spage%3D1402%26epage%3D1412%26doi%3D10.1258%2Febm.2012.012225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüggerhoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boß, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">N-Benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor γ modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=61-81&issue=1&author=R.+Bl%C3%B6cherauthor=C.+Lamersauthor=S.+K.+Wittmannauthor=D.+Merkauthor=M.+Hartmannauthor=L.+Weizelauthor=O.+Diehlauthor=A.+Br%C3%BCggerhoffauthor=M.+Bo%C3%9Fauthor=A.+Kaiserauthor=T.+Schaderauthor=T.+G%C3%B6belauthor=M.+Grundmannauthor=C.+Angioniauthor=J.+Heeringauthor=G.+Geisslingerauthor=M.+Wurglicsauthor=E.+Kostenisauthor=B.+Br%C3%BCneauthor=D.+Steinhilberauthor=M.+Schubert-Zsilaveczauthor=A.+S.+Kahntauthor=E.+Proschak&title=N-Benzylbenzamides%3A+a+novel+merged+scaffold+for+orally+available+dual+soluble+epoxide+hydrolase%2Fperoxisome+proliferator-activated+receptor+%CE%B3+modulators&doi=10.1021%2Facs.jmedchem.5b01239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators</span></div><div class="casAuthors">Blocher Rene; Lamers Christina; Wittmann Sandra K; Merk Daniel; Hartmann Markus; Weizel Lilia; Diehl Olaf; Bruggerhoff Astrid; Kaiser Astrid; Schader Tim; Gobel Tamara; Wurglics Mario; Steinhilber Dieter; Schubert-Zsilavecz Manfred; Kahnt Astrid S; Proschak Ewgenij; Boss Marcel; Brune Bernhard; Grundmann Manuel; Kostenis Evi; Angioni Carlo; Geisslinger Gerd; Heering Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome (MetS) is a multifactorial disease cluster that consists of dyslipidemia, cardiovascular disease, type 2 diabetes mellitus, and obesity.  MetS patients are strongly exposed to polypharmacy; however, the number of pharmacological compounds required for MetS treatment can be reduced by the application of multitarget compounds.  This study describes the design of dual-target ligands that target soluble epoxide hydrolase (sEH) and the peroxisome proliferator-activated receptor type γ (PPARγ).  Simultaneous modulation of sEH and PPARγ can improve diabetic conditions and hypertension at once.  N-Benzylbenzamide derivatives were determined to fit a merged sEH/PPARγ pharmacophore, and structure-activity relationship studies were performed on both targets, resulting in a submicromolar (sEH IC50 = 0.3 μM/PPARγ EC50 = 0.3 μM) modulator 14c.  In vitro and in vivo evaluations revealed good ADME properties qualifying 14c as a pharmacological tool compound for long-term animal models of MetS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEKlCRcJ5_1JcXNb62YGmbfW6udTcc2eZtfQLsOL4uGrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D&md5=86c5861a77820ae8878382eae893b116</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01239%26sid%3Dliteratum%253Aachs%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DDiehl%26aufirst%3DO.%26aulast%3DBr%25C3%25BCggerhoff%26aufirst%3DA.%26aulast%3DBo%25C3%259F%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DSchader%26aufirst%3DT.%26aulast%3DG%25C3%25B6bel%26aufirst%3DT.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DN-Benzylbenzamides%253A%2520a%2520novel%2520merged%2520scaffold%2520for%2520orally%2520available%2520dual%2520soluble%2520epoxide%2520hydrolase%252Fperoxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D1%26spage%3D61%26epage%3D81%26doi%3D10.1021%2Facs.jmedchem.5b01239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hye
Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skibba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">A Novel Dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of Type 2 Diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2235</span>– <span class="NLM_lpage">2246</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4685-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1007%2Fs00125-018-4685-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=30032428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2235-2246&issue=10&author=M.+A.+Hye%0AKhanauthor=L.+Kolbauthor=M.+Skibbaauthor=M.+Hartmannauthor=R.+Bl%C3%B6cherauthor=E.+Proschakauthor=J.+D.+Imig&title=A+Novel+Dual+PPAR-%CE%B3+agonist%2FsEH+inhibitor+treats+diabetic+complications+in+a+rat+model+of+Type+2+Diabetes&doi=10.1007%2Fs00125-018-4685-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes</span></div><div class="casAuthors">Hye Khan, Md Abdul; Kolb, Lauren; Skibba, Melissa; Hartmann, Markus; Blocher, Rene; Proschak, Ewgenij; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2235-2246</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes.  The present study aims to evaluate a novel mol. with a dual action against the metabolic syndrome and type 2 diabetes.  Methods: We developed and tested a novel dual modulator, RB394, which acts as a sol. epoxide hydrolase (sEH) inhibitor and a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist in rat models of the metabolic syndrome-the obese spontaneously hypertensive (SHROB) rat and the obese diabetic Zucker fatty/spontaneously hypertensive heart failure F1 hybrid (ZSF1) rat.  In SHROB rats we studied the ability of RB394 to prevent metabolic syndrome phenotypes, while in ZSF1 obese diabetic rats we compared RB394 with the ACE inhibitor enalapril in the treatment of type 2 diabetes and assocd. comorbid conditions.  RB394 (10 mg/kg daily) and enalapril (10 mg/kg daily) were administered orally for 8 wk.  Results: RB394 blunted the development of hypertension, insulin resistance, hyperlipidemia and kidney injury in SHROB rats and reduced fasting blood glucose and HbA1c, improved glucose tolerance, reduced blood pressure and improved lipid profiles in obese ZSF1 rats.  A redn. in liver fibrosis and hepatosteatosis was evident in RB394-treated obese ZSF1 rats.  Unlike RB394, enalapril did not demonstrate any pos. effects in relation to diabetes, hyperlipidemia or liver dysfunction in obese ZSF1 rats.  RB394 ameliorated diabetic nephropathy by reducing renal interstitial fibrosis and renal tubular and glomerular injury in obese diabetic ZSF1 rats.  Intriguingly, enalapril demonstrated a weaker action against diabetic nephropathy in obese ZSF1 rats.  Conclusions/interpretation: These findings demonstrate that a novel sHE inhibitor/PPAR-γ agonist mol. targets multiple risk factors of the metabolic syndrome and is a glucose-lowering agent with a strong ability to treat diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLbjByYxgOqLVg90H21EOLACvtfcHk0lh5RcUXbRF-FQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL&md5=b5c538cfa9fe0b8040e19fe230547202</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4685-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4685-0%26sid%3Dliteratum%253Aachs%26aulast%3DHye%2BKhan%26aufirst%3DM.%2BA.%26aulast%3DKolb%26aufirst%3DL.%26aulast%3DSkibba%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DA%2520Novel%2520Dual%2520PPAR-%25CE%25B3%2520agonist%252FsEH%2520inhibitor%2520treats%2520diabetic%2520complications%2520in%2520a%2520rat%2520model%2520of%2520Type%25202%2520Diabetes%26jtitle%3DDiabetologia%26date%3D2018%26volume%3D61%26issue%3D10%26spage%3D2235%26epage%3D2246%26doi%3D10.1007%2Fs00125-018-4685-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Efficient asymmetric synthesis of (S)-2-ethylphenylpropanoic acid derivative, a selective agonist for human peroxisome proliferator-activated receptor alpha</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2101</span>– <span class="NLM_lpage">2104</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00375-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2FS0960-894X%2802%2900375-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=12127513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVeksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2101-2104&issue=16&author=M.+Nomuraauthor=T.+Tanaseauthor=H.+Miyachi&title=Efficient+asymmetric+synthesis+of+%28S%29-2-ethylphenylpropanoic+acid+derivative%2C+a+selective+agonist+for+human+peroxisome+proliferator-activated+receptor+alpha&doi=10.1016%2FS0960-894X%2802%2900375-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient asymmetric synthesis of (S)-2-ethylphenylpropanoic acid derivative, a selective agonist for human peroxisome proliferator-activated receptor alpha</span></div><div class="casAuthors">Nomura, Masahiro; Tanase, Takahiro; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2101-2104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An optically active phenylpropanoic acid deriv. (I), a selective agonist for human peroxisome proliferator-activated receptor alpha, was efficiently prepd. in high optical purity by using Evans chiral oxazolidinone technique as a key step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmRpMWCcRPaLVg90H21EOLACvtfcHk0lisypw6U4theQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVeksr0%253D&md5=bb54313843c74c79e6cd987ff4d2552d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900375-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900375-X%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DTanase%26aufirst%3DT.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DEfficient%2520asymmetric%2520synthesis%2520of%2520%2528S%2529-2-ethylphenylpropanoic%2520acid%2520derivative%252C%2520a%2520selective%2520agonist%2520for%2520human%2520peroxisome%2520proliferator-activated%2520receptor%2520alpha%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D16%26spage%3D2101%26epage%3D2104%26doi%3D10.1016%2FS0960-894X%2802%2900375-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gellrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arifi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogoda, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">L-Thyroxin and the nonclassical thyroid hormone TETRAC are potent activators of PPARγ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6727</span>– <span class="NLM_lpage">6740</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02150</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02150" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotl2qt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6727-6740&issue=13&author=L.+Gellrichauthor=P.+Heitelauthor=J.+Heeringauthor=W.+Kiluauthor=J.+Pollingerauthor=T.+Goebelauthor=A.+Kahntauthor=S.+Arifiauthor=W.+Pogodaauthor=A.+Paulkeauthor=D.+Steinhilberauthor=E.+Proschakauthor=M.+Wurglicsauthor=M.+Schubert-Zsilaveczauthor=A.+Chaikuadauthor=S.+Knappauthor=I.+Bischoffauthor=R.+F%C3%BCrstauthor=D.+Merk&title=L-Thyroxin+and+the+nonclassical+thyroid+hormone+TETRAC+are+potent+activators+of+PPAR%CE%B3&doi=10.1021%2Facs.jmedchem.9b02150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">L-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ</span></div><div class="casAuthors">Gellrich, Leonie; Heitel, Pascal; Heering, Jan; Kilu, Whitney; Pollinger, Julius; Goebel, Tamara; Kahnt, Astrid; Arifi, Silvia; Pogoda, Werner; Paulke, Alexander; Steinhilber, Dieter; Proschak, Ewgenij; Wurglics, Mario; Schubert-Zsilavecz, Manfred; Chaikuad, Apirat; Knapp, Stefan; Bischoff, Iris; Fuerst, Robert; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6727-6740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thyroid hormones (THs) operate numerous physiol. processes through modulation of the nuclear thyroid hormone receptors and several other proteins.  We report direct activation of the nuclear peroxisome proliferator-activated receptor gamma (PPARγ) and retinoid X receptor (RXR) by classical and non-classical THs as another mol. activity of THs.  The T4 metabolite TETRAC was the most active TH on PPARγ with nanomolar potency and binding affinity.  We demonstrate that TETRAC promotes PPARγ/RXR signaling in cell-free, cellular and in vivo settings.  Simultaneous activation of the heterodimer partners PPARγ and RXR resulted in high dimer activation efficacy.  Compared to fatty acids as known natural ligands of PPARγ and RXR, TETRAC differs markedly in its mol. structure and the PPARγ-TETRAC complex revealed a distinctive binding mode of the TH.  Our observations suggest a potential connection of TH and PPAR signaling through overlapping ligand recognition and may hold implications for TH and PPAR pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7-20jUnvVH7Vg90H21EOLACvtfcHk0lisypw6U4theQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotl2qt7k%253D&md5=ef11092bf1432477ab92bda15bf37c46</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02150%26sid%3Dliteratum%253Aachs%26aulast%3DGellrich%26aufirst%3DL.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DKilu%26aufirst%3DW.%26aulast%3DPollinger%26aufirst%3DJ.%26aulast%3DGoebel%26aufirst%3DT.%26aulast%3DKahnt%26aufirst%3DA.%26aulast%3DArifi%26aufirst%3DS.%26aulast%3DPogoda%26aufirst%3DW.%26aulast%3DPaulke%26aufirst%3DA.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBischoff%26aufirst%3DI.%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DL-Thyroxin%2520and%2520the%2520nonclassical%2520thyroid%2520hormone%2520TETRAC%2520are%2520potent%2520activators%2520of%2520PPAR%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D13%26spage%3D6727%26epage%3D6740%26doi%3D10.1021%2Facs.jmedchem.9b02150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, K.</span></span> <span> </span><span class="NLM_article-title">Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1107/S0907444909015935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444909015935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=19622862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=786-795&author=T.+Oyamaauthor=K.+Toyotaauthor=T.+Wakuauthor=Y.+Hirakawaauthor=N.+Nagasawaauthor=J.+I.+Kasugaauthor=Y.+Hashimotoauthor=H.+Miyachiauthor=K.+Morikawa&title=Adaptability+and+selectivity+of+human+peroxisome+proliferator-activated+receptor+%28PPAR%29+pan+agonists+revealed+from+crystal+structures&doi=10.1107%2FS0907444909015935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures</span></div><div class="casAuthors">Oyama, Takuji; Toyota, Kenji; Waku, Tsuyoshi; Hirakawa, Yuko; Nagasawa, Naoko; Kasuga, Jun ichi; Hashimoto, Yuichi; Miyachi, Hiroyuki; Morikawa, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">786-795</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor family, which is defined as transcriptional factors that are activated by the binding of ligands to their ligand-binding domains (LBDs).  Although the three PPAR subtypes display different tissue distribution patterns and distinct pharmacol. profiles, they all are essentially related to fatty-acid and glucose metab.  Since the PPARs share similar 3-dimensional structures within the LBDs, synthetic ligands which simultaneously activate 2 or all of the PPARs could be potent candidates in terms of drugs for the treatment of abnormal metabolic homeostasis.  The structures of several PPAR LBDs were detd. in complex with synthetic ligands, derivs. of 3-(4-alkoxyphenyl)propanoic acid, which exhibit unique agonistic activities.  The PPARα and PPARγ LBDs were complexed with the same pan agonist, TIPP-703, which activates all three PPARs and their crystal structures were detd.  The two LBD-ligand complex structures revealed how the pan agonist is adapted to the similar, but significantly different, ligand-binding pockets of the PPARs.  The structures of the PPARδ LBD in complex with an α/δ-selective ligand, TIPP-401, and with a related δ-specific ligand, TIPP-204, were also detd.  The comparison between the two PPARδ complexes revealed how each ligand exhibits either a 'dual selective' or 'single specific' binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsqRY6vaJ6TLVg90H21EOLACvtfcHk0lisypw6U4theQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D&md5=417380ca8b0392b5ee4909ec3f9eb017</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0907444909015935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909015935%26sid%3Dliteratum%253Aachs%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DToyota%26aufirst%3DK.%26aulast%3DWaku%26aufirst%3DT.%26aulast%3DHirakawa%26aufirst%3DY.%26aulast%3DNagasawa%26aufirst%3DN.%26aulast%3DKasuga%26aufirst%3DJ.%2BI.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DK.%26atitle%3DAdaptability%2520and%2520selectivity%2520of%2520human%2520peroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529%2520pan%2520agonists%2520revealed%2520from%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D786%26epage%3D795%26doi%3D10.1107%2FS0907444909015935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomioka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagisawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1021/jm2014293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=893-902&author=N.+Kuwabaraauthor=T.+Oyamaauthor=D.+Tomiokaauthor=M.+Ohashiauthor=J.+Yanagisawaauthor=T.+Shimizuauthor=H.+Miyachi&title=Peroxisome+proliferator-activated+receptors+%28PPARs%29+have+multiple+binding+points+that+accommodate+ligands+in+various+conformations%3A+phenylpropanoic+acid-type+PPAR+ligands+bind+to+PPAR+in+different+conformations%2C+depending+on+the+subtype&doi=10.1021%2Fjm2014293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptors (PPARs) Have Multiple Binding Points That Accommodate Ligands in Various Conformations: Phenylpropanoic Acid-Type PPAR Ligands Bind to PPAR in Different Conformations, Depending on the Subtype</span></div><div class="casAuthors">Kuwabara, Naoyuki; Oyama, Takuji; Tomioka, Daisuke; Ohashi, Masao; Yanagisawa, Junn; Shimizu, Toshiyuki; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">893-902</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human peroxisome proliferator-activated receptors (hPPARs) are ligand-dependent transcription factors that control various biol. responses, and there are three subtypes: hPPARα, hPPARδ, and hPPARγ.  We report here that α-substituted phenylpropanoic acid-type hPPAR agonists with similar structure bind to the hPPAR ligand binding domain (LBD) in different conformations, depending on the receptor subtype.  These results might indicate that hPPAR ligand binding pockets have multiple binding points that can be utilized to accommodate structurally flexible hPPAR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXDIdMBoH0LVg90H21EOLACvtfcHk0liha9We-8CLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersL7F&md5=11145d2f98658e52874119bcdb5b301d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm2014293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014293%26sid%3Dliteratum%253Aachs%26aulast%3DKuwabara%26aufirst%3DN.%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DTomioka%26aufirst%3DD.%26aulast%3DOhashi%26aufirst%3DM.%26aulast%3DYanagisawa%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptors%2520%2528PPARs%2529%2520have%2520multiple%2520binding%2520points%2520that%2520accommodate%2520ligands%2520in%2520various%2520conformations%253A%2520phenylpropanoic%2520acid-type%2520PPAR%2520ligands%2520bind%2520to%2520PPAR%2520in%2520different%2520conformations%252C%2520depending%2520on%2520the%2520subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D893%26epage%3D902%26doi%3D10.1021%2Fjm2014293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3581</span>– <span class="NLM_lpage">3599</span>, <span class="refDoi"> DOI: 10.1021/jm0205144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0205144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Churw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3581-3599&author=M.+Nomuraauthor=T.+Tanaseauthor=T.+Ideauthor=M.+Tsunodaauthor=M.+Suzukiauthor=H.+Uchikiauthor=K.+Murakamiauthor=H.+Miyachi&title=Design%2C+synthesis%2C+and+evaluation+of+substituted+phenylpropanoic+acid+derivatives+as+human+peroxisome+proliferator+activated+receptor+activators.+Discovery+of+potent+and+human+peroxisome+proliferator+activated+receptor+alpha+subtype-selective+activators&doi=10.1021%2Fjm0205144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Substituted Phenylpropanoic Acid Derivatives as Human Peroxisome Proliferator Activated Receptor Activators. Discovery of Potent and Human Peroxisome Proliferator Activated Receptor α Subtype-Selective Activators</span></div><div class="casAuthors">Nomura, Masahiro; Tanase, Takahiro; Ide, Tomohiro; Tsunoda, Masaki; Suzuki, Masahiro; Uchiki, Hideharu; Murakami, Koji; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3581-3599</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted phenylpropanoic acid derivs. such as I are prepd. as selective human peroxisome proliferator activated receptor α (PPARα) activators.  Structure-activity relationships for the binding of a variety of substituted phenylpropanoic acid derivs. to human peroxisome proliferator activated receptors are detd.  The nature and the stereochem. of the substituent at the α-position of the head part contg. the carboxyl group, the distance between the carboxyl group and the central benzene ring, the linking group between the central benzene ring and the distal benzene ring, and the substituent at the distal hydrophobic tail part of the mol. all play key roles in detg. the potency and selectivity of PPAR subtype transactivation.  Mol. mechanics calcns. of the conformers of phenylpropanoic acid derivs. and of the enantiomers of an α-ethyl-substituted phenylpropanoic acid deriv. are discussed.  I is a particularly effective PPARα activator with significant selectivity for PPARα.  In rats, I decreases serum cholesterol and lipids over five days of administration in a dose-dependent manner and with a significantly greater efficacy than a representative fibrate (bezafibrate) used for comparison.  Phenylpropanoic acid II is found to be a dual activator of PPARα and of PPARδ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBRw0M6BoOObVg90H21EOLACvtfcHk0liha9We-8CLBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Churw%253D&md5=4dc2eb5a19959a3af94afb0748e1c641</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0205144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205144%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DTanase%26aufirst%3DT.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DUchiki%26aufirst%3DH.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520substituted%2520phenylpropanoic%2520acid%2520derivatives%2520as%2520human%2520peroxisome%2520proliferator%2520activated%2520receptor%2520activators.%2520Discovery%2520of%2520potent%2520and%2520human%2520peroxisome%2520proliferator%2520activated%2520receptor%2520alpha%2520subtype-selective%2520activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3581%26epage%3D3599%26doi%3D10.1021%2Fjm0205144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wabitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melzner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauner, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1038/sj.ijo.0801520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fsj.ijo.0801520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=11244452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BD38%252Fgs1GitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=8-15&author=M.+Wabitschauthor=R.+E.+Brennerauthor=I.+Melznerauthor=M.+Braunauthor=P.+M%C3%B6llerauthor=E.+Heinzeauthor=K.+M.+Debatinauthor=H.+Hauner&title=Characterization+of+a+human+preadipocyte+cell+strain+with+high+capacity+for+adipose+differentiation&doi=10.1038%2Fsj.ijo.0801520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation</span></div><div class="casAuthors">Wabitsch M; Brenner R E; Melzner I; Braun M; Moller P; Heinze E; Debatin K M; Hauner H</div><div class="citationInfo"><span class="NLM_cas:title">International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop and to characterize a human preadipocyte cell strain with high capacity for adipose differentiation serving as a model for studying human adipocyte development and metabolism in vitro.  METHODS:  Cells were derived from the stromal cells fraction of subcutaneous adipose tissue of an infant with Simpson-Golabi-Behmel syndrome (SGBS).  Adipose differentiation was induced under serum-free culture conditions by exposure to 10 nM insulin, 200 pM triiodothyronine, 1 microM cortisol and 2 microM BRL 49653, a PPAR gamma agonist.  RESULTS:  During the differentiation process SGBS cells developed a gene expression pattern similar to that found in differentiating human preadipocytes with a characteristic increase in fat cell-specific mRNAs encoding lipoprotein lipase (LPL), glycero-3-phosphate dehydrogenase (GPDH), GLUT4, leptin and others.  Differentiated SGBS cells exhibited an increase in glucose uptake upon insulin stimulation and in glycerol release upon catecholamine exposure.  SGBS adipocytes were morphologically, biochemically and functionally identical to in vitro differentiated adipocytes from healthy subjects.  However, while preadipocytes from healthy control infants rapidly lost their capacity to differentiate after a few cell divisions in culture, SGBS cells maintained their differentiation capacity over many generations: upon appropriate stimulation 95% of SGBS cells of generation 30 developed into adipocytes.  A mutation in the glypican 3 gene was not detected in the patient.  Thus, it remains unclear whether the molecular alteration in SGBS cells is also responsible for the high differentiation capacity and further investigations are required.  CONCLUSION:  The human cell strain described here provides an almost unlimited source of human preadipocytes with high capacity for adipose differentiation and may, therefore, represent a unique tool for studying human fat cell development and metabolism.  International Journal of Obesity (2001) 25, 8-15</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhCslT4vmO2R0LsK7uFuY7fW6udTcc2eaoNiWN-x_-Vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252Fgs1GitQ%253D%253D&md5=2319939c4fc03ceb25f58a776d8a75be</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijo.0801520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijo.0801520%26sid%3Dliteratum%253Aachs%26aulast%3DWabitsch%26aufirst%3DM.%26aulast%3DBrenner%26aufirst%3DR.%2BE.%26aulast%3DMelzner%26aufirst%3DI.%26aulast%3DBraun%26aufirst%3DM.%26aulast%3DM%25C3%25B6ller%26aufirst%3DP.%26aulast%3DHeinze%26aufirst%3DE.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DHauner%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520a%2520human%2520preadipocyte%2520cell%2520strain%2520with%2520high%2520capacity%2520for%2520adipose%2520differentiation%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2001%26volume%3D25%26spage%3D8%26epage%3D15%26doi%3D10.1038%2Fsj.ijo.0801520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer-Posovszky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wabitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tornqvist, H. E.</span></span> <span> </span><span class="NLM_article-title">Human SGBS cells – a unique tool for studies of human fat cell biology</span>. <i>Obes. Facts</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1159/000145784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1159%2F000145784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=20054179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC3crhtFOhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=184-189&author=P.+Fischer-Posovszkyauthor=F.+S.+Newellauthor=M.+Wabitschauthor=H.+E.+Tornqvist&title=Human+SGBS+cells+%E2%80%93+a+unique+tool+for+studies+of+human+fat+cell+biology&doi=10.1159%2F000145784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Human SGBS cells - a unique tool for studies of human fat cell biology</span></div><div class="casAuthors">Fischer-Posovszky Pamela; Newell Felicity S; Wabitsch Martin; Tornqvist Hans E</div><div class="citationInfo"><span class="NLM_cas:title">Obesity facts</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">184-9</span>
        ISSN:<span class="NLM_cas:issn">1662-4025</span>.
    </div><div class="casAbstract">The human Simpson-Golabi-Behmel syndrome (SGBS) preadipocyte cell strain provides a unique and useful tool for studies of human adipocyte biology.  The cells originate from an adipose tissue specimen of a patient with SGBS.  They are neither transformed nor immortalized, and provide an almost unlimited source due to their ability to proliferate for up to 50 generations with retained capacity for adipogenic differentiation.  So far, the cells have been used for a number of studies on adipose differentiation, adipocyte glucose uptake, lipolysis, apoptosis, regulation of expression of adipokines, and protein translocation.  The cells are efficiently differentiated in the presence of PPARgammaagonists and in the absence of serum and albumin.  SGBS adipocytes respond to insulin stimulation by increasing glucose uptake several-fold (EC50 approximately 100 pmol/l), and by very effectively inhibiting (IC50 approximately 10 pmol/l) catecholamine-stimulated lipolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4ZM6c80VUFJ0d-O_J5C0AfW6udTcc2eaoNiWN-x_-Vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3crhtFOhsg%253D%253D&md5=c4be7bc48447c030f9cee7cd043f48ca</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1159%2F000145784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000145784%26sid%3Dliteratum%253Aachs%26aulast%3DFischer-Posovszky%26aufirst%3DP.%26aulast%3DNewell%26aufirst%3DF.%2BS.%26aulast%3DWabitsch%26aufirst%3DM.%26aulast%3DTornqvist%26aufirst%3DH.%2BE.%26atitle%3DHuman%2520SGBS%2520cells%2520%25E2%2580%2593%2520a%2520unique%2520tool%2520for%2520studies%2520of%2520human%2520fat%2520cell%2520biology%26jtitle%3DObes.%2520Facts%26date%3D2008%26volume%3D1%26spage%3D184%26epage%3D189%26doi%3D10.1159%2F000145784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halbgebauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlhaus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wabitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer-Posovszky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tews, D.</span></span> <span> </span><span class="NLM_article-title">Browning capabilities of human primary adipose-derived stromal cells compared to SGBS cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">9632</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-64369-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fs41598-020-64369-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=32541826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BB38ngt1eltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=9632&author=D.+Halbgebauerauthor=M.+Dahlhausauthor=M.+Wabitschauthor=P.+Fischer-Posovszkyauthor=D.+Tews&title=Browning+capabilities+of+human+primary+adipose-derived+stromal+cells+compared+to+SGBS+cells&doi=10.1038%2Fs41598-020-64369-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Browning capabilities of human primary adipose-derived stromal cells compared to SGBS cells</span></div><div class="casAuthors">Halbgebauer D; Dahlhaus M; Wabitsch M; Fischer-Posovszky P; Tews D</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9632</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ9X-tDafDMehLDWw4HIq2sfW6udTcc2eaoNiWN-x_-Vrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38ngt1eltQ%253D%253D&md5=00e37a9e15246622bd8c47af7d8c8c2d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-64369-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-64369-7%26sid%3Dliteratum%253Aachs%26aulast%3DHalbgebauer%26aufirst%3DD.%26aulast%3DDahlhaus%26aufirst%3DM.%26aulast%3DWabitsch%26aufirst%3DM.%26aulast%3DFischer-Posovszky%26aufirst%3DP.%26aulast%3DTews%26aufirst%3DD.%26atitle%3DBrowning%2520capabilities%2520of%2520human%2520primary%2520adipose-derived%2520stromal%2520cells%2520compared%2520to%2520SGBS%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D9632%26doi%3D10.1038%2Fs41598-020-64369-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref200"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref200'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seale, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroe, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1172/JCI44271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1172%2FJCI44271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=21123942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1ynsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=96-105&author=P.+Sealeauthor=H.+M.+Conroeauthor=J.+Estallauthor=S.+Kajimuraauthor=A.+Frontiniauthor=J.+Ishibashiauthor=P.+Cohenauthor=S.+Cintiauthor=B.+M.+Spiegelman&title=Prdm16+determines+the+thermogenic+program+of+subcutaneous+white+adipose+tissue+in+mice&doi=10.1172%2FJCI44271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice</span></div><div class="casAuthors">Seale, Patrick; Conroe, Heather M.; Estall, Jennifer; Kajimura, Shingo; Frontini, Andrea; Ishibashi, Jeff; Cohen, Paul; Cinti, Saverio; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-105</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The white adipose organ is composed of both s.c. and several intra-abdominal depots.  Excess abdominal adiposity is a major risk factor for metabolic disease in rodents and humans, while expansion of s.c. fat does not carry the same risks.  Brown adipose produces heat as a defense against hypothermia and obesity, and the appearance of brown-like adipocytes within white adipose tissue depots is assocd. with improved metabolic phenotypes.  Thus, understanding the differences in cell biol. and function of these different adipose cell types and depots may be crit. to the development of new therapies for metabolic disease.  Here, we found that Prdm16, a brown adipose detn. factor, is selectively expressed in s.c. white adipocytes relative to other white fat depots in mice.  Transgenic expression of Prdm16 in fat tissue robustly induced the development of brown-like adipocytes in s.c., but not epididymal, adipose depots.  Prdm16 transgenic mice displayed increased energy expenditure, limited wt. gain, and improved glucose tolerance in response to a high-fat diet.  ShRNA-mediated depletion of Prdm16 in isolated s.c. adipocytes caused a sharp decrease in the expression of thermogenic genes and a redn. in uncoupled cellular respiration.  Finally, Prdm16 haploinsufficiency reduced the brown fat phenotype in white adipose tissue stimulated by β-adrenergic agonists.  These results demonstrate that Prdm16 is a cell-autonomous determinant of a brown fat-like gene program and thermogenesis in s.c. adipose tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWKhiouTX3rVg90H21EOLACvtfcHk0liN6LmPi7AZoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1ynsA%253D%253D&md5=5a3307db34df29f9741444f642d2e963</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1172%2FJCI44271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI44271%26sid%3Dliteratum%253Aachs%26aulast%3DSeale%26aufirst%3DP.%26aulast%3DConroe%26aufirst%3DH.%2BM.%26aulast%3DEstall%26aufirst%3DJ.%26aulast%3DKajimura%26aufirst%3DS.%26aulast%3DFrontini%26aufirst%3DA.%26aulast%3DIshibashi%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCinti%26aufirst%3DS.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DPrdm16%2520determines%2520the%2520thermogenic%2520program%2520of%2520subcutaneous%2520white%2520adipose%2520tissue%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D96%26epage%3D105%26doi%3D10.1172%2FJCI44271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, M. A.</span></span> <span> </span><span class="NLM_article-title">Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ</span>. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">R676</span>– <span class="NLM_lpage">R688</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.00237.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajpregu.00237.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=27488890" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=R676-R688&author=A.+Hanifauthor=M.+L.+Edinauthor=D.+C.+Zeldinauthor=C.+Morisseauauthor=M.+A.+Nayeem&title=Deletion+of+soluble+epoxide+hydrolase+enhances+coronary+reactive+hyperemia+in+isolated+mouse+heart%3A+role+of+oxylipins+and+PPAR%CE%B3&doi=10.1152%2Fajpregu.00237.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00237.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00237.2016%26sid%3Dliteratum%253Aachs%26aulast%3DHanif%26aufirst%3DA.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DNayeem%26aufirst%3DM.%2BA.%26atitle%3DDeletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520enhances%2520coronary%2520reactive%2520hyperemia%2520in%2520isolated%2520mouse%2520heart%253A%2520role%2520of%2520oxylipins%2520and%2520PPAR%25CE%25B3%26jtitle%3DAm.%2520J.%2520Physiol.%2520Regul.%2520Integr.%2520Comp.%2520Physiol.%26date%3D2016%26volume%3D311%26spage%3DR676%26epage%3DR688%26doi%3D10.1152%2Fajpregu.00237.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoopes, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. W.</span></span> <span> </span><span class="NLM_article-title">Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1093/cvr/cvv018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1093%2Fcvr%2Fcvv018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=25618409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Cqt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=304-317&author=Z.+Heauthor=X.+Zhangauthor=C.+Chenauthor=Z.+Wenauthor=S.+L.+Hoopesauthor=D.+C.+Zeldinauthor=D.+W.+Wang&title=Cardiomyocyte-specific+expression+of+CYP2J2+prevents+development+of+cardiac+remodelling+induced+by+angiotensin+II&doi=10.1093%2Fcvr%2Fcvv018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II</span></div><div class="casAuthors">He, Zuowen; Zhang, Xu; Chen, Chen; Wen, Zheng; Hoopes, Samantha L.; Zeldin, Darryl C.; Wang, Dao Wen</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-317</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims Cardiac remodelling is one of the key pathol. changes that occur with cardiovascular disease.  Previous studies have demonstrated the beneficial effects of CYP2J2 expression on cardiac injury.  In the present study, we investigated the effects of cardiomyocyte-specific CYP2J2 expression and EET treatment on angiotensin II-induced cardiac remodelling and sought to det. the underlying mol. mechanisms involved in this process.  Methods and results Eight-week-old mice with cardiomyocyte-specific CYP2J2 expression (aMHC-CYP2J2-Tr) and wild-type (WT) control mice were treated with Ang-II.  Ang-II treatment of WT mice induced changes in heart morphol., cardiac hypertrophy and dysfunction, as well as collagen accumulation; however, cardiomyocyte-specific expression of CYP2J2 attenuated these effects.  The cardioprotective effects obsd. in α-MHC-CYP2J2-Tr mice were assocd. with peroxisome proliferator-activated receptor (PPAR)-γ activation, reduced oxidative stress, reduced NF-κBp65 nuclear translocation, and inhibition of TGF-β1/smad pathway.  The effects seen with cardiomyocyte-specific expression of CYP2J2 were partially blocked by treatment with PPAR-γ antagonist GW9662.  In in vitro studies, 11,12-EET(1 μmol/L) treatment attenuated cardiomyocyte hypertrophy and remodelling-related protein (collagen I, TGF-β1, TIMP1) expression by inhibiting the oxidative stress-mediated NF-κB pathway via PPAR-γ activation.  Furthermore, conditioned media from neonatal cardiomyocytes treated with 11,12-EET inhibited activation of cardiac fibroblasts and TGF-β1/smad pathway.  Conclusion Cardiomyocyte-specific expression of CYP2J2 or treatment with EETs protects against cardiac remodelling by attenuating oxidative stress-mediated NF-κBp65 nuclear translocation via PPAR-γ activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYG8Qz-t2hsLVg90H21EOLACvtfcHk0liN6LmPi7AZoA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Cqt7vM&md5=e13295d939c2a05daaa417cc6c074a8f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fcvr%2Fcvv018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcvr%252Fcvv018%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DHoopes%26aufirst%3DS.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DD.%2BW.%26atitle%3DCardiomyocyte-specific%2520expression%2520of%2520CYP2J2%2520prevents%2520development%2520of%2520cardiac%2520remodelling%2520induced%2520by%2520angiotensin%2520II%26jtitle%3DCardiovasc.%2520Res.%26date%3D2015%26volume%3D105%26spage%3D304%26epage%3D317%26doi%3D10.1093%2Fcvr%2Fcvv018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degraff, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and P42/P44 MAPK pathway</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000139436.89654.c8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1161%2F01.RES.0000139436.89654.c8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=15256482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntVCrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=506-514&author=J.+Seubertauthor=B.+Yangauthor=J.+A.+Bradburyauthor=J.+Gravesauthor=L.+M.+Degraffauthor=S.+Gabelauthor=R.+Goochauthor=J.+Foleyauthor=J.+Newmanauthor=L.+Maoauthor=H.+A.+Rockmanauthor=B.+D.+Hammockauthor=E.+Murphyauthor=D.+C.+Zeldin&title=Enhanced+postischemic+functional+recovery+in+CYP2J2+transgenic+hearts+involves+mitochondrial+ATP-sensitive+K%2B+channels+and+P42%2FP44+MAPK+pathway&doi=10.1161%2F01.RES.0000139436.89654.c8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway</span></div><div class="casAuthors">Seubert, John; Yang, Baichun; Bradbury, J. Alyce; Graves, Joan; Degraff, Laura M.; Gabel, Scott; Gooch, Rebecca; Foley, Julie; Newman, John; Mao, Lan; Rockman, Howard A.; Hammock, Bruce D.; Murphy, Elizabeth; Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">506-514</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Human CYP2J2 is abundant in heart and active in the biosynthesis of epoxyeicosatrienoic acids (EETs); however, the functional role of this P 450 and its eicosanoid products in the heart remains unknown.  Transgenic mice with cardiomyocyte-specific overexpression of CYP2J2 were generated.  CYP2J2 transgenic (Tr) mice have normal heart anatomy and basal contractile function.  CYP2J2 Tr hearts have improved recovery of left ventricular developed pressure (LVDP) compared with wild-type (WT) hearts after 20 min ischemia and 40 min reperfusion.  Perfusion with the selective P 450 epoxygenase inhibitor N-methylsulfonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 min before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.  Perfusion with the ATP-sensitive K+ channel (KATP) inhibitor glibenclamide (GLIB) or the mitochondrial KATP (mitoKATP) inhibitor 5-hydroxydecanoate (5-HD) for 20 min before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.  Flavoprotein fluorescence, a marker of mitoKATP activity, is higher in cardiomyocytes from CYP2J2 Tr vs. WT mice.  Moreover, CYP2J2-derived EETs (1 to 5 μM) increase flavoprotein fluorescence in WT cardiomyocytes.  CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addn. of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.  Together, these data suggest that CYP2J2-derived metabolites are cardioprotective after ischemia, and the mechanism for this cardioprotection involves activation of mitoKATP and p42/p44 MAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtZdja4T-SA7Vg90H21EOLACvtfcHk0lhM85AABqnprg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntVCrtLo%253D&md5=2094898d6437b9127e06ed89d2f6ddae</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000139436.89654.c8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000139436.89654.c8%26sid%3Dliteratum%253Aachs%26aulast%3DSeubert%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DGraves%26aufirst%3DJ.%26aulast%3DDegraff%26aufirst%3DL.%2BM.%26aulast%3DGabel%26aufirst%3DS.%26aulast%3DGooch%26aufirst%3DR.%26aulast%3DFoley%26aufirst%3DJ.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DEnhanced%2520postischemic%2520functional%2520recovery%2520in%2520CYP2J2%2520transgenic%2520hearts%2520involves%2520mitochondrial%2520ATP-sensitive%2520K%252B%2520channels%2520and%2520P42%252FP44%2520MAPK%2520pathway%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D95%26spage%3D506%26epage%3D514%26doi%3D10.1161%2F01.RES.0000139436.89654.c8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyal, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogardus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lih, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapieha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. E. H.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 2C8 Ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--Brief Report</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.113.302927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1161%2FATVBAHA.113.302927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24458713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislGktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=581-586&author=Z.+Shaoauthor=Z.+Fuauthor=A.+Stahlauthor=J.-S.+Joyalauthor=C.+Hattonauthor=A.+Juanauthor=C.+Hurstauthor=L.+Evansauthor=Z.+Cuiauthor=D.+Peiauthor=Y.+Gongauthor=D.+Xuauthor=K.+Tianauthor=H.+Bogardusauthor=M.+L.+Edinauthor=F.+Lihauthor=P.+Sapiehaauthor=J.+Chenauthor=D.+Panigrahyauthor=A.+Hellstromauthor=D.+C.+Zeldinauthor=L.+E.+H.+Smith&title=Cytochrome+P450+2C8+%CE%A93-long-chain+polyunsaturated+fatty+acid+metabolites+increase+mouse+retinal+pathologic+neovascularization%2D%2DBrief+Report&doi=10.1161%2FATVBAHA.113.302927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 2C8 ω3-Long-Chain Polyunsaturated Fatty Acid Metabolites Increase Mouse Retinal Pathologic Neovascularization-Brief Report</span></div><div class="casAuthors">Shao, Zhuo; Fu, Zhongjie; Stahl, Andreas; Joyal, Jean-Sebastien; Hatton, Colman; Juan, Aimee; Hurst, Christian; Evans, Lucy; Cui, Zhenghao; Pei, Dorothy; Gong, Yan; Xu, Dan; Tian, Katherine; Bogardus, Hannah; Edin, Matthew L.; Lih, Fred; Sapieha, Przemyslaw; Chen, Jing; Panigrahy, Dipak; Hellstrom, Ann; Zeldin, Darryl C.; Smith, Lois E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">581-586</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: Regulation of angiogenesis is crit. for many diseases.  Specifically, pathol. retinal neovascularization, a major cause of blindness, is suppressed with dietary ω3-long-chain polyunsatd. fatty acids (ω3LCPUFAs) through antiangiogenic metabolites of cyclooxygenase and lipoxygenase.  Cytochrome P 450 epoxygenases (CYP2C8) also metabolize LCPUFAs, producing bioactive epoxides, which are inactivated by sol. epoxide hydrolase (sEH) to transdihydrodiols.  The effect of these enzymes and their metabolites on neovascularization is unknown.  APPROACH AND RESULTS-: The mouse model of oxygen-induced retinopathy was used to investigate retinal neovascularization.  We found that CYP2C (localized in wild-type monocytes/macrophages) is upregulated in oxygen-induced retinopathy, whereas sEH is suppressed, resulting in an increased retinal epoxide:diol ratio.  With a ω3LCPUFA-enriched diet, retinal neovascularization increases in Tie2-driven human-CYP2C8-overexpressing mice (Tie2-CYP2C8-Tg), assocd. with increased plasma 19,20-epoxydocosapentaenoic acid and retinal epoxide:diol ratio. 19,20-Epoxydocosapentaenoic acids and the epoxide:diol ratio are decreased with overexpression of sEH (Tie2-sEH-Tg).  Overexpression of CYP2C8 or sEH in mice does not change normal retinal vascular development compared with their wild-type littermate controls.  The proangiogenic role in retina of CYP2C8 with both ω3LCPUFA and ω6LCPUFA and antiangiogenic role of sEH in ω3LCPUFA metab. were corroborated in aortic ring assays.  CONCLUSIONS-: Our results suggest that CYP2C ω3LCPUFA metabolites promote retinal pathol. angiogenesis.  CYP2C8 is part of a novel lipid metabolic pathway influencing retinal neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofDklhXO9eCbVg90H21EOLACvtfcHk0lhM85AABqnprg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislGktro%253D&md5=84bb4c23e67aa96979a9cab642515e90</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.113.302927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.113.302927%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DStahl%26aufirst%3DA.%26aulast%3DJoyal%26aufirst%3DJ.-S.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DJuan%26aufirst%3DA.%26aulast%3DHurst%26aufirst%3DC.%26aulast%3DEvans%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DZ.%26aulast%3DPei%26aufirst%3DD.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DK.%26aulast%3DBogardus%26aufirst%3DH.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DLih%26aufirst%3DF.%26aulast%3DSapieha%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DHellstrom%26aufirst%3DA.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DSmith%26aufirst%3DL.%2BE.%2BH.%26atitle%3DCytochrome%2520P450%25202C8%2520%25CE%25A93-long-chain%2520polyunsaturated%2520fatty%2520acid%2520metabolites%2520increase%2520mouse%2520retinal%2520pathologic%2520neovascularization--Brief%2520Report%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2014%26volume%3D34%26spage%3D581%26epage%3D586%26doi%3D10.1161%2FATVBAHA.113.302927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable potent soluble epoxide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1021/jm070270t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070270t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3825-3840&author=S.+H.+Hwangauthor=H.-J.+Tsaiauthor=J.-Y.+Liuauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Orally+bioavailable+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm070270t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors</span></div><div class="casAuthors">Hwang, Sung Hee; Tsai, Hsing-Ju; Liu, Jun-Yan; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3825-3840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepd. and tested as sol. epoxide hydrolase (sEH) inhibitors.  This series of compds. showed low nanomolar to picomolar activities against recombinant human sEH.  Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes.  Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors.  Trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (I, t-AUCB, IC50 = 1.3 ± 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVS4Wx8hrt_bVg90H21EOLACvtfcHk0lhM85AABqnprg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D&md5=ad2116c2671dc36d35b44ff93d55863d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm070270t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070270t%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DH.-J.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOrally%2520bioavailable%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3825%26epage%3D3840%26doi%3D10.1021%2Fjm070270t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziumbla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibli, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukunft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frömel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhart, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaubitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/nature25013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fnature25013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=29211719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=248-252&author=J.+Huauthor=S.+Dziumblaauthor=J.+Linauthor=S.-I.+Bibliauthor=S.+Zukunftauthor=J.+de+Mosauthor=K.+Awwadauthor=T.+Fr%C3%B6melauthor=A.+Jungmannauthor=K.+Devrajauthor=Z.+Chengauthor=L.+Wangauthor=S.+Fauserauthor=C.+G.+Eberhartauthor=A.+Sodhiauthor=B.+D.+Hammockauthor=S.+Liebnerauthor=O.+J.+M%C3%BCllerauthor=C.+Glaubitzauthor=H.-P.+Hammesauthor=R.+Poppauthor=I.+Fleming&title=Inhibition+of+soluble+epoxide+hydrolase+prevents+diabetic+retinopathy&doi=10.1038%2Fnature25013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span></div><div class="casAuthors">Hu, Jiong; Dziumbla, Sarah; Lin, Jihong; Bibli, Sofia-Iris; Zukunft, Sven; de Mos, Julian; Awwad, Khader; Froemel, Timo; Jungmann, Andreas; Devraj, Kavi; Cheng, Zhixing; Wang, Liya; Fauser, Sascha; Eberhart, Charles G.; Sodhi, Akrit; Hammock, Bruce D.; Liebner, Stefan; Mueller, Oliver J.; Glaubitz, Clemens; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7684</span>),
    <span class="NLM_cas:pages">248-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Diabetic retinopathy is an important cause of blindness in adults, and is characterized by progressive loss of vascular cells and slow dissoln. of inter-vascular junctions, which result in vascular leakage and retinal edema.  Later stages of the disease are characterized by inflammatory cell infiltration, tissue destruction and neovascularization.  Here we identify sol. epoxide hydrolase (sEH) as a key enzyme that initiates pericyte loss and breakdown of endothelial barrier function by generating the diol 19,20-dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid.  The expression of sEH and the accumulation of 19,20-dihydroxydocosapentaenoic acid were increased in diabetic mouse retinas and in the retinas and vitreous humor of patients with diabetes.  Mechanistically, the diol targeted the cell membrane to alter the localization of cholesterol-binding proteins, and prevented the assocn. of presenilin 1 with N-cadherin and VE-cadherin, thereby compromising pericyte-endothelial cell interactions and inter-endothelial cell junctions.  Treating diabetic mice with a specific sEH inhibitor prevented the pericyte loss and vascular permeability that are characteristic of non-proliferative diabetic retinopathy.  Conversely, overexpression of sEH in the retinal Muller glial cells of non-diabetic mice resulted in similar vessel abnormalities to those seen in diabetic mice with retinopathy.  Thus, increased expression of sEH is a key determinant in the pathogenesis of diabetic retinopathy, and inhibition of sEH can prevent progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbmkpvr75AMbVg90H21EOLACvtfcHk0lhcbJBxy_5Xhg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ&md5=9006381439cc2662b20d97160bfce71b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature25013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25013%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDziumbla%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DBibli%26aufirst%3DS.-I.%26aulast%3DZukunft%26aufirst%3DS.%26aulast%3Dde%2BMos%26aufirst%3DJ.%26aulast%3DAwwad%26aufirst%3DK.%26aulast%3DFr%25C3%25B6mel%26aufirst%3DT.%26aulast%3DJungmann%26aufirst%3DA.%26aulast%3DDevraj%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFauser%26aufirst%3DS.%26aulast%3DEberhart%26aufirst%3DC.%2BG.%26aulast%3DSodhi%26aufirst%3DA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLiebner%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DO.%2BJ.%26aulast%3DGlaubitz%26aufirst%3DC.%26aulast%3DHammes%26aufirst%3DH.-P.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520diabetic%2520retinopathy%26jtitle%3DNature%26date%3D2017%26volume%3D552%26spage%3D248%26epage%3D252%26doi%3D10.1038%2Fnature25013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, S. J.</span></span> <span> </span><span class="NLM_article-title">A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">H1668</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00495.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajpheart.00495.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24043252" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2013&pages=H1668-1679&author=X.+Zhouauthor=B.+Tengauthor=S.+Tilleyauthor=S.+J.+Mustafa&title=A1+adenosine+receptor+negatively+modulates+coronary+reactive+hyperemia+via+counteracting+A2A-mediated+H2O2+production+and+KATP+opening+in+isolated+mouse+hearts&doi=10.1152%2Fajpheart.00495.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00495.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00495.2013%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DTeng%26aufirst%3DB.%26aulast%3DTilley%26aufirst%3DS.%26aulast%3DMustafa%26aufirst%3DS.%2BJ.%26atitle%3DA1%2520adenosine%2520receptor%2520negatively%2520modulates%2520coronary%2520reactive%2520hyperemia%2520via%2520counteracting%2520A2A-mediated%2520H2O2%2520production%2520and%2520KATP%2520opening%2520in%2520isolated%2520mouse%2520hearts%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2013%26volume%3D305%26spage%3DH1668%26epage%3D1679%26doi%3D10.1152%2Fajpheart.00495.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overby, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildreth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition by t-TUCB promotes brown adipogenesis and reduces serum triglycerides in diet-induced obesity</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7039</span>, <span class="refDoi"> DOI: 10.3390/ijms21197039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.3390%2Fijms21197039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFWjtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=7039&author=H.+Overbyauthor=Y.+Yangauthor=X.+Xuauthor=K.+Grahamauthor=K.+Hildrethauthor=S.+Choiauthor=D.+Wanauthor=C.+Morisseauauthor=D.+C.+Zeldinauthor=B.+D.+Hammockauthor=S.+Wangauthor=A.+Bettaiebauthor=L.+Zhao&title=Soluble+epoxide+hydrolase+inhibition+by+t-TUCB+promotes+brown+adipogenesis+and+reduces+serum+triglycerides+in+diet-induced+obesity&doi=10.3390%2Fijms21197039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition by t-TUCB promotes brown adipogenesis and reduces serum triglycerides in diet-induced obesity</span></div><div class="casAuthors">Overby, Haley; Yang, Yang; Xu, Xinyun; Graham, Katherine; Hildreth, Kelsey; Choi, Sue; Wan, Debin; Morisseau, Christophe; Zeldin, Darryl C.; Hammock, Bruce D.; Wang, Shu; Bettaieb, Ahmed; Zhao, Ling</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7039</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Brown adipose tissue (BAT) is an important target for obesity treatment and prevention.  Sol. epoxide hydrolase (sEH) converts bioactive epoxy fatty acids (EpFAs) into less active diols. sEH inhibitors (sEHI) are beneficial in many chronic diseases by stabilizing EpFAs.  However, roles of sEH and sEHI in brown adipogenesis and BAT activity in treating diet-induced obesity (DIO) have not been reported. sEH expression was studied in in vitro models of brown adipogenesis and the fat tissues of DIO mice.  The effects of the sEHI, trans-4-4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy-benzoic acid (t-TUCB), were studied in vitro and in the obese mice via mini osmotic pump delivery. sEH expression was increased in brown adipogenesis and the BAT of the DIO mice. t-TUCB promoted brown adipogenesis in vitro.  Although t-TCUB did not change body wt., fat pad wt., or glucose and insulin tolerance in the obese mice, it decreased serum triglycerides and increased protein expression of genes important for lipid metab. in the BAT.  Our results suggest that sEH may play a crit. role in brown adipogenesis, and sEHI may be beneficial in improving BAT protein expression involved in lipid metab.  Further studies using the sEHI combined with EpFA generating diets for obesity treatment and prevention are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzWcXvxhv6LVg90H21EOLACvtfcHk0lgKaIOi676oXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFWjtLjK&md5=02d30e435cb1ab69fb9518e1edb220c5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3390%2Fijms21197039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21197039%26sid%3Dliteratum%253Aachs%26aulast%3DOverby%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DHildreth%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DD.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DL.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520by%2520t-TUCB%2520promotes%2520brown%2520adipogenesis%2520and%2520reduces%2520serum%2520triglycerides%2520in%2520diet-induced%2520obesity%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D7039%26doi%3D10.3390%2Fijms21197039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiesinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogoryelov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Computer-aided selective optimization of side activities of talinolol</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">903</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=899-903&author=K.+Hiesingerauthor=J.+S.+Kramerauthor=J.+Achenbachauthor=D.+Moserauthor=J.+Weberauthor=S.+K.+Wittmannauthor=C.+Morisseauauthor=C.+Angioniauthor=G.+Geisslingerauthor=A.+S.+Kahntauthor=A.+Kaiserauthor=A.+Proschakauthor=D.+Steinhilberauthor=D.+Pogoryelovauthor=K.+Wagnerauthor=B.+D.+Hammockauthor=E.+Proschak&title=Computer-aided+selective+optimization+of+side+activities+of+talinolol&doi=10.1021%2Facsmedchemlett.9b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-Aided Selective Optimization of Side Activities of Talinolol</span></div><div class="casAuthors">Hiesinger, Kerstin; Kramer, Jan S.; Achenbach, Janosch; Moser, Daniel; Weber, Julia; Wittmann, Sandra K.; Morisseau, Christophe; Angioni, Carlo; Geisslinger, Gerd; Kahnt, Astrid S.; Kaiser, Astrid; Proschak, Anna; Steinhilber, Dieter; Pogoryelov, Denys; Wagner, Karen; Hammock, Bruce D.; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">899-903</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective optimization of side activities is a valuable source of novel lead structures in drug discovery.  In this study, a computer-aided approach was used to deorphanize the pleiotropic cholesterol-lowering effects of the beta-blocker talinolol, which result from the inhibition of the enzyme sol. epoxide hydrolase (sEH).  X-ray structure anal. of the sEH in complex with talinolol enables a straightforward optimization of inhibitory potency.  The resulting lead structure exhibited in vivo activity in a rat model of diabetic neuropatic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHAoP0jFjh_rVg90H21EOLACvtfcHk0lgKaIOi676oXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtrzI&md5=943ab10c43ec4cf82b269666bf2316dd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00075%26sid%3Dliteratum%253Aachs%26aulast%3DHiesinger%26aufirst%3DK.%26aulast%3DKramer%26aufirst%3DJ.%2BS.%26aulast%3DAchenbach%26aufirst%3DJ.%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DWeber%26aufirst%3DJ.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DProschak%26aufirst%3DA.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DPogoryelov%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DComputer-aided%2520selective%2520optimization%2520of%2520side%2520activities%2520of%2520talinolol%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D899%26epage%3D903%26doi%3D10.1021%2Facsmedchemlett.9b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Development of a high-throughput screen for soluble epoxide hydrolase inhibition</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2006.04.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.ab.2006.04.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16729954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD28XntV2mtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=71-80&author=N.+M.+Wolfauthor=C.+Morisseauauthor=P.+D.+Jonesauthor=B.+Hockauthor=B.+D.+Hammock&title=Development+of+a+high-throughput+screen+for+soluble+epoxide+hydrolase+inhibition&doi=10.1016%2Fj.ab.2006.04.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-throughput screen for soluble epoxide hydrolase inhibition</span></div><div class="casAuthors">Wolf, Nicola M.; Morisseau, Christophe; Jones, Paul D.; Hock, Bertold; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-80</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mammalian sol. epoxide hydrolase (sEH) represents a highly promising new target for drug development.  Chem. inhibition of this enzyme in animal models was shown to treat hypertension and vascular inflammation as well as related syndromes.  Existing sEH inhibitors are relatively potent and specific.  However, the low soly. and relatively fast metab. of described sEH inhibitors make them less than therapeutically efficient, stating the need for novel inhibitor structures.  Therefore, a series of α-cyanoester and α-cyanocarbonate epoxides were evaluated as potential human sEH (HsEH) substrates for the high-throughput screen (HTS) of compd. libraries.  (3-Phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-Me ester (PHOME), which displayed the highest aq. stability and soly., was selected for the development of an HTS assay with long incubation times at room temp.  Concns. of HsEH and PHOME were optimized to ensure assay sensitivity, reliability, and reproducibility.  Assay validation, which employed these optimized concns., resulted in good accuracy (60-100%) and high precision (<7% relative std. deviation).  In addn., an overall Z' value of 0.7 proved the system's robustness and potential for HTS.  The developed assay system will be a valuable tool to discover new structures for the therapeutic inhibition of sEH to treat various cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq20AjMwRKlBLVg90H21EOLACvtfcHk0lgKaIOi676oXQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntV2mtr8%253D&md5=0ba5caacb00e49d2aeace507a3be352e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2006.04.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2006.04.045%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DN.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DHock%26aufirst%3DB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520screen%2520for%2520soluble%2520epoxide%2520hydrolase%2520inhibition%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D355%26spage%3D71%26epage%3D80%26doi%3D10.1016%2Fj.ab.2006.04.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlinzki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linhard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gande, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">Molecular tuning of farnesoid X receptor partial agonism</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2915</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-10853-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fs41467-019-10853-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=31266946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BB3MzjsFSmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2915&author=D.+Merkauthor=S.+Sreeramuluauthor=D.+Kudlinzkiauthor=K.+Saxenaauthor=V.+Linhardauthor=S.+L.+Gandeauthor=F.+Hillerauthor=C.+Lamersauthor=E.+Nilssonauthor=A.+Aagaardauthor=L.+Wisslerauthor=N.+Dekkerauthor=K.+Bambergauthor=M.+Schubert-Zsilaveczauthor=H.+Schwalbe&title=Molecular+tuning+of+farnesoid+X+receptor+partial+agonism&doi=10.1038%2Fs41467-019-10853-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular tuning of farnesoid X receptor partial agonism</span></div><div class="casAuthors">Merk Daniel; Lamers Christina; Schubert-Zsilavecz Manfred; Sreeramulu Sridhar; Kudlinzki Denis; Saxena Krishna; Linhard Verena; Gande Santosh L; Hiller Fabian; Schwalbe Harald; Kudlinzki Denis; Saxena Krishna; Gande Santosh L; Schwalbe Harald; Kudlinzki Denis; Saxena Krishna; Gande Santosh L; Schwalbe Harald; Nilsson Ewa; Aagaard Anna; Wissler Lisa; Dekker Niek; Bamberg Krister</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2915</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The bile acid-sensing transcription factor farnesoid X receptor (FXR) regulates multiple metabolic processes.  Modulation of FXR is desired to overcome several metabolic pathologies but pharmacological administration of full FXR agonists has been plagued by mechanism-based side effects.  We have developed a modulator that partially activates FXR in vitro and in mice.  Here we report the elucidation of the molecular mechanism that drives partial FXR activation by crystallography- and NMR-based structural biology.  Natural and synthetic FXR agonists stabilize formation of an extended helix α11 and the α11-α12 loop upon binding.  This strengthens a network of hydrogen bonds, repositions helix α12 and enables co-activator recruitment.  Partial agonism in contrast is conferred by a kink in helix α11 that destabilizes the α11-α12 loop, a critical determinant for helix α12 orientation.  Thereby, the synthetic partial agonist induces conformational states, capable of recruiting both co-repressors and co-activators leading to an equilibrium of co-activator and co-repressor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTttHveiMTXKwHqQV89nF-2fW6udTcc2eYyUZ4iYQkDJbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzjsFSmtA%253D%253D&md5=60a0d5ab5343b7c9db55077ca0f675ab</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-10853-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-10853-2%26sid%3Dliteratum%253Aachs%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DKudlinzki%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DLinhard%26aufirst%3DV.%26aulast%3DGande%26aufirst%3DS.%2BL.%26aulast%3DHiller%26aufirst%3DF.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DNilsson%26aufirst%3DE.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DDekker%26aufirst%3DN.%26aulast%3DBamberg%26aufirst%3DK.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DMolecular%2520tuning%2520of%2520farnesoid%2520X%2520receptor%2520partial%2520agonism%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D2915%26doi%3D10.1038%2Fs41467-019-10853-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schierle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohrndorf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Tuning nuclear receptor selectivity of Wy14,643 towards selective retinoid X receptor modulation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2112</span>– <span class="NLM_lpage">2126</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2112-2126&author=J.+Pollingerauthor=L.+Gellrichauthor=S.+Schierleauthor=W.+Kiluauthor=J.+Schmidtauthor=L.+Kalinowskyauthor=J.+Ohrndorfauthor=A.+Kaiserauthor=J.+Heeringauthor=E.+Proschakauthor=D.+Merk&title=Tuning+nuclear+receptor+selectivity+of+Wy14%2C643+towards+selective+retinoid+X+receptor+modulation&doi=10.1021%2Facs.jmedchem.8b01848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning nuclear receptor selectivity of Wy14,643 towards selective retinoid X receptor modulation</span></div><div class="casAuthors">Pollinger, Julius; Gellrich, Leonie; Schierle, Simone; Kilu, Whitney; Schmidt, Jurema; Kalinowsky, Lena; Ohrndorf, Julia; Kaiser, Astrid; Heering, Jan; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2112-2126</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fatty acid sensing nuclear receptor families retinoid X receptors (RXRs) and peroxisome proliferator-activated receptors (PPARs) hold therapeutic potential in neurodegeneration.  Valuable pleiotropic activities of Wy14,643 (I) in models of such conditions exceed its known PPAR agonistic profile.  Here, we characterize the compd. as an RXR agonist explaining the pleiotropic effects and report its systematic structure-activity relationship anal. with the discovery of specific mol. determinants driving activity on PPARs and RXRs.  We have designed close analogs of the drug comprising selective and dual agonism on RXRs and PPARs that may serve as superior pharmacol. tools to study the role and interplay of the nuclear receptors in various pathologies.  A systematically optimized high potency RXR agonist (II) revealed activity in vivo and active concns. in brain.  With its lack of RXR/liver X receptor-mediated side effects and superior profile compared to classical rexinoids, it establishes a new class of innovative RXR modulators to overcome key challenges in RXR targeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkzZeRGQnW7rVg90H21EOLACvtfcHk0lgUhfZ5Un1OdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCgs78%253D&md5=627619c57f03ff4d0223c791154a9cff</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01848%26sid%3Dliteratum%253Aachs%26aulast%3DPollinger%26aufirst%3DJ.%26aulast%3DGellrich%26aufirst%3DL.%26aulast%3DSchierle%26aufirst%3DS.%26aulast%3DKilu%26aufirst%3DW.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DOhrndorf%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DTuning%2520nuclear%2520receptor%2520selectivity%2520of%2520Wy14%252C643%2520towards%2520selective%2520retinoid%2520X%2520receptor%2520modulation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2112%26epage%3D2126%26doi%3D10.1021%2Facs.jmedchem.8b01848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohrndorf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Computer-assisted discovery and structural optimization of a novel retinoid X receptor agonist chemotype</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00551</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00551" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=203-208&author=P.+Heitelauthor=L.+Gellrichauthor=L.+Kalinowskyauthor=J.+Heeringauthor=A.+Kaiserauthor=J.+Ohrndorfauthor=E.+Proschakauthor=D.+Merk&title=Computer-assisted+discovery+and+structural+optimization+of+a+novel+retinoid+X+receptor+agonist+chemotype&doi=10.1021%2Facsmedchemlett.8b00551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype</span></div><div class="casAuthors">Heitel, Pascal; Gellrich, Leonie; Kalinowsky, Lena; Heering, Jan; Kaiser, Astrid; Ohrndorf, Julia; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-208</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As universal heterodimer partners of many nuclear receptors, the retinoid X receptors (RXRs) constitute key transcription factors.  They regulate cell proliferation, differentiation, inflammation, and metabolic homeostasis and have recently been proposed as potential drug targets for neurodegenerative and inflammatory diseases.  Owing to the hydrophobic nature of RXR ligand binding sites, available synthetic RXR ligands are lipophilic, and their structural diversity is limited.  Here, we disclose the computer-assisted discovery of a novel RXR agonist chemotype and its systematic optimization toward potent RXR modulators.  We have developed a nanomolar RXR agonist with high selectivity among nuclear receptors and superior physicochem. properties compared to classical rexinoids that appears suitable for in vivo applications and as lead for future RXR-targeting medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcTGv0sL0Tr7Vg90H21EOLACvtfcHk0lgUhfZ5Un1OdQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslClsQ%253D%253D&md5=fbab609776ae1450cd1f35b3e02abf48</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00551%26sid%3Dliteratum%253Aachs%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DGellrich%26aufirst%3DL.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DOhrndorf%26aufirst%3DJ.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DComputer-assisted%2520discovery%2520and%2520structural%2520optimization%2520of%2520a%2520novel%2520retinoid%2520X%2520receptor%2520agonist%2520chemotype%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D203%26epage%3D208%26doi%3D10.1021%2Facsmedchemlett.8b00551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitzkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meindl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingermann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Tawab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span> <span> </span><span class="NLM_article-title">Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1055/s-2006-946680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1055%2Fs-2006-946680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16858665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpsl2itLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=881-887&author=O.+Rauauthor=M.+Wurglicsauthor=A.+Paulkeauthor=J.+Zitzkowskiauthor=N.+Meindlauthor=A.+Bockauthor=T.+Dingermannauthor=M.+Abdel-Tawabauthor=M.+Schubert-Zsilavecz&title=Carnosic+acid+and+carnosol%2C+phenolic+diterpene+compounds+of+the+labiate+herbs+rosemary+and+sage%2C+are+activators+of+the+human+peroxisome+proliferator-activated+receptor+gamma&doi=10.1055%2Fs-2006-946680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma</span></div><div class="casAuthors">Rau, Oliver; Wurglics, Mario; Paulke, Alexander; Zitzkowski, Jessica; Meindl, Nadine; Bock, Andreas; Dingermann, Theodor; Abdel-Tawab, Mona; Schubert-Zsilavecz, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">881-887</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand activated transcription factor, belonging to the metazoan family of nuclear hormone receptors.  Activation of PPARγ increases the transcription of enzymes involved in primary metab., leading to lower blood levels of fatty acids and glucose.  Hence, PPARγ represents the major target for the glitazone type of drugs currently being used clin. for the treatment of type 2 diabetes.  Furthermore, activators of PPARγ show beneficial anti-inflammatory and anti-tumor effects.  Utilizing a fusion receptor of the yeast Gal4-DNA binding domain joined to the hinge region and ligand binding domain of the human PPARγ in combination with a Gal4-driven luciferase reporter gene, cotransfected into Cos7 cells, we tested sage and rosemary exts. prepd. with 80% aq. ethanol for possible PPARγ activation.  This revealed that both exts. are capable of selectively activating Gal4-PPARγ fusion receptor, in a concn.-dependent manner, with EC50 values of 22.8 ± 8.4 mg/L and 33.7 ± 7.3 mg/L for rosemary and sage, resp.  Subsequent anal. of the characteristic constituents revealed the phenolic diterpene compds. carnosol, present in both herbs, and carnosic acid to be active principles of these exts., showing EC50 values of 41.2 ± 5.9 μM and 19.6 ± 2.0 μM, resp.  Thus it can be concluded that the glucose lowering effect reported recently for rosemary may be attributed to PPARγ activation.  Moreover, our observations may also explain the anti-inflammatory and antiproliferative effects of both compds. published previously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxnVO3BnMZNrVg90H21EOLACvtfcHk0lgzhJcpYd75RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpsl2itLg%253D&md5=64985985a1bde827b6323126858b03a1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-946680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-946680%26sid%3Dliteratum%253Aachs%26aulast%3DRau%26aufirst%3DO.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DPaulke%26aufirst%3DA.%26aulast%3DZitzkowski%26aufirst%3DJ.%26aulast%3DMeindl%26aufirst%3DN.%26aulast%3DBock%26aufirst%3DA.%26aulast%3DDingermann%26aufirst%3DT.%26aulast%3DAbdel-Tawab%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DCarnosic%2520acid%2520and%2520carnosol%252C%2520phenolic%2520diterpene%2520compounds%2520of%2520the%2520labiate%2520herbs%2520rosemary%2520and%2520sage%252C%2520are%2520activators%2520of%2520the%2520human%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%26jtitle%3DPlanta%2520Med.%26date%3D2006%26volume%3D72%26spage%3D881%26epage%3D887%26doi%3D10.1055%2Fs-2006-946680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouroupis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span> <span> </span><span class="NLM_article-title">Assay validation for the assessment of adipogenesis of multipotential stromal cells--a direct comparison of four different methods</span>. <i>Cytotherapy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.jcyt.2012.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.jcyt.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=23260089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ylurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=89-101&author=A.+Aldridgeauthor=D.+Kouroupisauthor=S.+Churchmanauthor=A.+Englishauthor=E.+Inghamauthor=E.+Jones&title=Assay+validation+for+the+assessment+of+adipogenesis+of+multipotential+stromal+cells%2D%2Da+direct+comparison+of+four+different+methods&doi=10.1016%2Fj.jcyt.2012.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Assay validation for the assessment of adipogenesis of multipotential stromal cells-a direct comparison of four different methods</span></div><div class="casAuthors">Aldridge, Andrew; Kouroupis, Dimitrios; Churchman, Sarah; English, Anne; Ingham, Eileen; Jones, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Cytotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-101</span>CODEN:
                <span class="NLM_cas:coden">CYTRF3</span>;
        ISSN:<span class="NLM_cas:issn">1465-3249</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mesenchymal stromal cells (MSCs) are regenerative and immuno-privileged cells that are used for both tissue regeneration and treatment of severe inflammation-related disease.  For quality control of manufd. MSC batches in regard to mature fat cell contamination, a quant. method for measuring adipogenesis is needed.  Four previously proposed methods were validated with the use of bone marrow (BM) MSCs during a 21-day in vitro assay.  Oil red staining was scored semiquant.; peroxisome proliferator activated receptor-γ and fatty acid binding protein (FABP)4 transcripts were measured by quant. real-time polymerase chain reaction; FABP4 protein accumulation was evaluated by flow cytometry; and Nile red/4',6-diamidino-2-phenylindole (DAPI) ratios were measured in fluorescent microplate assay.  Skin fibroblasts and MSCs from fat pad, cartilage and umbilical cord were used as controls.  Oil red staining indicated considerable heterogeneity between BM donors and individual cells within the same culture.  FABP4 transcript levels increased 100- to 5000-fold by day 21, with large donor variability obsd.  Flow cytometry revealed increasing intra-culture heterogeneity over time; more granular cells accumulated more FABP4 protein and Nile red fluorescence compared with less granular cells.  Nile red increase in day-21 MSCs was ∼5- and 4-fold, measured by flow cytometry or microplate assay, resp.  MSC proliferation/apoptosis was accounted through the use of Nile red/DAPI ratios; adipogenesis levels in day-21 BM MSCs increased ∼13-fold, with significant correlations with oil red scoring obsd. for MSC from other sources.  Flow cytometry permits the study of MSC differentiation at the single-cell level and sorting more and less mature cells from mixed cell populations.  The microplate assay with the use of the Nile red/DAPI ratio provides rapid quant. measurements and could be used as a low-cost, high-throughput method to quality-control MSC batches from different tissue sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUmCXX4iqoILVg90H21EOLACvtfcHk0lgzhJcpYd75RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ylurbF&md5=e1c31abf2e983f5bf4bd8da6f31b9ac8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jcyt.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcyt.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DAldridge%26aufirst%3DA.%26aulast%3DKouroupis%26aufirst%3DD.%26aulast%3DChurchman%26aufirst%3DS.%26aulast%3DEnglish%26aufirst%3DA.%26aulast%3DIngham%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DE.%26atitle%3DAssay%2520validation%2520for%2520the%2520assessment%2520of%2520adipogenesis%2520of%2520multipotential%2520stromal%2520cells--a%2520direct%2520comparison%2520of%2520four%2520different%2520methods%26jtitle%3DCytotherapy%26date%3D2013%26volume%3D15%26spage%3D89%26epage%3D101%26doi%3D10.1016%2Fj.jcyt.2012.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raspotnig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jantscher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windischhofer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schachl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leis, H. J.</span></span> <span> </span><span class="NLM_article-title">Colorimetric determination of cell numbers by Janus Green staining</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1006/abio.1999.4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1006%2Fabio.1999.4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10542111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1999&pages=74-83&author=G.+Raspotnigauthor=G.+Faulerauthor=A.+Jantscherauthor=W.+Windischhoferauthor=K.+Schachlauthor=H.+J.+Leis&title=Colorimetric+determination+of+cell+numbers+by+Janus+Green+staining&doi=10.1006%2Fabio.1999.4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Colorimetric Determination of Cell Numbers by Janus Green Staining</span></div><div class="casAuthors">Raspotnig, G.; Fauler, G.; Jantscher, A.; Windischhofer, W.; Schachl, K.; Leis, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-83</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A colorimetric assay using the basic azo dye Janus green has been developed to assess cell nos. in anchorage-dependent cell cultures, with special regard to the enumeration of osteoblastic cells.  Therefore, cells are fixed in ethanol and stained with a 0.2% soln. of Janus green for 3 min, followed by a destaining step of 1 min in tap water.  The addn. of dild. hydrochloric acid easily and immediately leads to dye elution from stained cell layers into the acidic supernatant which consequently is transferred into 96-well plates and read on a microplate reader at 595 nm.  Working under standardized conditions, Janus green uptake in several cell lines is shown to be linearly correlated with cell nos. over a broad range of cell densities, in MC3T3-E1 cells from about 3% up to more than 300% of confluency.  Abs. sensitivity of the assay allows detection of less than 1000 cells/cm2.  In comparison to many other colorimetric assays, the Janus green technique is simple to perform, fast, precise, stable, cheap, and well suited for processing large quantities of samples.  Moreover, it is applicable to any culture formate and size, from irregular formed carriers up to 96-multiwell plates.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQYsmJytFCnrVg90H21EOLACvtfcHk0lgzhJcpYd75RQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVynuro%253D&md5=23020ba0b8a9a4c42485acdfd9018c00</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4309%26sid%3Dliteratum%253Aachs%26aulast%3DRaspotnig%26aufirst%3DG.%26aulast%3DFauler%26aufirst%3DG.%26aulast%3DJantscher%26aufirst%3DA.%26aulast%3DWindischhofer%26aufirst%3DW.%26aulast%3DSchachl%26aufirst%3DK.%26aulast%3DLeis%26aufirst%3DH.%2BJ.%26atitle%3DColorimetric%2520determination%2520of%2520cell%2520numbers%2520by%2520Janus%2520Green%2520staining%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D275%26spage%3D74%26epage%3D83%26doi%3D10.1006%2Fabio.1999.4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Xds</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0liUf7oe1HMiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0liUf7oe1HMiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span> <span> </span><span class="NLM_article-title">Acknowledging errors: advanced molecular replacement with Phaser</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1607</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-7000-1_18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1007%2F978-1-4939-7000-1_18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=28573584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOgt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1607&publication_year=2017&pages=421-453&author=A.+J.+McCoy&title=Acknowledging+errors%3A+advanced+molecular+replacement+with+Phaser&doi=10.1007%2F978-1-4939-7000-1_18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Acknowledging errors: advanced molecular replacement with phaser</span></div><div class="casAuthors">McCoy, Airlie J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1607</span>
        (<span class="NLM_cas:issue">Protein Crystallography</span>),
    <span class="NLM_cas:pages">421-453</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mol. replacement is a method for solving the crystallog. phase problem using an at. model for the target structure.  State-of-the-art methods have moved the field significantly from when it was first envisaged as a method for solving cases of high homol. and completeness between a model and target structure.  Improvements brought about by application of max. likelihood statistics mean that various errors in the model and pathologies in the data can be accounted for, so that cases hitherto thought to be intractable are standardly solvable.  As a result, mol. replacement phasing now accounts for the lion's share of structures deposited in the Protein Data Bank.  However, there will always be cases at the fringes of solvability.  I discuss here the approaches that will help tackle challenging mol. replacement cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp1cYKuTlwgbVg90H21EOLACvtfcHk0liUf7oe1HMiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOgt7fP&md5=baeaf4699f241d0aa603fd43611ec020</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-7000-1_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-7000-1_18%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26atitle%3DAcknowledging%2520errors%253A%2520advanced%2520molecular%2520replacement%2520with%2520Phaser%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1607%26spage%3D421%26epage%3D453%26doi%3D10.1007%2F978-1-4939-7000-1_18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: Model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0liUf7oe1HMiJQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubák, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lj5_dODH4fbHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Structural refinement of inhibitors of urea-based soluble epoxide hydrolases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(02)00952-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2FS0006-2952%2802%2900952-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=12007563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=1599-1608&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=J.+W.+Newmanauthor=C.+E.+Wheelockauthor=D.+L.+Dowdyauthor=B.+D.+Hammock&title=Structural+refinement+of+inhibitors+of+urea-based+soluble+epoxide+hydrolases&doi=10.1016%2FS0006-2952%2802%2900952-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural refinement of inhibitors of urea-based soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Newman, John W.; Wheelock, Craig E.; Dowdy, Deanna L.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1599-1608</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) is involved in the metab. of arachidonic, linoleic, and other fatty acid epoxides, endogenous chem. mediators that play an important role in blood pressure regulation and inflammation. 1,3-Disubstituted ureas, carbamates, and amides are new potent and stable inhibitors of sEH.  However, the poor soly. of the lead compds. limits their use.  Inhibitor structure-activity relationships were investigated to better define the structural requirements for inhibition and to identify points in the mol. topog. that could accept polar groups without diminishing inhibition potency.  Results indicate that lipophilicity is an important factor controlling inhibitor potency.  Polar groups could be incorporated into one of the alkyl groups without loss of activity if they were placed at a sufficient distance from the urea function.  The resulting compds. had a 2-fold higher water soly.  These findings will facilitate the rational design and optimization of sEH inhibitors with better phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCZUVkekez5rVg90H21EOLACvtfcHk0lj5_dODH4fbHQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D&md5=9d9aa4d7254d7fe156719d17fb80e0ad</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2900952-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252900952-8%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DDowdy%26aufirst%3DD.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DStructural%2520refinement%2520of%2520inhibitors%2520of%2520urea-based%2520soluble%2520epoxide%2520hydrolases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D63%26spage%3D1599%26epage%3D1608%26doi%3D10.1016%2FS0006-2952%2802%2900952-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibli, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukunft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">5204</span>– <span class="NLM_lpage">5218</span>, <span class="refDoi"> DOI: 10.1172/JCI123835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1172%2FJCI123835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=31479425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsFKgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=5204-5218&author=J.+Huauthor=S.-I.+Bibliauthor=J.+Wittigauthor=S.+Zukunftauthor=J.+Linauthor=H.-P.+Hammesauthor=R.+Poppauthor=I.+Fleming&title=Soluble+epoxide+hydrolase+promotes+astrocyte+survival+in+retinopathy+of+prematurity&doi=10.1172%2FJCI123835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity</span></div><div class="casAuthors">Hu, Jiong; Bibli, Sofia-Iris; Wittig, Janina; Zukunft, Sven; Lin, Jihong; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5204-5218</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">1558-8238</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Polyunsatd. fatty acids such as docosahexaenoic acid (DHA) pos. affect the outcome of retinopathy of prematurity (ROP).  Given that DHA metab. by cytochrome P 450 and sol. epoxide hydrolase (sEH) enzymes affects retinal angiogenesis and vascular stability, we investigated the role of sEH in a mouse model of ROP.  In WT mice, hyperoxia elicited tyrosine nitration and inhibition of sEH and decreased generation of the DHA-derived diol 19,20-dihydroxydocosapentaenoic acid (19,20-DHDP).  Correspondingly, in a murine model of ROP, sEH-/- mice developed a larger central avascular zone and peripheral pathol. vascular tuft formation than did their WT littermates.  Astrocytes were the cells most affected by sEH deletion, and hyperoxia increased astrocyte apoptosis.  In rescue expts., 19,20-DHDP prevented astrocyte loss by targeting the mitochondrial membrane to prevent the hyperoxia-induced dissocn. of presenilin-1 and presenilin-1-assocd. protein to attenuate poly ADP-ribose polymerase activation and mitochondrial DNA damage.  Therapeutic intravitreal administration of 19,20-DHDP not only suppressed astrocyte loss, but also reduced pathol. vascular tuft formation in sEH-/- mice.  Our data indicate that sEH activity is required for mitochondrial integrity and retinal astrocyte survival in ROP.  Moreover, 19,20-DHDP may be more effective than DHA as a nutritional supplement for preventing retinopathy in preterm infants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcPDSRyJnLCrVg90H21EOLACvtfcHk0ljBgaxt1W0QnA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsFKgtbk%253D&md5=848c1304d37ff3b60f223e2137ea54f0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1172%2FJCI123835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI123835%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DBibli%26aufirst%3DS.-I.%26aulast%3DWittig%26aufirst%3DJ.%26aulast%3DZukunft%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHammes%26aufirst%3DH.-P.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520promotes%2520astrocyte%2520survival%2520in%2520retinopathy%2520of%2520prematurity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D5204%26epage%3D5218%26doi%3D10.1172%2FJCI123835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref200':['cit200'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article has not yet been cited by other publications.</p></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0011.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Selective sEH inhibitor <b>1</b>, selective PPARγ agonist <b>2</b>, and dual sEH/PPARγ modulator <b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0010.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label"><sup>a</sup></span>(a) 1.0 equiv BnBr, 1.0 equiv Cs<sub>2</sub>CO<sub>3</sub>, DMF abs, rt, 3 h, 91%; (b) 1.0 equiv NaBH<sub>4</sub>, MeOH, 0 °C, 16 h, 71%; (c) 1.0 equiv PBr<sub>3</sub>, THF abs, 0 °C → rt, 3 h, 83%; (d) 1.0 equiv <i>n</i>-BuLi, 1.1 equiv butyryl chloride, −78 °C, 30 min, 94%; (e) 1.1 equiv NaHMDS, 1.5 equiv <b>7</b>, THF abs, −78 °C, 67%; (f) Pd/C, 5 bar H<sub>2</sub>, MeOH, 5 h, rt, 76–86%; (g) 1.0 equiv <b>11</b>, 1.5 equiv HBTU, 1.5 equiv EDC × HCl, 6.0 equiv <i>N</i>-methylmorpholine, 1.1 equiv 4-methoxy-2-(trifluoromethyl)benzylamine, rt, 16 h, 75–84%; (h) 8.0 equiv H<sub>2</sub>O<sub>2</sub>, 2.0 equiv LiOH, THF:H<sub>2</sub>O (3:1 v/v), rt, 16 h, 87–92%.</p></p></figure><figure data-id="fig2" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0002.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. CD spectra of the enantiomers (<i>R</i>)-<b>3</b> and (<i>S</i>)-<b>3</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0003.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. <b>3</b> promotes PPARγ cofactor recruitment (A) and inhibits sEH in vitro (B).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0004.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Crystal structures of (<i>R</i>)-<b>3</b> in complex with sEH (A) and PPARγ (C). Electron density maps contoured at 1σ for the bound ligand are shown in the right panel (B + D).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0005.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Structural comparison of PPARγ between (<i>R</i>)-<b>3</b> (cyan) bound and TIPP-703 bound (salmon stick) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VJI">3VJI</a>)</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0006.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. <b>3</b> promotes reporter gene expression in Gal4-chimera assays. (A) (<i>R</i>)-<b>3</b> is acting as full agonist of PPARγ, while (<i>S</i>)-<b>3</b> exhibits partial agonistic activity. (B) (<i>R</i>)-<b>3</b> selectively activates PPARγ but not other nuclear receptors at 10 μM.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0007.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. <b>3</b> promotes adipogenic differentiation of SGBS cells. SGBS cells were subjected to adipogenic differentiation in the in the presence of <b>2</b>, (<i>R</i>)-<b>3</b>, and (<i>S</i>)-<b>3.</b> (A) Representative microphotographs of cell cultures. Adipogenic differentiation was further assessed by intracellular lipid staining using Nile red (B) and mRNA expression of perilipin A (PLIN) (C). Mean values + SEM of <i>n</i> = 3 independent experiments are shown. Two-way ANOVA (vs vehicle control), *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0008.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. <b>3</b> induces browning in human white adipocytes. SGBS cells were differentiated into adipocytes in the presence of increasing concentrations of <b>2</b>, (<i>R</i>)-<b>3</b>, and (<i>S</i>)-<b>3</b>. Expression of the brown adipocyte marker uncoupling protein 1 (UCP1, A), and the mitochondrial marker UQCRC2 (B) was determined by qRT-PCR. Cellular respiration in the presence of dibutyryl-cAMP was determined using a plate-based respirometer (C–E). Basal (C), ATP-linked/oligomycin-sensitve (D), and proton leak/oligomycin-insensitive (E) respiration was calculated from the data before and after oligomycin injection. Mean values + SEM of <i>n</i> = 3 independent experiments are shown. Two-way ANOVA (vs vehicle control), *<i>p</i> < 0.05, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/medium/jm0c02063_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0009.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Effects of (<i>R</i>)-<b>3</b> in heart function. (A) Heart rate of perfused hearts treated with solvent alone (DMSO), or the indicated concentrations of t-AUCB and (<i>R</i>)-<b>3</b>. (B) 14,15 EET/DHET ratio in the perfusates of hearts under basal conditions (before drug application) and 15 min following 3 nM circulating application of the compounds. WT and sEH–/– were used. (C) Coronary flow tracing following 15 s of occlusion in isolated hearts treated with solvent, t-AUCB, and (<i>R</i>)-<b>3</b> with 3 nmol/L 15 min prior to occlusion in WT or sEH–/– hearts. (D) Repayment volume in 1 min in hearts as in (C). (E) Infarct sizes of isolated wild-type and sEH<sup>–/–</sup> hearts after ischemia/reperfusion injury. Infarct sizes were visualized by TTC staining (lower panel; infarct areas are presented discolored) and the ratio of the infarcted areas relative to the whole myocardial areas is presented as %. <i>n</i> = 5 per group; ***<i>p</i> < 0.001. (F) Left ventricular developed pressure (LVDP) and (G) left ventricular end diastolic pressure (LVEDP) in perfused hearts from WT mice treated as in (C) <i>n</i> = 4–6/group. One- or Two-Way ANOVA (Bonferroni), *<i>p</i> < 0.5, **<i>p</i> < 0.01, ***<i>p</i> < 0.001.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-5/acs.jmedchem.0c02063/20210305/images/large/jm0c02063_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.0c02063&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i49">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47356" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47356" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 54 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Saklayen, M. G.</span></span> <span> </span><span class="NLM_article-title">The global epidemic of the metabolic syndrome</span>. <i>Curr. Hypertens. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.1007/s11906-018-0812-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1007%2Fs11906-018-0812-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=29480368" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC1MrltlShug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2018&pages=12&author=M.+G.+Saklayen&title=The+global+epidemic+of+the+metabolic+syndrome&doi=10.1007%2Fs11906-018-0812-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">The Global Epidemic of the Metabolic Syndrome</span></div><div class="casAuthors">Saklayen Mohammad G</div><div class="citationInfo"><span class="NLM_cas:title">Current hypertension reports</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">12</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome, variously known also as syndrome X, insulin resistance, etc., is defined by WHO as a pathologic condition characterized by abdominal obesity, insulin resistance, hypertension, and hyperlipidemia.  Though there is some variation in the definition by other health care organization, the differences are minor.  With the successful conquest of communicable infectious diseases in most of the world, this new non-communicable disease (NCD) has become the major health hazard of modern world.  Though it started in the Western world, with the spread of the Western lifestyle across the globe, it has become now a truly global problem.  The prevalence of the metabolic syndrome is often more in the urban population of some developing countries than in its Western counterparts.  The two basic forces spreading this malady are the increase in consumption of high calorie-low fiber fast food and the decrease in physical activity due to mechanized transportations and sedentary form of leisure time activities.  The syndrome feeds into the spread of the diseases like type 2 diabetes, coronary diseases, stroke, and other disabilities.  The total cost of the malady including the cost of health care and loss of potential economic activity is in trillions.  The present trend is not sustainable unless a magic cure is found (unlikely) or concerted global/governmental/societal efforts are made to change the lifestyle that is promoting it.  There are certainly some elements in the causation of the metabolic syndrome that cannot be changed but many are amenable for corrections and curtailments.  For example, better urban planning to encourage active lifestyle, subsidizing consumption of whole grains and possible taxing high calorie snacks, restricting media advertisement of unhealthy food, etc.  Revitalizing old fashion healthier lifestyle, promoting old-fashioned foods using healthy herbs rather than oil and sugar, and educating people about choosing healthy/wholesome food over junks are among the steps that can be considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTnFm2oNMafwjUE-swuRqsHfW6udTcc2eaogbPjKrVtCrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1MrltlShug%253D%253D&md5=c02a7c88c75bedba56a72fcdb6666e7f</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.1007%2Fs11906-018-0812-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs11906-018-0812-z%26sid%3Dliteratum%253Aachs%26aulast%3DSaklayen%26aufirst%3DM.%2BG.%26atitle%3DThe%2520global%2520epidemic%2520of%2520the%2520metabolic%2520syndrome%26jtitle%3DCurr.%2520Hypertens.%2520Rep.%26date%3D2018%26volume%3D20%26spage%3D12%26doi%3D10.1007%2Fs11906-018-0812-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Grundy, S. M.</span></span> <span> </span><span class="NLM_article-title">Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy</span>. <i>Nat. Rev. Drug Discovery</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">295</span>– <span class="NLM_lpage">309</span>, <span class="refDoi"> DOI: 10.1038/nrd2005</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fnrd2005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16582875" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD28XjtVaksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=295-309&author=S.+M.+Grundy&title=Drug+therapy+of+the+metabolic+syndrome%3A+minimizing+the+emerging+crisis+in+polypharmacy&doi=10.1038%2Fnrd2005"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2R"><div class="casContent"><span class="casTitleNuber">2</span><div class="casTitle"><span class="NLM_cas:atitle">Drug therapy of the metabolic syndrome: minimizing the emerging crisis in polypharmacy</span></div><div class="casAuthors">Grundy, Scott M.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Drug Discovery</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">295-309</span>CODEN:
                <span class="NLM_cas:coden">NRDDAG</span>;
        ISSN:<span class="NLM_cas:issn">1474-1776</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The metabolic syndrome - a collection of factors assocd. with increased risk for cardiovascular disease and diabetes - is becoming increasingly common, largely as a result of the increase in the prevalence of obesity.  Although it is generally agreed that first-line clin. intervention for the metabolic syndrome is lifestyle change, this is insufficient to normalize the risk factors in many patients, and so residual risk could be high enough to justify drug therapy.  However, at present there are no approved drugs that can reliably reduce all of the metabolic risk factors over the long term, and so there is growing interest in therapeutic strategies that might target multiple risk factors more effectively, thereby minimizing problems with polypharmacy.  This review summarizes current understanding of the nature of the metabolic syndrome, and discusses each of the risk factors of the metabolic syndrome as possible primary drug targets; potential secondary or tertiary targets are also considered.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkr5GF2KUFU7Vg90H21EOLACvtfcHk0lgJi9RDmLSkAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjtVaksr4%253D&md5=bc5c9f4b7bf4d81c65cd2e564e350a4a</span></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.1038%2Fnrd2005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrd2005%26sid%3Dliteratum%253Aachs%26aulast%3DGrundy%26aufirst%3DS.%2BM.%26atitle%3DDrug%2520therapy%2520of%2520the%2520metabolic%2520syndrome%253A%2520minimizing%2520the%2520emerging%2520crisis%2520in%2520polypharmacy%26jtitle%3DNat.%2520Rev.%2520Drug%2520Discovery%26date%3D2006%26volume%3D5%26spage%3D295%26epage%3D309%26doi%3D10.1038%2Fnrd2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Masquio, D. C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Piano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campos, R. M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanches, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnier, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Corgosinho, F. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Netto, B. D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carvalho-Ferreira, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nascimento, C. M. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mello, M. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tufik, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dâmaso, A. R.</span></span> <span> </span><span class="NLM_article-title">The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents</span>. <i>Br. J. Nutr.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>113</i></span>,  <span class="NLM_fpage">1920</span>– <span class="NLM_lpage">1930</span>, <span class="refDoi"> DOI: 10.1017/S0007114515001129</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1017%2FS0007114515001129" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=25907896" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=113&publication_year=2015&pages=1920-1930&author=D.+C.+L.+Masquioauthor=A.+de+Pianoauthor=R.+M.+S.+Camposauthor=P.+L.+Sanchesauthor=J.+Carnierauthor=F.+C.+Corgosinhoauthor=B.+D.+M.+Nettoauthor=J.+P.+Carvalho-Ferreiraauthor=L.+M.+Oyamaauthor=C.+M.+O.+Nascimentoauthor=M.+T.+de+Melloauthor=S.+Tufikauthor=A.+R.+D%C3%A2maso&title=The+role+of+multicomponent+therapy+in+the+metabolic+syndrome%2C+inflammation+and+cardiovascular+risk+in+obese+adolescents&doi=10.1017%2FS0007114515001129"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">The role of multicomponent therapy in the metabolic syndrome, inflammation and cardiovascular risk in obese adolescents</span></div><div class="casAuthors">Masquio, Deborah C. L.; de Piano, Aline; Campos, Raquel M. S.; Sanches, Priscila L.; Carnier, June; Corgosinho, Flavia C.; Netto, Barbara D. M.; Carvalho-Ferreira, Joana P.; Oyama, Lila M.; Nascimento, Claudia M. O.; de Mello, Marco T.; Tufik, Sergio; Damaso, Ana R.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Nutrition</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">113</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1920-1930</span>CODEN:
                <span class="NLM_cas:coden">BJNUAV</span>;
        ISSN:<span class="NLM_cas:issn">0007-1145</span>.
    
            (<span class="NLM_cas:orgname">Cambridge University Press</span>)
        </div><div class="casAbstract">Obesity is characterized by low-grade inflammation, which increases the metabolic syndrome (MetS) and cardiovascular risks.  The aim of the present study was to verify the role of multicomponent therapy in controlling the MetS, inflammation and carotid intima-media thickness (cIMT) in obese adolescents.  The second aim was to investigate the relationships between adipokines, the MetS parameters and cIMT.  A total of sixty-nine obese adolescents participated in the present study and completed 1 yr of multicomponent therapy (a combination of strategies involving nutrition, psychol., phys. exercise and clin. therapy), and were divided according to their MetS diagnosis as follows: MetS (n 19); non-MetS (n 50).  Blood analyses of glucose, lipid and adipokine concns. (adiponectin, leptin, plasminogen activator inhibitor 1 (PAI-1) and C-reactive protein) were collected.  Insulin resistance was assessed using the homeostasis model assessment for insulin resistance, quant. insulin sensitivity check index and homeostasis model assessment-adiponectin. cIMT and visceral and s.c. fat were estd. using ultrasonog.  At baseline, the MetS group presented higher waist circumference, glucose and insulin levels, and systolic and median blood pressures compared with the non-MetS group.  After therapy, both groups showed improvements in the anthropometric profile, body compn., insulin level, insulin resistance, insulin sensibility, TAG and VLDL-cholesterol, adiponectin, leptin and PAI-1 levels, blood pressure and cIMT.  The prevalence of the MetS was reduced from 27·5 to 13·0 %.  Metabolic syndrome patients showed resistance in the attenuation of total cholesterol and LDL-cholesterol (LDL-C) levels and leptin:adiponectin and adiponectin:leptin ratios.  In the MetS group, the variation in the adiponectin:leptin ratio was correlated with variations in glucose, insulin sensibility, total cholesterol, LDL-c and systolic blood pressure.  Addnl., the no. of MetS parameters was correlated with the carotid measurement.  Moreover, the variation in cIMT was correlated with the variations in insulin sensibility, total cholesterol and LDL-c.  For the entire group, the no. of MetS alterations was correlated with the leptin level and leptin:adiponectin ratio and adiponectin:leptin ratio after therapy.  In conclusion, multicomponent therapy was effective in controlling the MetS, inflammation and cIMT in the obese adolescents.  However, the MetS patients showed resistance in the attenuation of the atherogenic lipid profile and leptin:adiponectin ratio and adiponectin:leptin ratio.  These results suggest that the MetS patients have increased cardiovascular risks, and that it is important to attempt to control the inflammatory process that occurs due to obesity in clin. practice in order to improve the health of adolescents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwQ2CPRJqyybVg90H21EOLACvtfcHk0lg7g1OQFJJIHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFWmt7%252FL&md5=c50ee408c995b7a6069d52b146113dbb</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1017%2FS0007114515001129&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1017%252FS0007114515001129%26sid%3Dliteratum%253Aachs%26aulast%3DMasquio%26aufirst%3DD.%2BC.%2BL.%26aulast%3Dde%2BPiano%26aufirst%3DA.%26aulast%3DCampos%26aufirst%3DR.%2BM.%2BS.%26aulast%3DSanches%26aufirst%3DP.%2BL.%26aulast%3DCarnier%26aufirst%3DJ.%26aulast%3DCorgosinho%26aufirst%3DF.%2BC.%26aulast%3DNetto%26aufirst%3DB.%2BD.%2BM.%26aulast%3DCarvalho-Ferreira%26aufirst%3DJ.%2BP.%26aulast%3DOyama%26aufirst%3DL.%2BM.%26aulast%3DNascimento%26aufirst%3DC.%2BM.%2BO.%26aulast%3Dde%2BMello%26aufirst%3DM.%2BT.%26aulast%3DTufik%26aufirst%3DS.%26aulast%3DD%25C3%25A2maso%26aufirst%3DA.%2BR.%26atitle%3DThe%2520role%2520of%2520multicomponent%2520therapy%2520in%2520the%2520metabolic%2520syndrome%252C%2520inflammation%2520and%2520cardiovascular%2520risk%2520in%2520obese%2520adolescents%26jtitle%3DBr.%2520J.%2520Nutr.%26date%3D2015%26volume%3D113%26spage%3D1920%26epage%3D1930%26doi%3D10.1017%2FS0007114515001129" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Scheen, A. J.</span></span> <span> </span><span class="NLM_article-title">Management of the metabolic syndrome</span>. <i>Minerva Endocrinol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">31</span>– <span class="NLM_lpage">45</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=15257254" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BD2czltlOqsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2004&pages=31-45&author=A.+J.+Scheen&title=Management+of+the+metabolic+syndrome"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Management of the metabolic syndrome</span></div><div class="casAuthors">Scheen A J</div><div class="citationInfo"><span class="NLM_cas:title">Minerva endocrinologica</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">31-45</span>
        ISSN:<span class="NLM_cas:issn">0391-1977</span>.
    </div><div class="casAbstract">The metabolic syndrome (MetS) is strongly associated with insulin resistance and consists of a constellation of factors that raise the risk for cardiovascular diseases and diabetes mellitus.  Therefore, the primary goals of treating MetS are prevention of type 2 diabetes and cardiovascular events.  Three levels of intervention may be considered for individuals with MetS : 1) management of underlying risk conditions by controlling weight excess, enhancing regular physical exercise and promoting healthy diet; 2) management of individual risk factors such as dyslipidaemia, hypertension, hyperglycaemia and prothrombotic state; and 3) targeting insulin resistance by using specific insulin sensitizers such as thiazolidinediones.  The most important therapeutic intervention effective in subjects with MetS should focus on modest weight reduction and regular leisure-time physical activities.  Although lifestyle modification is the first-line therapy, drug therapy may be necessary in many patients to achieve recommended goals regarding lipid profile, blood pressure and blood glucose control.  Rather than to use a magic bullet that might fully reverse the underlying cause of the syndrome, one appealing alternative would be to use a so-called "polypill" targeting each of the components of MetS.  However, such a polypill should ideally contain numerous molecules that all have shown a potential interest for the management of MetS such as metformin, acarbose, a thiazolidinedione, a statin, a fibrate, an inhibitor of the renin-angiotensin system, aspirin.  The growing prevalence and high-risk nature of MetS highlights the need to identify individuals with this condition and to treat them with an aggressive multitargeted approach.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRvHJ3qSMrH5D0O18WR3iAofW6udTcc2ebNJoYRuKzUvbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2czltlOqsA%253D%253D&md5=10a02189186d78c97e73c7a038585ce8</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DScheen%26aufirst%3DA.%2BJ.%26atitle%3DManagement%2520of%2520the%2520metabolic%2520syndrome%26jtitle%3DMinerva%2520Endocrinol.%26date%3D2004%26volume%3D29%26spage%3D31%26epage%3D45" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Artasensi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pedretti, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vistoli, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fumagalli, L.</span></span> <span> </span><span class="NLM_article-title">Type 2 Diabetes Mellitus: A review of multi-target drugs</span>. <i>Molecules</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1987</span>, <span class="refDoi"> DOI: 10.3390/molecules25081987</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.3390%2Fmolecules25081987" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXhtVekurvM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2020&pages=1987&author=A.+Artasensiauthor=A.+Pedrettiauthor=G.+Vistoliauthor=L.+Fumagalli&title=Type+2+Diabetes+Mellitus%3A+A+review+of+multi-target+drugs&doi=10.3390%2Fmolecules25081987"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Type 2 diabetes mellitus: a review of multi-target drugs</span></div><div class="casAuthors">Artasensi, Angelica; Pedretti, Alessandro; Vistoli, Giulio; Fumagalli, Laura</div><div class="citationInfo"><span class="NLM_cas:title">Molecules</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1987</span>CODEN:
                <span class="NLM_cas:coden">MOLEFW</span>;
        ISSN:<span class="NLM_cas:issn">1420-3049</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">A review.  Diabetes Mellitus (DM) is a multi-factorial chronic health condition that affects a large part of population and according to the World Health Organization (WHO) the no. of adults living with diabetes is expected to increase.  Since type 2 diabetes mellitus (T2DM) is suffered by the majority of diabetic patients (around 90-95%) and often the mono-target therapy fails in managing blood glucose levels and the other comorbidities, this review focuses on the potential drugs acting on multi-targets involved in the treatment of this type of diabetes.  In particular, the review considers the main systems directly involved in T2DM or involved in diabetes comorbidities.  Agonists acting on incretin, glucagon systems, as well as on peroxisome proliferation activated receptors are considered.  Inhibitors which target either aldose reductase and tyrosine phosphatase 1B or sodium glucose transporters 1 and 2 are taken into account.  Moreover, with a view at the multi-target approaches for T2DM some phytocomplexes are also discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrXBBSvnXojZrVg90H21EOLACvtfcHk0lg7g1OQFJJIHA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXhtVekurvM&md5=322b179431f83be70a49934d0408fdca</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.3390%2Fmolecules25081987&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmolecules25081987%26sid%3Dliteratum%253Aachs%26aulast%3DArtasensi%26aufirst%3DA.%26aulast%3DPedretti%26aufirst%3DA.%26aulast%3DVistoli%26aufirst%3DG.%26aulast%3DFumagalli%26aufirst%3DL.%26atitle%3DType%25202%2520Diabetes%2520Mellitus%253A%2520A%2520review%2520of%2520multi-target%2520drugs%26jtitle%3DMolecules%26date%3D2020%26volume%3D25%26spage%3D1987%26doi%3D10.3390%2Fmolecules25081987" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ammazzalorso, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maccallini, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoia, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amoroso, R.</span></span> <span> </span><span class="NLM_article-title">Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>173</i></span>,  <span class="NLM_fpage">261</span>– <span class="NLM_lpage">273</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2019.04.030</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.ejmech.2019.04.030" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=31009912" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXot1Sqtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=173&publication_year=2019&pages=261-273&author=A.+Ammazzalorsoauthor=C.+Maccalliniauthor=P.+Amoiaauthor=R.+Amoroso&title=Multitarget+PPAR%CE%B3+agonists+as+innovative+modulators+of+the+metabolic+syndrome&doi=10.1016%2Fj.ejmech.2019.04.030"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">Multitarget PPARγ agonists as innovative modulators of the metabolic syndrome</span></div><div class="casAuthors">Ammazzalorso, Alessandra; Maccallini, Cristina; Amoia, Pasquale; Amoroso, Rosa</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">173</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">261-273</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">A multitarget pharmacol. approach could be advantageous for the therapy of metabolic multiple diseases, such as the metabolic syndrome, which is characterized by metabolic abnormalities assocd. with diabetes, obesity, hypertension, and increased cardiovascular risk.  PPAR receptors play a crit. role in metabolic disorders, affecting glucose and lipid metab.  Drugs simultaneously targeting PPAR and other validated metabolic targets, represent a promising multitarget approach to combine antihyperglycemic, antihyperlipidemic, and antihypertensive effects.  This review offers a survey of recently developed multitarget PPARγ agonists as antidiabetic and antihypertensive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGon-jgSct1kWrVg90H21EOLACvtfcHk0ljYEj_kVJ0UqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXot1Sqtbw%253D&md5=505cfff367fe74704ef5f2c7a27719ec</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2019.04.030&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2019.04.030%26sid%3Dliteratum%253Aachs%26aulast%3DAmmazzalorso%26aufirst%3DA.%26aulast%3DMaccallini%26aufirst%3DC.%26aulast%3DAmoia%26aufirst%3DP.%26aulast%3DAmoroso%26aufirst%3DR.%26atitle%3DMultitarget%2520PPAR%25CE%25B3%2520agonists%2520as%2520innovative%2520modulators%2520of%2520the%2520metabolic%2520syndrome%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2019%26volume%3D173%26spage%3D261%26epage%3D273%26doi%3D10.1016%2Fj.ejmech.2019.04.030" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mansour, M.</span></span> <span> </span><span class="NLM_article-title">The roles of peroxisome proliferator-activated receptors in the metabolic syndrome</span>. <i>Prog. Mol. Biol. Transl Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">217</span>– <span class="NLM_lpage">266</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-800101-1.00007-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2FB978-0-12-800101-1.00007-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24373239" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXmvVyru7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2014&pages=217-266&author=M.+Mansour&title=The+roles+of+peroxisome+proliferator-activated+receptors+in+the+metabolic+syndrome&doi=10.1016%2FB978-0-12-800101-1.00007-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">The roles of peroxisome proliferator-activated receptors in the metabolic syndrome</span></div><div class="casAuthors">Mansour, Mahmoud</div><div class="citationInfo"><span class="NLM_cas:title">Progress in Molecular Biology and Translational Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">Glucose Homeostatis and the Pathogenesis of Diabetes Mellitus</span>),
    <span class="NLM_cas:pages">217-266</span>CODEN:
                <span class="NLM_cas:coden">PNARC5</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">A review.  The epidemic of obesity and its assocn. with insulin resistance, glucose intolerance, hypertension, and dyslipidemia, collectively known as the metabolic syndrome or syndrome X, is one of the most challenging health problems facing industrialized countries.  The nuclear receptors, peroxisome proliferator-activated receptors (PPARs alpha (α), beta (β) also known as delta (δ), and gamma (γ)), have well-documented roles in lipid and glucose metab.  Pharmacol., PPARα is activated by fibrate hypolipidemic drugs, whereas PPARγ is activated by insulin sensitizers thiazolidinediones (TZDs).  No marketed drug is yet available for PPARβ(δ).  The identification of fibrates and TZDs as resp. ligands for PPARα and PPARγ was a groundbreaking finding that sparked notable pharmaceutical interest in PPARs as potential drug targets for treatment of the metabolic syndrome.  Limiting side effects assocd. with clin. use of TZDs have emerged in recent years.  New and novel PPAR drugs with broad safety margins and therapeutic potentials for the metabolic syndrome are in development.  These include partial, dual, or pan PPAR agonists; PPAR antagonists; and selective PPAR modulators.  The objective of this chapter is to highlight the therapeutic benefits of targeting more than one PPAR subtype in the treatment of the metabolic syndrome.  The pros and cons obsd. during clin. use of TZDs and the strategies and progress made in the prodn. of new generations of safe and effective PPAR ligands are discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWkbaPrTcBRLVg90H21EOLACvtfcHk0ljYEj_kVJ0UqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXmvVyru7k%253D&md5=a7429187568000b6fef10914d0ae67b3</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-800101-1.00007-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-800101-1.00007-7%26sid%3Dliteratum%253Aachs%26aulast%3DMansour%26aufirst%3DM.%26atitle%3DThe%2520roles%2520of%2520peroxisome%2520proliferator-activated%2520receptors%2520in%2520the%2520metabolic%2520syndrome%26jtitle%3DProg.%2520Mol.%2520Biol.%2520Transl%2520Sci.%26date%3D2014%26volume%3D121%26spage%3D217%26epage%3D266%26doi%3D10.1016%2FB978-0-12-800101-1.00007-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eldor, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeFronzo, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdul-Ghani, M.</span></span> <span> </span><span class="NLM_article-title">In Vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion</span>. <i>Diabetes Care</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">S162</span>– <span class="NLM_lpage">S174</span>, <span class="refDoi"> DOI: 10.2337/dcS13-2003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.2337%2FdcS13-2003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=23882042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtl2ksrrI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2013&pages=S162-S174&author=R.+Eldorauthor=R.+A.+DeFronzoauthor=M.+Abdul-Ghani&title=In+Vivo+actions+of+peroxisome+proliferator-activated+receptors%3A+glycemic+control%2C+insulin+sensitivity%2C+and+insulin+secretion&doi=10.2337%2FdcS13-2003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">In vivo actions of peroxisome proliferator-activated receptors: glycemic control, insulin sensitivity, and insulin secretion</span></div><div class="casAuthors">Eldor, Roy; DeFronzo, Ralph A.; Abdul-Ghani, Muhammad</div><div class="citationInfo"><span class="NLM_cas:title">Diabetes Care</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">Suppl. 2</span>),
    <span class="NLM_cas:pages">S162-S174</span>CODEN:
                <span class="NLM_cas:coden">DICAD2</span>;
        ISSN:<span class="NLM_cas:issn">0149-5992</span>.
    
            (<span class="NLM_cas:orgname">American Diabetes Association, Inc.</span>)
        </div><div class="casAbstract">A review.  Troglitazone also was shown to improve endothelial dysfunction in obesity and T2DM, induce ovulation in PCOS, and effectively treat lipodystrophy.  This article describes the in vivo actions of peroxisome proliferator-activated receptors (PPARs).  PPARγ agonists, thiazolidinediones, are potent insulin sensitizers, enhance insulin secretion and improve glucose tolerance are focused.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoasSu_DODI-LVg90H21EOLACvtfcHk0ljYEj_kVJ0UqA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtl2ksrrI&md5=6487c51b2ef0de5711e8f966bdc2fc1b</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.2337%2FdcS13-2003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2337%252FdcS13-2003%26sid%3Dliteratum%253Aachs%26aulast%3DEldor%26aufirst%3DR.%26aulast%3DDeFronzo%26aufirst%3DR.%2BA.%26aulast%3DAbdul-Ghani%26aufirst%3DM.%26atitle%3DIn%2520Vivo%2520actions%2520of%2520peroxisome%2520proliferator-activated%2520receptors%253A%2520glycemic%2520control%252C%2520insulin%2520sensitivity%252C%2520and%2520insulin%2520secretion%26jtitle%3DDiabetes%2520Care%26date%3D2013%26volume%3D36%26spage%3DS162%26epage%3DS174%26doi%3D10.2337%2FdcS13-2003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kauter, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alam, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, L.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span>. <i>Exp. Diabetes Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>2012</i></span>,  <span class="NLM_fpage">758614</span>, <span class="refDoi"> DOI: 10.1155/2012/758614</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1155%2F2012%2F758614" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=22007192" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2012&publication_year=2012&pages=758614&author=A.+Iyerauthor=K.+Kauterauthor=M.+A.+Alamauthor=S.+H.+Hwangauthor=C.+Morisseauauthor=B.+D.+Hammockauthor=L.+Brown&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+ameliorates+diet-induced+metabolic+syndrome+in+rats&doi=10.1155%2F2012%2F758614"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats</span></div><div class="casAuthors">Iyer Abishek; Kauter Kathleen; Alam Md Ashraful; Hwang Sung Hee; Morisseau Christophe; Hammock Bruce D; Brown Lindsay</div><div class="citationInfo"><span class="NLM_cas:title">Experimental diabetes research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">2012</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">758614</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The signs of metabolic syndrome following chronic excessive macronutrient intake include body weight gain, excess visceral adipose deposition, hyperglycaemia, glucose and insulin intolerances, hypertension, dyslipidaemia, endothelial damage, cardiovascular hypertrophy, inflammation, ventricular contractile dysfunction, fibrosis, and fatty liver disease.  Recent studies show increased activity of soluble epoxide hydrolase (sEH) during obesity and metabolic dysfunction.  We have tested whether sEH inhibition has therapeutic potential in a rat model of diet-induced metabolic syndrome.  In these high-carbohydrate, high-fat-fed rats, chronic oral treatment with trans-4-[4-(3-adamantan-1-ylureido)-cyclohexyloxy]-benzoic acid (t-AUCB), a potent sEH inhibitor, alleviated the signs of metabolic syndrome in vivo including glucose, insulin, and lipid abnormalities, changes in pancreatic structure, increased systolic blood pressure, cardiovascular structural and functional abnormalities, and structural and functional changes in the liver.  The present study describes the pharmacological responses to this selective sEH inhibitor in rats with the signs of diet-induced metabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ1vi0lpx2a9IJKJbLTgsvCfW6udTcc2eZY0lfpK7qHXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3MbitValuw%253D%253D&md5=225f1e58564b2942facc133619680a62</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1155%2F2012%2F758614&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1155%252F2012%252F758614%26sid%3Dliteratum%253Aachs%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DKauter%26aufirst%3DK.%26aulast%3DAlam%26aufirst%3DM.%2BA.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DBrown%26aufirst%3DL.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520ameliorates%2520diet-induced%2520metabolic%2520syndrome%2520in%2520rats%26jtitle%3DExp.%2520Diabetes%2520Res.%26date%3D2012%26volume%3D2012%26spage%3D758614%26doi%3D10.1155%2F2012%2F758614" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tanne, J. H.</span></span> <span> </span><span class="NLM_article-title">FDA Places “Black Box” warning on antidiabetes drugs</span>. <i>BMJ</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>334</i></span>,  <span class="NLM_fpage">1237</span>, <span class="refDoi"> DOI: 10.1136/bmj.39244.394456.DB</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1136%2Fbmj.39244.394456.DB" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=17569906" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BD2szlsVygsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=334&publication_year=2007&pages=1237&author=J.+H.+Tanne&title=FDA+Places+%E2%80%9CBlack+Box%E2%80%9D+warning+on+antidiabetes+drugs&doi=10.1136%2Fbmj.39244.394456.DB"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">FDA places "black box" warning on antidiabetes drugs</span></div><div class="casAuthors">Tanne Janice Hopkins</div><div class="citationInfo"><span class="NLM_cas:title">BMJ (Clinical research ed.)</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">334</span>
        (<span class="NLM_cas:issue">7606</span>),
    <span class="NLM_cas:pages">1237</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSTaMDxcpb8CTEC-75aqa5AfW6udTcc2eZY0lfpK7qHXbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2szlsVygsg%253D%253D&md5=9c80d2778494351320db01b3f324345a</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1136%2Fbmj.39244.394456.DB&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1136%252Fbmj.39244.394456.DB%26sid%3Dliteratum%253Aachs%26aulast%3DTanne%26aufirst%3DJ.%2BH.%26atitle%3DFDA%2520Places%2520%25E2%2580%259CBlack%2520Box%25E2%2580%259D%2520warning%2520on%2520antidiabetes%2520drugs%26jtitle%3DBMJ%26date%3D2007%26volume%3D334%26spage%3D1237%26doi%3D10.1136%2Fbmj.39244.394456.DB" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Goltsman, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khoury, E. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winaver, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abassi, Z.</span></span> <span> </span><span class="NLM_article-title">Does thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?</span>. <i>Pharmacol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>168</i></span>,  <span class="NLM_fpage">75</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/j.pharmthera.2016.09.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.pharmthera.2016.09.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=27598860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsVOqur7I" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=168&publication_year=2016&pages=75-97&author=I.+Goltsmanauthor=E.+E.+Khouryauthor=J.+Winaverauthor=Z.+Abassi&title=Does+thiazolidinedione+therapy+exacerbate+fluid+retention+in+congestive+heart+failure%3F&doi=10.1016%2Fj.pharmthera.2016.09.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">Does Thiazolidinedione therapy exacerbate fluid retention in congestive heart failure?</span></div><div class="casAuthors">Goltsman, Ilia; Khoury, Emad E.; Winaver, Joseph; Abassi, Zaid</div><div class="citationInfo"><span class="NLM_cas:title">Pharmacology & Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">168</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">75-97</span>CODEN:
                <span class="NLM_cas:coden">PHTHDT</span>;
        ISSN:<span class="NLM_cas:issn">0163-7258</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">The ever-growing global burden of congestive heart failure (CHF) and type 2 diabetes mellitus (T2DM) as well as their co-existence necessitate that anti-diabetic pharmacotherapy will modulate the cardiovascular risk inherent to T2DM while complying with the accompanying restrictions imposed by CHF.  The thiazolidinedione (TZD) family of peroxisome proliferator-activated receptor γ (PPARγ) agonists initially provided a promising therapeutic option in T2DM owing to anti-diabetic efficacy combined with pleiotropic beneficial cardiovascular effects.  However, the utility of TZDs in T2DM has declined in the past decade, largely due to concomitant adverse effects of fluid retention and edema formation attributed to salt-retaining effects of PPARγ activation on the nephron.  Presumably, the latter effects are potentially deleterious in the context of pre-existing fluid retention in CHF.  However, despite a considerable body of evidence on mechanisms responsible for TZD-induced fluid retention suggesting that this class of drugs is rightfully prohibited from use in CHF patients, there is a paucity of exptl. and clin. studies that investigate the effects of TZDs on salt and water homeostasis in the CHF setting.  In an attempt to elucidate whether TZDs actually exacerbate the pre-existing fluid retention in CHF, our review summarizes the pathophysiol. of fluid retention in CHF.  Moreover, we thoroughly review the available data on TZD-induced fluid retention and proposed mechanisms in animals and patients.  Finally, we will present recent studies challenging the common notion that TZDs worsen renal salt and water retention in CHF.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqn2ZHQfnXqSLVg90H21EOLACvtfcHk0liaaTqVYo223w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsVOqur7I&md5=1241f6509961d4acd375f0f2fac0cb9c</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1016%2Fj.pharmthera.2016.09.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.pharmthera.2016.09.007%26sid%3Dliteratum%253Aachs%26aulast%3DGoltsman%26aufirst%3DI.%26aulast%3DKhoury%26aufirst%3DE.%2BE.%26aulast%3DWinaver%26aufirst%3DJ.%26aulast%3DAbassi%26aufirst%3DZ.%26atitle%3DDoes%2520thiazolidinedione%2520therapy%2520exacerbate%2520fluid%2520retention%2520in%2520congestive%2520heart%2520failure%253F%26jtitle%3DPharmacol.%2520Ther.%26date%3D2016%26volume%3D168%26spage%3D75%26epage%3D97%26doi%3D10.1016%2Fj.pharmthera.2016.09.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rao, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kohan, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Magnuson, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Redha, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Breyer, M. D.</span></span> <span> </span><span class="NLM_article-title">Thiazolidinediones expand body fluid volume through PPARgamma stimulation of ENaC-mediated renal salt absorption</span>. <i>Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">861</span>– <span class="NLM_lpage">866</span>, <span class="refDoi"> DOI: 10.1038/nm1278</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fnm1278" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16007095" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2MXmvFemsLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=861-866&author=Y.+Guanauthor=C.+Haoauthor=D.+R.+Chaauthor=R.+Raoauthor=W.+Luauthor=D.+E.+Kohanauthor=M.+A.+Magnusonauthor=R.+Redhaauthor=Y.+Zhangauthor=M.+D.+Breyer&title=Thiazolidinediones+expand+body+fluid+volume+through+PPARgamma+stimulation+of+ENaC-mediated+renal+salt+absorption&doi=10.1038%2Fnm1278"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12R"><div class="casContent"><span class="casTitleNuber">12</span><div class="casTitle"><span class="NLM_cas:atitle">Thiazolidinediones expand body fluid volume through PPARγ stimulation of ENaC-mediated renal salt absorption</span></div><div class="casAuthors">Guan, YouFei; Hao, Chuanming; Cha, Dae Ryong; Rao, Reena; Lu, Wendell; Kohan, Donald E.; Magnuson, Mark A.; Redha, Reyadh; Zhang, Yahua; Breyer, Matthew D.</div><div class="citationInfo"><span class="NLM_cas:title">Nature Medicine (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">861-866</span>CODEN:
                <span class="NLM_cas:coden">NAMEFI</span>;
        ISSN:<span class="NLM_cas:issn">1078-8956</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Thiazolidinediones (TZDs) are widely used to treat type 2 diabetes mellitus; however, their use is complicated by systemic fluid retention.  Along the nephron, the pharmacol. target of TZDs, peroxisome proliferator-activated receptor-γ (PPARγ, encoded by Pparg), is most abundant in the collecting duct.  Here we show that mice treated with TZDs experience early wt. gain from increased total body water.  Wt. gain was blocked by the collecting duct-specific diuretic amiloride and was also prevented by deletion of Pparg from the collecting duct, using Pparg flox/flox mice.  Deletion of collecting duct Pparg decreased renal Na+ avidity and increased plasma aldosterone.  Treating cultured collecting ducts with TZDs increased amiloride-sensitive Na+ absorption and Scnn1g mRNA (encoding the epithelial Na+ channel ENaCγ) expression through a PPARγ-dependent pathway.  These studies identify Scnn1g as a PPARγ target gene in the collecting duct.  Activation of this pathway mediates fluid retention assocd. with TZDs, and suggests amiloride might provide a specific therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoT0K7RMD2IPLVg90H21EOLACvtfcHk0liaaTqVYo223w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXmvFemsLY%253D&md5=783b458ea599055391ed0c1f050ad9e6</span></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1038%2Fnm1278&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnm1278%26sid%3Dliteratum%253Aachs%26aulast%3DGuan%26aufirst%3DY.%26aulast%3DHao%26aufirst%3DC.%26aulast%3DCha%26aufirst%3DD.%2BR.%26aulast%3DRao%26aufirst%3DR.%26aulast%3DLu%26aufirst%3DW.%26aulast%3DKohan%26aufirst%3DD.%2BE.%26aulast%3DMagnuson%26aufirst%3DM.%2BA.%26aulast%3DRedha%26aufirst%3DR.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DBreyer%26aufirst%3DM.%2BD.%26atitle%3DThiazolidinediones%2520expand%2520body%2520fluid%2520volume%2520through%2520PPARgamma%2520stimulation%2520of%2520ENaC-mediated%2520renal%2520salt%2520absorption%26jtitle%3DNat.%2520Med.%26date%3D2005%26volume%3D11%26spage%3D861%26epage%3D866%26doi%3D10.1038%2Fnm1278" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pidkovka, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mei, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harris, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, W.</span></span> <span> </span><span class="NLM_article-title">The Cyp2c44 epoxygenase regulates epithelial sodium channel activity and the blood pressure responses to increased dietary salt</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>289</i></span>,  <span class="NLM_fpage">4377</span>– <span class="NLM_lpage">4386</span>, <span class="refDoi"> DOI: 10.1074/jbc.M113.508416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1074%2Fjbc.M113.508416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24368771" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXisFWhtbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=289&publication_year=2014&pages=4377-4386&author=J.+H.+Capdevilaauthor=N.+Pidkovkaauthor=S.+Meiauthor=Y.+Gongauthor=J.+R.+Falckauthor=J.+D.+Imigauthor=R.+C.+Harrisauthor=W.+Wang&title=The+Cyp2c44+epoxygenase+regulates+epithelial+sodium+channel+activity+and+the+blood+pressure+responses+to+increased+dietary+salt&doi=10.1074%2Fjbc.M113.508416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">The Cyp2c44 Epoxygenase Regulates Epithelial Sodium Channel Activity and the Blood Pressure Responses to Increased Dietary Salt</span></div><div class="casAuthors">Capdevila, Jorge H.; Pidkovka, Nataliya; Mei, Shaojun; Gong, Yan; Falck, John R.; Imig, John D.; Harris, Raymond C.; Wang, Wenhui</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">289</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">4377-4386</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">Hypertension is a major risk factor for cerebral, cardiovascular, and renal disease, and its prevalence and devastating consequences raises a need for new strategies for its early diagnosis and treatment.  We show here that lack of a Cyp2c44 epoxygenase causes dietary salt-sensitive hypertension, a common form of the human disease.  Cyp2c44(-/-) mice on normal salt diets are normotensive but become hypertensive when fed high salt.  Hypertensive Cyp2c44(-/-) mice show a hyperactive kidney epithelial sodium channel (ENaC) and redns. in ERK1/2 and ENaC subunit phosphorylation.  The demonstration that amiloride, an ENaC inhibitor, lowers the blood pressure of hypertensive Cyp2c44(-/-) mice identifies a role for the channel in the hypertensive phenotype of the animals.  These studies: (a) identify an antihypertensive role for the kidney Cyp2c44 epoxygenase and for its epoxyeicosatrienoic acid (EET) metabolites in the in vivo control of ENaC activity and the activation of mitogenic kinase pathways; (b) provide evidence for a Cyp2c44 epoxygenase, EET-mediated mechanism of ENaC regulation involving an ERK1/2-catalyzed threonine phosphorylation of the channel γ subunit: and (c) characterize a common scientific platform that could explain the seemingly unrelated biol. activities attributed to the epoxygenase metabolites in cell proliferation, angiogenesis, channel activity, and blood pressure control.  It is expected that these results will serve as a basis for the development of novel strategies for the early diagnosis and treatment of hypertension and of pathophysiologies assocd. with dysfunctional mitogenic signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo23ueUEHF7RbVg90H21EOLACvtfcHk0lhoeI9-DrndOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXisFWhtbY%253D&md5=b8577bad7b9ee3f3002c40259f0a931b</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M113.508416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M113.508416%26sid%3Dliteratum%253Aachs%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DPidkovka%26aufirst%3DN.%26aulast%3DMei%26aufirst%3DS.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHarris%26aufirst%3DR.%2BC.%26aulast%3DWang%26aufirst%3DW.%26atitle%3DThe%2520Cyp2c44%2520epoxygenase%2520regulates%2520epithelial%2520sodium%2520channel%2520activity%2520and%2520the%2520blood%2520pressure%2520responses%2520to%2520increased%2520dietary%2520salt%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2014%26volume%3D289%26spage%3D4377%26epage%3D4386%26doi%3D10.1074%2Fjbc.M113.508416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlov, T. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Christain, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckář, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Staruschenko, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gauthier, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Capdevila, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falck, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Campbell, W. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition</span>. <i>Clin. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">463</span>– <span class="NLM_lpage">474</span>, <span class="refDoi"> DOI: 10.1042/CS20130479</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1042%2FCS20130479" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24707975" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXhtVGhurzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2014&pages=463-474&author=M.+A.+H.+Khanauthor=T.+S.+Pavlovauthor=S.+V.+Christainauthor=J.+Neck%C3%A1%C5%99author=A.+Staruschenkoauthor=K.+M.+Gauthierauthor=J.+H.+Capdevilaauthor=J.+R.+Falckauthor=W.+B.+Campbellauthor=J.+D.+Imig&title=Epoxyeicosatrienoic+acid+analogue+lowers+blood+pressure+through+vasodilation+and+sodium+channel+inhibition&doi=10.1042%2FCS20130479"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Epoxyeicosatrienoic acid analogue lowers blood pressure through vasodilation and sodium channel inhibition</span></div><div class="casAuthors">Khan, Md. Abdul Hye; Pavlov, Tengis S.; Christain, Sarah V.; Neckar, Jan; Staruschenko, Alexander; Gauthier, Kathryn M.; Capdevila, Jorge H.; Falck, John R.; Campbell, William B.; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Science</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">127</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">463-474</span>CODEN:
                <span class="NLM_cas:coden">CSCIAE</span>;
        ISSN:<span class="NLM_cas:issn">1470-8736</span>.
    
            (<span class="NLM_cas:orgname">Portland Press Ltd.</span>)
        </div><div class="casAbstract">Epoxyeicosatrienoic acids (EETs) contribute to hemodynamics, electrolyte homeostasis, and blood pressure regulation, leading to the concept that EETs can be therapeutically targeted for hypertension.  In the present study, multiple structural EET analogs were synthesized based on the EET pharmacophore and vasodilator structure-activity studies.  Four EET analogs with 91-119% vasodilatory activity in the isolated bovine coronary artery (EC50: 0.18-1.6 μM) were identified and studied for blood-pressure-lowering in hypertension.  Two EET analogs in which the COOH group at carbon 1 of the EET pharmacophore was replaced with either an aspartic acid (EET-A) or a heterocyclic surrogate (EET-X) were administered for 14 days [10 mg/kg per day i.p.].  Both EET-A and EET-X lowered blood pressure in spontaneously hypertensive rats (SHRs) and in angiotensin II (AngII) hypertension.  On day 14, the mean arterial pressures in EET analog-treated AngII-hypertensive and SHRs were 30-50 mm Hg (EET-A) and 15-20 mm Hg (EET-X) lower than those in vehicle-treated controls.  These EET analogs (10 mg/kg per day) were further tested in AngII hypertension by administering orally in drinking water for 14 days and EET-A lowered blood pressure.  Addnl. expts. demonstrated that EET-A inhibits epithelial sodium channel (ENaC) activity in cultured cortical collecting duct cells and reduced renal expression of ENaC subunits in AngII hypertension.  In conclusion, we have characterized EET-A as an orally active antihypertensive EET analog that protects vascular endothelial function and has ENaC inhibitory activity in AngII hypertension.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqVcQSUHDf_07Vg90H21EOLACvtfcHk0lhoeI9-DrndOQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXhtVGhurzI&md5=2b4f6e9877a4a077fefd9f08ee3141be</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1042%2FCS20130479&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1042%252FCS20130479%26sid%3Dliteratum%253Aachs%26aulast%3DKhan%26aufirst%3DM.%2BA.%2BH.%26aulast%3DPavlov%26aufirst%3DT.%2BS.%26aulast%3DChristain%26aufirst%3DS.%2BV.%26aulast%3DNeck%25C3%25A1%25C5%2599%26aufirst%3DJ.%26aulast%3DStaruschenko%26aufirst%3DA.%26aulast%3DGauthier%26aufirst%3DK.%2BM.%26aulast%3DCapdevila%26aufirst%3DJ.%2BH.%26aulast%3DFalck%26aufirst%3DJ.%2BR.%26aulast%3DCampbell%26aufirst%3DW.%2BB.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DEpoxyeicosatrienoic%2520acid%2520analogue%2520lowers%2520blood%2520pressure%2520through%2520vasodilation%2520and%2520sodium%2520channel%2520inhibition%26jtitle%3DClin.%2520Sci.%26date%3D2014%26volume%3D127%26spage%3D463%26epage%3D474%26doi%3D10.1042%2FCS20130479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Islam, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patil, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goswami, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Razdan, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inamdar, M. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rizwan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mathew, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inceoglu, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stephen
Lee, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Inhibitors of soluble epoxide hydrolase minimize ischemia-reperfusion-induced cardiac damage in normal, hypertensive, and diabetic rats</span>. <i>Cardiovasc. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">e12259</span>, <span class="refDoi"> DOI: 10.1111/1755-5922.12259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1111%2F1755-5922.12259" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=e12259&author=O.+Islamauthor=P.+Patilauthor=S.+K.+Goswamiauthor=R.+Razdanauthor=M.+N.+Inamdarauthor=M.+Rizwanauthor=J.+Mathewauthor=B.+Inceogluauthor=K.+S.+Stephen%0ALeeauthor=S.+H.+Hwangauthor=B.+D.+Hammock&title=Inhibitors+of+soluble+epoxide+hydrolase+minimize+ischemia-reperfusion-induced+cardiac+damage+in+normal%2C+hypertensive%2C+and+diabetic+rats&doi=10.1111%2F1755-5922.12259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1111%2F1755-5922.12259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252F1755-5922.12259%26sid%3Dliteratum%253Aachs%26aulast%3DIslam%26aufirst%3DO.%26aulast%3DPatil%26aufirst%3DP.%26aulast%3DGoswami%26aufirst%3DS.%2BK.%26aulast%3DRazdan%26aufirst%3DR.%26aulast%3DInamdar%26aufirst%3DM.%2BN.%26aulast%3DRizwan%26aufirst%3DM.%26aulast%3DMathew%26aufirst%3DJ.%26aulast%3DInceoglu%26aufirst%3DB.%26aulast%3DStephen%2BLee%26aufirst%3DK.%2BS.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DInhibitors%2520of%2520soluble%2520epoxide%2520hydrolase%2520minimize%2520ischemia-reperfusion-induced%2520cardiac%2520damage%2520in%2520normal%252C%2520hypertensive%252C%2520and%2520diabetic%2520rats%26jtitle%3DCardiovasc.%2520Ther.%26date%3D2017%26volume%3D35%26spage%3De12259%26doi%3D10.1111%2F1755-5922.12259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Froogh, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kandhi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duvvi, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Le, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Alruwaili, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ashe, J. O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, A.</span></span> <span> </span><span class="NLM_article-title">The contribution of chymase-dependent formation of ANG II to cardiac dysfunction in metabolic syndrome of young rats: roles of fructose and EETs</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>318</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">H985</span>– <span class="NLM_lpage">H993</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00633.2019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajpheart.00633.2019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=32167781" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=318&publication_year=2020&pages=H985-H993&issue=4&author=G.+Frooghauthor=S.+Kandhiauthor=R.+Duvviauthor=Y.+Leauthor=Z.+Wengauthor=N.+Alruwailiauthor=J.+O.+Asheauthor=D.+Sunauthor=A.+Huang&title=The+contribution+of+chymase-dependent+formation+of+ANG+II+to+cardiac+dysfunction+in+metabolic+syndrome+of+young+rats%3A+roles+of+fructose+and+EETs&doi=10.1152%2Fajpheart.00633.2019"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00633.2019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00633.2019%26sid%3Dliteratum%253Aachs%26aulast%3DFroogh%26aufirst%3DG.%26aulast%3DKandhi%26aufirst%3DS.%26aulast%3DDuvvi%26aufirst%3DR.%26aulast%3DLe%26aufirst%3DY.%26aulast%3DWeng%26aufirst%3DZ.%26aulast%3DAlruwaili%26aufirst%3DN.%26aulast%3DAshe%26aufirst%3DJ.%2BO.%26aulast%3DSun%26aufirst%3DD.%26aulast%3DHuang%26aufirst%3DA.%26atitle%3DThe%2520contribution%2520of%2520chymase-dependent%2520formation%2520of%2520ANG%2520II%2520to%2520cardiac%2520dysfunction%2520in%2520metabolic%2520syndrome%2520of%2520young%2520rats%253A%2520roles%2520of%2520fructose%2520and%2520EETs%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2020%26volume%3D318%26issue%3D4%26spage%3DH985%26epage%3DH993%26doi%3D10.1152%2Fajpheart.00633.2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, M. A.</span></span> <span> </span><span class="NLM_article-title">Effect of soluble epoxide hydrolase on the modulation of coronary reactive hyperemia: role of oxylipins and PPARγ</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span> (<span class="NLM_issue">9</span>), <span class="NLM_elocation-id">e0162147</span> <span class="refDoi"> DOI: 10.1371/journal.pone.0162147</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1371%2Fjournal.pone.0162147" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=27583776" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2sXitFKjsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&issue=9&author=A.+Hanifauthor=M.+L.+Edinauthor=D.+C.+Zeldinauthor=C.+Morisseauauthor=M.+A.+Nayeem&title=Effect+of+soluble+epoxide+hydrolase+on+the+modulation+of+coronary+reactive+hyperemia%3A+role+of+oxylipins+and+PPAR%CE%B3&doi=10.1371%2Fjournal.pone.0162147"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Effect of soluble epoxide hydrolase on the modulation of coronary reactive hyperemia: role of oxylipins and PPARγ</span></div><div class="casAuthors">Hanif, Ahmad; Edin, Matthew L.; Zeldin, Darryl C.; Morisseau, Christophe; Nayeem, Mohammed A.</div><div class="citationInfo"><span class="NLM_cas:title">PLoS One</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">e0162147/1-e0162147/22</span>CODEN:
                <span class="NLM_cas:coden">POLNCL</span>;
        ISSN:<span class="NLM_cas:issn">1932-6203</span>.
    
            (<span class="NLM_cas:orgname">Public Library of Science</span>)
        </div><div class="casAbstract">Coronary reactive hyperemia (CRH) is a physiol. response to ischemic insult that prevents the potential harm assocd. with an interruption of blood supply.  The relationship between the pharmacol. inhibition of sol. epoxide hydrolase (sEH) and CRH response to a brief ischemia is not known.  SEH is involved in the main catabolic pathway of epoxyeicosatrienoic acids (EETs), which are converted into dihydroxyeicosatrienoic acids (DHETs).  EETs protect against ischemia/reperfusion injury and have numerous beneficial physiol. effects.  We hypothesized that inhibition of sEH by t-AUCB enhances CRH in isolated mouse hearts through changing the oxylipin profiles, including an increase in EETs/DHETs ratio.  Compared to controls, t-AUCB-treated mice had increased CRH, including repayment vol. (RV), repayment duration, and repayment/debt ratio (p < 0.05).  Treatment with t-AUCB significantly changed oxylipin profiles, including an increase in EET/DHET ratio, increase in EpOME/DiHOME ratio, increase in the levels of HODEs, decrease in the levels of mid-chain HETEs, and decrease in prostanoids (p < 0.05).  Treatment with MS-PPOH (CYP epoxygenase inhibitor) reduced CRH, including RV (p < 0.05).  Involvement of PPARγ in the modulation of CRH was demonstrated using a PPARγ-antagonist (T0070907) and a PPARγ-agonist (rosiglitazone).  T0070907 reduced CRH (p < 0.05), whereas rosiglitazone enhanced CRH (p < 0.05) in isolated mouse hearts compared to the non-treated.  These data demonstrate that sEH inhibition enhances, whereas CYP epoxygenases- inhibition attenuates CRH, PPARγ mediate CRH downstream of the CYP epoxygenases- EET pathway, and the changes in oxylipin profiles assocd. with sEH-inhibition collectively contributed to the enhanced CRH.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpvJtAwIDhKO7Vg90H21EOLACvtfcHk0liOEfsM2qKVYQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXitFKjsbk%253D&md5=ca0c403dec657b9e0106b2f973dbf878</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0162147&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0162147%26sid%3Dliteratum%253Aachs%26aulast%3DHanif%26aufirst%3DA.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DNayeem%26aufirst%3DM.%2BA.%26atitle%3DEffect%2520of%2520soluble%2520epoxide%2520hydrolase%2520on%2520the%2520modulation%2520of%2520coronary%2520reactive%2520hyperemia%253A%2520role%2520of%2520oxylipins%2520and%2520PPAR%25CE%25B3%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26issue%3D9%26doi%3D10.1371%2Fjournal.pone.0162147" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Davis, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wasti, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chiamvimonvat, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span>. <i>Int. J. Cardiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>167</i></span> (<span class="NLM_issue">4</span>),  <span class="NLM_fpage">1298</span>– <span class="NLM_lpage">1304</span>, <span class="refDoi"> DOI: 10.1016/j.ijcard.2012.03.167</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.ijcard.2012.03.167" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=22525341" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=167&publication_year=2013&pages=1298-1304&issue=4&author=D.+Xuauthor=B.+B.+Davisauthor=Z.+Wangauthor=S.+Zhaoauthor=B.+Wastiauthor=Z.+Liuauthor=N.+Liauthor=C.+Morisseauauthor=N.+Chiamvimonvatauthor=B.+D.+Hammock&title=A+potent+soluble+epoxide+hydrolase+inhibitor%2C+t-AUCB%2C+acts+through+PPAR%CE%B3+to+modulate+the+function+of+endothelial+progenitor+cells+from+patients+with+acute+myocardial+infarction&doi=10.1016%2Fj.ijcard.2012.03.167"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">A potent soluble epoxide hydrolase inhibitor, t-AUCB, acts through PPARγ to modulate the function of endothelial progenitor cells from patients with acute myocardial infarction</span></div><div class="casAuthors">Xu Dan-yan; Davis Benjamin B; Wang Zhen-he; Zhao Shui-ping; Wasti Binaya; Liu Zhe-liang; Li Ning; Morisseau Christophe; Chiamvimonvat Nipavan; Hammock Bruce D</div><div class="citationInfo"><span class="NLM_cas:title">International journal of cardiology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">167</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1298-304</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  Epoxyeicosatrienoic acids (EETs) are natural angiogenic mediators regulated by soluble epoxide hydrolase (sEH).  Inhibitors of sEH can stabilize EETs levels and were reported to reduce atherosclerosis and inhibit myocardial infarction in animal models.  In this work, we investigated whether increasing EETs with the sEH inhibitor t-AUCB would increase angiogenesis related function in endothelial progenitor cells (EPCs) from patients with acute myocardial infarction (AMI).  METHODS AND RESULTS:  EPCs were isolated from 50 AMI patients and 50 healthy subjects (control).  EPCs were treated with different concentrations of t-AUCB for 24h with or without peroxisome proliferator activated receptor γ (PPARγ) inhibitor GW9662.  Migration of EPCs was assayed in trans-well chambers.  Angiogenesis assays were performed using a Matrigel-Matrix in vitro model.  The expression of vascular endothelial growth factor (VEGF), hypoxia-inducible factor 1α (HIF-1α) mRNA and protein in EPCs was measured by real-time PCR or Western blot, respectively.  Also, the concentration of EETs in the culture supernatant was detected by ELISA.  The activity of EPCs in the AMI patient group was reduced compared to healthy controls.  Whereas increasing EET levels with t-AUCB promoted a dose dependent angiogenesis and migration in EPCs from AMI patients.  Additionally, the t-AUCB dose dependently increased the expression of the angiogenic factors VEGF and HIF-α.  Lastly, we provide evidence that these effects were PPARγ dependent.  CONCLUSION:  The results demonstrate that the sEH inhibitor positively modulated the functions of EPCs in patients with AMI through the EETs-PPARγ pathway.  The present study suggests the potential utility of sEHi in the therapy of ischemic heart disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQvyM8pXNI2_xKDYG3bNImrfW6udTcc2eazIrHiSxi7kLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC38rnsVShsQ%253D%253D&md5=664e589b7aba463a46d40a45ef424ef8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.ijcard.2012.03.167&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijcard.2012.03.167%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DD.%26aulast%3DDavis%26aufirst%3DB.%2BB.%26aulast%3DWang%26aufirst%3DZ.%26aulast%3DZhao%26aufirst%3DS.%26aulast%3DWasti%26aufirst%3DB.%26aulast%3DLiu%26aufirst%3DZ.%26aulast%3DLi%26aufirst%3DN.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DChiamvimonvat%26aufirst%3DN.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DA%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitor%252C%2520t-AUCB%252C%2520acts%2520through%2520PPAR%25CE%25B3%2520to%2520modulate%2520the%2520function%2520of%2520endothelial%2520progenitor%2520cells%2520from%2520patients%2520with%2520acute%2520myocardial%2520infarction%26jtitle%3DInt.%2520J.%2520Cardiol.%26date%3D2013%26volume%3D167%26issue%3D4%26spage%3D1298%26epage%3D1304%26doi%3D10.1016%2Fj.ijcard.2012.03.167" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoon, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toews, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padanilam, B. J.</span></span> <span> </span><span class="NLM_article-title">Pharmacological inhibition of soluble epoxide hydrolase prevents renal interstitial fibrogenesis in obstructive nephropathy</span>. <i>Am. J. Physiol. Renal Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>308</i></span> (<span class="NLM_issue">2</span>),  <span class="NLM_fpage">F131</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1152/ajprenal.00531.2014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajprenal.00531.2014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=25377915" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=308&publication_year=2015&pages=F131-139&issue=2&author=J.+Kimauthor=S.+P.+Yoonauthor=M.+L.+Toewsauthor=J.+D.+Imigauthor=S.+H.+Hwangauthor=B.+D.+Hammockauthor=B.+J.+Padanilam&title=Pharmacological+inhibition+of+soluble+epoxide+hydrolase+prevents+renal+interstitial+fibrogenesis+in+obstructive+nephropathy&doi=10.1152%2Fajprenal.00531.2014"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1152%2Fajprenal.00531.2014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajprenal.00531.2014%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DJ.%26aulast%3DYoon%26aufirst%3DS.%2BP.%26aulast%3DToews%26aufirst%3DM.%2BL.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DPadanilam%26aufirst%3DB.%2BJ.%26atitle%3DPharmacological%2520inhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520renal%2520interstitial%2520fibrogenesis%2520in%2520obstructive%2520nephropathy%26jtitle%3DAm.%2520J.%2520Physiol.%2520Renal%2520Physiol.%26date%3D2015%26volume%3D308%26issue%3D2%26spage%3DF131%26epage%3D139%26doi%3D10.1152%2Fajprenal.00531.2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walsh, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khan, M. A. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cherian
Shaw, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaw, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span>. <i>Exp. Biol. Med. (London, U. K.)</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>237</i></span> (<span class="NLM_issue">12</span>),  <span class="NLM_fpage">1402</span>– <span class="NLM_lpage">1412</span>, <span class="refDoi"> DOI: 10.1258/ebm.2012.012225</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1258%2Febm.2012.012225" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=237&publication_year=2012&pages=1402-1412&issue=12&author=J.+D.+Imigauthor=K.+A.+Walshauthor=M.+A.+H.+Khanauthor=T.+Nagasawaauthor=M.+Cherian%0AShawauthor=S.+M.+Shawauthor=B.+D.+Hammock&title=Soluble+epoxide+hydrolase+inhibition+and+peroxisome+proliferator+activated+receptor+%CE%B3+agonist+improve+vascular+function+and+decrease+renal+injury+in+hypertensive+obese+rats&doi=10.1258%2Febm.2012.012225"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition and peroxisome proliferator activated receptor γ agonist improve vascular function and decrease renal injury in hypertensive obese rats</span></div><div class="casAuthors">Imig, John D.; Walsh, Katie A.; Abdul Hye Khan, Md; Nagasawa, Tasuku; Cherian-Shaw, Mary; Shaw, Sean M.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Biology and Medicine (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">237</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1402-1412</span>CODEN:
                <span class="NLM_cas:coden">EBMMBE</span>;
        ISSN:<span class="NLM_cas:issn">1535-3702</span>.
    
            (<span class="NLM_cas:orgname">Sage Publications Ltd.</span>)
        </div><div class="casAbstract">Cardiometabolic syndrome occurs with obesity and consists of pathophysiol. factors that increase the risk for cardiovascular events.  Sol. epoxide hydrolase inhibition (sEHi) is a novel therapeutic approach that exerts renal and cardiovascular protection.  Although sEHi as a therapeutic approach is promising, it could be more effective for the treatment of cardiometabolic syndrome when combined with peroxisome proliferator activated receptor γ (PPARγ) agonists.  We hypothesized that the PPARγ agonist, rosiglitazone in combination with a sEHi (tAUCB) will provide synergistic actions to decrease blood pressure, improve vascular function, decrease inflammation, and prevent renal damage in spontaneously hypertensive obese rats (SHROB).  SHROB were treated with rosiglitazone, tAUCB or the combination of tAUCB and rosiglitazone for four-weeks and compared with spontaneously hypertensive (SHR) and Wistar-Kyoto (WKY) rats.  Blood pressure increased in SHROB (164 ± 7 mmHg) and decreased 10 mmHg when treated with rosiglitazone, tAUCB, or tAUCB and rosiglitazone.  Mesenteric artery dilation to the KATP channel opener pinacidil was attenuated in SHROB (EMax = 77 ± 7%), compared with WKY (EMax = 115 ± 19) and SHR (EMax = 93 ± 12%).  Vasodilation to pinacidil was improved by rosiglitazone (EMax = 92 ± 14%) but not tAUCB.  Renal macrophage infiltration increased in SHROB and significantly decreased with rosiglitazone or tAUCB and rosiglitazone treatment.  Albuminuria was increased in SHROB (90 ± 20 mg/d) and was significantly decreased by the combination of tAUCB and rosiglitazone (37 ± 9 mg/d).  Glomerular injury in SHROB was also significantly decreased by tAUCB and rosiglitazone.  These results indicate that even though sEHi or PPARγ agonist have benefits when used individually, the combination is more beneficial for the multidisease features in cardiometabolic syndrome.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoq2SjZgeqAHrVg90H21EOLACvtfcHk0lhM3xb7yPgFLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjsFagtbk%253D&md5=d22fb0c9e2e8acf30dd6ce7614ad403c</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1258%2Febm.2012.012225&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1258%252Febm.2012.012225%26sid%3Dliteratum%253Aachs%26aulast%3DImig%26aufirst%3DJ.%2BD.%26aulast%3DWalsh%26aufirst%3DK.%2BA.%26aulast%3DKhan%26aufirst%3DM.%2BA.%2BH.%26aulast%3DNagasawa%26aufirst%3DT.%26aulast%3DCherian%2BShaw%26aufirst%3DM.%26aulast%3DShaw%26aufirst%3DS.%2BM.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520and%2520peroxisome%2520proliferator%2520activated%2520receptor%2520%25CE%25B3%2520agonist%2520improve%2520vascular%2520function%2520and%2520decrease%2520renal%2520injury%2520in%2520hypertensive%2520obese%2520rats%26jtitle%3DExp.%2520Biol.%2520Med.%2520%2528London%252C%2520U.%2520K.%2529%26date%3D2012%26volume%3D237%26issue%3D12%26spage%3D1402%26epage%3D1412%26doi%3D10.1258%2Febm.2012.012225" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weizel, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Diehl, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüggerhoff, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boß, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Göbel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grundmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kostenis, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brüne, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">N-Benzylbenzamides: a novel merged scaffold for orally available dual soluble epoxide hydrolase/peroxisome proliferator-activated receptor γ modulators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>59</i></span> (<span class="NLM_issue">1</span>),  <span class="NLM_fpage">61</span>– <span class="NLM_lpage">81</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.5b01239</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.5b01239" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2016&pages=61-81&issue=1&author=R.+Bl%C3%B6cherauthor=C.+Lamersauthor=S.+K.+Wittmannauthor=D.+Merkauthor=M.+Hartmannauthor=L.+Weizelauthor=O.+Diehlauthor=A.+Br%C3%BCggerhoffauthor=M.+Bo%C3%9Fauthor=A.+Kaiserauthor=T.+Schaderauthor=T.+G%C3%B6belauthor=M.+Grundmannauthor=C.+Angioniauthor=J.+Heeringauthor=G.+Geisslingerauthor=M.+Wurglicsauthor=E.+Kostenisauthor=B.+Br%C3%BCneauthor=D.+Steinhilberauthor=M.+Schubert-Zsilaveczauthor=A.+S.+Kahntauthor=E.+Proschak&title=N-Benzylbenzamides%3A+a+novel+merged+scaffold+for+orally+available+dual+soluble+epoxide+hydrolase%2Fperoxisome+proliferator-activated+receptor+%CE%B3+modulators&doi=10.1021%2Facs.jmedchem.5b01239"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">N-Benzylbenzamides: A Novel Merged Scaffold for Orally Available Dual Soluble Epoxide Hydrolase/Peroxisome Proliferator-Activated Receptor γ Modulators</span></div><div class="casAuthors">Blocher Rene; Lamers Christina; Wittmann Sandra K; Merk Daniel; Hartmann Markus; Weizel Lilia; Diehl Olaf; Bruggerhoff Astrid; Kaiser Astrid; Schader Tim; Gobel Tamara; Wurglics Mario; Steinhilber Dieter; Schubert-Zsilavecz Manfred; Kahnt Astrid S; Proschak Ewgenij; Boss Marcel; Brune Bernhard; Grundmann Manuel; Kostenis Evi; Angioni Carlo; Geisslinger Gerd; Heering Jan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of medicinal chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">59</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">61-81</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Metabolic syndrome (MetS) is a multifactorial disease cluster that consists of dyslipidemia, cardiovascular disease, type 2 diabetes mellitus, and obesity.  MetS patients are strongly exposed to polypharmacy; however, the number of pharmacological compounds required for MetS treatment can be reduced by the application of multitarget compounds.  This study describes the design of dual-target ligands that target soluble epoxide hydrolase (sEH) and the peroxisome proliferator-activated receptor type γ (PPARγ).  Simultaneous modulation of sEH and PPARγ can improve diabetic conditions and hypertension at once.  N-Benzylbenzamide derivatives were determined to fit a merged sEH/PPARγ pharmacophore, and structure-activity relationship studies were performed on both targets, resulting in a submicromolar (sEH IC50 = 0.3 μM/PPARγ EC50 = 0.3 μM) modulator 14c.  In vitro and in vivo evaluations revealed good ADME properties qualifying 14c as a pharmacological tool compound for long-term animal models of MetS.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQEKlCRcJ5_1JcXNb62YGmbfW6udTcc2ebZhFdOcbwXoLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28vksVWjtA%253D%253D&md5=86c5861a77820ae8878382eae893b116</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.5b01239&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.5b01239%26sid%3Dliteratum%253Aachs%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DWeizel%26aufirst%3DL.%26aulast%3DDiehl%26aufirst%3DO.%26aulast%3DBr%25C3%25BCggerhoff%26aufirst%3DA.%26aulast%3DBo%25C3%259F%26aufirst%3DM.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DSchader%26aufirst%3DT.%26aulast%3DG%25C3%25B6bel%26aufirst%3DT.%26aulast%3DGrundmann%26aufirst%3DM.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DKostenis%26aufirst%3DE.%26aulast%3DBr%25C3%25BCne%26aufirst%3DB.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DN-Benzylbenzamides%253A%2520a%2520novel%2520merged%2520scaffold%2520for%2520orally%2520available%2520dual%2520soluble%2520epoxide%2520hydrolase%252Fperoxisome%2520proliferator-activated%2520receptor%2520%25CE%25B3%2520modulators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2016%26volume%3D59%26issue%3D1%26spage%3D61%26epage%3D81%26doi%3D10.1021%2Facs.jmedchem.5b01239" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hye
Khan, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kolb, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skibba, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartmann, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blöcher, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Imig, J. D.</span></span> <span> </span><span class="NLM_article-title">A Novel Dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of Type 2 Diabetes</span>. <i>Diabetologia</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>61</i></span> (<span class="NLM_issue">10</span>),  <span class="NLM_fpage">2235</span>– <span class="NLM_lpage">2246</span>, <span class="refDoi"> DOI: 10.1007/s00125-018-4685-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1007%2Fs00125-018-4685-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=30032428" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2018&pages=2235-2246&issue=10&author=M.+A.+Hye%0AKhanauthor=L.+Kolbauthor=M.+Skibbaauthor=M.+Hartmannauthor=R.+Bl%C3%B6cherauthor=E.+Proschakauthor=J.+D.+Imig&title=A+Novel+Dual+PPAR-%CE%B3+agonist%2FsEH+inhibitor+treats+diabetic+complications+in+a+rat+model+of+Type+2+Diabetes&doi=10.1007%2Fs00125-018-4685-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">A novel dual PPAR-γ agonist/sEH inhibitor treats diabetic complications in a rat model of type 2 diabetes</span></div><div class="casAuthors">Hye Khan, Md Abdul; Kolb, Lauren; Skibba, Melissa; Hartmann, Markus; Blocher, Rene; Proschak, Ewgenij; Imig, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Diabetologia</span>
        (<span class="NLM_cas:date">2018</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2235-2246</span>CODEN:
                <span class="NLM_cas:coden">DBTGAJ</span>;
        ISSN:<span class="NLM_cas:issn">0012-186X</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Aims/hypothesis: The metabolic syndrome is a cluster of risk correlates that can progress to type 2 diabetes.  The present study aims to evaluate a novel mol. with a dual action against the metabolic syndrome and type 2 diabetes.  Methods: We developed and tested a novel dual modulator, RB394, which acts as a sol. epoxide hydrolase (sEH) inhibitor and a peroxisome proliferator-activated receptor-γ (PPAR-γ) agonist in rat models of the metabolic syndrome-the obese spontaneously hypertensive (SHROB) rat and the obese diabetic Zucker fatty/spontaneously hypertensive heart failure F1 hybrid (ZSF1) rat.  In SHROB rats we studied the ability of RB394 to prevent metabolic syndrome phenotypes, while in ZSF1 obese diabetic rats we compared RB394 with the ACE inhibitor enalapril in the treatment of type 2 diabetes and assocd. comorbid conditions.  RB394 (10 mg/kg daily) and enalapril (10 mg/kg daily) were administered orally for 8 wk.  Results: RB394 blunted the development of hypertension, insulin resistance, hyperlipidemia and kidney injury in SHROB rats and reduced fasting blood glucose and HbA1c, improved glucose tolerance, reduced blood pressure and improved lipid profiles in obese ZSF1 rats.  A redn. in liver fibrosis and hepatosteatosis was evident in RB394-treated obese ZSF1 rats.  Unlike RB394, enalapril did not demonstrate any pos. effects in relation to diabetes, hyperlipidemia or liver dysfunction in obese ZSF1 rats.  RB394 ameliorated diabetic nephropathy by reducing renal interstitial fibrosis and renal tubular and glomerular injury in obese diabetic ZSF1 rats.  Intriguingly, enalapril demonstrated a weaker action against diabetic nephropathy in obese ZSF1 rats.  Conclusions/interpretation: These findings demonstrate that a novel sHE inhibitor/PPAR-γ agonist mol. targets multiple risk factors of the metabolic syndrome and is a glucose-lowering agent with a strong ability to treat diabetic complications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrLbjByYxgOqLVg90H21EOLACvtfcHk0lhM3xb7yPgFLw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhtl2jsLbL&md5=b5c538cfa9fe0b8040e19fe230547202</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=10.1007%2Fs00125-018-4685-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00125-018-4685-0%26sid%3Dliteratum%253Aachs%26aulast%3DHye%2BKhan%26aufirst%3DM.%2BA.%26aulast%3DKolb%26aufirst%3DL.%26aulast%3DSkibba%26aufirst%3DM.%26aulast%3DHartmann%26aufirst%3DM.%26aulast%3DBl%25C3%25B6cher%26aufirst%3DR.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DImig%26aufirst%3DJ.%2BD.%26atitle%3DA%2520Novel%2520Dual%2520PPAR-%25CE%25B3%2520agonist%252FsEH%2520inhibitor%2520treats%2520diabetic%2520complications%2520in%2520a%2520rat%2520model%2520of%2520Type%25202%2520Diabetes%26jtitle%3DDiabetologia%26date%3D2018%26volume%3D61%26issue%3D10%26spage%3D2235%26epage%3D2246%26doi%3D10.1007%2Fs00125-018-4685-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Efficient asymmetric synthesis of (S)-2-ethylphenylpropanoic acid derivative, a selective agonist for human peroxisome proliferator-activated receptor alpha</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>12</i></span> (<span class="NLM_issue">16</span>),  <span class="NLM_fpage">2101</span>– <span class="NLM_lpage">2104</span>, <span class="refDoi"> DOI: 10.1016/S0960-894X(02)00375-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2FS0960-894X%2802%2900375-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=12127513" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD38XlsVeksr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2002&pages=2101-2104&issue=16&author=M.+Nomuraauthor=T.+Tanaseauthor=H.+Miyachi&title=Efficient+asymmetric+synthesis+of+%28S%29-2-ethylphenylpropanoic+acid+derivative%2C+a+selective+agonist+for+human+peroxisome+proliferator-activated+receptor+alpha&doi=10.1016%2FS0960-894X%2802%2900375-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient asymmetric synthesis of (S)-2-ethylphenylpropanoic acid derivative, a selective agonist for human peroxisome proliferator-activated receptor alpha</span></div><div class="casAuthors">Nomura, Masahiro; Tanase, Takahiro; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2101-2104</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ltd.</span>)
        </div><div class="casAbstract">An optically active phenylpropanoic acid deriv. (I), a selective agonist for human peroxisome proliferator-activated receptor alpha, was efficiently prepd. in high optical purity by using Evans chiral oxazolidinone technique as a key step.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmRpMWCcRPaLVg90H21EOLACvtfcHk0lj9IM6n01iI8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XlsVeksr0%253D&md5=bb54313843c74c79e6cd987ff4d2552d</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=10.1016%2FS0960-894X%2802%2900375-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0960-894X%252802%252900375-X%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DTanase%26aufirst%3DT.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DEfficient%2520asymmetric%2520synthesis%2520of%2520%2528S%2529-2-ethylphenylpropanoic%2520acid%2520derivative%252C%2520a%2520selective%2520agonist%2520for%2520human%2520peroxisome%2520proliferator-activated%2520receptor%2520alpha%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2002%26volume%3D12%26issue%3D16%26spage%3D2101%26epage%3D2104%26doi%3D10.1016%2FS0960-894X%2802%2900375-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gellrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pollinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goebel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arifi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogoda, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chaikuad, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knapp, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bischoff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fürst, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">L-Thyroxin and the nonclassical thyroid hormone TETRAC are potent activators of PPARγ</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>63</i></span> (<span class="NLM_issue">13</span>),  <span class="NLM_fpage">6727</span>– <span class="NLM_lpage">6740</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.9b02150</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.9b02150" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXotl2qt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2020&pages=6727-6740&issue=13&author=L.+Gellrichauthor=P.+Heitelauthor=J.+Heeringauthor=W.+Kiluauthor=J.+Pollingerauthor=T.+Goebelauthor=A.+Kahntauthor=S.+Arifiauthor=W.+Pogodaauthor=A.+Paulkeauthor=D.+Steinhilberauthor=E.+Proschakauthor=M.+Wurglicsauthor=M.+Schubert-Zsilaveczauthor=A.+Chaikuadauthor=S.+Knappauthor=I.+Bischoffauthor=R.+F%C3%BCrstauthor=D.+Merk&title=L-Thyroxin+and+the+nonclassical+thyroid+hormone+TETRAC+are+potent+activators+of+PPAR%CE%B3&doi=10.1021%2Facs.jmedchem.9b02150"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">L-Thyroxin and the Nonclassical Thyroid Hormone TETRAC Are Potent Activators of PPARγ</span></div><div class="casAuthors">Gellrich, Leonie; Heitel, Pascal; Heering, Jan; Kilu, Whitney; Pollinger, Julius; Goebel, Tamara; Kahnt, Astrid; Arifi, Silvia; Pogoda, Werner; Paulke, Alexander; Steinhilber, Dieter; Proschak, Ewgenij; Wurglics, Mario; Schubert-Zsilavecz, Manfred; Chaikuad, Apirat; Knapp, Stefan; Bischoff, Iris; Fuerst, Robert; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6727-6740</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Thyroid hormones (THs) operate numerous physiol. processes through modulation of the nuclear thyroid hormone receptors and several other proteins.  We report direct activation of the nuclear peroxisome proliferator-activated receptor gamma (PPARγ) and retinoid X receptor (RXR) by classical and non-classical THs as another mol. activity of THs.  The T4 metabolite TETRAC was the most active TH on PPARγ with nanomolar potency and binding affinity.  We demonstrate that TETRAC promotes PPARγ/RXR signaling in cell-free, cellular and in vivo settings.  Simultaneous activation of the heterodimer partners PPARγ and RXR resulted in high dimer activation efficacy.  Compared to fatty acids as known natural ligands of PPARγ and RXR, TETRAC differs markedly in its mol. structure and the PPARγ-TETRAC complex revealed a distinctive binding mode of the TH.  Our observations suggest a potential connection of TH and PPAR signaling through overlapping ligand recognition and may hold implications for TH and PPAR pharmacol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7-20jUnvVH7Vg90H21EOLACvtfcHk0lj9IM6n01iI8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXotl2qt7k%253D&md5=ef11092bf1432477ab92bda15bf37c46</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.9b02150&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.9b02150%26sid%3Dliteratum%253Aachs%26aulast%3DGellrich%26aufirst%3DL.%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DKilu%26aufirst%3DW.%26aulast%3DPollinger%26aufirst%3DJ.%26aulast%3DGoebel%26aufirst%3DT.%26aulast%3DKahnt%26aufirst%3DA.%26aulast%3DArifi%26aufirst%3DS.%26aulast%3DPogoda%26aufirst%3DW.%26aulast%3DPaulke%26aufirst%3DA.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DChaikuad%26aufirst%3DA.%26aulast%3DKnapp%26aufirst%3DS.%26aulast%3DBischoff%26aufirst%3DI.%26aulast%3DF%25C3%25BCrst%26aufirst%3DR.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DL-Thyroxin%2520and%2520the%2520nonclassical%2520thyroid%2520hormone%2520TETRAC%2520are%2520potent%2520activators%2520of%2520PPAR%25CE%25B3%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2020%26volume%3D63%26issue%3D13%26spage%3D6727%26epage%3D6740%26doi%3D10.1021%2Facs.jmedchem.9b02150" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toyota, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Waku, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hirakawa, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagasawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasuga, J. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hashimoto, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morikawa, K.</span></span> <span> </span><span class="NLM_article-title">Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">786</span>– <span class="NLM_lpage">795</span>, <span class="refDoi"> DOI: 10.1107/S0907444909015935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444909015935" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=19622862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2009&pages=786-795&author=T.+Oyamaauthor=K.+Toyotaauthor=T.+Wakuauthor=Y.+Hirakawaauthor=N.+Nagasawaauthor=J.+I.+Kasugaauthor=Y.+Hashimotoauthor=H.+Miyachiauthor=K.+Morikawa&title=Adaptability+and+selectivity+of+human+peroxisome+proliferator-activated+receptor+%28PPAR%29+pan+agonists+revealed+from+crystal+structures&doi=10.1107%2FS0907444909015935"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">Adaptability and selectivity of human peroxisome proliferator-activated receptor (PPAR) pan agonists revealed from crystal structures</span></div><div class="casAuthors">Oyama, Takuji; Toyota, Kenji; Waku, Tsuyoshi; Hirakawa, Yuko; Nagasawa, Naoko; Kasuga, Jun ichi; Hashimoto, Yuichi; Miyachi, Hiroyuki; Morikawa, Kosuke</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">65</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">786-795</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor family, which is defined as transcriptional factors that are activated by the binding of ligands to their ligand-binding domains (LBDs).  Although the three PPAR subtypes display different tissue distribution patterns and distinct pharmacol. profiles, they all are essentially related to fatty-acid and glucose metab.  Since the PPARs share similar 3-dimensional structures within the LBDs, synthetic ligands which simultaneously activate 2 or all of the PPARs could be potent candidates in terms of drugs for the treatment of abnormal metabolic homeostasis.  The structures of several PPAR LBDs were detd. in complex with synthetic ligands, derivs. of 3-(4-alkoxyphenyl)propanoic acid, which exhibit unique agonistic activities.  The PPARα and PPARγ LBDs were complexed with the same pan agonist, TIPP-703, which activates all three PPARs and their crystal structures were detd.  The two LBD-ligand complex structures revealed how the pan agonist is adapted to the similar, but significantly different, ligand-binding pockets of the PPARs.  The structures of the PPARδ LBD in complex with an α/δ-selective ligand, TIPP-401, and with a related δ-specific ligand, TIPP-204, were also detd.  The comparison between the two PPARδ complexes revealed how each ligand exhibits either a 'dual selective' or 'single specific' binding mode.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpsqRY6vaJ6TLVg90H21EOLACvtfcHk0lj9IM6n01iI8g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXovVCgurs%253D&md5=417380ca8b0392b5ee4909ec3f9eb017</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1107%2FS0907444909015935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909015935%26sid%3Dliteratum%253Aachs%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DToyota%26aufirst%3DK.%26aulast%3DWaku%26aufirst%3DT.%26aulast%3DHirakawa%26aufirst%3DY.%26aulast%3DNagasawa%26aufirst%3DN.%26aulast%3DKasuga%26aufirst%3DJ.%2BI.%26aulast%3DHashimoto%26aufirst%3DY.%26aulast%3DMiyachi%26aufirst%3DH.%26aulast%3DMorikawa%26aufirst%3DK.%26atitle%3DAdaptability%2520and%2520selectivity%2520of%2520human%2520peroxisome%2520proliferator-activated%2520receptor%2520%2528PPAR%2529%2520pan%2520agonists%2520revealed%2520from%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2009%26volume%3D65%26spage%3D786%26epage%3D795%26doi%3D10.1107%2FS0907444909015935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kuwabara, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oyama, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomioka, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohashi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yanagisawa, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shimizu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Peroxisome proliferator-activated receptors (PPARs) have multiple binding points that accommodate ligands in various conformations: phenylpropanoic acid-type PPAR ligands bind to PPAR in different conformations, depending on the subtype</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">893</span>– <span class="NLM_lpage">902</span>, <span class="refDoi"> DOI: 10.1021/jm2014293</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm2014293" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhs1ersL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=893-902&author=N.+Kuwabaraauthor=T.+Oyamaauthor=D.+Tomiokaauthor=M.+Ohashiauthor=J.+Yanagisawaauthor=T.+Shimizuauthor=H.+Miyachi&title=Peroxisome+proliferator-activated+receptors+%28PPARs%29+have+multiple+binding+points+that+accommodate+ligands+in+various+conformations%3A+phenylpropanoic+acid-type+PPAR+ligands+bind+to+PPAR+in+different+conformations%2C+depending+on+the+subtype&doi=10.1021%2Fjm2014293"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit26R"><div class="casContent"><span class="casTitleNuber">26</span><div class="casTitle"><span class="NLM_cas:atitle">Peroxisome Proliferator-Activated Receptors (PPARs) Have Multiple Binding Points That Accommodate Ligands in Various Conformations: Phenylpropanoic Acid-Type PPAR Ligands Bind to PPAR in Different Conformations, Depending on the Subtype</span></div><div class="casAuthors">Kuwabara, Naoyuki; Oyama, Takuji; Tomioka, Daisuke; Ohashi, Masao; Yanagisawa, Junn; Shimizu, Toshiyuki; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">893-902</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Human peroxisome proliferator-activated receptors (hPPARs) are ligand-dependent transcription factors that control various biol. responses, and there are three subtypes: hPPARα, hPPARδ, and hPPARγ.  We report here that α-substituted phenylpropanoic acid-type hPPAR agonists with similar structure bind to the hPPAR ligand binding domain (LBD) in different conformations, depending on the receptor subtype.  These results might indicate that hPPAR ligand binding pockets have multiple binding points that can be utilized to accommodate structurally flexible hPPAR ligands.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqlXDIdMBoH0LVg90H21EOLACvtfcHk0lg739JDIYqqOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhs1ersL7F&md5=11145d2f98658e52874119bcdb5b301d</span></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1021%2Fjm2014293&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm2014293%26sid%3Dliteratum%253Aachs%26aulast%3DKuwabara%26aufirst%3DN.%26aulast%3DOyama%26aufirst%3DT.%26aulast%3DTomioka%26aufirst%3DD.%26aulast%3DOhashi%26aufirst%3DM.%26aulast%3DYanagisawa%26aufirst%3DJ.%26aulast%3DShimizu%26aufirst%3DT.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DPeroxisome%2520proliferator-activated%2520receptors%2520%2528PPARs%2529%2520have%2520multiple%2520binding%2520points%2520that%2520accommodate%2520ligands%2520in%2520various%2520conformations%253A%2520phenylpropanoic%2520acid-type%2520PPAR%2520ligands%2520bind%2520to%2520PPAR%2520in%2520different%2520conformations%252C%2520depending%2520on%2520the%2520subtype%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D893%26epage%3D902%26doi%3D10.1021%2Fjm2014293" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nomura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanase, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ide, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsunoda, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suzuki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Uchiki, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murakami, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miyachi, H.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and evaluation of substituted phenylpropanoic acid derivatives as human peroxisome proliferator activated receptor activators. Discovery of potent and human peroxisome proliferator activated receptor alpha subtype-selective activators</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">3581</span>– <span class="NLM_lpage">3599</span>, <span class="refDoi"> DOI: 10.1021/jm0205144</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm0205144" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD3sXlt1Churw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2003&pages=3581-3599&author=M.+Nomuraauthor=T.+Tanaseauthor=T.+Ideauthor=M.+Tsunodaauthor=M.+Suzukiauthor=H.+Uchikiauthor=K.+Murakamiauthor=H.+Miyachi&title=Design%2C+synthesis%2C+and+evaluation+of+substituted+phenylpropanoic+acid+derivatives+as+human+peroxisome+proliferator+activated+receptor+activators.+Discovery+of+potent+and+human+peroxisome+proliferator+activated+receptor+alpha+subtype-selective+activators&doi=10.1021%2Fjm0205144"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Design, Synthesis, and Evaluation of Substituted Phenylpropanoic Acid Derivatives as Human Peroxisome Proliferator Activated Receptor Activators. Discovery of Potent and Human Peroxisome Proliferator Activated Receptor α Subtype-Selective Activators</span></div><div class="casAuthors">Nomura, Masahiro; Tanase, Takahiro; Ide, Tomohiro; Tsunoda, Masaki; Suzuki, Masahiro; Uchiki, Hideharu; Murakami, Koji; Miyachi, Hiroyuki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">3581-3599</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Substituted phenylpropanoic acid derivs. such as I are prepd. as selective human peroxisome proliferator activated receptor α (PPARα) activators.  Structure-activity relationships for the binding of a variety of substituted phenylpropanoic acid derivs. to human peroxisome proliferator activated receptors are detd.  The nature and the stereochem. of the substituent at the α-position of the head part contg. the carboxyl group, the distance between the carboxyl group and the central benzene ring, the linking group between the central benzene ring and the distal benzene ring, and the substituent at the distal hydrophobic tail part of the mol. all play key roles in detg. the potency and selectivity of PPAR subtype transactivation.  Mol. mechanics calcns. of the conformers of phenylpropanoic acid derivs. and of the enantiomers of an α-ethyl-substituted phenylpropanoic acid deriv. are discussed.  I is a particularly effective PPARα activator with significant selectivity for PPARα.  In rats, I decreases serum cholesterol and lipids over five days of administration in a dose-dependent manner and with a significantly greater efficacy than a representative fibrate (bezafibrate) used for comparison.  Phenylpropanoic acid II is found to be a dual activator of PPARα and of PPARδ.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrBRw0M6BoOObVg90H21EOLACvtfcHk0lg739JDIYqqOw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXlt1Churw%253D&md5=4dc2eb5a19959a3af94afb0748e1c641</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1021%2Fjm0205144&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm0205144%26sid%3Dliteratum%253Aachs%26aulast%3DNomura%26aufirst%3DM.%26aulast%3DTanase%26aufirst%3DT.%26aulast%3DIde%26aufirst%3DT.%26aulast%3DTsunoda%26aufirst%3DM.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DUchiki%26aufirst%3DH.%26aulast%3DMurakami%26aufirst%3DK.%26aulast%3DMiyachi%26aufirst%3DH.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520evaluation%2520of%2520substituted%2520phenylpropanoic%2520acid%2520derivatives%2520as%2520human%2520peroxisome%2520proliferator%2520activated%2520receptor%2520activators.%2520Discovery%2520of%2520potent%2520and%2520human%2520peroxisome%2520proliferator%2520activated%2520receptor%2520alpha%2520subtype-selective%2520activators%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2003%26volume%3D46%26spage%3D3581%26epage%3D3599%26doi%3D10.1021%2Fjm0205144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wabitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brenner, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Melzner, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Braun, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Möller, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinze, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Debatin, K. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hauner, H.</span></span> <span> </span><span class="NLM_article-title">Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation</span>. <i>Int. J. Obes.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">8</span>– <span class="NLM_lpage">15</span>, <span class="refDoi"> DOI: 10.1038/sj.ijo.0801520</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fsj.ijo.0801520" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=11244452" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref28/cit28&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BD38%252Fgs1GitQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2001&pages=8-15&author=M.+Wabitschauthor=R.+E.+Brennerauthor=I.+Melznerauthor=M.+Braunauthor=P.+M%C3%B6llerauthor=E.+Heinzeauthor=K.+M.+Debatinauthor=H.+Hauner&title=Characterization+of+a+human+preadipocyte+cell+strain+with+high+capacity+for+adipose+differentiation&doi=10.1038%2Fsj.ijo.0801520"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit28R"><div class="casContent"><span class="casTitleNuber">28</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a human preadipocyte cell strain with high capacity for adipose differentiation</span></div><div class="casAuthors">Wabitsch M; Brenner R E; Melzner I; Braun M; Moller P; Heinze E; Debatin K M; Hauner H</div><div class="citationInfo"><span class="NLM_cas:title">International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">8-15</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">OBJECTIVE:  To develop and to characterize a human preadipocyte cell strain with high capacity for adipose differentiation serving as a model for studying human adipocyte development and metabolism in vitro.  METHODS:  Cells were derived from the stromal cells fraction of subcutaneous adipose tissue of an infant with Simpson-Golabi-Behmel syndrome (SGBS).  Adipose differentiation was induced under serum-free culture conditions by exposure to 10 nM insulin, 200 pM triiodothyronine, 1 microM cortisol and 2 microM BRL 49653, a PPAR gamma agonist.  RESULTS:  During the differentiation process SGBS cells developed a gene expression pattern similar to that found in differentiating human preadipocytes with a characteristic increase in fat cell-specific mRNAs encoding lipoprotein lipase (LPL), glycero-3-phosphate dehydrogenase (GPDH), GLUT4, leptin and others.  Differentiated SGBS cells exhibited an increase in glucose uptake upon insulin stimulation and in glycerol release upon catecholamine exposure.  SGBS adipocytes were morphologically, biochemically and functionally identical to in vitro differentiated adipocytes from healthy subjects.  However, while preadipocytes from healthy control infants rapidly lost their capacity to differentiate after a few cell divisions in culture, SGBS cells maintained their differentiation capacity over many generations: upon appropriate stimulation 95% of SGBS cells of generation 30 developed into adipocytes.  A mutation in the glypican 3 gene was not detected in the patient.  Thus, it remains unclear whether the molecular alteration in SGBS cells is also responsible for the high differentiation capacity and further investigations are required.  CONCLUSION:  The human cell strain described here provides an almost unlimited source of human preadipocytes with high capacity for adipose differentiation and may, therefore, represent a unique tool for studying human fat cell development and metabolism.  International Journal of Obesity (2001) 25, 8-15</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhCslT4vmO2R0LsK7uFuY7fW6udTcc2eYSq6l4FpM7abntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD38%252Fgs1GitQ%253D%253D&md5=2319939c4fc03ceb25f58a776d8a75be</span></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1038%2Fsj.ijo.0801520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.ijo.0801520%26sid%3Dliteratum%253Aachs%26aulast%3DWabitsch%26aufirst%3DM.%26aulast%3DBrenner%26aufirst%3DR.%2BE.%26aulast%3DMelzner%26aufirst%3DI.%26aulast%3DBraun%26aufirst%3DM.%26aulast%3DM%25C3%25B6ller%26aufirst%3DP.%26aulast%3DHeinze%26aufirst%3DE.%26aulast%3DDebatin%26aufirst%3DK.%2BM.%26aulast%3DHauner%26aufirst%3DH.%26atitle%3DCharacterization%2520of%2520a%2520human%2520preadipocyte%2520cell%2520strain%2520with%2520high%2520capacity%2520for%2520adipose%2520differentiation%26jtitle%3DInt.%2520J.%2520Obes.%26date%3D2001%26volume%3D25%26spage%3D8%26epage%3D15%26doi%3D10.1038%2Fsj.ijo.0801520" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fischer-Posovszky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newell, F. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wabitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tornqvist, H. E.</span></span> <span> </span><span class="NLM_article-title">Human SGBS cells – a unique tool for studies of human fat cell biology</span>. <i>Obes. Facts</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>1</i></span>,  <span class="NLM_fpage">184</span>– <span class="NLM_lpage">189</span>, <span class="refDoi"> DOI: 10.1159/000145784</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1159%2F000145784" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=20054179" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BC3crhtFOhsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2008&pages=184-189&author=P.+Fischer-Posovszkyauthor=F.+S.+Newellauthor=M.+Wabitschauthor=H.+E.+Tornqvist&title=Human+SGBS+cells+%E2%80%93+a+unique+tool+for+studies+of+human+fat+cell+biology&doi=10.1159%2F000145784"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Human SGBS cells - a unique tool for studies of human fat cell biology</span></div><div class="casAuthors">Fischer-Posovszky Pamela; Newell Felicity S; Wabitsch Martin; Tornqvist Hans E</div><div class="citationInfo"><span class="NLM_cas:title">Obesity facts</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">184-9</span>
        ISSN:<span class="NLM_cas:issn">1662-4025</span>.
    </div><div class="casAbstract">The human Simpson-Golabi-Behmel syndrome (SGBS) preadipocyte cell strain provides a unique and useful tool for studies of human adipocyte biology.  The cells originate from an adipose tissue specimen of a patient with SGBS.  They are neither transformed nor immortalized, and provide an almost unlimited source due to their ability to proliferate for up to 50 generations with retained capacity for adipogenic differentiation.  So far, the cells have been used for a number of studies on adipose differentiation, adipocyte glucose uptake, lipolysis, apoptosis, regulation of expression of adipokines, and protein translocation.  The cells are efficiently differentiated in the presence of PPARgammaagonists and in the absence of serum and albumin.  SGBS adipocytes respond to insulin stimulation by increasing glucose uptake several-fold (EC50 approximately 100 pmol/l), and by very effectively inhibiting (IC50 approximately 10 pmol/l) catecholamine-stimulated lipolysis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcT4ZM6c80VUFJ0d-O_J5C0AfW6udTcc2ea0Nx8GywINELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3crhtFOhsg%253D%253D&md5=c4be7bc48447c030f9cee7cd043f48ca</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1159%2F000145784&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1159%252F000145784%26sid%3Dliteratum%253Aachs%26aulast%3DFischer-Posovszky%26aufirst%3DP.%26aulast%3DNewell%26aufirst%3DF.%2BS.%26aulast%3DWabitsch%26aufirst%3DM.%26aulast%3DTornqvist%26aufirst%3DH.%2BE.%26atitle%3DHuman%2520SGBS%2520cells%2520%25E2%2580%2593%2520a%2520unique%2520tool%2520for%2520studies%2520of%2520human%2520fat%2520cell%2520biology%26jtitle%3DObes.%2520Facts%26date%3D2008%26volume%3D1%26spage%3D184%26epage%3D189%26doi%3D10.1159%2F000145784" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Halbgebauer, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dahlhaus, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wabitsch, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fischer-Posovszky, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tews, D.</span></span> <span> </span><span class="NLM_article-title">Browning capabilities of human primary adipose-derived stromal cells compared to SGBS cells</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">9632</span>, <span class="refDoi"> DOI: 10.1038/s41598-020-64369-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fs41598-020-64369-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=32541826" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BB38ngt1eltQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2020&pages=9632&author=D.+Halbgebauerauthor=M.+Dahlhausauthor=M.+Wabitschauthor=P.+Fischer-Posovszkyauthor=D.+Tews&title=Browning+capabilities+of+human+primary+adipose-derived+stromal+cells+compared+to+SGBS+cells&doi=10.1038%2Fs41598-020-64369-7"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">Browning capabilities of human primary adipose-derived stromal cells compared to SGBS cells</span></div><div class="casAuthors">Halbgebauer D; Dahlhaus M; Wabitsch M; Fischer-Posovszky P; Tews D</div><div class="citationInfo"><span class="NLM_cas:title">Scientific reports</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">9632</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQ9X-tDafDMehLDWw4HIq2sfW6udTcc2ea0Nx8GywINELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB38ngt1eltQ%253D%253D&md5=00e37a9e15246622bd8c47af7d8c8c2d</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1038%2Fs41598-020-64369-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41598-020-64369-7%26sid%3Dliteratum%253Aachs%26aulast%3DHalbgebauer%26aufirst%3DD.%26aulast%3DDahlhaus%26aufirst%3DM.%26aulast%3DWabitsch%26aufirst%3DM.%26aulast%3DFischer-Posovszky%26aufirst%3DP.%26aulast%3DTews%26aufirst%3DD.%26atitle%3DBrowning%2520capabilities%2520of%2520human%2520primary%2520adipose-derived%2520stromal%2520cells%2520compared%2520to%2520SGBS%2520cells%26jtitle%3DSci.%2520Rep.%26date%3D2020%26volume%3D10%26spage%3D9632%26doi%3D10.1038%2Fs41598-020-64369-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref200"><div class="reference"><strong class="refLabel"><a href="#ref200" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit200"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seale, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Conroe, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estall, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kajimura, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frontini, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishibashi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cohen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cinti, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spiegelman, B. M.</span></span> <span> </span><span class="NLM_article-title">Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>121</i></span>,  <span class="NLM_fpage">96</span>– <span class="NLM_lpage">105</span>, <span class="refDoi"> DOI: 10.1172/JCI44271</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1172%2FJCI44271" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=21123942" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref200/cit200&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3MXis1ynsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=121&publication_year=2011&pages=96-105&author=P.+Sealeauthor=H.+M.+Conroeauthor=J.+Estallauthor=S.+Kajimuraauthor=A.+Frontiniauthor=J.+Ishibashiauthor=P.+Cohenauthor=S.+Cintiauthor=B.+M.+Spiegelman&title=Prdm16+determines+the+thermogenic+program+of+subcutaneous+white+adipose+tissue+in+mice&doi=10.1172%2FJCI44271"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit200R"><div class="casContent"><span class="casTitleNuber">200</span><div class="casTitle"><span class="NLM_cas:atitle">Prdm16 determines the thermogenic program of subcutaneous white adipose tissue in mice</span></div><div class="casAuthors">Seale, Patrick; Conroe, Heather M.; Estall, Jennifer; Kajimura, Shingo; Frontini, Andrea; Ishibashi, Jeff; Cohen, Paul; Cinti, Saverio; Spiegelman, Bruce M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">121</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">96-105</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">0021-9738</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">The white adipose organ is composed of both s.c. and several intra-abdominal depots.  Excess abdominal adiposity is a major risk factor for metabolic disease in rodents and humans, while expansion of s.c. fat does not carry the same risks.  Brown adipose produces heat as a defense against hypothermia and obesity, and the appearance of brown-like adipocytes within white adipose tissue depots is assocd. with improved metabolic phenotypes.  Thus, understanding the differences in cell biol. and function of these different adipose cell types and depots may be crit. to the development of new therapies for metabolic disease.  Here, we found that Prdm16, a brown adipose detn. factor, is selectively expressed in s.c. white adipocytes relative to other white fat depots in mice.  Transgenic expression of Prdm16 in fat tissue robustly induced the development of brown-like adipocytes in s.c., but not epididymal, adipose depots.  Prdm16 transgenic mice displayed increased energy expenditure, limited wt. gain, and improved glucose tolerance in response to a high-fat diet.  ShRNA-mediated depletion of Prdm16 in isolated s.c. adipocytes caused a sharp decrease in the expression of thermogenic genes and a redn. in uncoupled cellular respiration.  Finally, Prdm16 haploinsufficiency reduced the brown fat phenotype in white adipose tissue stimulated by β-adrenergic agonists.  These results demonstrate that Prdm16 is a cell-autonomous determinant of a brown fat-like gene program and thermogenesis in s.c. adipose tissues.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrKWKhiouTX3rVg90H21EOLACvtfcHk0liMBahoixJAOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXis1ynsA%253D%253D&md5=5a3307db34df29f9741444f642d2e963</span></div><a href="/servlet/linkout?suffix=cit200&amp;dbid=16384&amp;doi=10.1172%2FJCI44271&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI44271%26sid%3Dliteratum%253Aachs%26aulast%3DSeale%26aufirst%3DP.%26aulast%3DConroe%26aufirst%3DH.%2BM.%26aulast%3DEstall%26aufirst%3DJ.%26aulast%3DKajimura%26aufirst%3DS.%26aulast%3DFrontini%26aufirst%3DA.%26aulast%3DIshibashi%26aufirst%3DJ.%26aulast%3DCohen%26aufirst%3DP.%26aulast%3DCinti%26aufirst%3DS.%26aulast%3DSpiegelman%26aufirst%3DB.%2BM.%26atitle%3DPrdm16%2520determines%2520the%2520thermogenic%2520program%2520of%2520subcutaneous%2520white%2520adipose%2520tissue%2520in%2520mice%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2011%26volume%3D121%26spage%3D96%26epage%3D105%26doi%3D10.1172%2FJCI44271" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanif, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nayeem, M. A.</span></span> <span> </span><span class="NLM_article-title">Deletion of soluble epoxide hydrolase enhances coronary reactive hyperemia in isolated mouse heart: role of oxylipins and PPARγ</span>. <i>Am. J. Physiol. Regul. Integr. Comp. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>311</i></span>,  <span class="NLM_fpage">R676</span>– <span class="NLM_lpage">R688</span>, <span class="refDoi"> DOI: 10.1152/ajpregu.00237.2016</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajpregu.00237.2016" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=27488890" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=311&publication_year=2016&pages=R676-R688&author=A.+Hanifauthor=M.+L.+Edinauthor=D.+C.+Zeldinauthor=C.+Morisseauauthor=M.+A.+Nayeem&title=Deletion+of+soluble+epoxide+hydrolase+enhances+coronary+reactive+hyperemia+in+isolated+mouse+heart%3A+role+of+oxylipins+and+PPAR%CE%B3&doi=10.1152%2Fajpregu.00237.2016"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.1152%2Fajpregu.00237.2016&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpregu.00237.2016%26sid%3Dliteratum%253Aachs%26aulast%3DHanif%26aufirst%3DA.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DNayeem%26aufirst%3DM.%2BA.%26atitle%3DDeletion%2520of%2520soluble%2520epoxide%2520hydrolase%2520enhances%2520coronary%2520reactive%2520hyperemia%2520in%2520isolated%2520mouse%2520heart%253A%2520role%2520of%2520oxylipins%2520and%2520PPAR%25CE%25B3%26jtitle%3DAm.%2520J.%2520Physiol.%2520Regul.%2520Integr.%2520Comp.%2520Physiol.%26date%3D2016%26volume%3D311%26spage%3DR676%26epage%3DR688%26doi%3D10.1152%2Fajpregu.00237.2016" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">He, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoopes, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, D. W.</span></span> <span> </span><span class="NLM_article-title">Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II</span>. <i>Cardiovasc. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>105</i></span>,  <span class="NLM_fpage">304</span>– <span class="NLM_lpage">317</span>, <span class="refDoi"> DOI: 10.1093/cvr/cvv018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1093%2Fcvr%2Fcvv018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=25618409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC28Xht1Cqt7vM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=105&publication_year=2015&pages=304-317&author=Z.+Heauthor=X.+Zhangauthor=C.+Chenauthor=Z.+Wenauthor=S.+L.+Hoopesauthor=D.+C.+Zeldinauthor=D.+W.+Wang&title=Cardiomyocyte-specific+expression+of+CYP2J2+prevents+development+of+cardiac+remodelling+induced+by+angiotensin+II&doi=10.1093%2Fcvr%2Fcvv018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Cardiomyocyte-specific expression of CYP2J2 prevents development of cardiac remodelling induced by angiotensin II</span></div><div class="casAuthors">He, Zuowen; Zhang, Xu; Chen, Chen; Wen, Zheng; Hoopes, Samantha L.; Zeldin, Darryl C.; Wang, Dao Wen</div><div class="citationInfo"><span class="NLM_cas:title">Cardiovascular Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">105</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">304-317</span>CODEN:
                <span class="NLM_cas:coden">CVREAU</span>;
        ISSN:<span class="NLM_cas:issn">0008-6363</span>.
    
            (<span class="NLM_cas:orgname">Oxford University Press</span>)
        </div><div class="casAbstract">Aims Cardiac remodelling is one of the key pathol. changes that occur with cardiovascular disease.  Previous studies have demonstrated the beneficial effects of CYP2J2 expression on cardiac injury.  In the present study, we investigated the effects of cardiomyocyte-specific CYP2J2 expression and EET treatment on angiotensin II-induced cardiac remodelling and sought to det. the underlying mol. mechanisms involved in this process.  Methods and results Eight-week-old mice with cardiomyocyte-specific CYP2J2 expression (aMHC-CYP2J2-Tr) and wild-type (WT) control mice were treated with Ang-II.  Ang-II treatment of WT mice induced changes in heart morphol., cardiac hypertrophy and dysfunction, as well as collagen accumulation; however, cardiomyocyte-specific expression of CYP2J2 attenuated these effects.  The cardioprotective effects obsd. in α-MHC-CYP2J2-Tr mice were assocd. with peroxisome proliferator-activated receptor (PPAR)-γ activation, reduced oxidative stress, reduced NF-κBp65 nuclear translocation, and inhibition of TGF-β1/smad pathway.  The effects seen with cardiomyocyte-specific expression of CYP2J2 were partially blocked by treatment with PPAR-γ antagonist GW9662.  In in vitro studies, 11,12-EET(1 μmol/L) treatment attenuated cardiomyocyte hypertrophy and remodelling-related protein (collagen I, TGF-β1, TIMP1) expression by inhibiting the oxidative stress-mediated NF-κB pathway via PPAR-γ activation.  Furthermore, conditioned media from neonatal cardiomyocytes treated with 11,12-EET inhibited activation of cardiac fibroblasts and TGF-β1/smad pathway.  Conclusion Cardiomyocyte-specific expression of CYP2J2 or treatment with EETs protects against cardiac remodelling by attenuating oxidative stress-mediated NF-κBp65 nuclear translocation via PPAR-γ activation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYG8Qz-t2hsLVg90H21EOLACvtfcHk0lgpLJ4xl4wKbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28Xht1Cqt7vM&md5=e13295d939c2a05daaa417cc6c074a8f</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1093%2Fcvr%2Fcvv018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fcvr%252Fcvv018%26sid%3Dliteratum%253Aachs%26aulast%3DHe%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DChen%26aufirst%3DC.%26aulast%3DWen%26aufirst%3DZ.%26aulast%3DHoopes%26aufirst%3DS.%2BL.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DWang%26aufirst%3DD.%2BW.%26atitle%3DCardiomyocyte-specific%2520expression%2520of%2520CYP2J2%2520prevents%2520development%2520of%2520cardiac%2520remodelling%2520induced%2520by%2520angiotensin%2520II%26jtitle%3DCardiovasc.%2520Res.%26date%3D2015%26volume%3D105%26spage%3D304%26epage%3D317%26doi%3D10.1093%2Fcvr%2Fcvv018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Seubert, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradbury, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graves, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Degraff, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabel, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gooch, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Foley, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rockman, H. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murphy, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span> <span> </span><span class="NLM_article-title">Enhanced postischemic functional recovery in CYP2J2 transgenic hearts involves mitochondrial ATP-sensitive K+ channels and P42/P44 MAPK pathway</span>. <i>Circ. Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">506</span>– <span class="NLM_lpage">514</span>, <span class="refDoi"> DOI: 10.1161/01.RES.0000139436.89654.c8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1161%2F01.RES.0000139436.89654.c8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=15256482" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2cXntVCrtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2004&pages=506-514&author=J.+Seubertauthor=B.+Yangauthor=J.+A.+Bradburyauthor=J.+Gravesauthor=L.+M.+Degraffauthor=S.+Gabelauthor=R.+Goochauthor=J.+Foleyauthor=J.+Newmanauthor=L.+Maoauthor=H.+A.+Rockmanauthor=B.+D.+Hammockauthor=E.+Murphyauthor=D.+C.+Zeldin&title=Enhanced+postischemic+functional+recovery+in+CYP2J2+transgenic+hearts+involves+mitochondrial+ATP-sensitive+K%2B+channels+and+P42%2FP44+MAPK+pathway&doi=10.1161%2F01.RES.0000139436.89654.c8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit33R"><div class="casContent"><span class="casTitleNuber">33</span><div class="casTitle"><span class="NLM_cas:atitle">Enhanced Postischemic Functional Recovery in CYP2J2 Transgenic Hearts Involves Mitochondrial ATP-Sensitive K+ Channels and p42/p44 MAPK Pathway</span></div><div class="casAuthors">Seubert, John; Yang, Baichun; Bradbury, J. Alyce; Graves, Joan; Degraff, Laura M.; Gabel, Scott; Gooch, Rebecca; Foley, Julie; Newman, John; Mao, Lan; Rockman, Howard A.; Hammock, Bruce D.; Murphy, Elizabeth; Zeldin, Darryl C.</div><div class="citationInfo"><span class="NLM_cas:title">Circulation Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">95</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">506-514</span>CODEN:
                <span class="NLM_cas:coden">CIRUAL</span>;
        ISSN:<span class="NLM_cas:issn">0009-7330</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">Human CYP2J2 is abundant in heart and active in the biosynthesis of epoxyeicosatrienoic acids (EETs); however, the functional role of this P 450 and its eicosanoid products in the heart remains unknown.  Transgenic mice with cardiomyocyte-specific overexpression of CYP2J2 were generated.  CYP2J2 transgenic (Tr) mice have normal heart anatomy and basal contractile function.  CYP2J2 Tr hearts have improved recovery of left ventricular developed pressure (LVDP) compared with wild-type (WT) hearts after 20 min ischemia and 40 min reperfusion.  Perfusion with the selective P 450 epoxygenase inhibitor N-methylsulfonyl-6-(2-proparglyloxyphenyl)hexanamide (MS-PPOH) for 20 min before ischemia results in reduced postischemic LVDP recovery in WT hearts and abolishes the improved postischemic LVDP recovery in CYP2J2 Tr hearts.  Perfusion with the ATP-sensitive K+ channel (KATP) inhibitor glibenclamide (GLIB) or the mitochondrial KATP (mitoKATP) inhibitor 5-hydroxydecanoate (5-HD) for 20 min before ischemia abolishes the cardioprotective effects of CYP2J2 overexpression.  Flavoprotein fluorescence, a marker of mitoKATP activity, is higher in cardiomyocytes from CYP2J2 Tr vs. WT mice.  Moreover, CYP2J2-derived EETs (1 to 5 μM) increase flavoprotein fluorescence in WT cardiomyocytes.  CYP2J2 Tr mice exhibit increased expression of phospho-p42/p44 mitogen-activated protein kinase (MAPK) after ischemia, and addn. of the p42/p44 MAPK kinase (MEK) inhibitor PD98059 during reperfusion abolishes the cardioprotective effects of CYP2J2 overexpression.  Together, these data suggest that CYP2J2-derived metabolites are cardioprotective after ischemia, and the mechanism for this cardioprotection involves activation of mitoKATP and p42/p44 MAPK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtZdja4T-SA7Vg90H21EOLACvtfcHk0lgpLJ4xl4wKbg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXntVCrtLo%253D&md5=2094898d6437b9127e06ed89d2f6ddae</span></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.1161%2F01.RES.0000139436.89654.c8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252F01.RES.0000139436.89654.c8%26sid%3Dliteratum%253Aachs%26aulast%3DSeubert%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DB.%26aulast%3DBradbury%26aufirst%3DJ.%2BA.%26aulast%3DGraves%26aufirst%3DJ.%26aulast%3DDegraff%26aufirst%3DL.%2BM.%26aulast%3DGabel%26aufirst%3DS.%26aulast%3DGooch%26aufirst%3DR.%26aulast%3DFoley%26aufirst%3DJ.%26aulast%3DNewman%26aufirst%3DJ.%26aulast%3DMao%26aufirst%3DL.%26aulast%3DRockman%26aufirst%3DH.%2BA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DMurphy%26aufirst%3DE.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26atitle%3DEnhanced%2520postischemic%2520functional%2520recovery%2520in%2520CYP2J2%2520transgenic%2520hearts%2520involves%2520mitochondrial%2520ATP-sensitive%2520K%252B%2520channels%2520and%2520P42%252FP44%2520MAPK%2520pathway%26jtitle%3DCirc.%2520Res.%26date%3D2004%26volume%3D95%26spage%3D506%26epage%3D514%26doi%3D10.1161%2F01.RES.0000139436.89654.c8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stahl, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Joyal, J.-S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatton, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Juan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hurst, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Evans, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bogardus, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Edin, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lih, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sapieha, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Panigrahy, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hellstrom, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, L. E. H.</span></span> <span> </span><span class="NLM_article-title">Cytochrome P450 2C8 Ω3-long-chain polyunsaturated fatty acid metabolites increase mouse retinal pathologic neovascularization--Brief Report</span>. <i>Arterioscler., Thromb., Vasc. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>34</i></span>,  <span class="NLM_fpage">581</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1161/ATVBAHA.113.302927</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1161%2FATVBAHA.113.302927" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24458713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2cXislGktro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=2014&pages=581-586&author=Z.+Shaoauthor=Z.+Fuauthor=A.+Stahlauthor=J.-S.+Joyalauthor=C.+Hattonauthor=A.+Juanauthor=C.+Hurstauthor=L.+Evansauthor=Z.+Cuiauthor=D.+Peiauthor=Y.+Gongauthor=D.+Xuauthor=K.+Tianauthor=H.+Bogardusauthor=M.+L.+Edinauthor=F.+Lihauthor=P.+Sapiehaauthor=J.+Chenauthor=D.+Panigrahyauthor=A.+Hellstromauthor=D.+C.+Zeldinauthor=L.+E.+H.+Smith&title=Cytochrome+P450+2C8+%CE%A93-long-chain+polyunsaturated+fatty+acid+metabolites+increase+mouse+retinal+pathologic+neovascularization%2D%2DBrief+Report&doi=10.1161%2FATVBAHA.113.302927"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit34R"><div class="casContent"><span class="casTitleNuber">34</span><div class="casTitle"><span class="NLM_cas:atitle">Cytochrome P450 2C8 ω3-Long-Chain Polyunsaturated Fatty Acid Metabolites Increase Mouse Retinal Pathologic Neovascularization-Brief Report</span></div><div class="casAuthors">Shao, Zhuo; Fu, Zhongjie; Stahl, Andreas; Joyal, Jean-Sebastien; Hatton, Colman; Juan, Aimee; Hurst, Christian; Evans, Lucy; Cui, Zhenghao; Pei, Dorothy; Gong, Yan; Xu, Dan; Tian, Katherine; Bogardus, Hannah; Edin, Matthew L.; Lih, Fred; Sapieha, Przemyslaw; Chen, Jing; Panigrahy, Dipak; Hellstrom, Ann; Zeldin, Darryl C.; Smith, Lois E. H.</div><div class="citationInfo"><span class="NLM_cas:title">Arteriosclerosis, Thrombosis, and Vascular Biology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">581-586</span>CODEN:
                <span class="NLM_cas:coden">ATVBFA</span>;
        ISSN:<span class="NLM_cas:issn">1079-5642</span>.
    
            (<span class="NLM_cas:orgname">Lippincott Williams & Wilkins</span>)
        </div><div class="casAbstract">OBJECTIVE-: Regulation of angiogenesis is crit. for many diseases.  Specifically, pathol. retinal neovascularization, a major cause of blindness, is suppressed with dietary ω3-long-chain polyunsatd. fatty acids (ω3LCPUFAs) through antiangiogenic metabolites of cyclooxygenase and lipoxygenase.  Cytochrome P 450 epoxygenases (CYP2C8) also metabolize LCPUFAs, producing bioactive epoxides, which are inactivated by sol. epoxide hydrolase (sEH) to transdihydrodiols.  The effect of these enzymes and their metabolites on neovascularization is unknown.  APPROACH AND RESULTS-: The mouse model of oxygen-induced retinopathy was used to investigate retinal neovascularization.  We found that CYP2C (localized in wild-type monocytes/macrophages) is upregulated in oxygen-induced retinopathy, whereas sEH is suppressed, resulting in an increased retinal epoxide:diol ratio.  With a ω3LCPUFA-enriched diet, retinal neovascularization increases in Tie2-driven human-CYP2C8-overexpressing mice (Tie2-CYP2C8-Tg), assocd. with increased plasma 19,20-epoxydocosapentaenoic acid and retinal epoxide:diol ratio. 19,20-Epoxydocosapentaenoic acids and the epoxide:diol ratio are decreased with overexpression of sEH (Tie2-sEH-Tg).  Overexpression of CYP2C8 or sEH in mice does not change normal retinal vascular development compared with their wild-type littermate controls.  The proangiogenic role in retina of CYP2C8 with both ω3LCPUFA and ω6LCPUFA and antiangiogenic role of sEH in ω3LCPUFA metab. were corroborated in aortic ring assays.  CONCLUSIONS-: Our results suggest that CYP2C ω3LCPUFA metabolites promote retinal pathol. angiogenesis.  CYP2C8 is part of a novel lipid metabolic pathway influencing retinal neovascularization.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGofDklhXO9eCbVg90H21EOLACvtfcHk0liFYLn1L-Mdxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXislGktro%253D&md5=84bb4c23e67aa96979a9cab642515e90</span></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1161%2FATVBAHA.113.302927&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1161%252FATVBAHA.113.302927%26sid%3Dliteratum%253Aachs%26aulast%3DShao%26aufirst%3DZ.%26aulast%3DFu%26aufirst%3DZ.%26aulast%3DStahl%26aufirst%3DA.%26aulast%3DJoyal%26aufirst%3DJ.-S.%26aulast%3DHatton%26aufirst%3DC.%26aulast%3DJuan%26aufirst%3DA.%26aulast%3DHurst%26aufirst%3DC.%26aulast%3DEvans%26aufirst%3DL.%26aulast%3DCui%26aufirst%3DZ.%26aulast%3DPei%26aufirst%3DD.%26aulast%3DGong%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DD.%26aulast%3DTian%26aufirst%3DK.%26aulast%3DBogardus%26aufirst%3DH.%26aulast%3DEdin%26aufirst%3DM.%2BL.%26aulast%3DLih%26aufirst%3DF.%26aulast%3DSapieha%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DJ.%26aulast%3DPanigrahy%26aufirst%3DD.%26aulast%3DHellstrom%26aufirst%3DA.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DSmith%26aufirst%3DL.%2BE.%2BH.%26atitle%3DCytochrome%2520P450%25202C8%2520%25CE%25A93-long-chain%2520polyunsaturated%2520fatty%2520acid%2520metabolites%2520increase%2520mouse%2520retinal%2520pathologic%2520neovascularization--Brief%2520Report%26jtitle%3DArterioscler.%252C%2520Thromb.%252C%2520Vasc.%2520Biol.%26date%3D2014%26volume%3D34%26spage%3D581%26epage%3D586%26doi%3D10.1161%2FATVBAHA.113.302927" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hwang, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsai, H.-J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, J.-Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Orally bioavailable potent soluble epoxide hydrolase inhibitors</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">3825</span>– <span class="NLM_lpage">3840</span>, <span class="refDoi"> DOI: 10.1021/jm070270t</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070270t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=3825-3840&author=S.+H.+Hwangauthor=H.-J.+Tsaiauthor=J.-Y.+Liuauthor=C.+Morisseauauthor=B.+D.+Hammock&title=Orally+bioavailable+potent+soluble+epoxide+hydrolase+inhibitors&doi=10.1021%2Fjm070270t"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Orally Bioavailable Potent Soluble Epoxide Hydrolase Inhibitors</span></div><div class="casAuthors">Hwang, Sung Hee; Tsai, Hsing-Ju; Liu, Jun-Yan; Morisseau, Christophe; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">3825-3840</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A series of N,N'-disubstituted ureas having a conformationally restricted cis- or trans-1,4-cyclohexane α to the urea were prepd. and tested as sol. epoxide hydrolase (sEH) inhibitors.  This series of compds. showed low nanomolar to picomolar activities against recombinant human sEH.  Both isomers showed similar potencies, but the trans isomers were more metabolically stable in human hepatic microsomes.  Furthermore, these new potent inhibitors show a greater metabolic stability in vivo than previously described sEH inhibitors.  Trans-4-[4-(3-adamantan-1-ylureido)cyclohexyloxy]benzoic acid (I, t-AUCB, IC50 = 1.3 ± 0.05 nM) had excellent oral bioavailability (98%, n = 2) and blood area under the curve in dogs and was effective in vivo to treat hypotension in lipopolysaccharide challenged murine models.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoVS4Wx8hrt_bVg90H21EOLACvtfcHk0liFYLn1L-Mdxg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXns1Cksbg%253D&md5=ad2116c2671dc36d35b44ff93d55863d</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.1021%2Fjm070270t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070270t%26sid%3Dliteratum%253Aachs%26aulast%3DHwang%26aufirst%3DS.%2BH.%26aulast%3DTsai%26aufirst%3DH.-J.%26aulast%3DLiu%26aufirst%3DJ.-Y.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DOrally%2520bioavailable%2520potent%2520soluble%2520epoxide%2520hydrolase%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D3825%26epage%3D3840%26doi%3D10.1021%2Fjm070270t" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dziumbla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibli, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukunft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Mos, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Awwad, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frömel, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jungmann, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Devraj, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauser, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eberhart, C. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sodhi, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liebner, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Müller, O. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glaubitz, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>552</i></span>,  <span class="NLM_fpage">248</span>– <span class="NLM_lpage">252</span>, <span class="refDoi"> DOI: 10.1038/nature25013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fnature25013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=29211719" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=552&publication_year=2017&pages=248-252&author=J.+Huauthor=S.+Dziumblaauthor=J.+Linauthor=S.-I.+Bibliauthor=S.+Zukunftauthor=J.+de+Mosauthor=K.+Awwadauthor=T.+Fr%C3%B6melauthor=A.+Jungmannauthor=K.+Devrajauthor=Z.+Chengauthor=L.+Wangauthor=S.+Fauserauthor=C.+G.+Eberhartauthor=A.+Sodhiauthor=B.+D.+Hammockauthor=S.+Liebnerauthor=O.+J.+M%C3%BCllerauthor=C.+Glaubitzauthor=H.-P.+Hammesauthor=R.+Poppauthor=I.+Fleming&title=Inhibition+of+soluble+epoxide+hydrolase+prevents+diabetic+retinopathy&doi=10.1038%2Fnature25013"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit36R"><div class="casContent"><span class="casTitleNuber">36</span><div class="casTitle"><span class="NLM_cas:atitle">Inhibition of soluble epoxide hydrolase prevents diabetic retinopathy</span></div><div class="casAuthors">Hu, Jiong; Dziumbla, Sarah; Lin, Jihong; Bibli, Sofia-Iris; Zukunft, Sven; de Mos, Julian; Awwad, Khader; Froemel, Timo; Jungmann, Andreas; Devraj, Kavi; Cheng, Zhixing; Wang, Liya; Fauser, Sascha; Eberhart, Charles G.; Sodhi, Akrit; Hammock, Bruce D.; Liebner, Stefan; Mueller, Oliver J.; Glaubitz, Clemens; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">552</span>
        (<span class="NLM_cas:issue">7684</span>),
    <span class="NLM_cas:pages">248-252</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Research</span>)
        </div><div class="casAbstract">Diabetic retinopathy is an important cause of blindness in adults, and is characterized by progressive loss of vascular cells and slow dissoln. of inter-vascular junctions, which result in vascular leakage and retinal edema.  Later stages of the disease are characterized by inflammatory cell infiltration, tissue destruction and neovascularization.  Here we identify sol. epoxide hydrolase (sEH) as a key enzyme that initiates pericyte loss and breakdown of endothelial barrier function by generating the diol 19,20-dihydroxydocosapentaenoic acid, derived from docosahexaenoic acid.  The expression of sEH and the accumulation of 19,20-dihydroxydocosapentaenoic acid were increased in diabetic mouse retinas and in the retinas and vitreous humor of patients with diabetes.  Mechanistically, the diol targeted the cell membrane to alter the localization of cholesterol-binding proteins, and prevented the assocn. of presenilin 1 with N-cadherin and VE-cadherin, thereby compromising pericyte-endothelial cell interactions and inter-endothelial cell junctions.  Treating diabetic mice with a specific sEH inhibitor prevented the pericyte loss and vascular permeability that are characteristic of non-proliferative diabetic retinopathy.  Conversely, overexpression of sEH in the retinal Muller glial cells of non-diabetic mice resulted in similar vessel abnormalities to those seen in diabetic mice with retinopathy.  Thus, increased expression of sEH is a key determinant in the pathogenesis of diabetic retinopathy, and inhibition of sEH can prevent progression of the disease.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqbmkpvr75AMbVg90H21EOLACvtfcHk0lgsti39_GXu2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhvFGlsbzJ&md5=9006381439cc2662b20d97160bfce71b</span></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1038%2Fnature25013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature25013%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DDziumbla%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DBibli%26aufirst%3DS.-I.%26aulast%3DZukunft%26aufirst%3DS.%26aulast%3Dde%2BMos%26aufirst%3DJ.%26aulast%3DAwwad%26aufirst%3DK.%26aulast%3DFr%25C3%25B6mel%26aufirst%3DT.%26aulast%3DJungmann%26aufirst%3DA.%26aulast%3DDevraj%26aufirst%3DK.%26aulast%3DCheng%26aufirst%3DZ.%26aulast%3DWang%26aufirst%3DL.%26aulast%3DFauser%26aufirst%3DS.%26aulast%3DEberhart%26aufirst%3DC.%2BG.%26aulast%3DSodhi%26aufirst%3DA.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DLiebner%26aufirst%3DS.%26aulast%3DM%25C3%25BCller%26aufirst%3DO.%2BJ.%26aulast%3DGlaubitz%26aufirst%3DC.%26aulast%3DHammes%26aufirst%3DH.-P.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DInhibition%2520of%2520soluble%2520epoxide%2520hydrolase%2520prevents%2520diabetic%2520retinopathy%26jtitle%3DNature%26date%3D2017%26volume%3D552%26spage%3D248%26epage%3D252%26doi%3D10.1038%2Fnature25013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Teng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tilley, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mustafa, S. J.</span></span> <span> </span><span class="NLM_article-title">A1 adenosine receptor negatively modulates coronary reactive hyperemia via counteracting A2A-mediated H2O2 production and KATP opening in isolated mouse hearts</span>. <i>Am. J. Physiol. Heart Circ. Physiol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>305</i></span>,  <span class="NLM_fpage">H1668</span>– <span class="NLM_lpage">1679</span>, <span class="refDoi"> DOI: 10.1152/ajpheart.00495.2013</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1152%2Fajpheart.00495.2013" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=24043252" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=305&publication_year=2013&pages=H1668-1679&author=X.+Zhouauthor=B.+Tengauthor=S.+Tilleyauthor=S.+J.+Mustafa&title=A1+adenosine+receptor+negatively+modulates+coronary+reactive+hyperemia+via+counteracting+A2A-mediated+H2O2+production+and+KATP+opening+in+isolated+mouse+hearts&doi=10.1152%2Fajpheart.00495.2013"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1152%2Fajpheart.00495.2013&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1152%252Fajpheart.00495.2013%26sid%3Dliteratum%253Aachs%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DTeng%26aufirst%3DB.%26aulast%3DTilley%26aufirst%3DS.%26aulast%3DMustafa%26aufirst%3DS.%2BJ.%26atitle%3DA1%2520adenosine%2520receptor%2520negatively%2520modulates%2520coronary%2520reactive%2520hyperemia%2520via%2520counteracting%2520A2A-mediated%2520H2O2%2520production%2520and%2520KATP%2520opening%2520in%2520isolated%2520mouse%2520hearts%26jtitle%3DAm.%2520J.%2520Physiol.%2520Heart%2520Circ.%2520Physiol.%26date%3D2013%26volume%3D305%26spage%3DH1668%26epage%3D1679%26doi%3D10.1152%2Fajpheart.00495.2013" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Overby, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Graham, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hildreth, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeldin, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bettaieb, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, L.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase inhibition by t-TUCB promotes brown adipogenesis and reduces serum triglycerides in diet-induced obesity</span>. <i>Int. J. Mol. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2020</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">7039</span>, <span class="refDoi"> DOI: 10.3390/ijms21197039</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.3390%2Fijms21197039" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref38/cit38&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXisFWjtLjK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2020&pages=7039&author=H.+Overbyauthor=Y.+Yangauthor=X.+Xuauthor=K.+Grahamauthor=K.+Hildrethauthor=S.+Choiauthor=D.+Wanauthor=C.+Morisseauauthor=D.+C.+Zeldinauthor=B.+D.+Hammockauthor=S.+Wangauthor=A.+Bettaiebauthor=L.+Zhao&title=Soluble+epoxide+hydrolase+inhibition+by+t-TUCB+promotes+brown+adipogenesis+and+reduces+serum+triglycerides+in+diet-induced+obesity&doi=10.3390%2Fijms21197039"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit38R"><div class="casContent"><span class="casTitleNuber">38</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase inhibition by t-TUCB promotes brown adipogenesis and reduces serum triglycerides in diet-induced obesity</span></div><div class="casAuthors">Overby, Haley; Yang, Yang; Xu, Xinyun; Graham, Katherine; Hildreth, Kelsey; Choi, Sue; Wan, Debin; Morisseau, Christophe; Zeldin, Darryl C.; Hammock, Bruce D.; Wang, Shu; Bettaieb, Ahmed; Zhao, Ling</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Molecular Sciences</span>
        (<span class="NLM_cas:date">2020</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">7039</span>CODEN:
                <span class="NLM_cas:coden">IJMCFK</span>;
        ISSN:<span class="NLM_cas:issn">1422-0067</span>.
    
            (<span class="NLM_cas:orgname">MDPI AG</span>)
        </div><div class="casAbstract">Brown adipose tissue (BAT) is an important target for obesity treatment and prevention.  Sol. epoxide hydrolase (sEH) converts bioactive epoxy fatty acids (EpFAs) into less active diols. sEH inhibitors (sEHI) are beneficial in many chronic diseases by stabilizing EpFAs.  However, roles of sEH and sEHI in brown adipogenesis and BAT activity in treating diet-induced obesity (DIO) have not been reported. sEH expression was studied in in vitro models of brown adipogenesis and the fat tissues of DIO mice.  The effects of the sEHI, trans-4-4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy-benzoic acid (t-TUCB), were studied in vitro and in the obese mice via mini osmotic pump delivery. sEH expression was increased in brown adipogenesis and the BAT of the DIO mice. t-TUCB promoted brown adipogenesis in vitro.  Although t-TCUB did not change body wt., fat pad wt., or glucose and insulin tolerance in the obese mice, it decreased serum triglycerides and increased protein expression of genes important for lipid metab. in the BAT.  Our results suggest that sEH may play a crit. role in brown adipogenesis, and sEHI may be beneficial in improving BAT protein expression involved in lipid metab.  Further studies using the sEHI combined with EpFA generating diets for obesity treatment and prevention are warranted.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpEzWcXvxhv6LVg90H21EOLACvtfcHk0lgsti39_GXu2w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXisFWjtLjK&md5=02d30e435cb1ab69fb9518e1edb220c5</span></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.3390%2Fijms21197039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fijms21197039%26sid%3Dliteratum%253Aachs%26aulast%3DOverby%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DY.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGraham%26aufirst%3DK.%26aulast%3DHildreth%26aufirst%3DK.%26aulast%3DChoi%26aufirst%3DS.%26aulast%3DWan%26aufirst%3DD.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DZeldin%26aufirst%3DD.%2BC.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DWang%26aufirst%3DS.%26aulast%3DBettaieb%26aufirst%3DA.%26aulast%3DZhao%26aufirst%3DL.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520inhibition%2520by%2520t-TUCB%2520promotes%2520brown%2520adipogenesis%2520and%2520reduces%2520serum%2520triglycerides%2520in%2520diet-induced%2520obesity%26jtitle%3DInt.%2520J.%2520Mol.%2520Sci.%26date%3D2020%26volume%3D21%26spage%3D7039%26doi%3D10.3390%2Fijms21197039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hiesinger, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kramer, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Achenbach, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moser, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weber, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittmann, S. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Angioni, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Geisslinger, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kahnt, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steinhilber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pogoryelov, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wagner, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span> <span> </span><span class="NLM_article-title">Computer-aided selective optimization of side activities of talinolol</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">899</span>– <span class="NLM_lpage">903</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.9b00075</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.9b00075" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtrzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=899-903&author=K.+Hiesingerauthor=J.+S.+Kramerauthor=J.+Achenbachauthor=D.+Moserauthor=J.+Weberauthor=S.+K.+Wittmannauthor=C.+Morisseauauthor=C.+Angioniauthor=G.+Geisslingerauthor=A.+S.+Kahntauthor=A.+Kaiserauthor=A.+Proschakauthor=D.+Steinhilberauthor=D.+Pogoryelovauthor=K.+Wagnerauthor=B.+D.+Hammockauthor=E.+Proschak&title=Computer-aided+selective+optimization+of+side+activities+of+talinolol&doi=10.1021%2Facsmedchemlett.9b00075"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit39R"><div class="casContent"><span class="casTitleNuber">39</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-Aided Selective Optimization of Side Activities of Talinolol</span></div><div class="casAuthors">Hiesinger, Kerstin; Kramer, Jan S.; Achenbach, Janosch; Moser, Daniel; Weber, Julia; Wittmann, Sandra K.; Morisseau, Christophe; Angioni, Carlo; Geisslinger, Gerd; Kahnt, Astrid S.; Kaiser, Astrid; Proschak, Anna; Steinhilber, Dieter; Pogoryelov, Denys; Wagner, Karen; Hammock, Bruce D.; Proschak, Ewgenij</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">899-903</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Selective optimization of side activities is a valuable source of novel lead structures in drug discovery.  In this study, a computer-aided approach was used to deorphanize the pleiotropic cholesterol-lowering effects of the beta-blocker talinolol, which result from the inhibition of the enzyme sol. epoxide hydrolase (sEH).  X-ray structure anal. of the sEH in complex with talinolol enables a straightforward optimization of inhibitory potency.  The resulting lead structure exhibited in vivo activity in a rat model of diabetic neuropatic pain.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHAoP0jFjh_rVg90H21EOLACvtfcHk0lhrIk2enADIVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXhtVKgtrzI&md5=943ab10c43ec4cf82b269666bf2316dd</span></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.9b00075&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.9b00075%26sid%3Dliteratum%253Aachs%26aulast%3DHiesinger%26aufirst%3DK.%26aulast%3DKramer%26aufirst%3DJ.%2BS.%26aulast%3DAchenbach%26aufirst%3DJ.%26aulast%3DMoser%26aufirst%3DD.%26aulast%3DWeber%26aufirst%3DJ.%26aulast%3DWittmann%26aufirst%3DS.%2BK.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DAngioni%26aufirst%3DC.%26aulast%3DGeisslinger%26aufirst%3DG.%26aulast%3DKahnt%26aufirst%3DA.%2BS.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DProschak%26aufirst%3DA.%26aulast%3DSteinhilber%26aufirst%3DD.%26aulast%3DPogoryelov%26aufirst%3DD.%26aulast%3DWagner%26aufirst%3DK.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26aulast%3DProschak%26aufirst%3DE.%26atitle%3DComputer-aided%2520selective%2520optimization%2520of%2520side%2520activities%2520of%2520talinolol%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D899%26epage%3D903%26doi%3D10.1021%2Facsmedchemlett.9b00075" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wolf, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, P. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hock, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Development of a high-throughput screen for soluble epoxide hydrolase inhibition</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>355</i></span>,  <span class="NLM_fpage">71</span>– <span class="NLM_lpage">80</span>, <span class="refDoi"> DOI: 10.1016/j.ab.2006.04.045</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.ab.2006.04.045" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16729954" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD28XntV2mtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=355&publication_year=2006&pages=71-80&author=N.+M.+Wolfauthor=C.+Morisseauauthor=P.+D.+Jonesauthor=B.+Hockauthor=B.+D.+Hammock&title=Development+of+a+high-throughput+screen+for+soluble+epoxide+hydrolase+inhibition&doi=10.1016%2Fj.ab.2006.04.045"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit40R"><div class="casContent"><span class="casTitleNuber">40</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a high-throughput screen for soluble epoxide hydrolase inhibition</span></div><div class="casAuthors">Wolf, Nicola M.; Morisseau, Christophe; Jones, Paul D.; Hock, Bertold; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">355</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">71-80</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Mammalian sol. epoxide hydrolase (sEH) represents a highly promising new target for drug development.  Chem. inhibition of this enzyme in animal models was shown to treat hypertension and vascular inflammation as well as related syndromes.  Existing sEH inhibitors are relatively potent and specific.  However, the low soly. and relatively fast metab. of described sEH inhibitors make them less than therapeutically efficient, stating the need for novel inhibitor structures.  Therefore, a series of α-cyanoester and α-cyanocarbonate epoxides were evaluated as potential human sEH (HsEH) substrates for the high-throughput screen (HTS) of compd. libraries.  (3-Phenyl-oxiranyl)-acetic acid cyano-(6-methoxy-naphthalen-2-yl)-Me ester (PHOME), which displayed the highest aq. stability and soly., was selected for the development of an HTS assay with long incubation times at room temp.  Concns. of HsEH and PHOME were optimized to ensure assay sensitivity, reliability, and reproducibility.  Assay validation, which employed these optimized concns., resulted in good accuracy (60-100%) and high precision (<7% relative std. deviation).  In addn., an overall Z' value of 0.7 proved the system's robustness and potential for HTS.  The developed assay system will be a valuable tool to discover new structures for the therapeutic inhibition of sEH to treat various cardiovascular diseases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq20AjMwRKlBLVg90H21EOLACvtfcHk0lhrIk2enADIVA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XntV2mtr8%253D&md5=0ba5caacb00e49d2aeace507a3be352e</span></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2Fj.ab.2006.04.045&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ab.2006.04.045%26sid%3Dliteratum%253Aachs%26aulast%3DWolf%26aufirst%3DN.%2BM.%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DJones%26aufirst%3DP.%2BD.%26aulast%3DHock%26aufirst%3DB.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DDevelopment%2520of%2520a%2520high-throughput%2520screen%2520for%2520soluble%2520epoxide%2520hydrolase%2520inhibition%26jtitle%3DAnal.%2520Biochem.%26date%3D2006%26volume%3D355%26spage%3D71%26epage%3D80%26doi%3D10.1016%2Fj.ab.2006.04.045" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sreeramulu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kudlinzki, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saxena, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Linhard, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gande, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hiller, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lamers, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nilsson, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aagaard, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wissler, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bamberg, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwalbe, H.</span></span> <span> </span><span class="NLM_article-title">Molecular tuning of farnesoid X receptor partial agonism</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">2915</span>, <span class="refDoi"> DOI: 10.1038/s41467-019-10853-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1038%2Fs41467-019-10853-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=31266946" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A280%3ADC%252BB3MzjsFSmtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=2915&author=D.+Merkauthor=S.+Sreeramuluauthor=D.+Kudlinzkiauthor=K.+Saxenaauthor=V.+Linhardauthor=S.+L.+Gandeauthor=F.+Hillerauthor=C.+Lamersauthor=E.+Nilssonauthor=A.+Aagaardauthor=L.+Wisslerauthor=N.+Dekkerauthor=K.+Bambergauthor=M.+Schubert-Zsilaveczauthor=H.+Schwalbe&title=Molecular+tuning+of+farnesoid+X+receptor+partial+agonism&doi=10.1038%2Fs41467-019-10853-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular tuning of farnesoid X receptor partial agonism</span></div><div class="casAuthors">Merk Daniel; Lamers Christina; Schubert-Zsilavecz Manfred; Sreeramulu Sridhar; Kudlinzki Denis; Saxena Krishna; Linhard Verena; Gande Santosh L; Hiller Fabian; Schwalbe Harald; Kudlinzki Denis; Saxena Krishna; Gande Santosh L; Schwalbe Harald; Kudlinzki Denis; Saxena Krishna; Gande Santosh L; Schwalbe Harald; Nilsson Ewa; Aagaard Anna; Wissler Lisa; Dekker Niek; Bamberg Krister</div><div class="citationInfo"><span class="NLM_cas:title">Nature communications</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">2915</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">The bile acid-sensing transcription factor farnesoid X receptor (FXR) regulates multiple metabolic processes.  Modulation of FXR is desired to overcome several metabolic pathologies but pharmacological administration of full FXR agonists has been plagued by mechanism-based side effects.  We have developed a modulator that partially activates FXR in vitro and in mice.  Here we report the elucidation of the molecular mechanism that drives partial FXR activation by crystallography- and NMR-based structural biology.  Natural and synthetic FXR agonists stabilize formation of an extended helix α11 and the α11-α12 loop upon binding.  This strengthens a network of hydrogen bonds, repositions helix α12 and enables co-activator recruitment.  Partial agonism in contrast is conferred by a kink in helix α11 that destabilizes the α11-α12 loop, a critical determinant for helix α12 orientation.  Thereby, the synthetic partial agonist induces conformational states, capable of recruiting both co-repressors and co-activators leading to an equilibrium of co-activator and co-repressor binding.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTttHveiMTXKwHqQV89nF-2fW6udTcc2eZG8sQoK19Bc7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BB3MzjsFSmtA%253D%253D&md5=60a0d5ab5343b7c9db55077ca0f675ab</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1038%2Fs41467-019-10853-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fs41467-019-10853-2%26sid%3Dliteratum%253Aachs%26aulast%3DMerk%26aufirst%3DD.%26aulast%3DSreeramulu%26aufirst%3DS.%26aulast%3DKudlinzki%26aufirst%3DD.%26aulast%3DSaxena%26aufirst%3DK.%26aulast%3DLinhard%26aufirst%3DV.%26aulast%3DGande%26aufirst%3DS.%2BL.%26aulast%3DHiller%26aufirst%3DF.%26aulast%3DLamers%26aufirst%3DC.%26aulast%3DNilsson%26aufirst%3DE.%26aulast%3DAagaard%26aufirst%3DA.%26aulast%3DWissler%26aufirst%3DL.%26aulast%3DDekker%26aufirst%3DN.%26aulast%3DBamberg%26aufirst%3DK.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26aulast%3DSchwalbe%26aufirst%3DH.%26atitle%3DMolecular%2520tuning%2520of%2520farnesoid%2520X%2520receptor%2520partial%2520agonism%26jtitle%3DNat.%2520Commun.%26date%3D2019%26volume%3D10%26spage%3D2915%26doi%3D10.1038%2Fs41467-019-10853-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pollinger, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schierle, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilu, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schmidt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohrndorf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Tuning nuclear receptor selectivity of Wy14,643 towards selective retinoid X receptor modulation</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>62</i></span>,  <span class="NLM_fpage">2112</span>– <span class="NLM_lpage">2126</span>, <span class="refDoi"> DOI: 10.1021/acs.jmedchem.8b01848</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.jmedchem.8b01848" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXitlCgs78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=62&publication_year=2019&pages=2112-2126&author=J.+Pollingerauthor=L.+Gellrichauthor=S.+Schierleauthor=W.+Kiluauthor=J.+Schmidtauthor=L.+Kalinowskyauthor=J.+Ohrndorfauthor=A.+Kaiserauthor=J.+Heeringauthor=E.+Proschakauthor=D.+Merk&title=Tuning+nuclear+receptor+selectivity+of+Wy14%2C643+towards+selective+retinoid+X+receptor+modulation&doi=10.1021%2Facs.jmedchem.8b01848"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Tuning nuclear receptor selectivity of Wy14,643 towards selective retinoid X receptor modulation</span></div><div class="casAuthors">Pollinger, Julius; Gellrich, Leonie; Schierle, Simone; Kilu, Whitney; Schmidt, Jurema; Kalinowsky, Lena; Ohrndorf, Julia; Kaiser, Astrid; Heering, Jan; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">62</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">2112-2126</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The fatty acid sensing nuclear receptor families retinoid X receptors (RXRs) and peroxisome proliferator-activated receptors (PPARs) hold therapeutic potential in neurodegeneration.  Valuable pleiotropic activities of Wy14,643 (I) in models of such conditions exceed its known PPAR agonistic profile.  Here, we characterize the compd. as an RXR agonist explaining the pleiotropic effects and report its systematic structure-activity relationship anal. with the discovery of specific mol. determinants driving activity on PPARs and RXRs.  We have designed close analogs of the drug comprising selective and dual agonism on RXRs and PPARs that may serve as superior pharmacol. tools to study the role and interplay of the nuclear receptors in various pathologies.  A systematically optimized high potency RXR agonist (II) revealed activity in vivo and active concns. in brain.  With its lack of RXR/liver X receptor-mediated side effects and superior profile compared to classical rexinoids, it establishes a new class of innovative RXR modulators to overcome key challenges in RXR targeting drug discovery.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpkzZeRGQnW7rVg90H21EOLACvtfcHk0ljJUiULrbvakw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXitlCgs78%253D&md5=627619c57f03ff4d0223c791154a9cff</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1021%2Facs.jmedchem.8b01848&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.jmedchem.8b01848%26sid%3Dliteratum%253Aachs%26aulast%3DPollinger%26aufirst%3DJ.%26aulast%3DGellrich%26aufirst%3DL.%26aulast%3DSchierle%26aufirst%3DS.%26aulast%3DKilu%26aufirst%3DW.%26aulast%3DSchmidt%26aufirst%3DJ.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DOhrndorf%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DTuning%2520nuclear%2520receptor%2520selectivity%2520of%2520Wy14%252C643%2520towards%2520selective%2520retinoid%2520X%2520receptor%2520modulation%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2019%26volume%3D62%26spage%3D2112%26epage%3D2126%26doi%3D10.1021%2Facs.jmedchem.8b01848" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Heitel, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gellrich, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kalinowsky, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heering, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kaiser, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohrndorf, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Proschak, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merk, D.</span></span> <span> </span><span class="NLM_article-title">Computer-assisted discovery and structural optimization of a novel retinoid X receptor agonist chemotype</span>. <i>ACS Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">208</span>, <span class="refDoi"> DOI: 10.1021/acsmedchemlett.8b00551</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acsmedchemlett.8b00551" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1MXkslClsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2019&pages=203-208&author=P.+Heitelauthor=L.+Gellrichauthor=L.+Kalinowskyauthor=J.+Heeringauthor=A.+Kaiserauthor=J.+Ohrndorfauthor=E.+Proschakauthor=D.+Merk&title=Computer-assisted+discovery+and+structural+optimization+of+a+novel+retinoid+X+receptor+agonist+chemotype&doi=10.1021%2Facsmedchemlett.8b00551"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">Computer-Assisted Discovery and Structural Optimization of a Novel Retinoid X Receptor Agonist Chemotype</span></div><div class="casAuthors">Heitel, Pascal; Gellrich, Leonie; Kalinowsky, Lena; Heering, Jan; Kaiser, Astrid; Ohrndorf, Julia; Proschak, Ewgenij; Merk, Daniel</div><div class="citationInfo"><span class="NLM_cas:title">ACS Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">203-208</span>CODEN:
                <span class="NLM_cas:coden">AMCLCT</span>;
        ISSN:<span class="NLM_cas:issn">1948-5875</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As universal heterodimer partners of many nuclear receptors, the retinoid X receptors (RXRs) constitute key transcription factors.  They regulate cell proliferation, differentiation, inflammation, and metabolic homeostasis and have recently been proposed as potential drug targets for neurodegenerative and inflammatory diseases.  Owing to the hydrophobic nature of RXR ligand binding sites, available synthetic RXR ligands are lipophilic, and their structural diversity is limited.  Here, we disclose the computer-assisted discovery of a novel RXR agonist chemotype and its systematic optimization toward potent RXR modulators.  We have developed a nanomolar RXR agonist with high selectivity among nuclear receptors and superior physicochem. properties compared to classical rexinoids that appears suitable for in vivo applications and as lead for future RXR-targeting medicinal chem.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpcTGv0sL0Tr7Vg90H21EOLACvtfcHk0ljJUiULrbvakw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1MXkslClsQ%253D%253D&md5=fbab609776ae1450cd1f35b3e02abf48</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Facsmedchemlett.8b00551&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facsmedchemlett.8b00551%26sid%3Dliteratum%253Aachs%26aulast%3DHeitel%26aufirst%3DP.%26aulast%3DGellrich%26aufirst%3DL.%26aulast%3DKalinowsky%26aufirst%3DL.%26aulast%3DHeering%26aufirst%3DJ.%26aulast%3DKaiser%26aufirst%3DA.%26aulast%3DOhrndorf%26aufirst%3DJ.%26aulast%3DProschak%26aufirst%3DE.%26aulast%3DMerk%26aufirst%3DD.%26atitle%3DComputer-assisted%2520discovery%2520and%2520structural%2520optimization%2520of%2520a%2520novel%2520retinoid%2520X%2520receptor%2520agonist%2520chemotype%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2019%26volume%3D10%26spage%3D203%26epage%3D208%26doi%3D10.1021%2Facsmedchemlett.8b00551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rau, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wurglics, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Paulke, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zitzkowski, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meindl, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bock, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dingermann, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Abdel-Tawab, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schubert-Zsilavecz, M.</span></span> <span> </span><span class="NLM_article-title">Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma</span>. <i>Planta Med.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">881</span>– <span class="NLM_lpage">887</span>, <span class="refDoi"> DOI: 10.1055/s-2006-946680</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1055%2Fs-2006-946680" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=16858665" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD28Xpsl2itLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2006&pages=881-887&author=O.+Rauauthor=M.+Wurglicsauthor=A.+Paulkeauthor=J.+Zitzkowskiauthor=N.+Meindlauthor=A.+Bockauthor=T.+Dingermannauthor=M.+Abdel-Tawabauthor=M.+Schubert-Zsilavecz&title=Carnosic+acid+and+carnosol%2C+phenolic+diterpene+compounds+of+the+labiate+herbs+rosemary+and+sage%2C+are+activators+of+the+human+peroxisome+proliferator-activated+receptor+gamma&doi=10.1055%2Fs-2006-946680"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit44R"><div class="casContent"><span class="casTitleNuber">44</span><div class="casTitle"><span class="NLM_cas:atitle">Carnosic acid and carnosol, phenolic diterpene compounds of the labiate herbs rosemary and sage, are activators of the human peroxisome proliferator-activated receptor gamma</span></div><div class="casAuthors">Rau, Oliver; Wurglics, Mario; Paulke, Alexander; Zitzkowski, Jessica; Meindl, Nadine; Bock, Andreas; Dingermann, Theodor; Abdel-Tawab, Mona; Schubert-Zsilavecz, Manfred</div><div class="citationInfo"><span class="NLM_cas:title">Planta Medica</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">881-887</span>CODEN:
                <span class="NLM_cas:coden">PLMEAA</span>;
        ISSN:<span class="NLM_cas:issn">0032-0943</span>.
    
            (<span class="NLM_cas:orgname">Georg Thieme Verlag</span>)
        </div><div class="casAbstract">Peroxisome proliferator-activated receptor gamma (PPARγ) is a ligand activated transcription factor, belonging to the metazoan family of nuclear hormone receptors.  Activation of PPARγ increases the transcription of enzymes involved in primary metab., leading to lower blood levels of fatty acids and glucose.  Hence, PPARγ represents the major target for the glitazone type of drugs currently being used clin. for the treatment of type 2 diabetes.  Furthermore, activators of PPARγ show beneficial anti-inflammatory and anti-tumor effects.  Utilizing a fusion receptor of the yeast Gal4-DNA binding domain joined to the hinge region and ligand binding domain of the human PPARγ in combination with a Gal4-driven luciferase reporter gene, cotransfected into Cos7 cells, we tested sage and rosemary exts. prepd. with 80% aq. ethanol for possible PPARγ activation.  This revealed that both exts. are capable of selectively activating Gal4-PPARγ fusion receptor, in a concn.-dependent manner, with EC50 values of 22.8 ± 8.4 mg/L and 33.7 ± 7.3 mg/L for rosemary and sage, resp.  Subsequent anal. of the characteristic constituents revealed the phenolic diterpene compds. carnosol, present in both herbs, and carnosic acid to be active principles of these exts., showing EC50 values of 41.2 ± 5.9 μM and 19.6 ± 2.0 μM, resp.  Thus it can be concluded that the glucose lowering effect reported recently for rosemary may be attributed to PPARγ activation.  Moreover, our observations may also explain the anti-inflammatory and antiproliferative effects of both compds. published previously.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxnVO3BnMZNrVg90H21EOLACvtfcHk0lhyOsNyST9TQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xpsl2itLg%253D&md5=64985985a1bde827b6323126858b03a1</span></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1055%2Fs-2006-946680&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1055%252Fs-2006-946680%26sid%3Dliteratum%253Aachs%26aulast%3DRau%26aufirst%3DO.%26aulast%3DWurglics%26aufirst%3DM.%26aulast%3DPaulke%26aufirst%3DA.%26aulast%3DZitzkowski%26aufirst%3DJ.%26aulast%3DMeindl%26aufirst%3DN.%26aulast%3DBock%26aufirst%3DA.%26aulast%3DDingermann%26aufirst%3DT.%26aulast%3DAbdel-Tawab%26aufirst%3DM.%26aulast%3DSchubert-Zsilavecz%26aufirst%3DM.%26atitle%3DCarnosic%2520acid%2520and%2520carnosol%252C%2520phenolic%2520diterpene%2520compounds%2520of%2520the%2520labiate%2520herbs%2520rosemary%2520and%2520sage%252C%2520are%2520activators%2520of%2520the%2520human%2520peroxisome%2520proliferator-activated%2520receptor%2520gamma%26jtitle%3DPlanta%2520Med.%26date%3D2006%26volume%3D72%26spage%3D881%26epage%3D887%26doi%3D10.1055%2Fs-2006-946680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aldridge, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kouroupis, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Churchman, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">English, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingham, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, E.</span></span> <span> </span><span class="NLM_article-title">Assay validation for the assessment of adipogenesis of multipotential stromal cells--a direct comparison of four different methods</span>. <i>Cytotherapy</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">89</span>– <span class="NLM_lpage">101</span>, <span class="refDoi"> DOI: 10.1016/j.jcyt.2012.07.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2Fj.jcyt.2012.07.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=23260089" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref45/cit45&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1ylurbF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=89-101&author=A.+Aldridgeauthor=D.+Kouroupisauthor=S.+Churchmanauthor=A.+Englishauthor=E.+Inghamauthor=E.+Jones&title=Assay+validation+for+the+assessment+of+adipogenesis+of+multipotential+stromal+cells%2D%2Da+direct+comparison+of+four+different+methods&doi=10.1016%2Fj.jcyt.2012.07.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit45R"><div class="casContent"><span class="casTitleNuber">45</span><div class="casTitle"><span class="NLM_cas:atitle">Assay validation for the assessment of adipogenesis of multipotential stromal cells-a direct comparison of four different methods</span></div><div class="casAuthors">Aldridge, Andrew; Kouroupis, Dimitrios; Churchman, Sarah; English, Anne; Ingham, Eileen; Jones, Elena</div><div class="citationInfo"><span class="NLM_cas:title">Cytotherapy</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">89-101</span>CODEN:
                <span class="NLM_cas:coden">CYTRF3</span>;
        ISSN:<span class="NLM_cas:issn">1465-3249</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Mesenchymal stromal cells (MSCs) are regenerative and immuno-privileged cells that are used for both tissue regeneration and treatment of severe inflammation-related disease.  For quality control of manufd. MSC batches in regard to mature fat cell contamination, a quant. method for measuring adipogenesis is needed.  Four previously proposed methods were validated with the use of bone marrow (BM) MSCs during a 21-day in vitro assay.  Oil red staining was scored semiquant.; peroxisome proliferator activated receptor-γ and fatty acid binding protein (FABP)4 transcripts were measured by quant. real-time polymerase chain reaction; FABP4 protein accumulation was evaluated by flow cytometry; and Nile red/4',6-diamidino-2-phenylindole (DAPI) ratios were measured in fluorescent microplate assay.  Skin fibroblasts and MSCs from fat pad, cartilage and umbilical cord were used as controls.  Oil red staining indicated considerable heterogeneity between BM donors and individual cells within the same culture.  FABP4 transcript levels increased 100- to 5000-fold by day 21, with large donor variability obsd.  Flow cytometry revealed increasing intra-culture heterogeneity over time; more granular cells accumulated more FABP4 protein and Nile red fluorescence compared with less granular cells.  Nile red increase in day-21 MSCs was ∼5- and 4-fold, measured by flow cytometry or microplate assay, resp.  MSC proliferation/apoptosis was accounted through the use of Nile red/DAPI ratios; adipogenesis levels in day-21 BM MSCs increased ∼13-fold, with significant correlations with oil red scoring obsd. for MSC from other sources.  Flow cytometry permits the study of MSC differentiation at the single-cell level and sorting more and less mature cells from mixed cell populations.  The microplate assay with the use of the Nile red/DAPI ratio provides rapid quant. measurements and could be used as a low-cost, high-throughput method to quality-control MSC batches from different tissue sources.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUmCXX4iqoILVg90H21EOLACvtfcHk0lhyOsNyST9TQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1ylurbF&md5=e1c31abf2e983f5bf4bd8da6f31b9ac8</span></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1016%2Fj.jcyt.2012.07.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jcyt.2012.07.001%26sid%3Dliteratum%253Aachs%26aulast%3DAldridge%26aufirst%3DA.%26aulast%3DKouroupis%26aufirst%3DD.%26aulast%3DChurchman%26aufirst%3DS.%26aulast%3DEnglish%26aufirst%3DA.%26aulast%3DIngham%26aufirst%3DE.%26aulast%3DJones%26aufirst%3DE.%26atitle%3DAssay%2520validation%2520for%2520the%2520assessment%2520of%2520adipogenesis%2520of%2520multipotential%2520stromal%2520cells--a%2520direct%2520comparison%2520of%2520four%2520different%2520methods%26jtitle%3DCytotherapy%26date%3D2013%26volume%3D15%26spage%3D89%26epage%3D101%26doi%3D10.1016%2Fj.jcyt.2012.07.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Raspotnig, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fauler, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jantscher, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Windischhofer, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schachl, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leis, H. J.</span></span> <span> </span><span class="NLM_article-title">Colorimetric determination of cell numbers by Janus Green staining</span>. <i>Anal. Biochem.</i> <span class="NLM_year" style="font-weight: bold;">1999</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">74</span>– <span class="NLM_lpage">83</span>, <span class="refDoi"> DOI: 10.1006/abio.1999.4309</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1006%2Fabio.1999.4309" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10542111" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADyaK1MXmvVynuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=1999&pages=74-83&author=G.+Raspotnigauthor=G.+Faulerauthor=A.+Jantscherauthor=W.+Windischhoferauthor=K.+Schachlauthor=H.+J.+Leis&title=Colorimetric+determination+of+cell+numbers+by+Janus+Green+staining&doi=10.1006%2Fabio.1999.4309"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">Colorimetric Determination of Cell Numbers by Janus Green Staining</span></div><div class="casAuthors">Raspotnig, G.; Fauler, G.; Jantscher, A.; Windischhofer, W.; Schachl, K.; Leis, H. J.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Biochemistry</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">74-83</span>CODEN:
                <span class="NLM_cas:coden">ANBCA2</span>;
        ISSN:<span class="NLM_cas:issn">0003-2697</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">A colorimetric assay using the basic azo dye Janus green has been developed to assess cell nos. in anchorage-dependent cell cultures, with special regard to the enumeration of osteoblastic cells.  Therefore, cells are fixed in ethanol and stained with a 0.2% soln. of Janus green for 3 min, followed by a destaining step of 1 min in tap water.  The addn. of dild. hydrochloric acid easily and immediately leads to dye elution from stained cell layers into the acidic supernatant which consequently is transferred into 96-well plates and read on a microplate reader at 595 nm.  Working under standardized conditions, Janus green uptake in several cell lines is shown to be linearly correlated with cell nos. over a broad range of cell densities, in MC3T3-E1 cells from about 3% up to more than 300% of confluency.  Abs. sensitivity of the assay allows detection of less than 1000 cells/cm2.  In comparison to many other colorimetric assays, the Janus green technique is simple to perform, fast, precise, stable, cheap, and well suited for processing large quantities of samples.  Moreover, it is applicable to any culture formate and size, from irregular formed carriers up to 96-multiwell plates.  (c) 1999 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoQYsmJytFCnrVg90H21EOLACvtfcHk0lhyOsNyST9TQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXmvVynuro%253D&md5=23020ba0b8a9a4c42485acdfd9018c00</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1006%2Fabio.1999.4309&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabio.1999.4309%26sid%3Dliteratum%253Aachs%26aulast%3DRaspotnig%26aufirst%3DG.%26aulast%3DFauler%26aufirst%3DG.%26aulast%3DJantscher%26aufirst%3DA.%26aulast%3DWindischhofer%26aufirst%3DW.%26aulast%3DSchachl%26aufirst%3DK.%26aulast%3DLeis%26aufirst%3DH.%2BJ.%26atitle%3DColorimetric%2520determination%2520of%2520cell%2520numbers%2520by%2520Janus%2520Green%2520staining%26jtitle%3DAnal.%2520Biochem.%26date%3D1999%26volume%3D275%26spage%3D74%26epage%3D83%26doi%3D10.1006%2Fabio.1999.4309" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kabsch, W.</span></span> <span> </span><span class="NLM_article-title">Xds</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>66</i></span>,  <span class="NLM_fpage">125</span>– <span class="NLM_lpage">132</span>, <span class="refDoi"> DOI: 10.1107/S0907444909047337</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444909047337" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=20124692" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=66&publication_year=2010&pages=125-132&author=W.+Kabsch&title=Xds&doi=10.1107%2FS0907444909047337"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Software XDS for image rotation, recognition and crystal symmetry assignment</span></div><div class="casAuthors">Kabsch, Wolfgang</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">66</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">125-132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">The usage and control of recent modifications of the program package XDS for the processing of rotation images are described in the context of previous versions.  New features include automatic detn. of spot size and reflecting range and recognition and assignment of crystal symmetry.  Moreover, the limitations of earlier package versions on the no. of correction/scaling factors and the representation of pixel contents have been removed.  Large program parts have been restructured for parallel processing so that the quality and completeness of collected data can be assessed soon after measurement.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpv5AyUw00DYbVg90H21EOLACvtfcHk0lh0w1qJOrltWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhs1SisLc%253D&md5=1aa9a38aeb3ce95af4ffb7d8b8a142bd</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1107%2FS0907444909047337&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444909047337%26sid%3Dliteratum%253Aachs%26aulast%3DKabsch%26aufirst%3DW.%26atitle%3DXds%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2010%26volume%3D66%26spage%3D125%26epage%3D132%26doi%3D10.1107%2FS0907444909047337" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Evans, P. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span> <span> </span><span class="NLM_article-title">How good are my data and what is the resolution?</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>69</i></span>,  <span class="NLM_fpage">1204</span>– <span class="NLM_lpage">1214</span>, <span class="refDoi"> DOI: 10.1107/S0907444913000061</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444913000061" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=23793146" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=69&publication_year=2013&pages=1204-1214&author=P.+R.+Evansauthor=G.+N.+Murshudov&title=How+good+are+my+data+and+what+is+the+resolution%3F&doi=10.1107%2FS0907444913000061"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">How good are my data and what is the resolution?</span></div><div class="casAuthors">Evans, Philip R.; Murshudov, Garib N.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">69</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1204-1214</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">Following integration of the obsd. diffraction spots, the process of  data redn.' initially aims to det. the point-group symmetry of the data and the likely space group.  This can be performed with the program POINTLESS.  The scaling program then puts all the measurements on a common scale, avs. measurements of symmetry-related reflections (using the symmetry detd. previously) and produces many statistics that provide the first important measures of data quality.  A new scaling program, AIMLESS, implements scaling models similar to those in SCALA but adds some addnl. analyses.  From the analyses, a no. of decisions can be made about the quality of the data and whether some measurements should be discarded.  The effective  resoln.' of a data set is a difficult and possibly contentious question (particularly with referees of papers) and this is discussed in the light of tests comparing the data-processing statistics with trials of refinement against obsd. and simulated data, and automated model-building and comparison of maps calcd. with different resoln. limits.  These trials show that adding weak high-resoln. data beyond the commonly used limits may make some improvement and does no harm.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreOyPAR8GLBrVg90H21EOLACvtfcHk0lh0w1qJOrltWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXpvVejsL8%253D&md5=3f649426c21e9d423f94ef8d7c568233</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1107%2FS0907444913000061&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444913000061%26sid%3Dliteratum%253Aachs%26aulast%3DEvans%26aufirst%3DP.%2BR.%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26atitle%3DHow%2520good%2520are%2520my%2520data%2520and%2520what%2520is%2520the%2520resolution%253F%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2013%26volume%3D69%26spage%3D1204%26epage%3D1214%26doi%3D10.1107%2FS0907444913000061" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">McCoy, A. J.</span></span> <span> </span><span class="NLM_article-title">Acknowledging errors: advanced molecular replacement with Phaser</span>. <i>Methods Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>1607</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">453</span>, <span class="refDoi"> DOI: 10.1007/978-1-4939-7000-1_18</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1007%2F978-1-4939-7000-1_18" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=28573584" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC1cXhsFOgt7fP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1607&publication_year=2017&pages=421-453&author=A.+J.+McCoy&title=Acknowledging+errors%3A+advanced+molecular+replacement+with+Phaser&doi=10.1007%2F978-1-4939-7000-1_18"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit49R"><div class="casContent"><span class="casTitleNuber">49</span><div class="casTitle"><span class="NLM_cas:atitle">Acknowledging errors: advanced molecular replacement with phaser</span></div><div class="casAuthors">McCoy, Airlie J.</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Molecular Biology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">1607</span>
        (<span class="NLM_cas:issue">Protein Crystallography</span>),
    <span class="NLM_cas:pages">421-453</span>CODEN:
                <span class="NLM_cas:coden">MMBIED</span>;
        ISSN:<span class="NLM_cas:issn">1940-6029</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Mol. replacement is a method for solving the crystallog. phase problem using an at. model for the target structure.  State-of-the-art methods have moved the field significantly from when it was first envisaged as a method for solving cases of high homol. and completeness between a model and target structure.  Improvements brought about by application of max. likelihood statistics mean that various errors in the model and pathologies in the data can be accounted for, so that cases hitherto thought to be intractable are standardly solvable.  As a result, mol. replacement phasing now accounts for the lion's share of structures deposited in the Protein Data Bank.  However, there will always be cases at the fringes of solvability.  I discuss here the approaches that will help tackle challenging mol. replacement cases.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqp1cYKuTlwgbVg90H21EOLACvtfcHk0lh0w1qJOrltWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC1cXhsFOgt7fP&md5=baeaf4699f241d0aa603fd43611ec020</span></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1007%2F978-1-4939-7000-1_18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252F978-1-4939-7000-1_18%26sid%3Dliteratum%253Aachs%26aulast%3DMcCoy%26aufirst%3DA.%2BJ.%26atitle%3DAcknowledging%2520errors%253A%2520advanced%2520molecular%2520replacement%2520with%2520Phaser%26jtitle%3DMethods%2520Mol.%2520Biol.%26date%3D2017%26volume%3D1607%26spage%3D421%26epage%3D453%26doi%3D10.1007%2F978-1-4939-7000-1_18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Emsley, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cowtan, K.</span></span> <span> </span><span class="NLM_article-title">Coot: Model-building tools for molecular graphics</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>60</i></span>,  <span class="NLM_fpage">2126</span>– <span class="NLM_lpage">2132</span>, <span class="refDoi"> DOI: 10.1107/S0907444904019158</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444904019158" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=15572765" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=60&publication_year=2004&pages=2126-2132&author=P.+Emsleyauthor=K.+Cowtan&title=Coot%3A+Model-building+tools+for+molecular+graphics&doi=10.1107%2FS0907444904019158"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Coot: model-building tools for molecular graphics</span></div><div class="casAuthors">Emsley, Paul; Cowtan, Kevin</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">D60</span>
        (<span class="NLM_cas:issue">12, Pt. 1</span>),
    <span class="NLM_cas:pages">2126-2132</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">CCP4mg is a project that aims to provide a general-purpose tool for structural biologists, providing tools for x-ray structure soln., structure comparison and anal., and publication-quality graphics.  The map-fitting tools are available as a stand-alone package, distributed as 'Coot'.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMisM42468k7Vg90H21EOLACvtfcHk0lh0w1qJOrltWw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXhtVars73P&md5=1be390f3bb6fd584468499ad0921161e</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1107%2FS0907444904019158&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444904019158%26sid%3Dliteratum%253Aachs%26aulast%3DEmsley%26aufirst%3DP.%26aulast%3DCowtan%26aufirst%3DK.%26atitle%3DCoot%253A%2520Model-building%2520tools%2520for%2520molecular%2520graphics%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2004%26volume%3D60%26spage%3D2126%26epage%3D2132%26doi%3D10.1107%2FS0907444904019158" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Murshudov, G. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Skubák, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lebedev, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pannu, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Steiner, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nicholls, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winn, M. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Long, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vagin, A. A.</span></span> <span> </span><span class="NLM_article-title">REFMAC5 for the refinement of macromolecular crystal structures</span>. <i>Acta Crystallogr., Sect. D: Biol. Crystallogr.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">367</span>, <span class="refDoi"> DOI: 10.1107/S0907444911001314</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1107%2FS0907444911001314" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=21460454" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref51/cit51&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2011&pages=355-367&author=G.+N.+Murshudovauthor=P.+Skub%C3%A1kauthor=A.+A.+Lebedevauthor=N.+S.+Pannuauthor=R.+A.+Steinerauthor=R.+A.+Nichollsauthor=M.+D.+Winnauthor=F.+Longauthor=A.+A.+Vagin&title=REFMAC5+for+the+refinement+of+macromolecular+crystal+structures&doi=10.1107%2FS0907444911001314"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit51R"><div class="casContent"><span class="casTitleNuber">51</span><div class="casTitle"><span class="NLM_cas:atitle">REFMAC5 for the refinement of macromolecular crystal structures</span></div><div class="casAuthors">Murshudov, Garib N.; Skubak, Pavol; Lebedev, Andrey A.; Pannu, Navraj S.; Steiner, Roberto A.; Nicholls, Robert A.; Winn, Martyn D.; Long, Fei; Vagin, Alexei A.</div><div class="citationInfo"><span class="NLM_cas:title">Acta Crystallographica, Section D: Biological Crystallography</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">355-367</span>CODEN:
                <span class="NLM_cas:coden">ABCRE6</span>;
        ISSN:<span class="NLM_cas:issn">0907-4449</span>.
    
            (<span class="NLM_cas:orgname">International Union of Crystallography</span>)
        </div><div class="casAbstract">This paper describes various components of the macromol. crystallog. refinement program REFMAC5, which is distributed as part of the CCP4 suite.  REFMAC5 utilizes different likelihood functions depending on the diffraction data employed (amplitudes or intensities), the presence of twinning and the availability of SAD/SIRAS exptl. diffraction data.  To ensure chem. and structural integrity of the refined model, REFMAC5 offers several classes of restraints and choices of model parameterization.  Reliable models at resolns. at least as low as 4 Å can be achieved thanks to low-resoln. refinement tools such as secondary-structure restraints, restraints to known homologous structures, automatic global and local NCS restraints, 'jelly-body' restraints and the use of novel long-range restraints on at. displacement parameters (ADPs) based on the Kullback-Leibler divergence.  REFMAC5 addnl. offers TLS parameterization and, when high-resoln. data are available, fast refinement of anisotropic ADPs.  Refinement in the presence of twinning is performed in a fully automated fashion.  REFMAC5 is a flexible and highly optimized refinement package that is ideally suited for refinement across the entire resoln. spectrum encountered in macromol. crystallog.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5Jq-i2qIq5rVg90H21EOLACvtfcHk0lij2N-jLeGZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXktFWqtbk%253D&md5=f8f3202d246908500057ad7c71015b7b</span></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1107%2FS0907444911001314&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1107%252FS0907444911001314%26sid%3Dliteratum%253Aachs%26aulast%3DMurshudov%26aufirst%3DG.%2BN.%26aulast%3DSkub%25C3%25A1k%26aufirst%3DP.%26aulast%3DLebedev%26aufirst%3DA.%2BA.%26aulast%3DPannu%26aufirst%3DN.%2BS.%26aulast%3DSteiner%26aufirst%3DR.%2BA.%26aulast%3DNicholls%26aufirst%3DR.%2BA.%26aulast%3DWinn%26aufirst%3DM.%2BD.%26aulast%3DLong%26aufirst%3DF.%26aulast%3DVagin%26aufirst%3DA.%2BA.%26atitle%3DREFMAC5%2520for%2520the%2520refinement%2520of%2520macromolecular%2520crystal%2520structures%26jtitle%3DActa%2520Crystallogr.%252C%2520Sect.%2520D%253A%2520Biol.%2520Crystallogr.%26date%3D2011%26volume%3D67%26spage%3D355%26epage%3D367%26doi%3D10.1107%2FS0907444911001314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Morisseau, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodrow, M. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newman, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wheelock, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowdy, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammock, B. D.</span></span> <span> </span><span class="NLM_article-title">Structural refinement of inhibitors of urea-based soluble epoxide hydrolases</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>63</i></span>,  <span class="NLM_fpage">1599</span>– <span class="NLM_lpage">1608</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(02)00952-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1016%2FS0006-2952%2802%2900952-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=12007563" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=63&publication_year=2002&pages=1599-1608&author=C.+Morisseauauthor=M.+H.+Goodrowauthor=J.+W.+Newmanauthor=C.+E.+Wheelockauthor=D.+L.+Dowdyauthor=B.+D.+Hammock&title=Structural+refinement+of+inhibitors+of+urea-based+soluble+epoxide+hydrolases&doi=10.1016%2FS0006-2952%2802%2900952-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">Structural refinement of inhibitors of urea-based soluble epoxide hydrolases</span></div><div class="casAuthors">Morisseau, Christophe; Goodrow, Marvin H.; Newman, John W.; Wheelock, Craig E.; Dowdy, Deanna L.; Hammock, Bruce D.</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">63</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">1599-1608</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">The sol. epoxide hydrolase (sEH) is involved in the metab. of arachidonic, linoleic, and other fatty acid epoxides, endogenous chem. mediators that play an important role in blood pressure regulation and inflammation. 1,3-Disubstituted ureas, carbamates, and amides are new potent and stable inhibitors of sEH.  However, the poor soly. of the lead compds. limits their use.  Inhibitor structure-activity relationships were investigated to better define the structural requirements for inhibition and to identify points in the mol. topog. that could accept polar groups without diminishing inhibition potency.  Results indicate that lipophilicity is an important factor controlling inhibitor potency.  Polar groups could be incorporated into one of the alkyl groups without loss of activity if they were placed at a sufficient distance from the urea function.  The resulting compds. had a 2-fold higher water soly.  These findings will facilitate the rational design and optimization of sEH inhibitors with better phys. properties.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrCZUVkekez5rVg90H21EOLACvtfcHk0lij2N-jLeGZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XjsVSksbc%253D&md5=9d9aa4d7254d7fe156719d17fb80e0ad</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2802%2900952-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252802%252900952-8%26sid%3Dliteratum%253Aachs%26aulast%3DMorisseau%26aufirst%3DC.%26aulast%3DGoodrow%26aufirst%3DM.%2BH.%26aulast%3DNewman%26aufirst%3DJ.%2BW.%26aulast%3DWheelock%26aufirst%3DC.%2BE.%26aulast%3DDowdy%26aufirst%3DD.%2BL.%26aulast%3DHammock%26aufirst%3DB.%2BD.%26atitle%3DStructural%2520refinement%2520of%2520inhibitors%2520of%2520urea-based%2520soluble%2520epoxide%2520hydrolases%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2002%26volume%3D63%26spage%3D1599%26epage%3D1608%26doi%3D10.1016%2FS0006-2952%2802%2900952-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibli, S.-I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wittig, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zukunft, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammes, H.-P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popp, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fleming, I.</span></span> <span> </span><span class="NLM_article-title">Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity</span>. <i>J. Clin. Invest.</i> <span class="NLM_year" style="font-weight: bold;">2019</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">5204</span>– <span class="NLM_lpage">5218</span>, <span class="refDoi"> DOI: 10.1172/JCI123835</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=10.1172%2FJCI123835" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=31479425" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;key=1%3ACAS%3A528%3ADC%252BB3cXnsFKgtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2019&pages=5204-5218&author=J.+Huauthor=S.-I.+Bibliauthor=J.+Wittigauthor=S.+Zukunftauthor=J.+Linauthor=H.-P.+Hammesauthor=R.+Poppauthor=I.+Fleming&title=Soluble+epoxide+hydrolase+promotes+astrocyte+survival+in+retinopathy+of+prematurity&doi=10.1172%2FJCI123835"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Soluble epoxide hydrolase promotes astrocyte survival in retinopathy of prematurity</span></div><div class="casAuthors">Hu, Jiong; Bibli, Sofia-Iris; Wittig, Janina; Zukunft, Sven; Lin, Jihong; Hammes, Hans-Peter; Popp, Ruediger; Fleming, Ingrid</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Clinical Investigation</span>
        (<span class="NLM_cas:date">2019</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5204-5218</span>CODEN:
                <span class="NLM_cas:coden">JCINAO</span>;
        ISSN:<span class="NLM_cas:issn">1558-8238</span>.
    
            (<span class="NLM_cas:orgname">American Society for Clinical Investigation</span>)
        </div><div class="casAbstract">Polyunsatd. fatty acids such as docosahexaenoic acid (DHA) pos. affect the outcome of retinopathy of prematurity (ROP).  Given that DHA metab. by cytochrome P 450 and sol. epoxide hydrolase (sEH) enzymes affects retinal angiogenesis and vascular stability, we investigated the role of sEH in a mouse model of ROP.  In WT mice, hyperoxia elicited tyrosine nitration and inhibition of sEH and decreased generation of the DHA-derived diol 19,20-dihydroxydocosapentaenoic acid (19,20-DHDP).  Correspondingly, in a murine model of ROP, sEH-/- mice developed a larger central avascular zone and peripheral pathol. vascular tuft formation than did their WT littermates.  Astrocytes were the cells most affected by sEH deletion, and hyperoxia increased astrocyte apoptosis.  In rescue expts., 19,20-DHDP prevented astrocyte loss by targeting the mitochondrial membrane to prevent the hyperoxia-induced dissocn. of presenilin-1 and presenilin-1-assocd. protein to attenuate poly ADP-ribose polymerase activation and mitochondrial DNA damage.  Therapeutic intravitreal administration of 19,20-DHDP not only suppressed astrocyte loss, but also reduced pathol. vascular tuft formation in sEH-/- mice.  Our data indicate that sEH activity is required for mitochondrial integrity and retinal astrocyte survival in ROP.  Moreover, 19,20-DHDP may be more effective than DHA as a nutritional supplement for preventing retinopathy in preterm infants.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqcPDSRyJnLCrVg90H21EOLACvtfcHk0lij2N-jLeGZUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BB3cXnsFKgtbk%253D&md5=848c1304d37ff3b60f223e2137ea54f0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1172%2FJCI123835&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1172%252FJCI123835%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DJ.%26aulast%3DBibli%26aufirst%3DS.-I.%26aulast%3DWittig%26aufirst%3DJ.%26aulast%3DZukunft%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DJ.%26aulast%3DHammes%26aufirst%3DH.-P.%26aulast%3DPopp%26aufirst%3DR.%26aulast%3DFleming%26aufirst%3DI.%26atitle%3DSoluble%2520epoxide%2520hydrolase%2520promotes%2520astrocyte%2520survival%2520in%2520retinopathy%2520of%2520prematurity%26jtitle%3DJ.%2520Clin.%2520Invest.%26date%3D2019%26volume%3D129%26spage%3D5204%26epage%3D5218%26doi%3D10.1172%2FJCI123835" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VJI" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3VJI','PDB','3VJI'); return false;">PDB: 3VJI</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TSG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6TSG','PDB','6TSG'); return false;">PDB: 6TSG</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FR2" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=6FR2','PDB','6FR2'); return false;">PDB: 6FR2</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7G" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7G','PDB','7A7G'); return false;">PDB: 7A7G</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7H" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7H','PDB','7A7H'); return false;">PDB: 7A7H</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i44"><a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02063">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_88147"></div></div></div></div></div><hr /></hr><p class="last">The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jmedchem.0c02063?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jmedchem.0c02063</a>.<ul id="rightTab-silist" class="NLM_list-list_type-label"><li><p class="inline">Electropherograms for determination of enantiomeric excess, data collection, and refinement statistics (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_001.pdf">PDF</a>)</p></li><li><p class="inline">Molecular formula strings (<a class="ext-link" href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_002.csv">CSV</a>)</p></li></ul></p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_001.pdf">jm0c02063_si_001.pdf (463.02 kb)</a></li><li><a class="suppl-anchor" href="/doi/suppl/10.1021/acs.jmedchem.0c02063/suppl_file/jm0c02063_si_002.csv">jm0c02063_si_002.csv (0.22 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">Atomic coordinates and experimental details for all new crystal structures will be released from the Protein Data Bank upon article publication: sEH in complex with (<i>R</i>)-<b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7G">7A7G</a>), PPARγ in complex with (<i>R</i>)-<b>3</b> (<a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=7A7H">7A7H</a>).</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.0c02063&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.0c02063%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2021.64.issue-5%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.0c02063" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"679aa6daaf803da0","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
